"antitubercular drugs. this classification denotes drugs used in the treatment of tuberculosis, any of the infectious diseases of man and other animals caused by species of mycobacterium. such drugs are divided into two main classes: first-line agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and second-line drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.. . "
"antitubercular drugs. this classification denotes drugs used in the treatment of tuberculosis, any of the infectious diseases of man and other animals caused by species of mycobacterium. such drugs are divided into two main classes: first-line agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and second-line drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.. ethambutol. this classification denotes an antitubercular agent with the molecular formula c10h24n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8g167061qz, chemically known as 2,2-(1,2-ethylenediimino)-di-1-butanol but generally known as ethambutol, which bears us nih compound identifier 3279. european medicines agency schedules ethambutol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07271mig. the term ethambutol is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules ethambutol in its anatomical therapeutic chemical (atc) classification. ethambutol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ethambutol under hs 29221980 and sitc 51461. as of q4 2014, ethambutol remains the us fda preferred term for this commodity. ethambutol bears us nlm identifiers umls id c0014964 and nci concept code c61755. smiles: ccc(co)nccnc(cc)co.. "
"antitubercular drugs. this classification denotes drugs used in the treatment of tuberculosis, any of the infectious diseases of man and other animals caused by species of mycobacterium. such drugs are divided into two main classes: first-line agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and second-line drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.. isoniazid. this classification denotes an antitubercular agent with the molecular formula c6h7n3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier v83o1voz8l, chemically known as 4-pyridinecarboxylic acid, hydrazide but generally known as isoniazid, which bears us nih compound identifier 3767. european medicines agency schedules isoniazid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08326mig. the term isoniazid is an international non-proprietary name. world health organization schedules isoniazid in its anatomical therapeutic chemical (atc) classification. isoniazid is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule isoniazid under hs 29333999 and sitc 51574. as of q4 2014, isoniazid remains the us fda preferred term for this commodity. isoniazid bears us nlm identifiers umls id c0022209 and nci concept code c600. smiles: o=c(nn)c1ccncc1.. "
"antitubercular drugs. this classification denotes drugs used in the treatment of tuberculosis, any of the infectious diseases of man and other animals caused by species of mycobacterium. such drugs are divided into two main classes: first-line agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and second-line drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.. amithiozone or thiacetazone. this classification denotes an antitubercular agent with the molecular formula c10h12n4os, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier mmg78x7ssr, chemically known as acetanilide, 4-formyl-, thiosemicarbazone but generally known as amithiozone, which bears us nih compound identifier 2733749. amithiozone most often comes in base and thiacetazone forms. the term amithiozone is an international non-proprietary name. amithiozone or thiacetazone bears us nlm identifiers umls id c0878231 and nci concept code c90769. smiles: cc(=o)nc1=cc=c(c=c1)c=nnc(=s)n.. "
"antitubercular drugs. this classification denotes drugs used in the treatment of tuberculosis, any of the infectious diseases of man and other animals caused by species of mycobacterium. such drugs are divided into two main classes: first-line agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and second-line drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.. pyrazinamide. this classification denotes an antitubercular agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2kni5n06ti. european medicines agency schedules pyrazinamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10163mig. pyrazinamide generally arises in the molecular formula c5h5n3o. the term pyrazinamide is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4.) pyrazinamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pyrazinamide under hs 29339990 and sitc 51577. as of q4 2014, pyrazinamide remains the us fda preferred term for this commodity. pyrazinamide bears us nlm identifiers umls id c0034239 and nci concept code c29395. smiles: o=c(n)c1nccnc1.. "
"antitubercular drugs. this classification denotes drugs used in the treatment of tuberculosis, any of the infectious diseases of man and other animals caused by species of mycobacterium. such drugs are divided into two main classes: first-line agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and second-line drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.. protionamide. this classification denotes an antitubercular agent with the molecular formula c9h12n2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 76yoo33643, chemically known as 4-pyridinecarbothioamide, 2-propyl- (9ci) but generally known as protionamide, which bears us nih compound identifier 666418. european medicines agency schedules protionamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10141mig. the term protionamide is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7). world health organization schedules protionamide in its anatomical therapeutic chemical (atc) classification. protionamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule protionamide under hs 29333999 and sitc 51574. as of q4 2014, protionamide remains the us fda preferred term for this commodity. protionamide bears us nlm identifiers umls id c0033705 and nci concept code c72605. smiles: s=c(n)c1cc(ncc1)ccc.. "
"antitubercular drugs. this classification denotes drugs used in the treatment of tuberculosis, any of the infectious diseases of man and other animals caused by species of mycobacterium. such drugs are divided into two main classes: first-line agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and second-line drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.. aminosalicylic acid. this classification denotes an antitubercular agent with the molecular formula c7h7no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5b2658e0n2, chemically known as 6018-19-5 (monosodium, dihydrate) but generally known as aminosalicylic acid, which bears us nih compound identifier 4649. european medicines agency schedules aminosalicylic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12862mig. world health organization schedules aminosalicylic acid in its anatomical therapeutic chemical (atc) classification. as of q4 2014, aminosalicylic acid remains the us fda preferred term for this commodity. aminosalicylic acid bears us nlm identifiers umls id c0030125 and nci concept code c47394. smiles: oc1c(ccc(n)c1)c(=o)o.. "
"antitubercular drugs. this classification denotes drugs used in the treatment of tuberculosis, any of the infectious diseases of man and other animals caused by species of mycobacterium. such drugs are divided into two main classes: first-line agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and second-line drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.. ethionamide. this classification denotes an antitubercular agent with the molecular formula c8h10n2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier oay8ors3cq, chemically known as cyclohexanol, 1-ethynyl-, carbamate but generally known as ethionamide, which bears us nih compound identifier 3284. european medicines agency schedules ethionamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07278mig. the term ethionamide is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules ethionamide in its anatomical therapeutic chemical (atc) classification. ethionamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ethionamide under hs 29333999 and sitc 51574. as of q4 2014, ethionamide remains the us fda preferred term for this commodity. ethionamide bears us nlm identifiers umls id c0733402 and nci concept code c47522. smiles: o(c1(ccccc1)c#c)c(=o)n.. "
"antitubercular drugs. this classification denotes drugs used in the treatment of tuberculosis, any of the infectious diseases of man and other animals caused by species of mycobacterium. such drugs are divided into two main classes: first-line agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and second-line drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.. morinamide or morphazinamide or morinamid. this classification denotes an antitubercular agent with the molecular formula c10h14n4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8cfl28pa3w, chemically known as pyrazinecarboxamide, n-(morpholinomethyl)- but generally known as morinamide, which bears us nih compound identifier 70374. european medicines agency schedules morinamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09067mig. the term morinamide is an international non-proprietary name. world health organization schedules morinamide in its anatomical therapeutic chemical (atc) classification. morinamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: c1coccn1cnc(=o)c2=nc=cn=c2.. "
"antitubercular drugs. this classification denotes drugs used in the treatment of tuberculosis, any of the infectious diseases of man and other animals caused by species of mycobacterium. such drugs are divided into two main classes: first-line agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and second-line drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.. terizidone. this classification denotes an antitubercular agent with the molecular formula c14h14n4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1199lex5n8, chemically known as 4,4-(p-phenylenebis(methyleneamino))di-(isoxazolidin-3-one) but generally known as terizidone, which bears us nih compound identifier 65720. european medicines agency schedules terizidone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15487mig. the term terizidone is an international non-proprietary name. world health organization schedules terizidone in its anatomical therapeutic chemical (atc) classification. terizidone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule terizidone under hs 29349990 and sitc 51579. as of q4 2014, terizidone remains the us fda preferred term for this commodity. terizidone bears us nlm identifiers umls id c0145184 and nci concept code c90772. smiles: o1nc(=o)c(/n=c/c2ccc(/c=n/c3conc3=o)cc2)c1.. "
"antitubercular drugs. this classification denotes drugs used in the treatment of tuberculosis, any of the infectious diseases of man and other animals caused by species of mycobacterium. such drugs are divided into two main classes: first-line agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and second-line drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.. tiocarlide. this classification denotes an antitubercular agent, thiourea isoxyl, and phenylthiourea analog with the molecular formula c23h32n2o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 43m23x81y2, chemically known as 4,4-diisoamyloxythiocarbanilide but generally known as tiocarlide, which bears us nih compound identifier 3001386. european medicines agency schedules tiocarlide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11078mig. world health organization schedules tiocarlide in its anatomical therapeutic chemical (atc) classification. tiocarlide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tiocarlide under hs 29309085 and sitc 51549. as of q4 2014, tiocarlide remains the us fda preferred term for this commodity. smiles: s=c(nc1ccc(occc(c)c)cc1)nc1ccc(occc(c)c)cc1.. "
"antitubercular drugs. this classification denotes drugs used in the treatment of tuberculosis, any of the infectious diseases of man and other animals caused by species of mycobacterium. such drugs are divided into two main classes: first-line agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and second-line drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.. ethambutol dihydrochloride. this classification denotes an antitubercular agent with the molecular formula c10h24n2o2.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier qe4vw5fo07, chemically known as 1-butanol, 2,2(1,2-ethanediyldiimino)bis-, dihydrochloride, (-(r*,r*)), but more generally known as ethambutol dihydrochloride, which bears us nih compound identifier 3279. european medicines agency schedules ethambutol dihydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07271mig. most nations, for tariff purposes, schedule ethambutol dihydrochloride under hs 29221980. smiles: cc[c@@h](co)nccn[c@@h](cc)co.cl.cl.. "
"antitubercular drugs. this classification denotes drugs used in the treatment of tuberculosis, any of the infectious diseases of man and other animals caused by species of mycobacterium. such drugs are divided into two main classes: first-line agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and second-line drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.. verazide. this classification denotes an antitubercular agent with the molecular formula c15h15n3o3, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier xo8d6i4i5l, chemically known as 3,4-dimethoxybenzal isonicotinoylhydrazone but more generally known as verazide, which bears u.s. national institutes of health compound identifier 162228. the european medicines agency schedules verazide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00039mig. the term verazide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 13, no. 12, 1959, list 3). verazide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: o(c1c(oc)ccc(c1)/c=n/nc(=o)c1ccncc1)c.. "
"antitubercular drugs. this classification denotes drugs used in the treatment of tuberculosis, any of the infectious diseases of man and other animals caused by species of mycobacterium. such drugs are divided into two main classes: first-line agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and second-line drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.. ethambutol hydrochloride. this classification denotes an antitubercular agent with the molecular formula c10h24n2o2.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier qe4vw5fo07, chemically known as 2,2-(1,2-ethylenediimino)-di-1-butanol but more generally known as ethambutol hydrochloride, which bears us nih compound identifier 3279. european medicines agency schedules ethambutol hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11945mig. most nations, for tariff and trade purposes, schedule ethambutol hydrochloride under hs 29221980. as of q4 2014, ethambutol hydrochloride remains us fdas preferred term for this commodity. ethambutol hydrochloride bears us nlm identifiers umls id c0026895 and nci concept code c29033. smiles: cc[c@@h](co)nccn[c@@h](cc)co.cl.cl.. "
"antitubercular drugs. this classification denotes drugs used in the treatment of tuberculosis, any of the infectious diseases of man and other animals caused by species of mycobacterium. such drugs are divided into two main classes: first-line agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and second-line drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.. isoniazid calcium pyruvate. this classification denotes an antitubercular agent with the molecular formula 2c9h8n3o3.ca, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m4q640072z, chemically known as isonicotinic acid, (1-carboxyethylidene)hydrazide calcium salt (2:1), but more generally known as isoniazid calcium pyruvate, which bears us nih compound identifier 9568684. european medicines agency schedules isoniazid calcium pyruvate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08326mig. most nations, for tariff purposes, schedule isoniazid calcium pyruvate under hs 29333999. smiles: cc(=nnc(=o)c1ccncc1)c(=o)[o-].cc(=nnc(=o)c1ccncc1)c(=o)[o-].[ca+2].. "
"antitubercular drugs. this classification denotes drugs used in the treatment of tuberculosis, any of the infectious diseases of man and other animals caused by species of mycobacterium. such drugs are divided into two main classes: first-line agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and second-line drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.. isoniazid methanesulfonate. this classification denotes an antitubercular agent with the molecular formula c7h9n3o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier gn8s7zes0f, chemically known as isonicotinic acid 2-(sulfomethyl)hydrazine, but more generally known as isoniazid methanesulfonate, which bears us nih compound identifier 3769. european medicines agency schedules isoniazid methanesulfonate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08326mig. most nations, for tariff purposes, schedule isoniazid methanesulfonate under hs 29333999. smiles: c1cnccc1c(=o)nncs(=o)(=o)o.. "
"antitubercular drugs. this classification denotes drugs used in the treatment of tuberculosis, any of the infectious diseases of man and other animals caused by species of mycobacterium. such drugs are divided into two main classes: first-line agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and second-line drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.. morinamide hydrochloride. this classification denotes an antitubercular agent c10h14n4o2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2f6f46t9yc, chemically known as 2-pyrazinecarboxamide, n-(4-morpholinylmethyl)-, hydrochloride (1:1), but more generally known as morinamide hydrochloride, which bears us nih compound identifier 164837. european medicines agency schedules morinamide hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03330mig. most nations, for tariff and trade purposes, schedule morinamide hydrochloride under hs 29349990 and sitc 51579. as of q4 2014, morinamide hydrochloride remains us fdas preferred term for this commodity. smiles: c1cnc(cn1)c(=o)ncn2ccocc2.cl.. "
"antitubercular drugs. this classification denotes drugs used in the treatment of tuberculosis, any of the infectious diseases of man and other animals caused by species of mycobacterium. such drugs are divided into two main classes: first-line agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and second-line drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.. fenamisal. this classification denotes an antitubercular agent with the molecular formula c13h11no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 52936sip7v, chemically known as salicylic acid, 4-amino-, phenyl ester (8ci) but more generally known as fenamisal, which bears us nih compound identifier 8609. european medicines agency schedules fenamisal in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07538mig. the term fenamisal is an international non-proprietary name. fenamisal is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: o(c(=o)c1c(o)cc(n)cc1)c1ccccc1.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. . "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. bluensomycin. this classification denotes an aminoglycoside antibiotic with the molecular formula c21h39n5o14, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier lwv7pwe57u, chemically known as d-scyllo-inositol, o-2-deoxy-2-(methylamino)-alpha-l-glucopyranosyl-(1=>2)-o-5-deoxy-3-c-(hydroxymethyl)-alpha-l-lyxofuranosyl-(1=>2)-1-((aminoiminomethyl)amino)-1-deoxy-, 5-carbamate but generally known as bluensomycin, which bears us nih compound identifier 65603. bluensomycin most often comes in base and sulfate forms. the term bluensomycin is an international non-proprietary name. bluensomycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bluensomycin under hs 29412080 and sitc 54132. as of q4 2014, bluensomycin remains the us fda preferred term for this commodity. bluensomycin bears us nlm identifiers umls id c0053859 and nci concept code c90636. smiles: cc1c(c(c(o1)oc2c(c(c(c(c2o)o)oc(=o)n)o)n=c(n)n)oc3c(c(c(c(o3)co)o)o)nc)(co)o.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. spectinomycin. this classification denotes an aminoglycoside antibiotic with the molecular formula c14h24n2o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 93aki1u6qf, chemically known as 4h-pyrano(2,3-b)(1,4)benzodioxin-4-one, decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)- but generally known as spectinomycin, which bears us nih compound identifier 2021. european medicines agency schedules spectinomycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10614mig. the term spectinomycin is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules spectinomycin in its anatomical therapeutic chemical (atc) classification. spectinomycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule spectinomycin under hs 29419000 and sitc 54139. as of q4 2014, spectinomycin remains the us fda preferred term for this commodity. spectinomycin bears us nlm identifiers umls id c0001268 and nci concept code c61951. smiles: o1c2c(oc3oc(cc(=o)c13o)c)c(o)c(nc)c(o)c2nc.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. apramycin. this classification denotes an antibiotic with the molecular formula c21h41n5o11, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 388k3tr36z, chemically known as 4-o-((8r)-2-amino-8-o-(4-amino-4-deoxy-alpha-d-glucopyranosyl)-2,3,7-trideoxy-7-(methylamino)-d-glycero-alpha-d-allo-octodialdo-1,5:8,4-dipyranos-1-yl)-2-deoxy-d-streptamine but generally known as apramycin, which bears us nih compound identifier 71428. apramycin most often comes in base and sulphate forms. european medicines agency schedules apramycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05540mig. the term apramycin is an international non-proprietary name or inn (see who inn reference publication, volume 33, no. 10 1979, list 19). apramycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule apramycin under hs 29419000 and sitc 54139. as of q4 2014, apramycin remains the us fda preferred term for this commodity. apramycin bears us nlm identifiers umls id c0052231 and nci concept code c78789. smiles: o1c2c(oc(oc3oc(c(n)c(o)c3o)co)c(nc)c2o)cc(n)c1oc1c(n)cc(n)c(o)c1o.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. arbekacin. this classification denotes an aminoglycoside antibiotic with the molecular formula c22h44n6o10, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g7v6sli20l, chemically known as o-3-amino-3-deoxy-alpha-d-glucopyranosyl-(1->4)-o-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-d-erythro-hexopyranosyl-(1->6))-n-((2s)-4-amino-2-hydroxybutyryl)-2-deoxy-l-streptamine but generally known as arbekacin, which bears us nih compound identifier 68682. arbekacin most often comes in base and sulfate forms. european medicines agency schedules arbekacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05554mig. the term arbekacin is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). world health organization schedules arbekacin in its anatomical therapeutic chemical (atc) classification. arbekacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule arbekacin under hs 29419000 and sitc 54139. as of q4 2014, arbekacin remains the us fda preferred term for this commodity. arbekacin bears us nlm identifiers umls id c0062073 and nci concept code c76145. smiles: o(c1c(nc(=o)c(o)ccn)cc(n)c(oc2oc(ccc2n)cn)c1o)c1oc(c(o)c(n)c1o)co.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. bekanamycin. this classification denotes an aminoglycoside antibiotic with the molecular formula c18h37n5o10, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 15jt14c3gi chemically known as (1r,2s,3s,4r,6s)-4,6-diamino-3-((3-amino-3-deoxy-.alpha.-d-glucopyranosyl)oxy)-2-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-.alpha.-d-glucopyranoside but generally known as bekanamycin, which bears us nih compound identifier 816. european medicines agency schedules bekanamycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05684mig. the term bekanamycin is an international non-proprietary name or inn (see who inn reference publication, volume 25 , no. 10 1971, list 11. ). most nations schedule bekanamycin under hs 29419000 and sitc 54139. as of q4 2014, bekanamycin remains the us fda preferred term for this commodity. bekanamycin bears us nlm identifiers umls id c0053076 and nci concept code c65248. smiles: c1c(c(c(c(c1n)oc2c(c(c(c(o2)co)o)n)o)o)oc3c(c(c(c(o3)cn)o)o)n)n.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. betamicin. this classification denotes an aminoglycoside antibiotic with the molecular formula c19h38n4o10, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 67w9dgg4c7 chemically known as d-streptamine, o-6-amino-6-deoxy-.alpha.-d-glucopyranosyl-(1->4)-o-(3-deoxy-4-c-methyl-3-(methylamino)-.beta.-l-arabinopyranosyl-(1->6))-2-deoxy- but generally known as betamicin, which bears us nih compound identifier 37569. european medicines agency schedules betamicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05799mig. the term betamicin is an international non-proprietary name or inn. most nations schedule betamicin under hs 29419000 and sitc 54139. as of q4 2014, betamicin remains the us fda preferred term for this commodity. betamicin bears us nlm identifiers umls id c0061208 and nci concept code c81375. smiles: o(c1c(o)c(oc2oc(c(o)c(o)c2o)cn)c(n)cc1n)c1occ(o)(c(nc)c1o)c.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. gentamicin. this classification denotes an aminoglycoside antibiotic with the molecular formula c21h43n5o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t6z9v48ikg, more generally known as gentamicin. european medicines agency schedules gentamicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02326mig. the term gentamicin is an international non-proprietary name or inn. gentamicin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule gentamicin under hs 29419000 and sitc 54139. as of q4 2014, gentamicin remains the us fda preferred term for this commodity. gentamicin bears us nlm identifiers umls id c0017436 and nci concept code c519. smiles: cc(c1ccc(c(o1)oc2c(cc(c(c2o)oc3c(c(c(co3)(c)o)nc)o)n)n)n)nc.*.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. butikacin. this classification denotes an aminoglycoside antibiotic with the molecular formula c22h45n5o12, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier i61243pdcc, chemically known as uk-18,892 but generally known as butikacin, which bears us nih compound identifier 65487. european medicines agency schedules butikacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06017mig. the term butikacin is an international non-proprietary name or inn (see who inn reference publication, volume 33, no. 10 1979, list 19). butikacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule butikacin under hs 29419000 and sitc 54139. as of q4 2014, butikacin remains the us fda preferred term for this commodity. butikacin bears us nlm identifiers umls id c0054256 and nci concept code c90637. smiles: o(c1c(ncc(o)ccn)cc(n)c(oc2oc(c(o)c(o)c2o)cn)c1o)c1oc(c(o)c(n)c1o)co.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. daptomycin. this classification denotes an aminoglycoside antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier nwq5n31vkk. european medicines agency schedules daptomycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06910mig. daptomycin generally arises in the molecular formula c72h101n17o26. the term daptomycin is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29.) daptomycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule daptomycin under hs 29419000 and sitc 54139. as of q4 2014, daptomycin remains the us fda preferred term for this commodity. daptomycin bears us nlm identifiers umls id c0057144 and nci concept code c47470. smiles: o1c(c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)ccccccccc)cc2c3c([nh]c2)cccc3)cc(=o)n)cc(=o)o)c(=o)ncc(=o)nc(cccn)c(=o)nc(cc(=o)o)c(=o)nc(c(=o)nc(c(=o)ncc(=o)nc(c(=o)nc(c(cc(=o)o)c)c(=o)nc(cc(=o)c2c(n)cccc2)c1=o)co)cc(=o)o)c)c.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. dibekacin. this classification denotes an aminoglycoside antibiotic with the molecular formula c18h37n5o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 45zfo9e525, chemically known as 3,4-dideoxykanamycin b but generally known as dibekacin, which bears us nih compound identifier 3021. european medicines agency schedules dibekacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07072mig. the term dibekacin is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15). world health organization schedules dibekacin in its anatomical therapeutic chemical (atc) classification. dibekacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dibekacin under hs 29419000 and sitc 54139. as of q4 2014, dibekacin remains the us fda preferred term for this commodity. dibekacin bears us nlm identifiers umls id c0012024 and nci concept code c79114. smiles: o(c1c(o)c(oc2oc(ccc2n)cn)c(n)cc1n)c1oc(c(o)c(n)c1o)co.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. dihydrostreptomycin. this classification denotes an aminoglycoside antibiotic with the molecular formula c21h41n7o12, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier p2i6r8w6ua, chemically known as streptomycin, dihydro- but generally known as dihydrostreptomycin, which bears us nih compound identifier 31406. european medicines agency schedules dihydrostreptomycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07140mig. world health organization schedules dihydrostreptomycin in its anatomical therapeutic chemical (atc) classification. as of q4 2014, dihydrostreptomycin remains the us fda preferred term for this commodity. dihydrostreptomycin bears us nlm identifiers umls id c0262967 and nci concept code c61724. smiles: o(c1oc(c(o)(c1oc1oc(c(o)c(o)c1nc)co)co)c)c1c(/n=c(/n)n)c(o)c(/n=c(/n)n)c(o)c1o.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. elsamicin a or elsamitrucin. this classification denotes a topoisomerase-ii inhibitor and miscellaneous antineoplastic antibiotic with the molecular formula c33h35no13, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ztv0fob6nu, chemically known as 2-amino-2,6-dideoxy-3-o-methyl-d-galactose but generally known as elsamitrucin, which bears us nih compound identifier 5362259. european medicines agency schedules elsamitrucin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06493mig. the term elsamitrucin is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). elsamitrucin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. elsamicin a or elsamitrucin bears us nlm identifiers umls id c0059041 and nci concept code c1080. smiles: o(c1c(o)(c(o)c(oc1oc1c2c(c(o)c3c4c2oc(=o)c2c4c(oc3=o)ccc2c)ccc1)c)c)c1oc(c(o)c(oc)c1n)c.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. framycetin. this classification denotes an aminoglycoside antibiotic with the molecular formula c23h46n6o13, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4boc774388, chemically known as d-streptamine, o-2,6-diamino-2,6-dideoxy-alpha-d-glucopyranosyl-(1-4)-o-(o-2,6-diamino-2,6-dideoxy-beta-l-idopyranosyl-(1-3)-beta-d-ribofuranosyl-(1-5))-2-deoxy- but generally known as framycetin, which bears us nih compound identifier 8378. european medicines agency schedules framycetin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07814mig. the term framycetin is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17). world health organization schedules framycetin in its anatomical therapeutic chemical (atc) classification. framycetin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule framycetin under hs 29419000 and sitc 54139. as of q4 2014, framycetin remains the us fda preferred term for this commodity. framycetin bears us nlm identifiers umls id c0016673 and nci concept code c65770. smiles: o(c1c(oc2oc(c(o)c(o)c2n)cn)c(n)cc(n)c1o)c1oc(c(oc2oc(c(o)c(o)c2n)cn)c1o)co.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. netilmicin. this classification denotes an aminoglycoside antibiotic with the molecular formula c21h41n5o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4o5j85gjjb, chemically known as o-(2,6-diamino-2,3,4,6-tetradesoxy-alpha-glycero-4-hexenopyranosyl-(1-4)-o-(3-desoxy-4-c-methyl-3-methylamino-beta-l-arabinopyranosyl-(1-6)-2-desoxy-n1-ethyl-d-streptamin but generally known as netilmicin, which bears us nih compound identifier 41859. european medicines agency schedules netilmicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09210mig. the term netilmicin is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17). world health organization schedules netilmicin in its anatomical therapeutic chemical (atc) classification. netilmicin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule netilmicin under hs 29419000 and sitc 54139. as of q4 2014, netilmicin remains the us fda preferred term for this commodity. netilmicin bears us nlm identifiers umls id c0027780 and nci concept code c66236. smiles: o(c1c(ncc)cc(n)c(oc2oc(=ccc2n)cn)c1o)c1occ(o)(c(nc)c1o)c.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. isepamicin. this classification denotes an aminoglycoside antibiotic with the molecular formula c22h43n5o12, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g7k224460p, chemically known as (s)-o-6-amino-6-deoxy-alpha-d-glucopyranosyl-(1.4)-o-(3-deoxy-4-c-methyl-3-(methylamino)-beta-l-arabinopyranosyl-(1.6))-1,3-diamino-n1-(3-aminolactoyl)-1,2,3-trideoxy-d-scyllo-inositol but generally known as isepamicin, which bears us nih compound identifier 3755. european medicines agency schedules isepamicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08309mig. the term isepamicin is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). world health organization schedules isepamicin in its anatomical therapeutic chemical (atc) classification. isepamicin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule isepamicin under hs 29419000 and sitc 54139. as of q4 2014, isepamicin remains the us fda preferred term for this commodity. isepamicin bears us nlm identifiers umls id c0124008 and nci concept code c83838. smiles: o(c1c(nc(=o)c(o)cn)cc(n)c(oc2oc(c(o)c(o)c2o)cn)c1o)c1occ(o)(c(nc)c1o)c.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. kanamycin. this classification denotes an aminoglycoside antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ruc37xup2p. european medicines agency schedules kanamycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08362mig. kanamycin generally arises in the molecular formula c18h36n4o11. the term kanamycin is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4.) kanamycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule kanamycin under hs 29419000 and sitc 54139. as of q4 2014, kanamycin remains the us fda preferred term for this commodity. kanamycin bears us nlm identifiers umls id c0022487 and nci concept code c65997. smiles: c1c(c(c(c(c1n)oc2c(c(c(c(o2)cn)o)o)o)o)oc3c(c(c(c(o3)co)o)n)o)n.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. micronomicin. this classification denotes an aminoglycoside antibiotic with the molecular formula c20h41n5o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier s9az0r40qv, chemically known as o-2-amino-2,3,4,6-tetradeoxy-6-(methylamino)-a-d-erythro-hexopyranosyl-(1->4)-o-(3-deoxy-4-c-methyl-3-(methylamino)-beta-l-arabinopyranosyl-(1->6))-2-deoxy-d-streptamine but generally known as micronomicin, which bears us nih compound identifier 107677. european medicines agency schedules micronomicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08945mig. the term micronomicin is an international non-proprietary name. world health organization schedules micronomicin in its anatomical therapeutic chemical (atc) classification. micronomicin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule micronomicin under hs 29419000 and sitc 54139. as of q4 2014, micronomicin remains the us fda preferred term for this commodity. micronomicin bears us nlm identifiers umls id c0066520 and nci concept code c90638. smiles: o(c1c(o)c(oc2oc(ccc2n)cnc)c(n)cc1n)c1occ(o)(c(nc)c1o)c.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. neomycin. this classification denotes an aminoglycoside antibiotic with the molecular formula c23h46n6o13, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier i16qd7x297, more generally known as neomycin. european medicines agency schedules neomycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03406mig. the term neomycin is an international non-proprietary name or inn. see who inn reference publication, volume 32, no 10 1978, list 18. neomycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule neomycin under hs 29419000 and sitc 54139. as of q4 2014, neomycin remains the us fda preferred term for this commodity. neomycin bears us nlm identifiers umls id c0027603 and nci concept code c683. smiles: c1c(c(c(c(c1n)oc2c(c(c(c(o2)cn)o)o)n)oc3c(c(c(o3)co)oc4c(c(c(c(o4)cn)o)o)n)o)o)n.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. paromomycin. this classification denotes an aminoglycoside antibiotic with the molecular formula c23h45n5o14, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 61jjc8n5zk, chemically known as streptamine, o-2,6-diamino-2,6-dideoxy-beta-l-idopyranosyl-(1-3)-o-beta-d-ribofuranosyl-(1-5)-o-(2-amino-2-deoxy-alpha-d-glucopyranosyl-(1-4))-2-deoxy- but generally known as paromomycin, which bears us nih compound identifier 24176. european medicines agency schedules paromomycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09630mig. the term paromomycin is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules paromomycin in its anatomical therapeutic chemical (atc) classification. paromomycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule paromomycin under hs 29419000 and sitc 54139. as of q4 2014, paromomycin remains the us fda preferred term for this commodity. paromomycin bears us nlm identifiers umls id c0030576 and nci concept code c61878. smiles: o(c1c(oc2oc(c(o)c(o)c2n)co)c(n)cc(n)c1o)c1oc(c(oc2oc(c(o)c(o)c2n)cn)c1o)co.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. propikacin. this classification denotes an aminoglycoside antibiotic with the molecular formula c21h43n5o12, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9x6f5h479x, chemically known as uk 31,214 but generally known as propikacin, which bears us nih compound identifier 68557. european medicines agency schedules propikacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10107mig. the term propikacin is an international non-proprietary name. propikacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule propikacin under hs 29419000 and sitc 54139. as of q4 2014, propikacin remains the us fda preferred term for this commodity. propikacin bears us nlm identifiers umls id c0610191 and nci concept code c75063. smiles: o(c1c(nc(co)co)cc(n)c(oc2oc(c(o)c(o)c2n)cn)c1o)c1oc(c(o)c(n)c1o)co.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. ribostamycin. this classification denotes an aminoglycoside antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2q5jou7t53. european medicines agency schedules ribostamycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10300mig. ribostamycin generally arises in the molecular formula c17h34n4o10. the term ribostamycin is an international non-proprietary name or inn (see who inn reference publication, volume 26, no. 10 1972, list 12.) ribostamycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ribostamycin under hs 29419000 and sitc 54139. as of q4 2014, ribostamycin remains the us fda preferred term for this commodity. ribostamycin bears us nlm identifiers umls id c0035554 and nci concept code c90639. smiles: o(c1c(oc2oc(c(o)c2o)co)c(o)c(n)cc1n)c1oc(c(o)c(o)c1n)cn.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. sisomicin. this classification denotes an aminoglycoside antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x55xsl74yq. european medicines agency schedules sisomicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10538mig. sisomicin generally arises in the molecular formula c19h37n5o7. the term sisomicin is an international non-proprietary name or inn. sisomicin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sisomicin under hs 29419000 and sitc 54139. as of q4 2014, sisomicin remains the us fda preferred term for this commodity. sisomicin bears us nlm identifiers umls id c0037209 and nci concept code c72569. smiles: o(c1c(o)c(oc2oc(=ccc2n)cn)c(n)cc1n)c1occ(o)(c(nc)c1o)c.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. streptomycin. this classification denotes an aminoglycoside antibiotic with the molecular formula c21h39n7o12, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier y45qso73ob, chemically known as 2,4-diguanidino-3,5,6-trihydroxycyclohexyl 5-deoxy-2-o-(2-deoxy-2-methylamino-alpha-l-glucopyranosyl)-3-c-formyl-beta-l-lyxopentanofuranoside but generally known as streptomycin, which bears us nih compound identifier 5999. european medicines agency schedules streptomycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10656mig. world health organization schedules streptomycin in its anatomical therapeutic chemical (atc) classification. streptomycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule streptomycin under hs 29412080 and sitc 54132. as of q4 2014, streptomycin remains the us fda preferred term for this commodity. streptomycin bears us nlm identifiers umls id c0038425 and nci concept code c61952. smiles: o(c1c(/n=c(/n)n)c(o)c(/n=c(/n)n)c(o)c1o)c1oc(c(o)(c1oc1oc(c(o)c(o)c1nc)co)c=o)c.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. telavancin. this classification denotes an antibiotic with the molecular formula c80h106cl2n11o27p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier xk134822z0, chemically known as vancomycin, n3-(2-(decylamino)ethyl)-29-(((phosphonomethyl)amino)methyl)- but generally known as telavancin, which bears us nih compound identifier 3081362. european medicines agency schedules telavancin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub26698. the term telavancin is an international non-proprietary name or inn (see who inn reference publication, volume 19, no. 1, 2005, list 53). world health organization schedules telavancin in its anatomical therapeutic chemical (atc) classification. most nations schedule telavancin under hs 29419000 and sitc 54139. as of q4 2014, telavancin remains the us fda preferred term for this commodity. telavancin bears us nlm identifiers umls id c1453642 and nci concept code c87603. smiles: clc1c2oc3c(oc4oc(c(o)c(o)c4oc4oc(c(o)c(nccncccccccccc)(c4)c)c)co)c4oc5c(cl)cc(cc5)c(o)c(nc(=o)c(nc)cc(c)c)c(=o)nc(c(=o)nc(c(c3)c4)c(=o)nc3c(=o)nc(c(o)c(c1)cc2)c(=o)nc(c1c(c2cc3ccc2o)c(o)c(c(o)c1)cncp(=o)(o)o)c(=o)o)cc(=o)n.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. tobramycin. this classification denotes an aminoglycoside antibiotic with the molecular formula c18h37n5o9, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier vz8rrz51vk, chemically known as tobramycin, free base but generally known as tobramycin, which bears us nih compound identifier 5496. european medicines agency schedules tobramycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11134mig. the term tobramycin is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15). world health organization schedules tobramycin in its anatomical therapeutic chemical (atc) classification. tobramycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tobramycin under hs 29419000 and sitc 54139. as of q4 2014, tobramycin remains the us fda preferred term for this commodity. tobramycin bears us nlm identifiers umls id c0040341 and nci concept code c62082. smiles: o(c1c(o)c(oc2oc(c(o)cc2n)cn)c(n)cc1n)c1oc(c(o)c(n)c1o)co.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. amikacin. this classification denotes an aminoglycoside antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 84319sgc3c. european medicines agency schedules amikacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05431mig. amikacin generally arises in the molecular formula c22h43n5o13. the term amikacin is an international non-proprietary name or inn (see who inn reference publication, volume 28, no. 10 1974, list 14.) amikacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule amikacin under hs 29419000 and sitc 54139. as of q4 2014, amikacin remains the us fda preferred term for this commodity. amikacin bears us nlm identifiers umls id c0002499 and nci concept code c61615. smiles: o(c1c(nc(=o)c(o)ccn)cc(n)c(oc2oc(c(o)c(o)c2o)cn)c1o)c1oc(c(o)c(n)c1o)co.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. capreomycin. this classification denotes an antitubercular agent and aminoglycoside antibiotic with the molecular formula c19h30n12o6(r1)(r2), a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 232hyx66hc, more generally known as capreomycin. european medicines agency schedules capreomycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01028mig. the term capreomycin is an international non-proprietary name or inn. see who inn reference publication, volume 19 1975, list 5. capreomycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule capreomycin under hs 29419000 and sitc 54139. as of q4 2014, capreomycin remains the us fda preferred term for this commodity. capreomycin bears us nlm identifiers umls id c0262964 and nci concept code c72607. smiles: cc1c(=o)nc(c(=o)nc(=cnc(=o)n)c(=o)nc(c(=o)ncc(c(=o)n1)n)c2ccn=c(n2)n)cnc(=o)cc(cccn)n.c1cn=c(nc1c2c(=o)ncc(c(=o)nc(c(=o)nc(c(=o)nc(=cnc(=o)n)c(=o)n2)cnc(=o)cc(cccn)n)co)n)n.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. streptoduocin. this classification denotes an aminoglycoside antibiotic, european medicines agency schedules amikacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15402mig.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. astromicin. this classification denotes an aminoglycoside antibiotic with the molecular formula c17h35n5o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7jhd84h15j, chemically known as 2-amino-n-[(1s,2r,3r,4s,5s,6r)-4-amino-3-[(2r,3r,6s)-3-amino-6-(1-aminoethyl)tetrahydropyran-2-yl]oxy-2,5-dihydroxy-6-methoxy-cyclohexyl]-n-methyl-acetamide but generally known as astromicin, which bears us nih compound identifier 65345. european medicines agency schedules astromicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05587mig. most nations schedule astromicin under hs 29419000 and sitc 54139. as of q4 2014, astromicin remains the us fda preferred term for this commodity. astromicin bears us nlm identifiers umls id c0060685 and nci concept code c76146. smiles: cc(c1ccc(c(o1)oc2c(c(c(c(c2o)n(c)c(=o)cn)oc)o)n)n)n.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. viomycin. this classification denotes an antitubercular agent with the molecular formula c25h43n13o10, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, yvu35998k5 chemically known as glycine, 3-amino-n-((3s)-3,6-diamino-1-oxohexyl)-l-alanyl-l-seryl-l-seryl-(2z)-3-((aminocarbonyl)amino)-2,3-didehydroalanyl-2-((4r,6s)-2-amino-1,4,5,6-tetrahydro-6-hydroxy-4-pyrimidinyl)-, (5->13)-lactam, (2s)- but generally known as viomycin, which bears us nih compound identifier 3032902. european medicines agency schedules viomycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00078mig. the term viomycin is an international non-proprietary name or inn. most nations schedule viomycin under hs 29419000 and sitc 54139. as of q4 2014, viomycin remains the us fda preferred term for this commodity. viomycin bears us nlm identifiers umls id c0042697 and nci concept code c66654. smiles: oc1n=c(nc(c2nc(=o)c(=c\\nc(=o)n)\\nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)cc(n)cccn)cnc2=o)co)co)c1)n.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. amikacin sulfate. this classification denotes an aminoglycoside antibiotic with the molecular formula c22h43n5o13.2h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier n6m33094fd, chemically known as d-streptamine, o-3-amino-3-deoxy-alpha-d-glucopyranosyl-(1->6)-o-(6-amino-6-deoxy-alpha-d-glucopyranosyl-(1->4))-n(sup 1)-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (s)- but more generally known as amikacin sulfate, which bears us nih compound identifier 37768. the base compound, amikacin, most often comes in dihydrate, disulfate, hydrate, and sulfate forms. european medicines agency schedules amikacin sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00444mig. most nations, for tariff and trade purposes, schedule amikacin sulfate under hs 29419000 and sitc 54139. as of q4 2014, amikacin sulfate remains us fdas preferred term for this commodity. amikacin sulfate bears us nlm identifiers umls id c0700949 and nci concept code c230. smiles: c1[c@@h]([c@h]([c@@h]([c@h]([c@@h]1nc(=o)[c@h](ccn)o)o[c@@h]2[c@@h]([c@h]([c@@h]([c@h](o2)co)o)n)o)o)o[c@@h]3[c@@h]([c@h]([c@@h]([c@h](o3)cn)o)o)o)n.os(=o)(=o)o.os(=o)(=o)o.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. apramycin sulfate. this classification denotes an antibiotic with the molecular formula c21h41n5o11.(h2o4s)mod, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8uyl6naz3q. the term apramycin sulfate is a u.s. fda green book designation. most nations, for tariff and trade purposes, schedule apramycin sulfate under hs 29419000. smiles:. as of q4 2014, apramycin sulfate remains us fdas preferred term for this commodity. . apramycin sulfate bears us nlm identifiers umls id c0521895 and nci concept code c79973.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. arbekacin sulfate. this classification denotes an aminoglycoside antibiotic with the molecular formula c22h44n6o10.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g7395hz992, chemically known as d-streptamine, o-3-amino-3-deoxy-alpha-d-glucopyranosyl-(1-6)-o-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-d-erythro-hexopyranosyl-(1-4))-n-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (s)-, sulfate (salt) but more generally known as arbekacin sulfate, which bears us nih compound identifier 175989. european medicines agency schedules arbekacin sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12932mig. most nations, for tariff and trade purposes, schedule arbekacin sulfate under hs 29419000 and sitc 54139. as of q4 2014, arbekacin sulfate remains us fdas preferred term for this commodity. smiles: c1c[c@h]([c@h](o[c@@h]1cn)o[c@@h]2[c@h](c[c@h]([c@@h]([c@h]2o)o[c@@h]3[c@@h]([c@h]([c@@h]([c@h](o3)co)o)n)o)nc(=o)[c@h](ccn)o)n)n.os(=o)(=o)o.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. astromicin sulfate. this classification denotes an aminoglycoside antibiotic with the molecular formula c17h35n5o6.2h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier poy3s0t3bd, chemically known as 4-amino-1-(2-amino-n-methylacetamido)-1,4-dideoxy-3-o-(2,6-diamino-2,3,4,6,7-pentadeoxy-beta-l-lyxo-heptopyranosyl)-6-o-methyl-l-chiro-inositol sulfate (1:2) (salt) but more generally known as astromicin sulfate, which bears us nih compound identifier 51565. european medicines agency schedules astromicin sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00614mig. most nations, for tariff and trade purposes, schedule astromicin sulfate under hs 29419000 and sitc 54139. as of q4 2014, astromicin sulfate remains us fdas preferred term for this commodity. astromicin sulfate bears us nlm identifiers umls id c2698188 and nci concept code c76147. smiles: c[c@@h]([c@@h]1cc[c@h]([c@h](o1)o[c@@h]2[c@h]([c@@h]([c@@h]([c@h]([c@h]2o)n(c)c(=o)cn)oc)o)n)n)n.os(=o)(=o)o.os(=o)(=o)o.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. bekanamycin sulfate. this classification denotes the sulfate form of an aminoglycoside antibiotic with the molecular structure c18h37n5o10, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 15jt14c3gi chemically known as (1r,2s,3s,4r,6s)-4,6-diamino-3-((3-amino-3-deoxy-.alpha.-d-glucopyranosyl)oxy)-2-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-.alpha.-d-glucopyranoside, but more commonly known as bekanamycin, which bears us nih compound identifier 816. european medicines agency schedules bekanamycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05684mig. the term bekanamycin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 25 , no. 10 1971, list 11. ). most nations, for tariff and trade purposes, schedule bekanamycin sulfate under hs 29419000 and sitc 54139. as of q4 2014, bekanamycin sulfate remains us fdas preferred term for this commodity. bekanamycin sulfate bears us nlm identifiers umls id c0888075 and nci concept code c76153. smiles: c1[c@@h]([c@h]([c@@h]([c@h]([c@@h]1n)o[c@@h]2[c@@h]([c@h]([c@@h]([c@h](o2)co)o)n)o)o)o[c@@h]3[c@@h]([c@h]([c@@h]([c@h](o3)cn)o)o)n)n.os(=o)(=o)o.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. betamicin sulfate. this classification denotes the sulfate form of an aminoglycoside antibiotic with the molecular structure c19h38n4o10, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 67w9dgg4c7 chemically known as d-streptamine, o-6-amino-6-deoxy-.alpha.-d-glucopyranosyl-(1->4)-o-(3-deoxy-4-c-methyl-3-(methylamino)-.beta.-l-arabinopyranosyl-(1->6))-2-deoxy-, but more commonly known as betamicin, which bears us nih compound identifier 37569. european medicines agency schedules betamicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05799mig. the term betamicin is an international non-proprietary name or inn. most nations, for tariff and trade purposes, schedule betamicin sulfate under hs 29419000 and sitc 54139. as of q4 2014, betamicin sulfate remains us fdas preferred term for this commodity. betamicin sulfate bears us nlm identifiers umls id c0953456 and nci concept code c79527. smiles: c[c@@]1(co[c@@h]([c@@h]([c@h]1nc)o)o[c@h]2[c@@h](c[c@@h]([c@h]([c@@h]2o)o[c@@h]3[c@@h]([c@h]([c@@h]([c@h](o3)cn)o)o)o)n)n)o.os(=o)(=o)o.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. capreomycin ia. this classification denotes an antitubercular agent and aminoglycoside antibiotic with the molecular formula c25h44n14o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4auq151iuh, chemically known as cyclo(3-(((3s)-3,6-diamino-1-oxohexyl)amino)-l-alanyl-(2z)-3-((aminocarbonyl)amino)-2,3-didehydroalanyl-(2s)-2-((4r)-2-amino-1,4,5,6-tetrahydro-4-pyrimidinyl)glycyl-(2s)-2-amino-.beta.-alanyl-l-seryl), but more generally known as capreomycin ia, which bears us nih compound identifier 3032940. european medicines agency schedules capreomycin ia or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01028mig. most nations, for tariff purposes, schedule capreomycin ia under hs 29419000. smiles: c1cn=c(n[c@h]1[c@h]2c(=o)nc[c@@h](c(=o)n[c@h](c(=o)n[c@h](c(=o)n/c(=c\\nc(=o)n)/c(=o)n2)cnc(=o)c[c@h](cccn)n)co)n)n.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. capreomycin ib. this classification denotes an antitubercular agent and aminoglycoside antibiotic with the molecular formula c25h44n14o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2yp3ryc823, chemically known as cyclo((2s)-2-amino-.beta.-alanyl-l-alanyl-3-(((3s)-3,6-diamino-1-oxohexyl)amino)-l-alanyl-(2z)-3-((aminocarbonyl)amino)-2,3-didehydroalanyl-(2s)-2-((4r)-2-amino-3,4,5,6-tetrahydro-4-pyrimidinyl)glycyl), but more generally known as capreomycin ib, which bears us nih compound identifier 3034057. european medicines agency schedules capreomycin ib or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01028mig. most nations, for tariff purposes, schedule capreomycin ib under hs 29419000. smiles: c[c@h]1c(=o)n[c@h](c(=o)n/c(=c\\nc(=o)n)/c(=o)n[c@h](c(=o)nc[c@@h](c(=o)n1)n)[c@h]2ccn=c(n2)n)cnc(=o)c[c@h](cccn)n.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. capreomycin iia. this classification denotes an antitubercular agent and aminoglycoside antibiotic with the molecular formula c19h32n12o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 38tl5q9sm7, chemically known as cyclo(3-amino-l-alanyl-(2z)-3-((aminocarbonyl)amino)-2,3-didehydroalanyl-(2s)-2-((4r)-2-amino-3,4,5,6-tetrahydro-4-pyrimidinyl)glycyl-(2s)-2-amino-.beta.-alanyl-l-seryl), but more generally known as capreomycin iia, which bears us nih compound identifier 3034236. european medicines agency schedules capreomycin iia or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01028mig. most nations, for tariff purposes, schedule capreomycin iia under hs 29419000. smiles: c1cn=c(n[c@h]1[c@h]2c(=o)nc[c@@h](c(=o)n[c@h](c(=o)n[c@h](c(=o)n/c(=c\\nc(=o)n)/c(=o)n2)cn)co)n)n.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. capreomycin iib. this classification denotes an antitubercular agent and aminoglycoside antibiotic with the molecular formula c19h32n12o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k630580g1n, chemically known as cyclo((2s)-2-amino-.beta.-alanyl-l-alanyl-3-amino-l-alanyl-(2z)-3-((aminocarbonyl)amino)-2,3-didehydroalanyl-(2s)-2-((4r)-2-amino-3,4,5,6-tetrahydro-4-pyrimidinyl)glycyl), but more generally known as capreomycin iib, which bears us nih compound identifier 3034237. european medicines agency schedules capreomycin iib or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01028mig. most nations, for tariff purposes, schedule capreomycin iib under hs 29419000. smiles: c[c@h]1c(=o)n[c@h](c(=o)n/c(=c\\nc(=o)n)/c(=o)n[c@h](c(=o)nc[c@@h](c(=o)n1)n)[c@h]2ccn=c(n2)n)cn.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. capreomycin sulfate. this classification denotes an antitubercular agent and aminoglycoside antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9h8d3j7v21. european medicines agency schedules capreomycin sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01029mig. capreomycin sulfate generally arises in the molecular formula c25h46n14o12s. the term capreomycin sulfate is a united states adopted name designation. most nations, for tariff and trade purposes, schedule capreomycin sulfate under hs 29419000 and sitc 54139. capreomycin sulfate bears us nlm identifiers umls id c0006920 and nci concept code c73797. smiles: as of q4 2014, capreomycin sulfate remains us fdas preferred term for this commodity.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. dibekacin sulfate. this classification denotes an aminoglycoside antibiotic with the molecular formula c18h37n5o8.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier a0869i992z, chemically known as d-streptamine, o-3-amino-3-deoxy-alpha-d-glucopyranosyl-(1-6)-o-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-d-erythro-hexopyranosyl-(1-4))-2-deoxy-, sulfate (salt) but more generally known as dibekacin sulfate, which bears us nih compound identifier 162862. european medicines agency schedules dibekacin sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01657mig. most nations, for tariff and trade purposes, schedule dibekacin sulfate under hs 29419000 and sitc 54139. as of q4 2014, dibekacin sulfate remains us fdas preferred term for this commodity. smiles: c1c[c@h]([c@h](o[c@@h]1cn)o[c@@h]2[c@h](c[c@h]([c@@h]([c@h]2o)o[c@@h]3[c@@h]([c@h]([c@@h]([c@h](o3)co)o)n)o)n)n)n.os(=o)(=o)o.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. framycetin sulfate. this classification denotes an aminoglycoside antibiotic with the molecular formula c23h46n6o13.3h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier y3720kz4tq, chemically known as neomycin b, sulfate (salt) but more generally known as framycetin sulfate, which bears us nih compound identifier 197162. european medicines agency schedules framycetin sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02269mig. most nations, for tariff and trade purposes, schedule framycetin sulfate under hs 29419000 and sitc 54139. as of q4 2014, framycetin sulfate remains us fdas preferred term for this commodity. framycetin sulfate bears us nlm identifiers umls id c0770899 and nci concept code c75943. smiles: c1[c@h]([c@@h]([c@h]([c@@h]([c@h]1n)o[c@@h]2[c@@h]([c@h]([c@@h]([c@h](o2)cn)o)o)n)o[c@h]3[c@@h]([c@@h]([c@h](o3)co)o[c@@h]4[c@@h]([c@h]([c@@h]([c@@h](o4)cn)o)o)n)o)o)n.os(=o)(=o)o.os(=o)(=o)o.os(=o)(=o)o.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. gentamicin a. this classification denotes an aminoglycoside antibiotic with the molecular formula c18h36n4o10, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4w8r3urs2h, chemically known as d-streptamine, o-2-amino-2-deoxy-.alpha.-d-glucopyranosyl-(1->4)-o-(3-deoxy-3-(methylamino)-.alpha.-d-xylopyranosyl-(1->6))-2-deoxy-, but more generally known as gentamicin a, which bears us nih compound identifier 86474. european medicines agency schedules gentamicin a or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02326mig. most nations, for tariff purposes, schedule gentamicin a under hs 29419000. smiles: cn[c@h]1[c@h](co[c@@h]([c@@h]1o)o[c@h]2[c@@h](c[c@@h]([c@h]([c@@h]2o)o[c@@h]3[c@@h]([c@h]([c@@h]([c@h](o3)co)o)o)n)n)n)o.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. gentamicin c1a. this classification denotes an aminoglycoside antibiotic c19h39n5o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier av4a72iatd, chemically known as d-streptamine, o-3-deoxy-4-c-methyl-3-(methylamino)-.beta.-l-arabinopyranosyl-(1->6)-o-(2,6-diamino-2,3,4,6-tetradeoxy-.alpha.-d-erythro-hexopyranosyl-(1->4))-2-deoxy-, but more generally known as gentamicin c1a, which bears us nih compound identifier 72396. most nations, for tariff and trade purposes, schedule gentamicin c1a under hs 29419000 and sitc 54139. as of q4 2014, gentamicin c1a remains us fdas preferred term for this commodity. gentamicin c1a bears us nlm identifiers umls id c1563655 and nci concept code c76149. smiles: c[c@@]1(co[c@@h]([c@@h]([c@h]1nc)o)o[c@h]2[c@@h](c[c@@h]([c@h]([c@@h]2o)o[c@@h]3[c@@h](cc[c@h](o3)cn)n)n)n)o.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. gentamicin sulfate. this classification denotes an aminoglycoside antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8x7386qrlv. european medicines agency schedules gentamicin sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02327mig. gentamicin sulfate generally arises in the molecular formula c21h45n5o11s. the term gentamicin sulfate is a united states adopted name designation. most nations, for tariff and trade purposes, schedule gentamicin sulfate under hs 29419000 and sitc 54139. gentamicin sulfate bears us nlm identifiers umls id c0546866 and nci concept code c65803. smiles: as of q4 2014, gentamicin sulfate remains us fdas preferred term for this commodity.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. isepamicin sulfate. this classification denotes an aminoglycoside antibiotic with the molecular formula c22h43n5o12.2h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u606y00ewe, chemically known as d-streptamine, o-6-amino-6-deoxy-alpha-d-glucopyranosyl-(1-4)-o-(3-deoxy-4-c-methyl-3-(methylamino)-beta-l-arabinopyranosyl-(1-6))-n(sup 1)-(3-amino-2-hydroxy-1-oxopropyl)-2-deoxy-, (s)-, sulfate (salt) but more generally known as isepamicin sulfate, which bears us nih compound identifier 171883. european medicines agency schedules isepamicin sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02782mig. most nations, for tariff and trade purposes, schedule isepamicin sulfate under hs 29419000 and sitc 54139. as of q4 2014, isepamicin sulfate remains us fdas preferred term for this commodity. smiles: c[c@@]1(co[c@@h]([c@@h]([c@h]1nc)o)o[c@h]2[c@@h](c[c@@h]([c@h]([c@@h]2o)o[c@@h]3[c@@h]([c@h]([c@@h]([c@h](o3)cn)o)o)o)n)nc(=o)[c@h](cn)o)o.os(=o)(=o)o.os(=o)(=o)o.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. kanamycin a. this classification denotes an aminoglycoside antibiotic with the molecular formula c18h36n4o11, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier eqk9q303c5, chemically known as d-streptamine, o-3-amino-3-deoxy-.alpha.-d-glucopyranosyl-(1->6)-o-(6-amino-6-deoxy-.alpha.-d-glucopyranosyl-(1->4))-2-deoxy-, but more generally known as kanamycin a, which bears us nih compound identifier 6032. european medicines agency schedules kanamycin a or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08362mig. most nations, for tariff purposes, schedule kanamycin a under hs 29419000. kanamycin a bears us nlm identifiers umls id c0022489 and nci concept code c76151. smiles: c1[c@h]([c@@h]([c@h]([c@@h]([c@h]1n)o[c@@h]2[c@@h]([c@h]([c@@h]([c@h](o2)cn)o)o)o)o)o[c@@h]3[c@@h]([c@h]([c@@h]([c@h](o3)co)o)n)o)n.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. kanamycin a sulfate. this classification denotes an aminoglycoside antibiotic with the molecular formula c18h36n4o11.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier j80ex28smq, chemically known as d-streptamine, o-3-amino-3-deoxy-.alpha.-d-glucopyranosyl(1->6)-o-(6-amino-6-deoxy-.alpha.-d-glucopyranosyl(1->4))-2-deoxy-, sulfate (1:1) (salt), but more generally known as kanamycin a sulfate, which bears us nih compound identifier 32943. european medicines agency schedules kanamycin a sulfate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08362mig. most nations, for tariff purposes, schedule kanamycin a sulfate under hs 29419000. kanamycin a sulfate bears us nlm identifiers umls id c2697837 and nci concept code c76152. smiles: c1[c@h]([c@@h]([c@h]([c@@h]([c@h]1n)o[c@@h]2[c@@h]([c@h]([c@@h]([c@h](o2)cn)o)o)o)o)o[c@@h]3[c@@h]([c@h]([c@@h]([c@h](o3)co)o)n)o)n.os(=o)(=o)o.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. micronomicin sulfate. this classification denotes an aminoglycoside antibiotic with the molecular formula 2c20h41n5o7.5h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 09h5ukq7tz, chemically known as d-streptamine, o-2-amino-2,3,4,6-tetradeoxy-6-(methylamino)-.alpha.-d-erythro-hexopyranosyl-(1-4)-o-(3-deoxy-4-c-methyl-3-(methylamino)-.beta.-l-arabinopyranosyl-(1-6))-2-deoxy-, sulfate (salt), but more generally known as micronomicin sulfate, which bears us nih compound identifier 171808. european medicines agency schedules micronomicin sulfate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08945mig. most nations, for tariff purposes, schedule micronomicin sulfate under hs 29419000. smiles:.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. neomycin b sulphate. this classification denotes an aminoglycoside antibiotic with the molecular formula c23h46n6o13.3h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier y3720kz4tq, chemically known as neomycin b, sulfate (salt), but more generally known as neomycin b sulphate, which bears us nih compound identifier 197162. european medicines agency schedules neomycin b sulphate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03406mig. most nations, for tariff purposes, schedule neomycin b sulphate under hs 29419000. smiles: c1[c@h]([c@@h]([c@h]([c@@h]([c@h]1n)o[c@@h]2[c@@h]([c@h]([c@@h]([c@h](o2)cn)o)o)n)o[c@h]3[c@@h]([c@@h]([c@h](o3)co)o[c@@h]4[c@@h]([c@h]([c@@h]([c@@h](o4)cn)o)o)n)o)o)n.os(=o)(=o)o.os(=o)(=o)o.os(=o)(=o)o.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. neomycin c. this classification denotes an aminoglycoside antibiotic with the molecular formula c23h46n6o13, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6b1u1ns16z, chemically known as d-streptamine, o-2,6-diamino-2,6-dideoxy-.alpha.-d-glucopyranosyl-(1->3)-o-.beta.-d-ribofuranosyl-(1->5)-o-(2,6-diamino-2,6-dideoxy-.alpha.-d-glucopyranosyl-(1->4))-2-deoxy-, but more generally known as neomycin c, which bears us nih compound identifier 4454. european medicines agency schedules neomycin c or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03406mig. most nations, for tariff purposes, schedule neomycin c under hs 29419000. neomycin c bears us nlm identifiers umls id c0068521 and nci concept code c95127. smiles: c1[c@h]([c@@h]([c@h]([c@@h]([c@h]1n)o[c@@h]2[c@@h]([c@h]([c@@h]([c@h](o2)cn)o)o)n)o[c@h]3[c@@h]([c@@h]([c@h](o3)co)o[c@@h]4[c@@h]([c@h]([c@@h]([c@h](o4)cn)o)o)n)o)o)n.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. neomycin e. this classification denotes an aminoglycoside antibiotic with the molecular formula c23h45n5o14, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 61jjc8n5zk, chemically known as diamino-2,6-dideoxy-.beta.-l-idopyranosyl-(1->3)-o-.beta.-d-ribofuranosyl-(1->5)-o-(2-amino-2-deoxy-.alpha.-d-glucopyranosyl-(1->4))-2-deoxystreptamine, but more generally known as neomycin e, which bears us nih compound identifier 24176. european medicines agency schedules neomycin e or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03406mig. most nations, for tariff purposes, schedule neomycin e under hs 29419000. smiles: c1[c@h]([c@@h]([c@h]([c@@h]([c@h]1n)o[c@@h]2[c@@h]([c@h]([c@@h]([c@h](o2)co)o)o)n)o[c@h]3[c@@h]([c@@h]([c@h](o3)co)o[c@@h]4[c@@h]([c@h]([c@@h]([c@@h](o4)cn)o)o)n)o)o)n.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. neomycin sulfate. this classification denotes an aminoglycoside antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 057y626693. european medicines agency schedules neomycin sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03409mig. neomycin sulfate generally arises in the molecular formula c23h48n6o17s. the term neomycin sulfate is a u.s. pharmacopeial convention designation. most nations, for tariff and trade purposes, schedule neomycin sulfate under hs 29419000 and sitc 54139. neomycin sulfate bears us nlm identifiers umls id c0027607 and nci concept code c66227. smiles: as of q4 2014, neomycin sulfate remains us fdas preferred term for this commodity.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. netilmicin sulfate. this classification denotes an aminoglycoside antibiotic with the molecular formula 2c21h41n5o7.5h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier s741zjs97u, chemically known as o-3-deoxy-4-c-methyl-3-(methylamino)-beta-l-arabinopyranosyl-(1->4)-o-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-d-glycero-hex-4-enopyranosyl-(1->6))-2-deoxy-n(sup 3)-ethyl-l-streptamine sulfate (2:5) (salt) but more generally known as netilmicin sulfate, which bears us nih compound identifier 62115. european medicines agency schedules netilmicin sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03415mig. most nations, for tariff and trade purposes, schedule netilmicin sulfate under hs 29419000 and sitc 54139. netilmicin sulfate bears us nlm identifiers umls id c0700550 and nci concept code c66237. smiles: as of q4 2014, netilmicin sulfate remains us fdas preferred term for this commodity.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. paromomycin i. this classification denotes an aminoglycoside antibiotic with the molecular formula c23h45n5o14, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 61jjc8n5zk, chemically known as diamino-2,6-dideoxy-.beta.-l-idopyranosyl-(1->3)-o-.beta.-d-ribofuranosyl-(1->5)-o-(2-amino-2-deoxy-.alpha.-d-glucopyranosyl-(1->4))-2-deoxystreptamine, but more generally known as paromomycin i, which bears us nih compound identifier 4689. european medicines agency schedules paromomycin i or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09630mig. most nations, for tariff purposes, schedule paromomycin i under hs 29419000. smiles: c1[c@h]([c@@h]([c@h]([c@@h]([c@h]1n)o[c@@h]2[c@@h]([c@h]([c@@h]([c@h](o2)co)o)o)n)o[c@h]3[c@@h]([c@@h]([c@h](o3)co)o[c@@h]4[c@@h]([c@h]([c@@h]([c@@h](o4)cn)o)o)n)o)o)n.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. paromomycin sulfate. this classification denotes an aminoglycoside antibiotic with the molecular formula c23h45n5o14.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 845nu6gjps, chemically known as o-2,6-diamino-2,6-dideoxy-beta-l-idopyranosyl-(1->3)-o-beta-d-ribofuranosyl-(1->5)-o-(2-amino-2-deoxy-alpha-d-glucopyranosyl-(1->4))-2-deoxystreptamine sulfate (salt) but more generally known as paromomycin sulfate, which bears us nih compound identifier 64144. european medicines agency schedules paromomycin sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03654mig. most nations, for tariff and trade purposes, schedule paromomycin sulfate under hs 29419000 and sitc 54139. as of q4 2014, paromomycin sulfate remains us fdas preferred term for this commodity. paromomycin sulfate bears us nlm identifiers umls id c0733821 and nci concept code c47652. smiles: c1[c@h]([c@@h]([c@h]([c@@h]([c@h]1n)o[c@@h]2[c@@h]([c@h]([c@@h]([c@h](o2)co)o)o)n)o[c@h]3[c@@h]([c@@h]([c@h](o3)co)o[c@@h]4[c@@h]([c@h]([c@@h]([c@@h](o4)cn)o)o)n)o)o)n.os(=o)(=o)o.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. ribostamycin sulfate. this classification denotes an aminoglycoside antibiotic c17h34n4o10.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier qfn1qu7pen, chemically known as o-2,6-diamino-2,6-dideoxy-.alpha.-d-glucopyranosyl-(1->4)-o-(.beta-d-ribofuranosyl-(1->5))-2-deoxy-d-streptamine sulfate, but more generally known as ribostamycin sulfate, which bears us nih compound identifier 5702279. european medicines agency schedules in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04244mig. most nations, for tariff and trade purposes, schedule ribostamycin sulfate under hs 29419000 and sitc 54139. as of q4 2014, ribostamycin sulfate remains us fdas preferred term for this commodity. smiles: c1[c@h]([c@@h]([c@h]([c@@h]([c@h]1n)o[c@@h]2[c@@h]([c@h]([c@@h]([c@h](o2)cn)o)o)n)o[c@h]3[c@@h]([c@@h]([c@h](o3)co)o)o)o)n.os(=o)(=o)o.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. sisomicin sulfate. this classification denotes an aminoglycoside antibiotic with the molecular formula 2c19h37n5o7.5h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k14444371c, chemically known as o-3-deoxy-4-c-methyl-3-(methylamino)-beta-l-arabinopyranosyl-(1->4)-o-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-d-glycero-hex-4-enopyranosyl-(1->6))-2-deoxy-l-streptamine sulfate (2:5) (salt) but more generally known as sisomicin sulfate, which bears us nih compound identifier 65334. european medicines agency schedules sisomicin sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04405mig. most nations, for tariff and trade purposes, schedule sisomicin sulfate under hs 29419000 and sitc 54139. sisomicin sulfate bears us nlm identifiers umls id c0037210 and nci concept code c84147. smiles: as of q4 2014, sisomicin sulfate remains us fdas preferred term for this commodity.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. spectinomycin dihydrochloride. this classification denotes an aminoglycoside antibiotic with the molecular formula c14h24n2o7.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 296jei210z, chemically known as 4h-pyrano(2,3-b)(1,4)benzodioxin-4-one, decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, dihydrochloride, but more generally known as spectinomycin dihydrochloride, which bears us nih compound identifier 2021. european medicines agency schedules spectinomycin dihydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10614mig. most nations, for tariff purposes, schedule spectinomycin dihydrochloride under hs 29419000. smiles: c[c@@h]1cc(=o)[c@]2([c@@h](o1)o[c@@h]3[c@h]([c@@h]([c@@h]([c@@h]([c@h]3o2)nc)o)nc)o)o.cl.cl.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. spectinomycin dihydrochloride pentahydrate. this classification denotes an aminoglycoside antibiotic with the molecular formula c14h24n2o7.2clh.5h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hwt06h303z, chemically known as 4h-pyrano(2,3-b)(1,4)benzodioxin-4-one, decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, dihydrochloride, pentahydrate but more generally known as spectinomycin dihydrochloride pentahydrate, which bears us nih compound identifier 30971. european medicines agency schedules spectinomycin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12327mig. most nations, for tariff and trade purposes, schedule spectinomycin dihydrochloride pentahydrate under hs 29419000. smiles: c[c@@h]1cc(=o)[c@]2([c@@h](o1)o[c@@h]3[c@h]([c@@h]([c@@h]([c@@h]([c@h]3o2)nc)o)nc)o)o.o.o.o.o.o.cl.cl.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. spectinomycin hydrochloride. this classification denotes an aminoglycoside antibiotic with the molecular formula c14h24n2o7.2clh.5h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hwt06h303z, chemically known as 4h-pyrano(2,3-b)(1,4)benzodioxin-4-one, decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, dihydrochloride, pentahydrate but more generally known as spectinomycin dihydrochloride pentahydrate, which bears us nih compound identifier 30971. european medicines agency schedules spectinomycin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12327mig. most nations, for tariff and trade purposes, schedule spectinomycin hydrochloride under hs 29419000 and sitc 54139. as of q4 2014, spectinomycin hydrochloride remains us fdas preferred term for this commodity. spectinomycin hydrochloride bears us nlm identifiers umls id c0887525 and nci concept code c47728. smiles: c[c@@h]1cc(=o)[c@]2([c@@h](o1)o[c@@h]3[c@h]([c@@h]([c@@h]([c@@h]([c@h]3o2)nc)o)nc)o)o.o.o.o.o.o.cl.cl.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. spectinomycin hydrochloride anhydrous. this classification denotes an aminoglycoside antibiotic with the molecular formula c14h24n2o7.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 296jei210z, chemically known as 4h-pyrano(2,3-b)(1,4)benzodioxin-4-one, decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, dihydrochloride, but more generally known as spectinomycin hydrochloride anhydrous, which bears us nih compound identifier 3033928. european medicines agency schedules spectinomycin hydrochloride anhydrous or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10614mig. most nations, for tariff purposes, schedule spectinomycin hydrochloride anhydrous under hs 29419000. spectinomycin hydrochloride anhydrous bears us nlm identifiers umls id c2983839 and nci concept code c90690. smiles: c[c@@h]1cc(=o)[c@]2([c@@h](o1)o[c@@h]3[c@h]([c@@h]([c@@h]([c@@h]([c@h]3o2)nc)o)nc)o)o.cl.cl.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. spectinomycin sulfate. this classification denotes an antibiotic with the molecular formula c14h24n2o7.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier bz0h4tlf9x. most nations, for tariff and trade purposes, schedule spectinomycin sulfate under hs 29419000 and sitc 54139. as of q4 2014, spectinomycin sulfate remains us fdas preferred term for this commodity. spectinomycin sulfate bears us nlm identifiers umls id c2983840 and nci concept code c90691. smiles: c[c@@h]1cc(=o)[c@]2([c@@h](o1)o[c@@h]3[c@h]([c@@h]([c@@h]([c@@h]([c@h]3o2)nc)o)nc)o)o.os(=o)(=o)o.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. spectinomycin sulfate tetrahydrate. this classification denotes an aminoglycoside antibiotic c14h24n2o7.4h2o.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ys91p54918, chemically known as (2r-(2.alpha.,4a.beta.,5a.beta.,6.beta.,7.beta.,8.beta.,9.alpha.,9a.alpha.,10a.beta.))-decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-4h-pyrano(2,3-b)(1,4)benzodioxin-4-one sulfate tetrahydrate, but more generally known as spectinomycin sulfate tetrahydrate, which bears us nih compound identifier 64770. most nations, for tariff and trade purposes, schedule spectinomycin sulfate tetrahydrate under hs 29419000 and sitc 54139. as of q4 2014, spectinomycin sulfate tetrahydrate remains us fdas preferred term for this commodity. spectinomycin sulfate tetrahydrate bears us nlm identifiers umls id c2726834 and nci concept code c90692. smiles: c[c@@h]1cc(=o)[c@]2([c@@h](o1)o[c@@h]3[c@h]([c@@h]([c@@h]([c@@h]([c@h]3o2)nc)o)nc)o)o.o.o.o.o.os(=o)(=o)o.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. streptomycin b. this classification denotes an aminoglycoside antibiotic with the molecular formula c27h49n7o17, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier cj1467c885, chemically known as d-streptamine, o-.beta.-d-mannopyranosyl-(1->4)-o-2-deoxy-2-(methylamino)-.alpha.-l-glucopyranosyl-(1->2)-o-5-deoxy-3-c-formyl-.alpha.-l-lyxofuranosyl-(1->4)-n1,n3-bis(aminoiminomethyl)-, but more generally known as streptomycin b, which bears us nih compound identifier 121307. european medicines agency schedules streptomycin b or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10656mig. most nations, for tariff purposes, schedule streptomycin b under hs 29412080. smiles: c[c@h]1[c@@]([c@h]([c@@h](o1)o[c@@h]2[c@h]([c@@h]([c@h]([c@@h]([c@h]2o)o)nc(=n)n)o)nc(=n)n)o[c@h]3[c@h]([c@@h]([c@h]([c@@h](o3)co)o[c@@h]4[c@h]([c@h]([c@@h]([c@@h](o4)co)o)o)o)o)nc)(c=o)o.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. streptomycin hydrochloride. this classification denotes an aminoglycoside antibiotic with the molecular structure c21h39n7o12.3clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 8p331b9592 chemically known as d-streptamine, o-2-deoxy-2-(methylamino)-.alpha.-l-glucopyranosyl-(1->2)-o-5-deoxy-3-c-formyl-.alpha.-l-lyxofuranosyl-(1->4)-n,n-bis(aminoiminomethyl)-, trihydrochloride, but more commonly known as streptomycin hydrochloride, which bears us nih compound identifier 197844. european medicines agency schedules streptomycin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15404mig. most nations, for tariff and trade purposes, schedule streptomycin hydrochloride under hs 29412000 and sitc 54132. as of q4 2014, streptomycin hydrochloride remains us fdas preferred term for this commodity. smiles: c[c@h]1[c@@]([c@h]([c@@h](o1)o[c@@h]2[c@h]([c@@h]([c@h]([c@@h]([c@h]2o)o)nc(=n)n)o)nc(=n)n)o[c@h]3[c@h]([c@@h]([c@h]([c@@h](o3)co)o)o)nc)(c=o)o.cl.cl.cl.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. streptomycin sulfate. this classification denotes an aminoglycoside antibiotic with the molecular formula 2c21h39n7o12.3h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier cw25ikj202, chemically known as streptomycin, sulfate (2:3) (salt) but more generally known as streptomycin sulfate, which bears us nih compound identifier 19648. european medicines agency schedules streptomycin sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04593mig. most nations, for tariff and trade purposes, schedule streptomycin sulfate under hs 29412080 and sitc 54132. streptomycin sulfate bears us nlm identifiers umls id c0038426 and nci concept code c47729. smiles: as of q4 2014, streptomycin sulfate remains us fdas preferred term for this commodity.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. telavancin hydrochloride. this classification denotes an antimicrobial solution, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0701472zg0. european medicines agency schedules telavancin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub35005. telavancin hydrochloride generally arises in the molecular formula c80h106cl2n11o27p.clh. the term telavancin hydrochloride is a united states adopted name designation. most nations, for tariff and trade purposes, schedule telavancin hydrochloride under hs 29419000 and sitc 54139. telavancin hydrochloride bears us nlm identifiers umls id c2730005 and nci concept code c87636. smiles: as of q4 2014, telavancin hydrochloride remains us fdas preferred term for this commodity.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. tobramycin sulfate. this classification denotes an aminoglycoside antibiotic with the molecular formula 2c18h37n5o9.5h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hjt0rxd7jk, chemically known as tobramycin, free base but more generally known as tobramycin sulfate, which bears us nih compound identifier 5496. european medicines agency schedules tobramycin sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04896mig. most nations, for tariff and trade purposes, schedule tobramycin sulfate under hs 29419000 and sitc 54139. tobramycin sulfate bears us nlm identifiers umls id c0701392 and nci concept code c893. smiles: as of q4 2014, tobramycin sulfate remains us fdas preferred term for this commodity.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. viomycin hydrochloride. this classification denotes the hydrochloride form of an antitubercular agent with the molecular structure c25h43n13o10, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, yvu35998k5 chemically known as glycine, 3-amino-n-((3s)-3,6-diamino-1-oxohexyl)-l-alanyl-l-seryl-l-seryl-(2z)-3-((aminocarbonyl)amino)-2,3-didehydroalanyl-2-((4r,6s)-2-amino-1,4,5,6-tetrahydro-6-hydroxy-4-pyrimidinyl)-, (5->13)-lactam, (2s)-, but more commonly known as viomycin, which bears us nih compound identifier 3032902. european medicines agency schedules viomycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00078mig. the term viomycin is an international non-proprietary name or inn. most nations, for tariff and trade purposes, schedule viomycin hydrochloride under hs 29419000. smiles: c1[c@@h](n=c(n[c@h]1o)n)[c@h]2c(=o)nc[c@@h](c(=o)n[c@h](c(=o)n[c@h](c(=o)n/c(=c\\nc(=o)n)/c(=o)n2)co)co)nc(=o)c[c@h](cccn)n.cl.cl.cl.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. viomycin pantothenate sulfate. this classification denotes an antitubercular agent with the molecular formula c25h43n13o10.c9h17no5.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0jtb9x596d, chemically known as .beta.-alanine, n-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-, (r)-, compd. with viomycin, sulfate (salt) (1:1:1), but more generally known as viomycin pantothenate sulfate, which bears us nih compound identifier 3037980. european medicines agency schedules viomycin pantothenate sulfate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00078mig. most nations, for tariff purposes, schedule viomycin pantothenate sulfate under hs 29419000. smiles: cc(c)(co)[c@h](c(=o)nccc(=o)o)o.c1[c@@h](n=c(n[c@h]1o)n)[c@h]2c(=o)nc[c@@h](c(=o)n[c@h](c(=o)n[c@h](c(=o)n/c(=c\\nc(=o)n)/c(=o)n2)co)co)nc(=o)c[c@h](cccn)n.os(=o)(=o)o.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. viomycin sulfate. this classification denotes an antitubercular agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier lko141r05v. european medicines agency schedules viomycin sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05106mig. viomycin sulfate generally arises in the molecular formula c25h43n13o10.h2o4s. the term viomycin sulfate is a japanese accepted name designation. most nations, for tariff and trade purposes, schedule viomycin sulfate under hs 29419000 and sitc 54139. as of q4 2014, viomycin sulfate remains us fdas preferred term for this commodity. viomycin sulfate bears us nlm identifiers umls id c1321956 and nci concept code c66655. smiles: c1[c@@h](n=c(n[c@h]1o)n)[c@h]2c(=o)nc[c@@h](c(=o)n[c@h](c(=o)n[c@h](c(=o)n/c(=c\\nc(=o)n)/c(=o)n2)co)co)nc(=o)c[c@h](cccn)n.os(=o)(=o)o.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. viomycin trihydrochloride. this classification denotes the trihydrochloride form of an antitubercular agent with the molecular structure c25h43n13o10, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, yvu35998k5 chemically known as glycine, 3-amino-n-((3s)-3,6-diamino-1-oxohexyl)-l-alanyl-l-seryl-l-seryl-(2z)-3-((aminocarbonyl)amino)-2,3-didehydroalanyl-2-((4r,6s)-2-amino-1,4,5,6-tetrahydro-6-hydroxy-4-pyrimidinyl)-, (5->13)-lactam, (2s)-, but more commonly known as viomycin, which bears us nih compound identifier 3032902. european medicines agency schedules viomycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00078mig. the term viomycin is an international non-proprietary name or inn. most nations, for tariff and trade purposes, schedule viomycin trihydrochloride under hs 29419000. as of q4 2014, viomycin trihydrochloride remains us fdas preferred term for this commodity. smiles: c1[c@@h](n=c(n[c@h]1o)n)[c@h]2c(=o)nc[c@@h](c(=o)n[c@h](c(=o)n[c@h](c(=o)n/c(=c\\nc(=o)n)/c(=o)n2)co)co)nc(=o)c[c@h](cccn)n.cl.cl.cl.. "
"aminoglycosides. this classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called aminoglycosides.. porfiromycin. this classification denotes a mitomycin antibiotic with the molecular formula c16h20n4o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h1wk901oa6, chemically known as 6-amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-1,5-dimethylazirino(2,3:3,4)pyrrolo(1,2-a)indole-4,7-dione carbamate (ester) but more generally known as porfiromycin, which bears us nih compound identifier 13116. european medicines agency schedules porfiromycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09980mig. the term porfiromycin is an international non-proprietary name. porfiromycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: o(c12n(cc3n(c13)c)c1=c(c2coc(=o)n)c(=o)c(=c(c1=o)c)n)c.. "
"aminopenicillins. this classification denotes third-generation and semi-synthetic penicillins and antibiotics that evince activity against penicillin-sensitive gram-positive bacteria and some gram-negative bacteria, generally called amino-penicillins or aminopenicillins, such as ampicillin.. . "
"aminopenicillins. this classification denotes third-generation and semi-synthetic penicillins and antibiotics that evince activity against penicillin-sensitive gram-positive bacteria and some gram-negative bacteria, generally called amino-penicillins or aminopenicillins, such as ampicillin.. lenampicillin. this classification denotes a penicillin antibiotic with the molecular formula c21h23n3o7s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8m568dm08k, chemically known as 2,3-dihydroxy-2-butenyl(2s,5r,6r)-6-((r)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate, cyclic carbonate but generally known as lenampicillin, which bears us nih compound identifier 65646. european medicines agency schedules lenampicillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08430mig. the term lenampicillin is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24). lenampicillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule lenampicillin under hs 29411090 and sitc 54131. as of q4 2014, lenampicillin remains the us fda preferred term for this commodity. lenampicillin bears us nlm identifiers umls id c0125457 and nci concept code c90912. smiles: s1c2n(c(c1(c)c)c(=o)occ1oc(=o)oc1c)c(=o)c2nc(=o)c(n)c1ccccc1.. "
"aminopenicillins. this classification denotes third-generation and semi-synthetic penicillins and antibiotics that evince activity against penicillin-sensitive gram-positive bacteria and some gram-negative bacteria, generally called amino-penicillins or aminopenicillins, such as ampicillin.. amoxicillin. this classification denotes a penicillin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 804826j2hu. european medicines agency schedules amoxicillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05481mig. amoxicillin generally arises in the molecular formula c16h19n3o5s. the term amoxicillin is a european pharmacopoeia designation. amoxicillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule amoxicillin under hs 29411010 and sitc 54131. as of q4 2014, amoxicillin remains the us fda preferred term for this commodity. amoxicillin bears us nlm identifiers umls id c0002645 and nci concept code c237. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2nc(=o)c(n)c1ccc(o)cc1.. "
"aminopenicillins. this classification denotes third-generation and semi-synthetic penicillins and antibiotics that evince activity against penicillin-sensitive gram-positive bacteria and some gram-negative bacteria, generally called amino-penicillins or aminopenicillins, such as ampicillin.. ampicillin. this classification denotes a penicillin antibiotic with the molecular formula c16h19n3o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7c782967rd, chemically known as penicillin, (aminophenylmethyl)- but generally known as ampicillin, which bears us nih compound identifier 2174. ampicillin comes in various forms, including a, acid, anhydrate, anhydrous, base, benzathine, hydrate, natrium, n,n-dibenzylethylenediamine salt, pivaloyloxymethyl ester, pivaloyloxymethyl ester hydrochloride, potassium, sodium, and trihydrate and is often combined with cloxacillin and dicloxacillin sodium. european medicines agency schedules ampicillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05487mig. the term ampicillin is an international non-proprietary name or inn (see who inn reference publication, volume 22, no. 10, 1968, list 8). world health organization schedules ampicillin in its anatomical therapeutic chemical (atc) classification. ampicillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ampicillin under hs 29411020 and sitc 54131. as of q4 2014, ampicillin remains the us fda preferred term for this commodity. ampicillin bears us nlm identifiers umls id c0002680 and nci concept code c239. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2nc(=o)c(n)c1ccccc1.. "
"aminopenicillins. this classification denotes third-generation and semi-synthetic penicillins and antibiotics that evince activity against penicillin-sensitive gram-positive bacteria and some gram-negative bacteria, generally called amino-penicillins or aminopenicillins, such as ampicillin.. aspoxicillin. this classification denotes a penicillin antibiotic with the molecular formula c21h27n5o7s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0745kno26j, chemically known as glycinamide, n-methyl-d-asparaginyl-n-(2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl)-d-2-(4-hydroxyphenyl)-, (2s-(2-alpha,5-alpha,6-beta))- but generally known as aspoxicillin, which bears us nih compound identifier 71961. european medicines agency schedules aspoxicillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05585mig. the term aspoxicillin is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24). aspoxicillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule aspoxicillin under hs 29411090 and sitc 54131. as of q4 2014, aspoxicillin remains the us fda preferred term for this commodity. aspoxicillin bears us nlm identifiers umls id c0104449 and nci concept code c72706. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2nc(=o)c(nc(=o)c(n)cc(=o)nc)c1ccc(o)cc1.. "
"aminopenicillins. this classification denotes third-generation and semi-synthetic penicillins and antibiotics that evince activity against penicillin-sensitive gram-positive bacteria and some gram-negative bacteria, generally called amino-penicillins or aminopenicillins, such as ampicillin.. bacampicillin. this classification denotes a penicillin antibiotic with the molecular formula c21h27n3o7s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8gm2j22278, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, 1-((ethoxycarbonyl)oxy)ethyl ester, (2s-(2alpha,5alpha,6beta(s*)))- but generally known as bacampicillin, which bears us nih compound identifier 39849. bacampicillin most often comes in base and hydrochloride forms. european medicines agency schedules bacampicillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05666mig. the term bacampicillin is an international non-proprietary name. world health organization schedules bacampicillin in its anatomical therapeutic chemical (atc) classification. bacampicillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bacampicillin under hs 29411090 and sitc 54131. as of q4 2014, bacampicillin remains the us fda preferred term for this commodity. bacampicillin bears us nlm identifiers umls id c0052865 and nci concept code c65245. smiles: s1c2n(c(c1(c)c)c(=o)oc(oc(=o)occ)c)c(=o)c2nc(=o)c(n)c1ccccc1.. "
"aminopenicillins. this classification denotes third-generation and semi-synthetic penicillins and antibiotics that evince activity against penicillin-sensitive gram-positive bacteria and some gram-negative bacteria, generally called amino-penicillins or aminopenicillins, such as ampicillin.. ciclacillin or cyclacillin or gloximonam. this classification denotes a penicillin antibiotic with the molecular formula c15h23n3o4s, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 72zj154x86, chemically known as 6-(1-aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid but more generally known as ciclacillin, which bears u.s. national institutes of health compound identifier 19003. the european medicines agency schedules ciclacillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06232mig. the term ciclacillin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 26, no. 10 1972, list 12). ciclacillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)c3(ccccc3)n)c(=o)o)c.. "
"aminopenicillins. this classification denotes third-generation and semi-synthetic penicillins and antibiotics that evince activity against penicillin-sensitive gram-positive bacteria and some gram-negative bacteria, generally called amino-penicillins or aminopenicillins, such as ampicillin.. sarmoxicillin. this classification denotes a penicillin antibiotic with the molecular formula c21h27n3o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier r15k9z4384, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(4-(4-hydroxyphenyl)-2,2-dimethyl-5-oxo-1-imidazolidinyl)-3,3-dimethyl-7-oxo-, methoxymethyl ester, (2s-(2alpha,5alpha,6beta))- but generally known as sarmoxicillin, which bears us nih compound identifier 49808. european medicines agency schedules sarmoxicillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10453mig. the term sarmoxicillin is an international non-proprietary name or inn (see who inn reference publication, volume 33, no. 10 1979, list 19). sarmoxicillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sarmoxicillin under hs 29411090 and sitc 54131. as of q4 2014, sarmoxicillin remains the us fda preferred term for this commodity. sarmoxicillin bears us nlm identifiers umls id c0614192 and nci concept code c82302. smiles: s1c2n(c(c1(c)c)c(=o)ococ)c(=o)c2n1c(nc(c1=o)c1ccc(o)cc1)(c)c.. "
"aminopenicillins. this classification denotes third-generation and semi-synthetic penicillins and antibiotics that evince activity against penicillin-sensitive gram-positive bacteria and some gram-negative bacteria, generally called amino-penicillins or aminopenicillins, such as ampicillin.. sultamicillin. this classification denotes an anti-bacterial agent and ampicillin with the molecular formula c25h30n4o9s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 65dt0ml581, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, (((3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-2-yl)carbonyl)oxy)methyl ester, s,s-dioxide, (2s-(2alpha(2r*,5s*),5alpha,6beta(s*)))- but generally known as sultamicillin, which bears us nih compound identifier 53512. european medicines agency schedules sultamicillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10761mig. world health organization schedules sultamicillin in its anatomical therapeutic chemical (atc) classification. sultamicillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sultamicillin under hs 29411090 and sitc 54131. as of q4 2014, sultamicillin remains the us fda preferred term for this commodity. smiles: s1(=o)(=o)c(c(n2c1cc2=o)c(=o)ococ(=o)c1n2c(sc1(c)c)c(nc(=o)c(n)c1ccccc1)c2=o)(c)c.. "
"aminopenicillins. this classification denotes third-generation and semi-synthetic penicillins and antibiotics that evince activity against penicillin-sensitive gram-positive bacteria and some gram-negative bacteria, generally called amino-penicillins or aminopenicillins, such as ampicillin.. talampicillin. this classification denotes an anti-bacterial agent and ampicillin with the molecular formula c24h23n3o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 29oji73dpc, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, 1,3-dihydro-3-oxo-1-isobenzofuranyl ester, (2s-(2alpha,5alpha,6beta(s*)))- but generally known as talampicillin, which bears us nih compound identifier 39480. european medicines agency schedules talampicillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10800mig. world health organization schedules talampicillin in its anatomical therapeutic chemical (atc) classification. talampicillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule talampicillin under hs 29411090 and sitc 54131. as of q4 2014, talampicillin remains the us fda preferred term for this commodity. smiles: s1c2n(c(c1(c)c)c(=o)oc1oc(=o)c3c1cccc3)c(=o)c2nc(=o)c(n)c1ccccc1.. "
"aminopenicillins. this classification denotes third-generation and semi-synthetic penicillins and antibiotics that evince activity against penicillin-sensitive gram-positive bacteria and some gram-negative bacteria, generally called amino-penicillins or aminopenicillins, such as ampicillin.. amoxicillin anhydrous. this classification denotes a penicillin antibiotic with the molecular formula c16h19n3o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9em05410q9, chemically known as amoxicillin (anhydrous), but more generally known as amoxicillin anhydrous, which bears us nih compound identifier 33613. european medicines agency schedules amoxicillin anhydrous or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05481mig. most nations, for tariff purposes, schedule amoxicillin anhydrous under hs 29411010. amoxicillin anhydrous bears us nlm identifiers umls id c2828282 and nci concept code c87367. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)[c@@h](c3ccc(cc3)o)n)c(=o)o)c.. "
"aminopenicillins. this classification denotes third-generation and semi-synthetic penicillins and antibiotics that evince activity against penicillin-sensitive gram-positive bacteria and some gram-negative bacteria, generally called amino-penicillins or aminopenicillins, such as ampicillin.. amoxicillin hydrate. this classification denotes a penicillin antibiotic with the molecular formula c16h19n3o5s.3h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 804826j2hu, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((amino(4-hydroxyphenyl)acetyl)amino)-3,3-dimethyl-7-oxo-, trihydrate(2s-(2.alpha.,5.alpha.,6.beta.(s*)))-, but more generally known as amoxicillin hydrate, which bears us nih compound identifier 62883. european medicines agency schedules amoxicillin hydrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05481mig. most nations, for tariff purposes, schedule amoxicillin hydrate under hs 29411010. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)[c@@h](c3ccc(cc3)o)n)c(=o)o)c.o.o.o.. "
"aminopenicillins. this classification denotes third-generation and semi-synthetic penicillins and antibiotics that evince activity against penicillin-sensitive gram-positive bacteria and some gram-negative bacteria, generally called amino-penicillins or aminopenicillins, such as ampicillin.. amoxicillin sodium. this classification denotes a penicillin antibiotic with the molecular formula c16h18n3o5s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 544y3d6myh, chemically known as sodium (2s-(2alpha,5alpha,6beta(s*)))-6-((amino(4-hydroxyphenyl)acetyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate but more generally known as amoxicillin sodium, which bears us nih compound identifier 91616. amoxicillin most often comes in base, anhydrous, hydrate, natrium, sodium, and trihydrate forms and is often combined with clavulinic acid. european medicines agency schedules amoxicillin sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00503mig. most nations, for tariff and trade purposes, schedule amoxicillin sodium under hs 29411010 and sitc 54131. as of q4 2014, amoxicillin sodium remains us fdas preferred term for this commodity. amoxicillin sodium bears us nlm identifiers umls id c0887551 and nci concept code c72700. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)[c@@h](c3ccc(cc3)o)n)c(=o)[o-])c.[na+].. "
"aminopenicillins. this classification denotes third-generation and semi-synthetic penicillins and antibiotics that evince activity against penicillin-sensitive gram-positive bacteria and some gram-negative bacteria, generally called amino-penicillins or aminopenicillins, such as ampicillin.. amoxicillin trihydrate. this classification denotes a penicillin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 804826j2hu. european medicines agency schedules amoxicillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05481mig. amoxicillin generally arises in the molecular formula c16h19n3o5s. the term amoxicillin is a european pharmacopoeia designation. amoxicillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule amoxicillin trihydrate under hs 29411010 and sitc 54131. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)[c@@h](c3ccc(cc3)o)n)c(=o)o)c.o.o.o.. "
"aminopenicillins. this classification denotes third-generation and semi-synthetic penicillins and antibiotics that evince activity against penicillin-sensitive gram-positive bacteria and some gram-negative bacteria, generally called amino-penicillins or aminopenicillins, such as ampicillin.. ampicillin anhydrous. this classification denotes a penicillin antibiotic with the molecular formula c16h19n3o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7c782967rd, chemically known as penicillin, (aminophenylmethyl)- but more generally known as ampicillin, which bears us nih compound identifier 2174. ampicillin comes in various forms, including a, acid, anhydrate, anhydrous, base, benzathine, hydrate, natrium, n,n-dibenzylethylenediamine salt, pivaloyloxymethyl ester, pivaloyloxymethyl ester hydrochloride, potassium, sodium, and trihydrate and is often combined with cloxacillin and dicloxacillin sodium. european medicines agency schedules ampicillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05487mig. the term ampicillin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 22, no. 10, 1968, list 8). world health organization schedules ampicillin in its anatomical therapeutic chemical (atc) classification. ampicillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule ampicillin anhydrous under hs 29411020. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)[c@@h](c3ccccc3)n)c(=o)o)c.. "
"aminopenicillins. this classification denotes third-generation and semi-synthetic penicillins and antibiotics that evince activity against penicillin-sensitive gram-positive bacteria and some gram-negative bacteria, generally called amino-penicillins or aminopenicillins, such as ampicillin.. ampicillin benzathine. this classification denotes a penicillin antibiotic with the molecular structure c16h20n2.2c16h19n3o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, e1td7am884 chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((2r)-2-amino-2-phenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2s,5r,6r)-, compd. with n,n-bis(phenylmethyl)-1,2-ethanediamine (2:1), but more commonly known as ampicillin benzathine, which bears us nih compound identifier 94447. european medicines agency schedules ampicillin benzathine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00506mig. most nations, for tariff and trade purposes, schedule ampicillin benzathine under hs 29411020 and sitc 54131. as of q4 2014, ampicillin benzathine remains us fdas preferred term for this commodity. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)[c@@h](c3ccccc3)n)c(=o)o)c.cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)[c@@h](c3ccccc3)n)c(=o)o)c.c1ccc(cc1)cnccncc2ccccc2.. "
"aminopenicillins. this classification denotes third-generation and semi-synthetic penicillins and antibiotics that evince activity against penicillin-sensitive gram-positive bacteria and some gram-negative bacteria, generally called amino-penicillins or aminopenicillins, such as ampicillin.. ampicillin sodium. this classification denotes a penicillin antibiotic with the molecular formula c16h18n3o4s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier jfn36l5s8k, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, monosodium salt, (2s-(2alpha,5alpha,6beta(s*)))- but more generally known as ampicillin sodium, which bears us nih compound identifier 6248. the base compound also comes in various forms, including a, acid, anhydrate, anhydrous, base, benzathine, hydrate, natrium, n,n-dibenzylethylenediamine salt, pivaloyloxymethyl ester, pivaloyloxymethyl ester hydrochloride, potassium, and trihydrate and is often combined with cloxacillin and dicloxacillin sodium. european medicines agency schedules ampicillin sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00508mig. most nations, for tariff and trade purposes, schedule ampicillin sodium under hs 29411020 and sitc 54131. as of q4 2014, ampicillin sodium remains us fdas preferred term for this commodity. ampicillin sodium bears us nlm identifiers umls id c0282052 and nci concept code c47959. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)[c@@h](c3ccccc3)n)c(=o)[o-])c.[na+].. "
"aminopenicillins. this classification denotes third-generation and semi-synthetic penicillins and antibiotics that evince activity against penicillin-sensitive gram-positive bacteria and some gram-negative bacteria, generally called amino-penicillins or aminopenicillins, such as ampicillin.. ampicillin trihydrate. this classification denotes a penicillin antibiotic with the molecular formula c16h19n3o4s.3h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hxq6a1n7r6. european medicines agency schedules ampicillin trihydrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00509mig. the term ampicillin trihydrate is a u.s. fda designation. most nations, for tariff and trade purposes, schedule ampicillin trihydrate under hs 29411020 and sitc 54131. as of q4 2014, ampicillin trihydrate remains us fdas preferred term for this commodity. ampicillin trihydrate bears us nlm identifiers umls id c0700443 and nci concept code c47960. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)[c@@h](c3ccccc3)n)c(=o)o)c.o.o.o.. "
"aminopenicillins. this classification denotes third-generation and semi-synthetic penicillins and antibiotics that evince activity against penicillin-sensitive gram-positive bacteria and some gram-negative bacteria, generally called amino-penicillins or aminopenicillins, such as ampicillin.. bacampicillin hydrochloride. this classification denotes a penicillin antibiotic with the molecular formula c21h27n3o7s.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier pm034u953t, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, 1-((ethoxycarbonyl)oxy)ethyl ester, monohydrochloride, (2s-(2alpha,5alpha,6beta(s*)))- but more generally known as bacampicillin hydrochloride, which bears us nih compound identifier 71429. european medicines agency schedules bacampicillin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00649mig. most nations, for tariff and trade purposes, schedule bacampicillin hydrochloride under hs 29411090 and sitc 54131. as of q4 2014, bacampicillin hydrochloride remains us fdas preferred term for this commodity. bacampicillin hydrochloride bears us nlm identifiers umls id c1122338 and nci concept code c65246. smiles: ccoc(=o)oc(c)oc(=o)[c@h]1c(s[c@h]2n1c(=o)[c@h]2nc(=o)[c@@h](c3ccccc3)n)(c)c.cl.. "
"aminopenicillins. this classification denotes third-generation and semi-synthetic penicillins and antibiotics that evince activity against penicillin-sensitive gram-positive bacteria and some gram-negative bacteria, generally called amino-penicillins or aminopenicillins, such as ampicillin.. lenampicillin hydrochloride. this classification denotes a penicillin antibiotic c21h23n3o7s.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6u90e2wb40, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((2r)-2-amino-2-phenylacetyl)amino)-3,3-dimethyl-7-oxo-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester, hydrochloride (1:1), (2s,5r,6r)-, but more generally known as lenampicillin hydrochloride, which bears us nih compound identifier 6917773. european medicines agency schedules lenampicillin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02887mig. most nations, for tariff and trade purposes, schedule lenampicillin hydrochloride under hs 29411090 and sitc 54131. as of q4 2014, lenampicillin hydrochloride remains us fdas preferred term for this commodity. smiles: cc1c(oc(=o)o1)coc(=o)[c@h]2c(s[c@h]3n2c(=o)[c@h]3nc(=o)[c@@h](c4ccccc4)n)(c)c.cl.. "
"aminopenicillins. this classification denotes third-generation and semi-synthetic penicillins and antibiotics that evince activity against penicillin-sensitive gram-positive bacteria and some gram-negative bacteria, generally called amino-penicillins or aminopenicillins, such as ampicillin.. talampicillin hydrochloride. this classification denotes an anti-bacterial agent and ampicillin c24h23n3o6s.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4c5o3x072i, chemically known as (2s,5r,6r)-6-((r)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid ester with 3-hydroxyphthalide, monohydrochloride, but more generally known as talampicillin hydrochloride, which bears us nih compound identifier 71446. european medicines agency schedules talampicillin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15449mig. most nations, for tariff and trade purposes, schedule talampicillin hydrochloride under hs 29411090 and sitc 54131. as of q4 2014, talampicillin hydrochloride remains us fdas preferred term for this commodity. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)[c@@h](c3ccccc3)n)c(=o)oc4c5ccccc5c(=o)o4)c.cl.. "
"anthracyclines. this classification denotes antibiotics that bear a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.. . "
"anthracyclines. this classification denotes antibiotics that bear a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.. idarubicin. this classification denotes an anthracycline antibiotic with the molecular formula c26h27no9, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier zrp63d75jw, chemically known as 5,12-naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7s-cis)- but generally known as idarubicin, which bears us nih compound identifier 42890. european medicines agency schedules idarubicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08111mig. the term idarubicin is an international non-proprietary name. world health organization schedules idarubicin in its anatomical therapeutic chemical (atc) classification. idarubicin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule idarubicin under hs 29419000 and sitc 54139. as of q4 2014, idarubicin remains the us fda preferred term for this commodity. idarubicin bears us nlm identifiers umls id c0020789 and nci concept code c562. smiles: o(c1cc(o)(cc2c1c(o)c1c(c2o)c(=o)c2c(c1=o)cccc2)c(=o)c)c1oc(c(o)c(n)c1)c.. "
"anthracyclines. this classification denotes antibiotics that bear a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.. aclarubicin or aclacinomycin a. this classification denotes an aclacinomycin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 74kxf8i502. european medicines agency schedules aclarubicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05243mig. aclarubicin generally arises in the molecular formula c42h53no15. the term aclarubicin is an international non-proprietary name or inn. aclarubicin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: o(c1cc(o)(c(c2c1c(o)c1c(c2)c(=o)c2c(c1=o)c(o)ccc2)c(=o)oc)cc)c1oc(c(oc2oc(c(oc3oc(c(=o)cc3)c)c(o)c2)c)c(n(c)c)c1)c.. "
"anthracyclines. this classification denotes antibiotics that bear a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.. epirubicin. this classification denotes an anthracycline antibiotic with the molecular formula c27h29no11, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3z8479zz5x, chemically known as 5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-beta-l-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8s-cis)- but generally known as epirubicin, which bears us nih compound identifier 41867. european medicines agency schedules epirubicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06571mig. the term epirubicin is an international non-proprietary name. world health organization schedules epirubicin in its anatomical therapeutic chemical (atc) classification. epirubicin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule epirubicin under hs 29419000 and sitc 54139. as of q4 2014, epirubicin remains the us fda preferred term for this commodity. epirubicin bears us nlm identifiers umls id c0014582 and nci concept code c62028. smiles: o(c1cc(o)(cc2c1c(o)c1c(c2o)c(=o)c2c(c1=o)c(oc)ccc2)c(=o)co)c1oc(c(o)c(n)c1)c.. "
"anthracyclines. this classification denotes antibiotics that bear a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.. carubicin. this classification denotes an anthracycline antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier e7437k3983. european medicines agency schedules carubicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06151mig. carubicin generally arises in the molecular formula c26h27no10. the term carubicin is an international non-proprietary name or inn (see who inn reference publication, volume 33, no. 10 1979, list 19.) carubicin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule carubicin under hs 29419000 and sitc 54139. as of q4 2014, carubicin remains the us fda preferred term for this commodity. carubicin bears us nlm identifiers umls id c0007308 and nci concept code c352. smiles: o(c1cc(o)(cc2c1c(o)c1c(c2o)c(=o)c2c(c1=o)c(o)ccc2)c(=o)c)c1oc(c(o)c(n)c1)c.. "
"anthracyclines. this classification denotes antibiotics that bear a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.. daunorubicin. this classification denotes an anthracycline antibiotic with the molecular formula c27h29no10, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier zs7284e0zp, chemically known as 5,12-naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8s-cis)- but generally known as daunorubicin, which bears us nih compound identifier 30323. european medicines agency schedules daunorubicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06917mig. the term daunorubicin is an international non-proprietary name or inn (see who inn reference publication, volume 34, no. 10 1980, list 20). world health organization schedules daunorubicin in its anatomical therapeutic chemical (atc) classification. daunorubicin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule daunorubicin under hs 29419000 and sitc 54139. as of q4 2014, daunorubicin remains the us fda preferred term for this commodity. daunorubicin bears us nlm identifiers umls id c0011015 and nci concept code c62091. smiles: o(c1cc(o)(cc2c1c(o)c1c(c2o)c(=o)c2c(c1=o)c(oc)ccc2)c(=o)c)c1oc(c(o)c(n)c1)c.. "
"anthracyclines. this classification denotes antibiotics that bear a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.. doxorubicin. this classification denotes a doxorubicin preparation with the molecular formula c27h29no11, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 80168379ag, chemically known as 3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-naphthacenyl 3-amino-2,3,6-trideoxyhexopyranoside but generally known as doxorubicin, which bears us nih compound identifier 1691. european medicines agency schedules doxorubicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06391mig. the term doxorubicin is an international non-proprietary name or inn (see who inn reference publication, volume 25 , no. 10 1971, list 11). world health organization schedules doxorubicin in its anatomical therapeutic chemical (atc) classification. doxorubicin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule doxorubicin under hs 29419000 and sitc 54139. as of q4 2014, doxorubicin remains the us fda preferred term for this commodity. doxorubicin bears us nlm identifiers umls id c0013089 and nci concept code c456. smiles: o(c1cc(o)(cc2c1c(o)c1c(c2o)c(=o)c2c(c1=o)c(oc)ccc2)c(=o)co)c1oc(c(o)c(n)c1)c.. "
"anthracyclines. this classification denotes antibiotics that bear a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.. amrubicin. this classification denotes an anthracycline antibiotic with the molecular formula c25h25no9, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 93n13lb4z2, chemically known as ( -)-(7s,9s)-9-acetyl-9-amino-7-((2-deoxy-beta-d-erythro-pentopyranosyl)oxy)-7,8,9,10-tetrahydro-6,11-dihydroxy-5,12-naphthacenedione but generally known as amrubicin, which bears us nih compound identifier 178149. amrubicin most often comes in base and hydrochloride forms. european medicines agency schedules amrubicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05494mig. the term amrubicin is an international non-proprietary name or inn (see who inn reference publication, volume 6, no, 3 1992, list 32). world health organization schedules amrubicin in its anatomical therapeutic chemical (atc) classification. amrubicin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule amrubicin under hs 29419000 and sitc 54139. as of q4 2014, amrubicin remains the us fda preferred term for this commodity. amrubicin bears us nlm identifiers umls id cl405282 and nci concept code c80089. smiles: o(c1cc(n)(cc2c1c(o)c1c(c2o)c(=o)c2c(c1=o)cccc2)c(=o)c)c1occ(o)c(o)c1.. "
"anthracyclines. this classification denotes antibiotics that bear a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.. esorubicin. this classification denotes an anthracycline antibiotic with the molecular formula c27h29no10, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, rmc41l2wq3 chemically known as 5,12-naphthacenedione, 10-((4-aminotetrahydro-6-methyl-2h-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (2s-(2.alpha,(8r*,10r*),4.beta.,6.beta))- but generally known as esorubicin, which bears us nih compound identifier 44554. european medicines agency schedules esorubicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12442mig. the term esorubicin is an international non-proprietary name or inn. most nations schedule esorubicin under hs 29419000 and sitc 54139. as of q4 2014, esorubicin remains the us fda preferred term for this commodity. esorubicin bears us nlm identifiers umls id c0047760 and nci concept code c972. smiles: o(c1cc(o)(cc2c1c(o)c1c(c2o)c(=o)c2c(c1=o)c(oc)ccc2)c(=o)co)c1oc(cc(n)c1)c.. "
"anthracyclines. this classification denotes antibiotics that bear a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.. mitoxantrone. this classification denotes an anthraquinone compound with the molecular formula c22h28n4o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier bz114nvm5p, chemically known as 9,10-anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)- (9ci) but generally known as mitoxantrone, which bears us nih compound identifier 4212. european medicines agency schedules mitoxantrone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09012mig. the term mitoxantrone is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21). world health organization schedules mitoxantrone in its anatomical therapeutic chemical (atc) classification. mitoxantrone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mitoxantrone under hs 29225000 and sitc 51467. as of q4 2014, mitoxantrone remains the us fda preferred term for this commodity. mitoxantrone bears us nlm identifiers umls id c0026259 and nci concept code c62050. smiles: o=c1c2c(c(nccncco)ccc2nccncco)c(=o)c2c1c(o)ccc2o.. "
"anthracyclines. this classification denotes antibiotics that bear a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.. valrubicin. this classification denotes an anthracycline antibiotic with the molecular formula c34h36f3no13, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2c6num6878, chemically known as pentanoic acid, 2-((2s,4s)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-((2,3,6-trideoxy-3-((trifluoroacetylamino)-, alpha-l-lysohexopyranoxyl)oxy)-2-naphthacenyl)-2-oxoethyl ester but generally known as valrubicin, which bears us nih compound identifier 41744. european medicines agency schedules valrubicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05075mig. the term valrubicin is an international non-proprietary name or inn (see who inn reference publication, volume 13 no. 1, 1999, list 41). world health organization schedules valrubicin in its anatomical therapeutic chemical (atc) classification. most nations schedule valrubicin under hs 29419000 and sitc 54139. as of q4 2014, valrubicin remains the us fda preferred term for this commodity. valrubicin bears us nlm identifiers umls id c0068314 and nci concept code c1340. smiles: fc(f)(f)c(=o)nc1cc(oc2cc(o)(cc3c2c(o)c2c(c3o)c(=o)c3c(c2=o)c(oc)ccc3)c(=o)coc(=o)cccc)oc(c1o)c.. "
"anthracyclines. this classification denotes antibiotics that bear a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.. detorubicin. this classification denotes an anthracycline antibiotic with the molecular formula c33h39no14, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 822ec3xejz, chemically known as glyoxylic acid 3(sup 2)-ester with doxorubicin, 2-(diethyl acetal) but generally known as detorubicin, which bears us nih compound identifier 114806. european medicines agency schedules detorubicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07013mig. the term detorubicin is an international non-proprietary name or inn (see who inn reference publication, volume 33, no. 10 1979, list 19). detorubicin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule detorubicin under hs 29419000 and sitc 54139. as of q4 2014, detorubicin remains the us fda preferred term for this commodity. detorubicin bears us nlm identifiers umls id c0057578 and nci concept code c1066. smiles: o(c1cc(o)(cc2c1c(o)c1c(c2o)c(=o)c2c(c1=o)c(oc)ccc2)c(=o)coc(=o)c(occ)occ)c1oc(c(o)c(n)c1)c.. "
"anthracyclines. this classification denotes antibiotics that bear a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.. zorubicin. this classification denotes an anthracycline antibiotic with the molecular formula c34h35n3o10, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier v25f9362op, chemically known as rp-22,050 hydrochloride but generally known as zorubicin, which bears us nih compound identifier 6540456. european medicines agency schedules zorubicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00190mig. the term zorubicin is an international non-proprietary name or inn (see who inn reference publication, volume 32, no 10 1978, list 18). world health organization schedules zorubicin in its anatomical therapeutic chemical (atc) classification. zorubicin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule zorubicin under hs 29419000 and sitc 54139. as of q4 2014, zorubicin remains the us fda preferred term for this commodity. zorubicin bears us nlm identifiers umls id cl421815 and nci concept code c91365. smiles: o(c1cc(o)(cc2c1c(o)c1c(c2o)c(=o)c2c(c1=o)c(oc)ccc2)/c(=n/nc(=o)c1ccccc1)c)c1oc(c(o)c(n)c1)c.. "
"anthracyclines. this classification denotes antibiotics that bear a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.. aclarubicin hydrochloride. this classification denotes an aclacinomycin antibiotic with the molecular formula c42h53no15.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 501948ri66, chemically known as 1-naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-((2,3,6-trideoxy-4-o-(2,6-dideoxy-4-o-((2r-trans)-tetrahydro-6-methyl-5-oxo-2h-pyran-2-yl)-alpha-l-lyxo-hexopyranosyl)-3-(dimethylamino)-alpha-l-lyxo-hexopyranosyl)oxy)-, methyl ester, hydrochloride, (1r-(1alpha,2beta,4beta))- but more generally known as aclarubicin hydrochloride, which bears us nih compound identifier 153751. the base compound, aclarubicin, arises in both base and hydrochloride forms. european medicines agency schedules aclarubicin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00285mig. most nations, for tariff and trade purposes, schedule aclarubicin hydrochloride under hs 29419000. as of q4 2014, aclarubicin hydrochloride remains us fdas preferred term for this commodity. aclarubicin hydrochloride bears us nlm identifiers umls id c0591033 and nci concept code c95830. smiles: cc[c@]1(c[c@@h](c2c(cc3c(c2o)c(=o)c4c(cccc4o)c3=o)[c@h]1c(=o)oc)o[c@h]5c[c@@h]([c@@h]([c@@h](o5)c)o[c@h]6c[c@@h]([c@@h]([c@@h](o6)c)o[c@h]7ccc(=o)[c@@h](o7)c)o)n(c)c)o.cl.. "
"anthracyclines. this classification denotes antibiotics that bear a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.. amrubicin hydrochloride. this classification denotes an anthracycline antibiotic with the molecular formula c25h25no9.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier eul6mp8fzw, chemically known as 5,12-naphthacenedione, 9-acetyl-7-((2-deoxy-beta-d-erythro-pentopyranosyl)oxy)-7,8,9,10-tetrahydro-6,11-dihydroxy-, hydrochloride, (7s,9s)- but more generally known as amrubicin hydrochloride, which bears us nih compound identifier 114897. european medicines agency schedules amrubicin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20586. most nations, for tariff and trade purposes, schedule amrubicin hydrochloride under hs 29419000 and sitc 54139. as of q4 2014, amrubicin hydrochloride remains us fdas preferred term for this commodity. amrubicin hydrochloride bears us nlm identifiers umls id c0762659 and nci concept code c47948. smiles: cc(=o)[c@@]1(cc2c(c(c3c(c2o)c(=o)c4ccccc4c3=o)o)[c@h](c1)o[c@h]5c[c@@h]([c@@h](co5)o)o)n.cl.. "
"anthracyclines. this classification denotes antibiotics that bear a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.. carubicin hydrochloride. this classification denotes the hydrochloride form of an anthracycline antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier e7437k3983. european medicines agency schedules carubicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06151mig. carubicin generally arises in the molecular formula c26h27no10. the term carubicin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 33, no. 10 1979, list 19.) carubicin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule carubicin hydrochloride under hs 29419000 and sitc 54139. as of q4 2014, carubicin hydrochloride remains us fdas preferred term for this commodity. carubicin hydrochloride bears us nlm identifiers umls id c0282089 and nci concept code c1582. smiles: c[c@h]1[c@h]([c@h](c[c@@h](o1)o[c@h]2c[c@@](cc3c2c(c4c(c3o)c(=o)c5cccc(c5c4=o)o)o)(c(=o)c)o)n)o.cl.. "
"anthracyclines. this classification denotes antibiotics that bear a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.. daunorubicin aglycone. this classification denotes an anthracycline antibiotic with the molecular formula c21h18o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fn5680x78x, chemically known as 5,12-naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-1-methoxy-, (8s,10s)-, but more generally known as daunorubicin aglycone, which bears us nih compound identifier 83843. european medicines agency schedules daunorubicin aglycone or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06917mig. most nations, for tariff purposes, schedule daunorubicin aglycone under hs 29419000. smiles: cc(=o)[c@@]1(cc2c(c(c3c(c2o)c(=o)c4cccc(c4c3=o)oc)o)[c@h](c1)o)o.. "
"anthracyclines. this classification denotes antibiotics that bear a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.. doxorubicin aglycone. this classification denotes a doxorubicin preparation with the molecular formula c21h18o9, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x023t6c35l, chemically known as 5,12-naphthacenedione, 7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-8-(2-hydroxyacetyl)-1-methoxy-, (8s,10s)-, but more generally known as doxorubicin aglycone, which bears us nih compound identifier 72401. european medicines agency schedules doxorubicin aglycone or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06391mig. most nations, for tariff purposes, schedule doxorubicin aglycone under hs 29419000. smiles: coc1cccc2c1c(=o)c3c(c(c4c(c3o)[c@h](c[c@@](c4)(c(=o)co)o)o)o)c2=o.. "
"anthracyclines. this classification denotes antibiotics that bear a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.. doxorubicin hydrochloride. this classification denotes a doxorubicin preparation with the molecular formula c27h29no11.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 82f2g7bl4e, chemically known as 3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-naphthacenyl 3-amino-2,3,6-trideoxyhexopyranoside but more generally known as doxorubicin hydrochloride, which bears us nih compound identifier 1691. european medicines agency schedules doxorubicin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01827mig. most nations, for tariff and trade purposes, schedule doxorubicin hydrochloride under hs 29419000 and sitc 54139. as of q4 2014, doxorubicin hydrochloride remains us fdas preferred term for this commodity. doxorubicin hydrochloride bears us nlm identifiers umls id c0085752 and nci concept code c1326. smiles: c[c@h]1[c@h]([c@h](c[c@@h](o1)o[c@h]2c[c@@](cc3c2c(c4c(c3o)c(=o)c5cccc(c5c4=o)oc)o)(c(=o)co)o)n)o.cl.. "
"anthracyclines. this classification denotes antibiotics that bear a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.. epirubicin hydrochloride. this classification denotes an antineoplastic antibiotic with the molecular formula c27h29no11.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 22966tx7j5, chemically known as 5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxylacetyl)-1-methoxy-, hydrochloride (8s-cis)- but more generally known as epirubicin hydrochloride, which bears us nih compound identifier 32874. european medicines agency schedules epirubicin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01915mig. most nations, for tariff and trade purposes, schedule epirubicin hydrochloride under hs 29419000 and sitc 54139. as of q4 2014, epirubicin hydrochloride remains us fdas preferred term for this commodity. epirubicin hydrochloride bears us nlm identifiers umls id c0701345 and nci concept code c474. smiles: c[c@h]1[c@@h]([c@h](c[c@@h](o1)o[c@h]2c[c@@](cc3c2c(c4c(c3o)c(=o)c5cccc(c5c4=o)oc)o)(c(=o)co)o)n)o.cl.. "
"anthracyclines. this classification denotes antibiotics that bear a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.. esorubicin hydrochloride. this classification denotes an anthracycline antibiotic c27h29no10.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2ub1jjt82d, chemically known as (8s,10s)-10-(((2s,4r,6s)-4-aminotetrahydro-6-methyl-2h-pyran-2-yl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride, but more generally known as esorubicin hydrochloride, which bears us nih compound identifier 152035. most nations, for tariff and trade purposes, schedule esorubicin hydrochloride under hs 29419000 and sitc 54139. as of q4 2014, esorubicin hydrochloride remains us fdas preferred term for this commodity. esorubicin hydrochloride bears us nlm identifiers umls id c2700018 and nci concept code c74943. smiles: c[c@h]1c[c@h](c[c@@h](o1)o[c@h]2c[c@@](cc3c2c(c4c(c3o)c(=o)c5cccc(c5c4=o)oc)o)(c(=o)co)o)n.cl.. "
"anthracyclines. this classification denotes antibiotics that bear a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.. idarubicin hydrochloride. this classification denotes an anthracycline antibiotic with the molecular formula c26h27no9.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5vv3mdu5ie, chemically known as daunomycin, 4-demethoxy-, hydrochloride but more generally known as idarubicin hydrochloride, which bears us nih compound identifier 3685. european medicines agency schedules idarubicin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02635mig. most nations, for tariff and trade purposes, schedule idarubicin hydrochloride under hs 29419000 and sitc 54139. as of q4 2014, idarubicin hydrochloride remains us fdas preferred term for this commodity. idarubicin hydrochloride bears us nlm identifiers umls id c0086450 and nci concept code c1587. smiles: c[c@h]1[c@h]([c@h](c[c@@h](o1)o[c@h]2c[c@@](cc3c2c(c4c(c3o)c(=o)c5ccccc5c4=o)o)(c(=o)c)o)n)o.cl.. "
"anthracyclines. this classification denotes antibiotics that bear a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.. mitoxantrone dihydrochloride. this classification denotes an anthraquinone compound with the molecular formula c22h28n4o6.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u6usw86rd0, chemically known as 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)anthraquinone dihydrochloride, but more generally known as mitoxantrone dihydrochloride, which bears us nih compound identifier 4212. european medicines agency schedules mitoxantrone dihydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09012mig. most nations, for tariff purposes, schedule mitoxantrone dihydrochloride under hs 29225000. smiles: c1cc(c2c(c1nccncco)c(=o)c3c(ccc(c3c2=o)o)o)nccncco.cl.cl.. "
"anthracyclines. this classification denotes antibiotics that bear a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.. mitoxantrone hydrochloride. this classification denotes an anthracenedione-derived antineoplastic agent, analgesic, and anthraquinone with the molecular formula c22h28n4o6.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u6usw86rd0, chemically known as 9,10-anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)- (9ci) but more generally known as mitoxantrone hydrochloride, which bears us nih compound identifier 4212. european medicines agency schedules mitoxantrone hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03309mig. most nations, for tariff and trade purposes, schedule mitoxantrone hydrochloride under hs 29225000 and sitc 51467. as of q4 2014, mitoxantrone hydrochloride remains us fdas preferred term for this commodity. mitoxantrone hydrochloride bears us nlm identifiers umls id c1513359 and nci concept code c665. smiles: c1cc(c2c(c1nccncco)c(=o)c3c(ccc(c3c2=o)o)o)nccncco.cl.cl.. "
"anthracyclines. this classification denotes antibiotics that bear a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.. zorubicin hydrochloride. this classification denotes an anthracycline antibiotic with the molecular formula c34h35n3o10.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier wxm8d9m6de, chemically known as rp-22,050 hydrochloride but more generally known as zorubicin hydrochloride, which bears us nih compound identifier 6540456. european medicines agency schedules zorubicin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05194mig. most nations, for tariff and trade purposes, schedule zorubicin hydrochloride under hs 29419000 and sitc 54139. as of q4 2014, zorubicin hydrochloride remains us fdas preferred term for this commodity. zorubicin hydrochloride bears us nlm identifiers umls id c0206788 and nci concept code c1458. smiles: c[c@h]1[c@h]([c@h](c[c@@h](o1)o[c@h]2c[c@@](cc3c2c(c4c(c3o)c(=o)c5cccc(c5c4=o)oc)o)(c(=nnc(=o)c6ccccc6)c)o)n)o.cl.. "
"antineoplastics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. . "
"antineoplastics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. geranylhydroquinone or geroquinol. this classification denotes a quinolone antibiotic and antineoplastic antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4155989dn5. european medicines agency schedules geroquinol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07898mig. geroquinol generally arises in the molecular formula c16h22o2. the term geroquinol is an international non-proprietary name or inn (see who inn reference publication, volume 23, no. 10 1969, list 9.) geroquinol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. geranylhydroquinone or geroquinol bears us nlm identifiers umls id c0061232 and nci concept code c72639. smiles: cc(=ccc/c(=c/cc1=c(c=cc(=c1)o)o)/c)c.. "
"antineoplastics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. rifabutin. this classification denotes a heat shock protein inhibitor and antineoplastic antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1w306tda6s. european medicines agency schedules rifabutin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10304mig. rifabutin generally arises in the molecular formula c46h62n4o11. the term rifabutin is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25.) rifabutin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule rifabutin under hs 29419000 and sitc 54139. as of q4 2014, rifabutin remains the us fda preferred term for this commodity. rifabutin bears us nlm identifiers umls id c0140575 and nci concept code c1408. smiles: o(c1c(c(o)c(c(o)c(c)c=cc=c(c(=o)nc2=c3nc4(n=c3c3c(c2=o)c(o)c(c2oc(oc=cc(oc)c1c)(c(=o)c32)c)c)ccn(cc4)cc(c)c)c)c)c)c(=o)c.. "
"antineoplastics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. nemorubicin. this classification denotes an anthracycline antibiotic with the molecular formula c32h37no13, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7618o47bqm, chemically known as 5,12-naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-((2,3,6-trideoxy-3-(2-methoxy-4-morpholinyl)-alpha-l-lyxo-hexopyranosyl)oxy)-, (8s-cis)- but generally known as nemorubicin, which bears us nih compound identifier 65907. european medicines agency schedules nemorubicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09192mig. the term nemorubicin is an international non-proprietary name or inn (see who inn reference publication, volume 9, no. 3, 1995, list 35). nemorubicin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nemorubicin under hs 29419000 and sitc 54139. as of q4 2014, nemorubicin remains the us fda preferred term for this commodity. nemorubicin bears us nlm identifiers umls id c2827283 and nci concept code c83999. smiles: o(c1oc(c(o)c(n2cc(occ2)oc)c1)c)c1cc(o)(cc2c1c(o)c1c(c2o)c(=o)c2c(c1=o)c(oc)ccc2)c(=o)co.. "
"antineoplastics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. olivomycin. this classification denotes a dna minor groove binding agent and antineoplastic antibiotic with the molecular formula c58h84o26, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 44003517d1, chemically known as olivomycin d, 3(b)-o-(2,6-dideoxy-3-c-methyl-4-o-(2-methyl-1-oxopropyl)-alpha-l-arabino-hexopyranosyl)- but generally known as olivomycin, which bears us nih compound identifier 122806. european medicines agency schedules olivomycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03507mig. the term olivomycin is an international non-proprietary name or inn (see who inn reference publication, volume 22, no. 10, 1968, list 8). olivomycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule olivomycin under hs 29419000 and sitc 54139. as of q4 2014, olivomycin remains the us fda preferred term for this commodity. olivomycin bears us nlm identifiers umls id c0028967 and nci concept code c715. smiles: o(c1cc(oc2cc(oc3c(cc4c(c3=o)c(o)c3c(c4)cc(oc4oc(c(oc(=o)c)c(oc5oc(c(oc)c(o)c5)c)c4)c)cc3o)c(oc)c(=o)c(o)c(o)c)oc(c2o)c)oc(c1o)c)c1oc(c(oc(=o)c(c)c)c(o)(c1)c)c.. "
"antineoplastics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. plicamycin. this classification denotes an antineoplastic antibiotic and dna minor groove binding agent and bone resorption inhibitor with the molecular formula c52h76o24, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier nij123w41v, chemically known as 1(2h)-anthracenone, 6-((2,6-dideoxy-3-o-(2,6-dideoxy-beta-d-arabino-hexopyranosyl)-beta-d-arabino-h)-2-((o-2,6-dideoxy-3-c-methyl-beta-d-ribohexopyranosyl-(1,4)-o-2,6-dideoxy-alpha-d-lyxo-hexpyranosyl-(1-3)-2,6-dideoxy-beta-d-arabino-hexpyranosyl)oxy)-3-(3,4-dihydroxy-1-methoxy-2-oxopentyl)-3,4-dihydro-8,9-dihydroxy-7-methyl-, (2s-alpha,3beta(1r*,3r*4s*)))- but generally known as plicamycin, which bears us nih compound identifier 29051. european medicines agency schedules plicamycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09959mig. the term plicamycin is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24). world health organization schedules plicamycin in its anatomical therapeutic chemical (atc) classification. plicamycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule plicamycin under hs 29419000 and sitc 54139. as of q4 2014, plicamycin remains the us fda preferred term for this commodity. plicamycin bears us nlm identifiers umls id c0026234 and nci concept code c658. smiles: o(c1cc(oc2c(cc3c(c2=o)c(o)c2c(c3)cc(oc3oc(c(o)c(oc4oc(c(o)c(o)c4)c)c3)c)c(c2o)c)c(oc)c(=o)c(o)c(o)c)oc(c1o)c)c1oc(c(o)c(oc2oc(c(o)c(o)(c2)c)c)c1)c.. "
"antineoplastics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. puromycin. this classification denotes a protein synthesis inhibitor and miscellaneous antineoplastic antibiotic with the molecular formula c22h29n7o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4a6zs6q2cl, chemically known as 3123l, dihydrochloride but generally known as puromycin, which bears us nih compound identifier 4984. european medicines agency schedules puromycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10161mig. the term puromycin is an international non-proprietary name. puromycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule puromycin under hs 29419000 and sitc 54139. as of q4 2014, puromycin remains the us fda preferred term for this commodity. puromycin bears us nlm identifiers umls id c0034145 and nci concept code c787. smiles: o1c(c(nc(=o)c(n)cc2ccc(oc)cc2)c(o)c1n1c2ncnc(n(c)c)c2nc1)co.. "
"antineoplastics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. rufocromomycin or streptonigrin. this classification denotes an antineoplastic antibiotic with the molecular structure c25h22n4o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 261q3jb310 chemically known as 2-pyridinecarboxylic acid, 5-amino-6-(7-amino-5,8-dihydro-6-methoxy-5,8-dioxo-2-quinolinyl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methyl- but generally known as rufocromomycin, which bears us nih compound identifier 5323583. european medicines agency schedules rufocromomycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10405mig. the term rufocromomycin is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15. ). rufocromomycin or streptonigrin bears us nlm identifiers umls id c0038427 and nci concept code c844. smiles: o(c1=c(oc)c=cc(=c2\\c(c([nh]c(c2n)c2nc3c(cc2)c(=o)c(=c(n)c3=o)oc)c(=o)o)c)\\c1=o)c.. "
"antineoplastics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. streptozocin. this classification denotes a nitrosourea compound and antineoplastic antibiotic with the molecular formula c8h15n3o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5w494urq81, chemically known as streptozotocin, pure but generally known as streptozocin, which bears us nih compound identifier 5299. european medicines agency schedules streptozocin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10658mig. the term streptozocin is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15). world health organization schedules streptozocin in its anatomical therapeutic chemical (atc) classification. streptozocin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule streptozocin under hs 29419000 and sitc 54139. as of q4 2014, streptozocin remains the us fda preferred term for this commodity. streptozocin bears us nlm identifiers umls id c0038432 and nci concept code c845. smiles: oc(c(o)c(o)co)c(nc(=o)n(n=o)c)c=o.. "
"antineoplastics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. antramycin or anthramycin. this classification denotes a miscellaneous antineoplastic antibiotic and dna minor groove binding agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0wzd9y66wn. european medicines agency schedules antramycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05531mig. anthramycin generally arises in the molecular formula c16h17n3o4. the term anthramycin is an international non-proprietary name or inn. antramycin or anthramycin bears us nlm identifiers umls id c0003167 and nci concept code c252. smiles: cc1=c(c2=c(c=c1)c(=o)n3c=c(cc3cn2)c=cc(=o)n)o.. "
"antineoplastics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. nemorubicin hydrochloride. this classification denotes an anthracycline antibiotic c32h37no13.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2q6f8jyx76, chemically known as 5,12-naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-((2,3,6-trideoxy-3-((2s)-2-methoxy-4-morpholinyl)-.alpha.-l-lyxo-hexopyranosyl)oxy)-, hydrochloride, (8s,10s)-, but more generally known as nemorubicin hydrochloride, which bears us nih compound identifier 56840906. most nations, for tariff and trade purposes, schedule nemorubicin hydrochloride under hs 29419000 and sitc 54139. as of q4 2014, nemorubicin hydrochloride remains us fdas preferred term for this commodity. nemorubicin hydrochloride bears us nlm identifiers umls id c2827284 and nci concept code c84000. smiles: c[c@h]1[c@h]([c@h](c[c@@h](o1)o[c@h]2c[c@@](cc3c2c(c4c(c3o)c(=o)c5cccc(c5c4=o)oc)o)(c(=o)co)o)n6cco[c@@h](c6)oc)o.cl.. "
"antineoplastics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. olivomycin b. this classification denotes a dna minor groove binding agent and antineoplastic antibiotic with the molecular formula c56h80o26, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fo0e69826c, chemically known as olivomycin d, 3d-o-(4-o-acetyl-2,6-dideoxy-3-c-methyl-.alpha.-l-arabino-hexopyranosyl)-, but more generally known as olivomycin b, which bears us nih compound identifier 201840. european medicines agency schedules olivomycin b or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03507mig. most nations, for tariff purposes, schedule olivomycin b under hs 29419000. smiles:.. "
"antineoplastics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. puromycin aminonucleoside. this classification denotes a protein synthesis inhibitor and miscellaneous antineoplastic antibiotic with the molecular formula c12h18n6o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0q580u88v8, chemically known as 6-(dimethylamino)-9-(3-amino-3-deoxy-.beta.-d-ribofuranosyl)purine, but more generally known as puromycin aminonucleoside, which bears us nih compound identifier 1599. european medicines agency schedules puromycin aminonucleoside or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10161mig. most nations, for tariff purposes, schedule puromycin aminonucleoside under hs 29419000. smiles: cn(c)c1c2c(ncn1)n(cn2)[c@h]3[c@@h]([c@@h]([c@h](o3)co)n)o.. "
"antineoplastics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. pirarubicin. this classification denotes an anthracycline antibiotic, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier d58g680w0g. european medicines agency schedules pirarubicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09894mig. pirarubicin generally arises in the molecular formula c32h37no12. the term pirarubicin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 3, no. 3, 1989, list 29.) pirarubicin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix.. "
"actinomycines and bacitracins and chloramphenicols and cyclic peptide antibacterials and glycylcyclines. this classification denotes antibacterial drugs made from or based in part on actinomycines, bacitracins, chloramphenicols, cyclic peptide antibacterials, or glycylcyclines. . "
"actinomycines and bacitracins and chloramphenicols and cyclic peptide antibacterials and glycylcyclines. this classification denotes antibacterial drugs made from or based in part on actinomycines, bacitracins, chloramphenicols, cyclic peptide antibacterials, or glycylcyclines. dactinomycin. this classification denotes an actinomycin antibiotic with the molecular formula c62h86n12o16, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1cc1jfe158, chemically known as 4,6-dimethyl-3-oxo-3h-phenoxazine-1,9-dicarboxamide but generally known as dactinomycin, which bears us nih compound identifier 2019. european medicines agency schedules dactinomycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13528mig. the term dactinomycin is an international non-proprietary name or inn (see who inn reference publication, volume 22, no. 10, 1968, list 8). world health organization schedules dactinomycin in its anatomical therapeutic chemical (atc) classification. dactinomycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dactinomycin under hs 29419000 and sitc 54139. as of q4 2014, dactinomycin remains the us fda preferred term for this commodity. dactinomycin bears us nlm identifiers umls id c0010934 and nci concept code c412. smiles: o=c1n2c(ccc2)c(=o)n(cc(=o)n(c(c(c)c)c(=o)oc(c(nc(=o)c2c3nc4c(c(=o)nc5c(=o)nc(c(=o)n6c(ccc6)c(=o)n(cc(=o)n(c(c(c)c)c(=o)oc5c)c)c)c(c)c)ccc(c4oc3c(c(=o)c2n)c)c)c(=o)nc1c(c)c)c)c)c.. "
"actinomycines and bacitracins and chloramphenicols and cyclic peptide antibacterials and glycylcyclines. this classification denotes antibacterial drugs made from or based in part on actinomycines, bacitracins, chloramphenicols, cyclic peptide antibacterials, or glycylcyclines. bacitracin. this classification denotes an antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 58h6rwo52i. european medicines agency schedules bacitracin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00652mig. bacitracin generally arises in the molecular formula c66h103n17o16s. the term bacitracin is an international non-proprietary name or inn. bacitracin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bacitracin under hs 29419000 and sitc 54139. as of q4 2014, bacitracin remains the us fda preferred term for this commodity. bacitracin bears us nlm identifiers umls id c0004599 and nci concept code c295. smiles: ccc(c)c1c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)n1)cccn)ccccnc(=o)c(c(c)cc)nc(=o)c(ccc(=o)o)nc(=o)c(cc(c)c)nc(=o)c2csc(=n2)c(c(c)cc)n)cc(=o)n)cc(=o)o)cc3=cn=cn3)cc4=cc=cc=c4.. "
"actinomycines and bacitracins and chloramphenicols and cyclic peptide antibacterials and glycylcyclines. this classification denotes antibacterial drugs made from or based in part on actinomycines, bacitracins, chloramphenicols, cyclic peptide antibacterials, or glycylcyclines. tigecycline. this classification denotes an antibiotic with the molecular formula c29h39n5o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 70je2n95kr, chemically known as 2-naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-((((1,1-dimethylethyl)amino)acetyl)amino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4s,4as,5ar,12as)- but generally known as tigecycline, which bears us nih compound identifier 5282044. european medicines agency schedules tigecycline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub16467mig. the term tigecycline is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3, 2002, list 48). world health organization schedules tigecycline in its anatomical therapeutic chemical (atc) classification. most nations schedule tigecycline under hs 29413000 and sitc 54133. as of q4 2014, tigecycline remains the us fda preferred term for this commodity. tigecycline bears us nlm identifiers umls id c1260298 and nci concept code c72865. smiles: oc12c(cc3c(=c(o)c4c(c3)c(n(c)c)cc(nc(=o)cnc(c)(c)c)c4o)c1=o)c(n(c)c)c(=o)c(=c(\\o)n)\\c2=o.. "
"actinomycines and bacitracins and chloramphenicols and cyclic peptide antibacterials and glycylcyclines. this classification denotes antibacterial drugs made from or based in part on actinomycines, bacitracins, chloramphenicols, cyclic peptide antibacterials, or glycylcyclines. chloramphenicol or chloramphenicolum. this classification denotes a protein synthesis inhibitor and antibiotic with the molecular formula c11h12cl2n2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 66974fr9q1, chemically known as dl-threo-2,2-dichloro-n-(beta-hydroxy-alpha-hydroxymethyl-4-nitrophenethyl)acetamide but generally known as chloramphenicol, which bears us nih compound identifier 298. european medicines agency schedules chloramphenicol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06173mig. the term chloramphenicol is an international non-proprietary name. world health organization schedules chloramphenicol in its anatomical therapeutic chemical (atc) classification. chloramphenicol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. chloramphenicol or chloramphenicolum bears us nlm identifiers umls id c0008168 and nci concept code c363. smiles: c1=cc(=cc=c1c(c(co)nc(=o)c(cl)cl)o)[n+](=o)[o-].. "
"actinomycines and bacitracins and chloramphenicols and cyclic peptide antibacterials and glycylcyclines. this classification denotes antibacterial drugs made from or based in part on actinomycines, bacitracins, chloramphenicols, cyclic peptide antibacterials, or glycylcyclines. tyrothricin. this classification denotes a polypeptide antibiotic mixture obtained from bacillus brevis. it consists of a mixture of three tyrocidines (60%) and several gramicidins (20%), with the molecular formula c65h85n11o13, chemically known as 3-[(3r,6s,9s,12s,15s,17s,20s,22r,25s,28s)-20-(2-amino-2-oxoethyl)-9-(3-aminopropyl)-3,22,25-tribenzyl-15-[(4-hydroxyphenyl)methyl]-6-(2-methylpropyl)-2,5,8,11, 14,18,21,24,27-nonaoxo-12-propan-2-yl-1,4,7,10,13,16,19,23, 26-nonazabicyclo[26.3.0]hentriacontan-17-yl]propanoic acid, but generally known as tyrothricin. the term tyrothricin is an international non-proprietary name or inn (see who inn reference publication, 1955, 9, 185-194, list 1..) tyrothricin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tyrothricin under hs 29419000 and sitc 54139. smiles: cc(c)cc1c(=o)nc(c(=o)n2cccc2c(=o)nc(c(=o)nc(c(=o)c(nc(=o)c(nc(c(=o)nc(c(=o)nc(c(=o)n1)cccn)c(c)c)cc3=cc=c(c=c3)o)ccc(=o)o)cc(=o)n)cc4=cc=cc=c4)cc5=cc=cc=c5)cc6=cc=cc=c6.. "
"actinomycines and bacitracins and chloramphenicols and cyclic peptide antibacterials and glycylcyclines. this classification denotes antibacterial drugs made from or based in part on actinomycines, bacitracins, chloramphenicols, cyclic peptide antibacterials, or glycylcyclines. bacitracin a. this classification denotes an antibiotic with the molecular formula c66h103n17o16s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier dda3rrx0p7, chemically known as l-asparagine, n-(((4r)-2-((1s,2s)-1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl)carbonyl)-l-leucyl-d-.alpha.-glutamyl-l-isoleucyl-l-lysyl-d-ornithyl-l-isoleucyl-d-phenylalanyl-l-histidyl-d-.alpha.-aspartyl-, (10->4)-lactam, but more generally known as bacitracin a, which bears us nih compound identifier 65281. european medicines agency schedules bacitracin a or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00652mig. most nations, for tariff purposes, schedule bacitracin a under hs 29419000. smiles:. bacitracin a bears us nlm identifiers umls id c0052882 and nci concept code c76238.. "
"actinomycines and bacitracins and chloramphenicols and cyclic peptide antibacterials and glycylcyclines. this classification denotes antibacterial drugs made from or based in part on actinomycines, bacitracins, chloramphenicols, cyclic peptide antibacterials, or glycylcyclines. bacitracin methylenedisalicylate. this classification denotes an antibiotic with the molecular formula c81h117n17o23s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier jgv6oj52ft, chemically known as bacitracin methylenebis(2-hydroxybenzoate) (salt), but more generally known as bacitracin methylenedisalicylate, which bears us nih compound identifier 11980094. european medicines agency schedules bacitracin methylenedisalicylate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00652mig. most nations, for tariff purposes, schedule bacitracin methylenedisalicylate under hs 29419000. smiles:.. "
"actinomycines and bacitracins and chloramphenicols and cyclic peptide antibacterials and glycylcyclines. this classification denotes antibacterial drugs made from or based in part on actinomycines, bacitracins, chloramphenicols, cyclic peptide antibacterials, or glycylcyclines. bacitracin zinc. this classification denotes an antibiotic with the molecular formula c66h103n17o16szn, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 89y4m234es, chemically known as bacitracins, zinc complex, but more generally known as bacitracin zinc, which bears us nih compound identifier 3083711. european medicines agency schedules bacitracin zinc or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00652mig. most nations, for tariff purposes, schedule bacitracin zinc under hs 29419000. smiles:. bacitracin zinc bears us nlm identifiers umls id c0043483 and nci concept code c28857.. "
"actinomycines and bacitracins and chloramphenicols and cyclic peptide antibacterials and glycylcyclines. this classification denotes antibacterial drugs made from or based in part on actinomycines, bacitracins, chloramphenicols, cyclic peptide antibacterials, or glycylcyclines. chloramphenicol palmitate. this classification denotes an antibiotic with the molecular formula c27h42cl2n2o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 43vu4207nw, chemically known as palmitic acid, alpha-ester with d-threo-(-)-2,2-dichloro-n-(beta-hydroxy-alpha-(hydroxymethyl)-p-nitrophenethyl)acetamide but more generally known as chloramphenicol palmitate, which bears us nih compound identifier 10736. european medicines agency schedules chloramphenicol palmitate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01206mig. most nations, for tariff and trade purposes, schedule chloramphenicol palmitate under hs 29414000. as of q4 2014, chloramphenicol palmitate remains us fdas preferred term for this commodity. chloramphenicol palmitate bears us nlm identifiers umls id c0055337 and nci concept code c65313. smiles: cccccccccccccccc(=o)oc[c@h]([c@@h](c1ccc(cc1)[n+](=o)[o-])o)nc(=o)c(cl)cl.. "
"actinomycines and bacitracins and chloramphenicols and cyclic peptide antibacterials and glycylcyclines. this classification denotes antibacterial drugs made from or based in part on actinomycines, bacitracins, chloramphenicols, cyclic peptide antibacterials, or glycylcyclines. chloramphenicol sodium succinate. this classification denotes a protein synthesis inhibitor and antibiotic with the molecular structure c15h15cl2n2o8.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 872109hx6b chemically known as butanedioic acid, mono(2-((2,2-dichloroacetyl)amino)-3-hydroxy-3-(4-nitrophenyl)propyl) ester, monosodium salt, (r-(r*,r*))-, but more commonly known as chloramphenicol sodium succinate, which bears us nih compound identifier 298. european medicines agency schedules chloramphenicol sodium succinate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01207mig. most nations, for tariff and trade purposes, schedule chloramphenicol sodium succinate under hs 29414000. as of q4 2014, chloramphenicol sodium succinate remains us fdas preferred term for this commodity. chloramphenicol sodium succinate bears us nlm identifiers umls id c0109354 and nci concept code c47972. smiles: c1cc(ccc1[c@h]([c@@h](coc(=o)ccc(=o)[o-])nc(=o)c(cl)cl)o)[n+](=o)[o-].[na+].. "
"actinomycines and bacitracins and chloramphenicols and cyclic peptide antibacterials and glycylcyclines. this classification denotes antibacterial drugs made from or based in part on actinomycines, bacitracins, chloramphenicols, cyclic peptide antibacterials, or glycylcyclines. chloramphenicol stearate. this classification denotes a protein synthesis inhibitor and antibiotic c29h46cl2n2o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier dl2a9m9d6x, chemically known as octadecanoic acid, (2r,3r)-2-((2,2-dichloroacetyl)amino)-3-hydroxy-3-(4-nitrophenyl)propyl ester, but more generally known as chloramphenicol stearate, which bears us nih compound identifier 83945. european medicines agency schedules chloramphenicol stearate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub26903. most nations, for tariff and trade purposes, schedule chloramphenicol stearate under hs 29414000 and sitc 54139. as of q4 2014, chloramphenicol stearate remains us fdas preferred term for this commodity. smiles: cccccccccccccccccc(=o)oc[c@h]([c@@h](c1ccc(cc1)[n+](=o)[o-])o)nc(=o)c(cl)cl.. "
"actinomycines and bacitracins and chloramphenicols and cyclic peptide antibacterials and glycylcyclines. this classification denotes antibacterial drugs made from or based in part on actinomycines, bacitracins, chloramphenicols, cyclic peptide antibacterials, or glycylcyclines. chloramphenicol succinate. this classification denotes a protein synthesis inhibitor and antibiotic with the molecular formula c15h16cl2n2o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier zcx619u9a1, chemically known as succinic acid, alpha-monoester with d-threo-(-)-2,2-dichloro-n-(beta-hydroxy-alpha-(hydroxymethyl)-p-nitrophenethyl)acetamide but more generally known as chloramphenicol succinate, which bears us nih compound identifier 2709. most nations, for tariff and trade purposes, schedule chloramphenicol succinate under hs 29414000. as of q4 2014, chloramphenicol succinate remains us fdas preferred term for this commodity. smiles: c1cc(ccc1[c@h]([c@@h](coc(=o)ccc(=o)o)nc(=o)c(cl)cl)o)[n+](=o)[o-].. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. . "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. clavulanic acid. this classification denotes a beta-lactam antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 23521w1s24. european medicines agency schedules clavulanic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06642mig. clavulanic acid generally arises in the molecular formula c8h9no5. the term clavulanic acid is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21.) most nations schedule clavulanic acid under hs 29349990 and sitc 51579. as of q4 2014, clavulanic acid remains the us fda preferred term for this commodity. clavulanic acid bears us nlm identifiers umls id c0055860 and nci concept code c61681. smiles: o1c2n(c(c\\1=c\\co)c(=o)o)c(=o)c2.. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. amantocillin. this classification denotes a penicillin antibiotic with the molecular formula c19h27n3o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, gv5zhu20h9 chemically known as 6-(3-amino-1-adamantanecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid but generally known as amantocillin, which bears us nih compound identifier 168908. european medicines agency schedules amantocillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05391mig. the term amantocillin is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7. ). most nations schedule amantocillin under hs 29411090 and sitc 54131. as of q4 2014, amantocillin remains the us fda preferred term for this commodity. amantocillin bears us nlm identifiers umls id c2346728 and nci concept code c72693. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2nc(=o)c12cc3(n)cc(c1)cc(c2)c3.. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. azidocillin. this classification denotes a penicillin antibiotic with the molecular formula c16h17n5o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier r8xdp7l3sl, chemically known as 6-(2-azido-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-4-azabicyclo(3.2.0)heptane-2-carboxylic acid but generally known as azidocillin, which bears us nih compound identifier 71886. azidocillin most often comes in base, natrium, and sodium forms. european medicines agency schedules azidocillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05655mig. the term azidocillin is an international non-proprietary name or inn (see who inn reference publication, volume 22, no. 10, 1968, list 8). world health organization schedules azidocillin in its anatomical therapeutic chemical (atc) classification. azidocillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule azidocillin under hs 29411090 and sitc 54131. as of q4 2014, azidocillin remains the us fda preferred term for this commodity. azidocillin bears us nlm identifiers umls id c0052772 and nci concept code c76853. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2nc(=o)c(n=[n]=n)c1ccccc1.. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. carumonam. this classification denotes a beta-lactam antibiotic with the molecular formula c12h14n6o10s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 486890pi06 chemically known as acetic acid, (((2-((2-(((aminocarbonyl)oxy)methyl)-4-oxo-1-sulfo-3-azetidinyl)amino)-1-(2-amino-4-thiazolyl)-2-oxoethylidene)amino)oxy)-, (2s-(2.alpha.,3.alpha.(z)))- but generally known as carumonam, which bears us nih compound identifier 9576417. european medicines agency schedules carumonam in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06152mig. the term carumonam is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24. ). most nations schedule carumonam under hs 29419000 and sitc 54139. as of q4 2014, carumonam remains the us fda preferred term for this commodity. carumonam bears us nlm identifiers umls id c0054835 and nci concept code c79879. smiles: c1=c(n=c(s1)n)c(=nocc(=o)o)c(=o)nc2c(n(c2=o)s(=o)(=o)o)coc(=o)n.. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. latamoxef or moxalactam. this classification denotes a beta-lactam antibiotic with the molecular formula c20h20n6o9s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier vuf6c936z3, chemically known as 7-((carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid (6r-(6alpha,7alpha,7(s*)))- but generally known as latamoxef, which bears us nih compound identifier 47499. european medicines agency schedules latamoxef in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08408mig. the term latamoxef is an international non-proprietary name. world health organization schedules latamoxef in its anatomical therapeutic chemical (atc) classification. latamoxef is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. latamoxef or moxalactam bears us nlm identifiers umls id c0026651 and nci concept code c670. smiles: s(cc1=c(n2c(oc1)c(oc)(nc(=o)c(c1ccc(o)cc1)c(=o)o)c2=o)c(=o)o)c1n(nnn1)c.. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. clometocillin. this classification denotes a penicillin antibiotic with the molecular formula c17h18cl2n2o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier yi8ll014gf, chemically known as (3,4-dichloro-alpha-methoxybenzyl)penicillin but generally known as clometocillin, which bears us nih compound identifier 71807. european medicines agency schedules clometocillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06721mig. the term clometocillin is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules clometocillin in its anatomical therapeutic chemical (atc) classification. clometocillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule clometocillin under hs 29411090 and sitc 54131. as of q4 2014, clometocillin remains the us fda preferred term for this commodity. clometocillin bears us nlm identifiers umls id c0055921 and nci concept code c76221. smiles: clc1cc(c(oc)c(=o)nc2c3sc(c(n3c2=o)c(=o)o)(c)c)ccc1cl.. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. epicillin. this classification denotes a penicillin antibiotic with the molecular formula c16h21n3o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3lu1l73c8y, chemically known as 6-(d-2-amino-2-(1,4-cyclohexadien-1-yl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid but generally known as epicillin, which bears us nih compound identifier 71392. european medicines agency schedules epicillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06563mig. the term epicillin is an international non-proprietary name or inn (see who inn reference publication, volume 25 , no. 10 1971, list 11). world health organization schedules epicillin in its anatomical therapeutic chemical (atc) classification. epicillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule epicillin under hs 29411090 and sitc 54131. as of q4 2014, epicillin remains the us fda preferred term for this commodity. epicillin bears us nlm identifiers umls id c0059424 and nci concept code c80590. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2nc(=o)c(n)c1=ccc=cc1.. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. faropenem. this classification denotes a beta-lactam antibiotic with the molecular formula c12h15no5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, f52y83bgh3 chemically known as 4-thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-((1r)-1-hydroxyethyl)-7-oxo-3-((2r)-tetrahydro-2-furanyl)-,(5r,6s) but generally known as faropenem, which bears us nih compound identifier 3333. european medicines agency schedules faropenem in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07512mig. the term faropenem is an international non-proprietary name or inn (see who inn reference publication, volume 9, no. 3, 1995, list 35. ). most nations schedule faropenem under hs 29419000 and sitc 54139. as of q4 2014, faropenem remains the us fda preferred term for this commodity. faropenem bears us nlm identifiers umls id c0541153 and nci concept code c72776. smiles: clc1c(c2c(=c(nc(=c2c(=o)oc)c)c)c(=o)occ)cccc1cl.. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. faropenem sodium. this classification denotes a beta-lactam antibiotic with the molecular formula c12h14no5s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7o46g914rq. european medicines agency schedules faropenem sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub16432mig. the term faropenem sodium is a u.s. fda designation. most nations schedule faropenem sodium under hs 29419000 and sitc 54139. as of q4 2014, faropenem sodium remains the us fda preferred term for this commodity. smiles: cc(c1c2n(c1=o)c(=c(s2)c3ccco3)c(=o)[o-])o.[na+].. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. floxacillin or flucloxacillin. this classification denotes a penicillin antibiotic with the molecular formula c19h17clfn3o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 43b2m34g2v, chemically known as 6-(3-(2-chloro-6-fluorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid but generally known as floxacillin, which bears us nih compound identifier 21319. european medicines agency schedules floxacillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07673mig. the term flucloxacillin is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7). world health organization schedules floxacillin in its anatomical therapeutic chemical (atc) classification. floxacillin or flucloxacillin bears us nlm identifiers umls id c0016267 and nci concept code c80591. smiles: clc1c(c2noc(c2c(=o)nc2c3sc(c(n3c2=o)c(=o)o)(c)c)c)c(f)ccc1.. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. penamecillin. this classification denotes a benzylpenicillin acetoxymethyl ester and penicillin g analog with the molecular formula c19h22n2o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h0p1ye5581, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-(2s-(2alpha,5alpha,6beta))-, (acetyloxy)methyl ester but generally known as penamecillin, which bears us nih compound identifier 13795. european medicines agency schedules penamecillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09659mig. world health organization schedules penamecillin in its anatomical therapeutic chemical (atc) classification. penamecillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule penamecillin under hs 29411090 and sitc 54131. as of q4 2014, penamecillin remains the us fda preferred term for this commodity. smiles: s1c2n(c(c1(c)c)c(=o)ococ(=o)c)c(=o)c2nc(=o)cc1ccccc1.. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. isopropicillin. this classification denotes a penicillin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 05t9139tjw. european medicines agency schedules isopropicillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08333mig. isopropicillin generally arises in the molecular formula c18h22n2o5s. the term isopropicillin is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5.) isopropicillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule isopropicillin under hs 29411090 and sitc 54131. as of q4 2014, isopropicillin remains the us fda preferred term for this commodity. isopropicillin bears us nlm identifiers umls id c2827219 and nci concept code c83846. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2nc(=o)c(oc1ccccc1)(c)c.. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. propicillin. this classification denotes a penicillin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8x1r260v33. european medicines agency schedules propicillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10106mig. propicillin generally arises in the molecular formula c18h22n2o5s. the term propicillin is an international non-proprietary name or inn. propicillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule propicillin under hs 29411090 and sitc 54131. as of q4 2014, propicillin remains the us fda preferred term for this commodity. propicillin bears us nlm identifiers umls id c0072176 and nci concept code c66483. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2nc(=o)c(oc1ccccc1)cc.. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. metampicillin. this classification denotes a penicillin antibiotic with the molecular formula c17h19n3o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g0h6u7vstk, chemically known as 3,3-dimethyl-6-(2-(methyleneamino)-2-phenylacetamidol-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid but generally known as metampicillin, which bears us nih compound identifier 4084. european medicines agency schedules metampicillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08811mig. the term metampicillin is an international non-proprietary name or inn (see who inn reference publication, volume 23, no. 10 1969, list 9). world health organization schedules metampicillin in its anatomical therapeutic chemical (atc) classification. metampicillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule metampicillin under hs 29411020 and sitc 54131. as of q4 2014, metampicillin remains the us fda preferred term for this commodity. metampicillin bears us nlm identifiers umls id c0066082 and nci concept code c87368. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2nc(=o)c(n=c)c1ccccc1.. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. oximonam. this classification denotes a beta-lactam antibiotic with the molecular formula c12h15n5o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 482m43sl0k, chemically known as acetic acid, ((3-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-methyl-4-oxo-1-azetidinyl)oxy)-, (2s-(2alpha,3beta(z)))- but generally known as oximonam, which bears us nih compound identifier 9571070. european medicines agency schedules oximonam in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09531mig. the term oximonam is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). oximonam is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule oximonam under hs 29419000 and sitc 54139. as of q4 2014, oximonam remains the us fda preferred term for this commodity. oximonam bears us nlm identifiers umls id c1882240 and nci concept code c66266. smiles: cc1c(c(=o)n1occ(=o)o)nc(=o)c(=noc)c2=csc(=n2)n.. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. pivampicillin. this classification denotes a penicillin antibiotic with the molecular formula c22h29n3o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0hlm346ll7, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (2s-(2alpha,5alpha,6beta(s*)))- but generally known as pivampicillin, which bears us nih compound identifier 33478. european medicines agency schedules pivampicillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09949mig. the term pivampicillin is an international non-proprietary name or inn (see who inn reference publication, volume 24, no. 11 1970, list 10). world health organization schedules pivampicillin in its anatomical therapeutic chemical (atc) classification. pivampicillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pivampicillin under hs 29411020 and sitc 54131. as of q4 2014, pivampicillin remains the us fda preferred term for this commodity. pivampicillin bears us nlm identifiers umls id c0032032 and nci concept code c84068. smiles: s1c2n(c(c1(c)c)c(=o)ococ(=o)c(c)(c)c)c(=o)c2nc(=o)c(n)c1ccccc1.. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. sulbenicillin. this classification denotes a penicillin antibiotic with the molecular formula c16h18n2o7s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q2vyf0562d, chemically known as 3,3-dimethyl-7-oxo-6-(2-phenyl-2-sulfoacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid but generally known as sulbenicillin, which bears us nih compound identifier 39031. european medicines agency schedules sulbenicillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15423mig. the term sulbenicillin is an international non-proprietary name or inn (see who inn reference publication, volume 26, no. 10 1972, list 12). world health organization schedules sulbenicillin in its anatomical therapeutic chemical (atc) classification. sulbenicillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sulbenicillin under hs 29411090 and sitc 54131. as of q4 2014, sulbenicillin remains the us fda preferred term for this commodity. sulbenicillin bears us nlm identifiers umls id c0038666 and nci concept code c90915. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2nc(=o)c(s(=o)(=o)o)c1ccccc1.. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. ciclacillin or gloximonam. this classification denotes a penicillin antibiotic with the molecular formula c15h23n3o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 72zj154x86, chemically known as 6-(1-aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid but generally known as ciclacillin, which bears us nih compound identifier 19003. european medicines agency schedules ciclacillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06232mig. the term ciclacillin is an international non-proprietary name or inn (see who inn reference publication, volume 26, no. 10 1972, list 12). ciclacillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. ciclacillin or gloximonam bears us nlm identifiers umls id c1880987 and nci concept code c65806. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)c3(ccccc3)n)c(=o)o)c.. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. hetacillin. this classification denotes a penicillin antibiotic with the molecular formula c19h23n3o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier tn4jsc48cv, chemically known as 6-(2,2-dimethyl-5-oxo-4-phenyl-1-imidazolidinyl)penicillansaeure but generally known as hetacillin, which bears us nih compound identifier 3596. european medicines agency schedules hetacillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08020mig. the term hetacillin is an international non-proprietary name. world health organization schedules hetacillin in its anatomical therapeutic chemical (atc) classification. hetacillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule hetacillin under hs 29411090 and sitc 54131. as of q4 2014, hetacillin remains the us fda preferred term for this commodity. hetacillin bears us nlm identifiers umls id c0062587 and nci concept code c47555. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2n1c(nc(c1=o)c1ccccc1)(c)c.. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. azidocillin potassium. this classification denotes a penicillin antibiotic c16h16n5o4s.k, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7932098147, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((azidophenylacetyl)amino)-3,3-dimethyl-7-oxo-, monopotassium salt, (2s-(2.alpha.,5.alpha.,6.beta.(s*)))-, but more generally known as azidocillin potassium, which bears us nih compound identifier 71587048. european medicines agency schedules azidocillin potassium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00643mig. most nations, for tariff and trade purposes, schedule azidocillin potassium under hs 29411090 and sitc 54131. as of q4 2014, azidocillin potassium remains us fdas preferred term for this commodity. azidocillin potassium bears us nlm identifiers umls id c2986960 and nci concept code c95169. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)[c@@h](c3ccccc3)n=[n+]=[n-])c(=o)[o-])c.[k+].. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. sulbactam. this classification denotes a beta-lactam antibiotic with the molecular formula c8h11no5s, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier s4tf6i2330, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-, 4,4-dioxide, (2s-cis)- but more generally known as sulbactam, which bears u.s. national institutes of health compound identifier 50161. the european medicines agency schedules sulbactam in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10676mig. the term sulbactam is an international non-proprietary name or inn (see world health organization inn reference publication, volume 35, no. 5 1981, list 21). the world health organization schedules sulbactam in its anatomical therapeutic chemical (atc) classification. sulbactam is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s1(=o)(=o)c(c(n2c1cc2=o)c(=o)o)(c)c.. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. azidocillin sodium. this classification denotes a penicillin antibiotic with the molecular formula c16h16n5o4s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0xpt6w6670. european medicines agency schedules azidocillin sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00644mig. the term azidocillin sodium is a u.s. fda designation. most nations, for tariff and trade purposes, schedule azidocillin sodium under hs 29411090 and sitc 54131. as of q4 2014, azidocillin sodium remains us fdas preferred term for this commodity. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)[c@@h](c3ccccc3)n=[n+]=[n-])c(=o)[o-])c.[na+].. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. sulopenem. this classification denotes a beta-lactam antibiotic with the molecular formula c12h15no5s3, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier xx514bj1xw, chemically known as 4-thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-(1-hydroxyethyl)-7-oxo-3-((tetrahydro-3-thienyl)thio)-, s-oxide, (5r-(3(1r*,3s*),5alpha,6alpha(r*)))- but more generally known as sulopenem, which bears u.s. national institutes of health compound identifier 71341. the european medicines agency schedules sulopenem in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10754mig. the term sulopenem is an international non-proprietary name or inn (see world health organization inn reference publication, volume 7, no3, 1993, list 33). sulopenem is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: cc(c1c2n(c1=o)c(=c(s2)sc3ccs(=o)c3)c(=o)o)o.. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. carumonam sodium. this classification denotes a beta-lactam antibiotic with the molecular structure c12h12n6o10s2.2na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, b4j4m4939d chemically known as acetic acid, (((2-((2-(((aminocarbonyl)oxy)methyl)-4-oxo-1-sulfo-3-azetidinyl)amino)-1-(2-amino-4-thiazolyl)-2-oxoethyliden)amino)oxy)-, disodium salt, (2s-(2.alpha.,3.alpha.(z)))-, but more commonly known as carumonam sodium, which bears us nih compound identifier 9568618. european medicines agency schedules carumonam sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01073mig. most nations, for tariff and trade purposes, schedule carumonam sodium under hs 29419000 and sitc 54139. as of q4 2014, carumonam sodium remains us fdas preferred term for this commodity. carumonam sodium bears us nlm identifiers umls id c1612343 and nci concept code c79905. smiles: c1c(nc(s1)n)/c(=n/occ(=o)[o-])/c(=o)n[c@h]2[c@h](n(c2=o)s(=o)(=o)[o-])coc(=o)n.[na+].[na+].. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. tameticillin. this classification denotes a penicillin antibiotic with the molecular formula c23h33n3o6s, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 11mx0v916w, chemically known as 2-(diethylamino)ethyl (2s,5r,6r)-6-(2,6-dimethoxybenzamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate but more generally known as tameticillin, which bears u.s. national institutes of health compound identifier 68757. the european medicines agency schedules tameticillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10820mig. the term tameticillin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 30, no. 10 1976, list 16). tameticillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s1c2n(c(c1(c)c)c(=o)occn(cc)cc)c(=o)c2nc(=o)c1c(oc)cccc1oc.. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. clometocillin potassium. this classification denotes a penicillin antibiotic c17h17cl2n2o5s.k, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7c71k33pdj, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((2-(3,4-dichlorophenyl)-2-methoxyacetyl)amino)-3,3-dimethyl-7-oxo-, potassium salt (1:1), (2s,5r,6r)-, but more generally known as clometocillin potassium, which bears us nih compound identifier 24892866. european medicines agency schedules clometocillin potassium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01359mig. most nations, for tariff and trade purposes, schedule clometocillin potassium under hs 29411090 and sitc 54131. as of q4 2014, clometocillin potassium remains us fdas preferred term for this commodity. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)c(c3ccc(c(c3)cl)cl)oc)c(=o)[o-])c.[k+].. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. tazobactam. this classification denotes a penicillin antibiotic, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier se10g96m8w. the european medicines agency schedules tazobactam in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10849mig. tazobactam generally arises in the molecular formula c10h12n4o5s. the term tazobactam is an international non-proprietary name or inn (see world health organization inn reference publication, volume 3, no. 3, 1989, list 29.) tazobactam is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: cc1(c(n2c(s1(=o)=o)cc2=o)c(=o)o)cn3c=cn=n3.. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. faropenem daloxate. this classification denotes a beta-lactam antibiotic with the molecular formula c17h19no8s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5ok523o4fu, chemically known as 4-thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-((1r)-1-hydroxyethyl)-7-oxo-3-((2r)-tetrahydro-2-furanyl)-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester, (5r,6s), but more generally known as faropenem daloxate, which bears us nih compound identifier 6918218. european medicines agency schedules faropenem daloxate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07512mig. most nations, for tariff purposes, schedule faropenem daloxate under hs 29419000. smiles: cc1c(oc(=o)o1)coc(=o)c2=c(s[c@h]3n2c(=o)[c@@h]3[c@@h](c)o)[c@h]4ccco4.. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. faropenem medoxomil. this classification denotes a beta-lactam antibiotic c17h19no8s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5ok523o4fu, chemically known as (5-methyl-2-oxo-1,3-dioxoren-4-yl)methyl(5r,6s)-6-((r)-1-hydroxyethyl)-7-oxo-3-((r)-2-tetrahydrofuryl)-4-thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylate, but more generally known as faropenem medoxomil, which bears us nih compound identifier 6918218. most nations, for tariff and trade purposes, schedule faropenem medoxomil under hs 29419000 and sitc 54139. as of q4 2014, faropenem medoxomil remains us fdas preferred term for this commodity. faropenem medoxomil bears us nlm identifiers umls id c1880735 and nci concept code c65621. smiles: cc1c(oc(=o)o1)coc(=o)c2=c(s[c@h]3n2c(=o)[c@@h]3[c@@h](c)o)[c@h]4ccco4.. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. flucloxacillin sodium. this classification denotes a penicillin antibiotic with the molecular structure c19h16clfn3o5s.na.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, lmg7c674wj chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((3-(2-chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, sodium salt monohydrate (2s(2.alpha.,5.alpha.,6.beta.)), but more commonly known as flucloxacillin sodium, which bears us nih compound identifier 21319. european medicines agency schedules flucloxacillin sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02207mig. most nations, for tariff and trade purposes, schedule flucloxacillin sodium under hs 29411090. smiles: cc1c(c(no1)c2c(cccc2cl)f)c(=o)n[c@h]3[c@@h]4n(c3=o)[c@h](c(s4)(c)c)c(=o)[o-].o.[na+].. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. hetacillin potassium. this classification denotes a penicillin antibiotic c19h22n3o4s.k, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 95pfx5932y, chemically known as potassium 6-(2,2-dimethyl-5-oxo-4-phenyl-1-imidazolidinyl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate, but more generally known as hetacillin potassium, which bears us nih compound identifier 23677959. european medicines agency schedules hetacillin potassium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02502mig. most nations, for tariff and trade purposes, schedule hetacillin potassium under hs 29411090 and sitc 54131. as of q4 2014, hetacillin potassium remains us fdas preferred term for this commodity. hetacillin potassium bears us nlm identifiers umls id c0812398 and nci concept code c65845. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)n3c(=o)[c@h](nc3(c)c)c4ccccc4)c(=o)[o-])c.[k+].. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. metampicillin sodium. this classification denotes a penicillin antibiotic with the molecular formula c17h18n3o4s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1he2t55nh5, chemically known as sodium (6r)-6-(d-2-methyleneamino-2-phenylacetamido)penicillanate, but more generally known as metampicillin sodium, which bears us nih compound identifier 5702187. european medicines agency schedules metampicillin sodium or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08811mig. most nations, for tariff purposes, schedule metampicillin sodium under hs 29411020. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)[c@@h](c3ccccc3)n=c)c(=o)[o-])c.[na+].. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. moxalactam disodium. this classification denotes a beta-lactam antibiotic with the molecular structure c20h18n6o9s.2na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 5apw73w3qz chemically known as 5-oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, disodium salt, but more commonly known as moxalactam disodium, which bears us nih compound identifier 47500. european medicines agency schedules moxalactam disodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02867mig. most nations, for tariff and trade purposes, schedule moxalactam disodium under hs 29419000. as of q4 2014, moxalactam disodium remains us fdas preferred term for this commodity. moxalactam disodium bears us nlm identifiers umls id c0813197 and nci concept code c66207. smiles: cn1c(nnn1)scc2=c(n3[c@@h]([c@@](c3=o)(nc(=o)c(c4ccc(cc4)o)c(=o)[o-])oc)oc2)c(=o)[o-].[na+].[na+].. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. oximonam sodium. this classification denotes a beta-lactam antibiotic c12h14n5o6s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g274r51qfv, chemically known as acetic acid, 2-(((2s,3s)-3-(((2z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl)amino)-2-methyl-4-oxo-1-azetidinyl)oxy)-, sodium salt (1:1), but more generally known as oximonam sodium, which bears us nih compound identifier 23663948. most nations, for tariff and trade purposes, schedule oximonam sodium under hs 29419000 and sitc 54139. as of q4 2014, oximonam sodium remains us fdas preferred term for this commodity. oximonam sodium bears us nlm identifiers umls id c1882241 and nci concept code c66267. smiles: c[c@h]1[c@@h](c(=o)n1occ(=o)[o-])nc(=o)/c(=n\\oc)/c2csc(n2)n.[na+].. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. pivampicillin hydrochloride. this classification denotes a penicillin antibiotic with the molecular formula c22h29n3o6s.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier v9hoc53l7l, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, monohydrochloride, (2s-(2alpha,5alpha,6beta(s*)))- but more generally known as pivampicillin hydrochloride, which bears us nih compound identifier 33477. european medicines agency schedules pivampicillin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03883mig. most nations, for tariff and trade purposes, schedule pivampicillin hydrochloride under hs 29411020 and sitc 54131. as of q4 2014, pivampicillin hydrochloride remains us fdas preferred term for this commodity. pivampicillin hydrochloride bears us nlm identifiers umls id c0085884 and nci concept code c73834. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)[c@@h](c3ccccc3)n)c(=o)ococ(=o)c(c)(c)c)c.cl.. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. pivampicillin pamoate. this classification denotes a penicillin antibiotic with the molecular formula c23h16o6.2c22h29n3o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5z5trg74ey, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (2s-((2 alpha, 5 alpha, 6 beta(s*))))-, 4,4-methylenebis(3-hydroxy-2-naphthalenecarboxylate) (2:1) but more generally known as pivampicillin pamoate, which bears us nih compound identifier 3084732. most nations, for tariff and trade purposes, schedule pivampicillin pamoate under hs 29411020 and sitc 54131. as of q4 2014, pivampicillin pamoate remains us fdas preferred term for this commodity. pivampicillin pamoate bears us nlm identifiers umls id c2347522 and nci concept code c73835. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)[c@@h](c3ccccc3)n)c(=o)ococ(=o)c(c)(c)c)c.cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)[c@@h](c3ccccc3)n)c(=o)ococ(=o)c(c)(c)c)c.c1ccc2c(c1)cc(c(c2cc3c4ccccc4cc(c3o)c(=o)o)o)c(=o)o.. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. propicillin potassium. this classification denotes a penicillin antibiotic with the molecular structure c18h21n2o5s.k, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 75rxw2p83y chemically known as (2s,5r,6r)-3,3-dimethyl-7-oxo-6-((1-oxo-2-phenoxybutyl)amino)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid potassium salt, but more commonly known as propicillin potassium, which bears us nih compound identifier 92878. european medicines agency schedules propicillin potassium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04082mig. most nations, for tariff and trade purposes, schedule propicillin potassium under hs 29411090 and sitc 54131. as of q4 2014, propicillin potassium remains us fdas preferred term for this commodity. propicillin potassium bears us nlm identifiers umls id c0771910 and nci concept code c87371. smiles: ccc(c(=o)n[c@h]1[c@@h]2n(c1=o)[c@h](c(s2)(c)c)c(=o)[o-])oc3ccccc3.[k+].. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. sulbenicillin disodium. this classification denotes a penicillin antibiotic with the molecular formula c16h16n2o7s2.2na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 29so9lim1q, chemically known as d-(-)-.alpha.-sulfobenzylpenicillin sodium salt, but more generally known as sulbenicillin disodium, which bears us nih compound identifier 134931. european medicines agency schedules sulbenicillin disodium or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15423mig. most nations, for tariff purposes, schedule sulbenicillin disodium under hs 29411090. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)[c@@h](c3ccccc3)s(=o)(=o)[o-])c(=o)[o-])c.[na+].[na+].. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. sulbenicillin sodium. this classification denotes a penicillin antibiotic with the molecular structure c16h16n2o7s2.2na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 29so9lim1q chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((2-phenyl-2-sulfoacetyl)amino)-, sodium salt (1:2), (2s,5r,6r)-, but more commonly known as sulbenicillin sodium, which bears us nih compound identifier 443984. european medicines agency schedules sulbenicillin sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21912. most nations, for tariff and trade purposes, schedule sulbenicillin sodium under hs 29411090 and sitc 54131. as of q4 2014, sulbenicillin sodium remains us fdas preferred term for this commodity. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)[c@@h](c3ccccc3)s(=o)(=o)[o-])c(=o)[o-])c.[na+].[na+].. "
"beta-lactams. this classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.. furbucillin. this classification denotes a penicillin antibiotic with the molecular formula c19h24n2o7s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 104nhk678e, chemically known as 6-((r)-2-hydroxy-4-methylvaleramido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid 2-furoate (ester). but more generally known as furbucillin, which bears us nih compound identifier 216269. european medicines agency schedules furbucillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07836mig. the term furbucillin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 28, no. 10 1974, list 14). furbucillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2nc(=o)c(oc(=o)c1occc1)cc(c)c.. "
"cephamycins. this classification denotes naturally occurring antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms.. . "
"cephamycins. this classification denotes naturally occurring antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms.. cefotetan. this classification denotes a cephalosporin antibiotic with the molecular formula c17h17n7o8s4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 48spp0pa9q, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl)carbonyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r-(6alpha,7alpha))- but generally known as cefotetan, which bears us nih compound identifier 50614. european medicines agency schedules cefotetan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07406mig. the term cefotetan is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21). world health organization schedules cefotetan in its anatomical therapeutic chemical (atc) classification. cefotetan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefotetan under hs 29419000 and sitc 54139. as of q4 2014, cefotetan remains the us fda preferred term for this commodity. cefotetan bears us nlm identifiers umls id c0007555 and nci concept code c61664. smiles: s1c2n(c(=o)c2(oc)nc(=o)c2s/c(=c(/c(=o)n)c(=o)o)s2)c(=c(c1)csc1n(nnn1)c)c(=o)o.. "
"cephamycins. this classification denotes naturally occurring antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms.. cefoxitin. this classification denotes a cephalosporin antibiotic with the molecular formula c16h17n3o7s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6oev9dx57y, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-methoxy-8-oxo-7-((2-thienylacetyl)amino)-, (6r-cis)- but generally known as cefoxitin, which bears us nih compound identifier 37194. european medicines agency schedules cefoxitin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07409mig. the term cefoxitin is an international non-proprietary name. world health organization schedules cefoxitin in its anatomical therapeutic chemical (atc) classification. cefoxitin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefoxitin under hs 29419000 and sitc 54139. as of q4 2014, cefoxitin remains the us fda preferred term for this commodity. cefoxitin bears us nlm identifiers umls id c0007557 and nci concept code c61665. smiles: s1c2n(c(=o)c2(oc)nc(=o)cc2sccc2)c(=cc1coc(=o)n)c(=o)o.. "
"cephamycins. this classification denotes naturally occurring antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms.. flomoxef. this classification denotes a cephalosporin antibiotic with the molecular formula c15h18f2n6o7s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier v9e5u5xf42, chemically known as (-)-(6r,7r)-7-(2-((difluoromethyl)thio)acetamido)-3-(((1-(2-hydroxyethyl)-1h-tetrazol-5-yl)thio)methyl)-7-methoxy-8-oxo-5-oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid but generally known as flomoxef, which bears us nih compound identifier 65864. european medicines agency schedules flomoxef in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07646mig. the term flomoxef is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). flomoxef is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule flomoxef under hs 29419000 and sitc 54139. as of q4 2014, flomoxef remains the us fda preferred term for this commodity. flomoxef bears us nlm identifiers umls id c0117881 and nci concept code c65693. smiles: s(cc1=c(n2c(oc1)c(oc)(nc(=o)csc(f)f)c2=o)c(=o)o)c1n(nnn1)cco.. "
"cephamycins. this classification denotes naturally occurring antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms.. cefmetazole. this classification denotes a cephalosporin antibiotic with the molecular formula c15h17n7o5s3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3j962ujt8h, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((((cyanomethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r-cis)- but generally known as cefmetazole, which bears us nih compound identifier 42008. european medicines agency schedules cefmetazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07399mig. the term cefmetazole is an international non-proprietary name or inn (see who inn reference publication, volume 32, no 10 1978, list 18). world health organization schedules cefmetazole in its anatomical therapeutic chemical (atc) classification. cefmetazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefmetazole under hs 29419000 and sitc 54139. as of q4 2014, cefmetazole remains the us fda preferred term for this commodity. cefmetazole bears us nlm identifiers umls id c0007550 and nci concept code c65297. smiles: s1c2n(c(=o)c2(oc)nc(=o)cscc#n)c(=c(c1)csc1n(nnn1)c)c(=o)o.. "
"cephamycins. this classification denotes naturally occurring antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms.. cefmetazole sodium. this classification denotes a cephalosporin antibiotic with the molecular formula c15h16n7o5s3.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 37y9vr4w7a, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((((cyanomethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r-cis)- but more generally known as cefmetazole sodium, which bears us nih compound identifier 42008. european medicines agency schedules cefmetazole sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01118mig. most nations, for tariff and trade purposes, schedule cefmetazole sodium under hs 29419000 and sitc 54139. as of q4 2014, cefmetazole sodium remains us fdas preferred term for this commodity. cefmetazole sodium bears us nlm identifiers umls id c0700470 and nci concept code c65298. smiles: cn1c(nnn1)scc2=c(n3[c@@h]([c@@](c3=o)(nc(=o)cscc#n)oc)sc2)c(=o)[o-].[na+].. "
"cephamycins. this classification denotes naturally occurring antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms.. cefotetan disodium. this classification denotes a cephalosporin antibiotic with the molecular formula c17h15n7o8s4.2na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0gxp746vxb, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl)carbonyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, disodium salt, (6r-(6alpha,7alpha))- but more generally known as cefotetan disodium, which bears us nih compound identifier 53024. european medicines agency schedules cefotetan disodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01124mig. most nations, for tariff and trade purposes, schedule cefotetan disodium under hs 29419000 and sitc 54139. as of q4 2014, cefotetan disodium remains us fdas preferred term for this commodity. cefotetan disodium bears us nlm identifiers umls id c0007553 and nci concept code c47437. smiles: cn1c(nnn1)scc2=c(n3[c@@h]([c@@](c3=o)(nc(=o)c4sc(=c(c(=o)n)c(=o)[o-])s4)oc)sc2)c(=o)[o-].[na+].[na+].. "
"cephamycins. this classification denotes naturally occurring antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms.. cefotetan sodium. this classification denotes a cephalosporin antibiotic with the molecular formula c17h15n7o8s4.2na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0gxp746vxb, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl)carbonyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, disodium salt, (6r-(6alpha,7alpha))- but more generally known as cefotetan disodium, which bears us nih compound identifier 53024. european medicines agency schedules cefotetan disodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01124mig. most nations, for tariff and trade purposes, schedule cefotetan sodium under hs 29419000. smiles: cn1c(nnn1)scc2=c(n3[c@@h]([c@@](c3=o)(nc(=o)c4sc(=c(c(=o)n)c(=o)[o-])s4)oc)sc2)c(=o)[o-].[na+].[na+].. "
"cephamycins. this classification denotes naturally occurring antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms.. cefoxitin sodium. this classification denotes a cephalosporin antibiotic with the molecular formula c16h16n3o7s2.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q68050h03t, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-methoxy-8-oxo-7-((2-thienylacetyl)amino)-, sodium salt, (6r-cis)- but more generally known as cefoxitin sodium, which bears us nih compound identifier 36551. european medicines agency schedules cefoxitin sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13277mig. most nations, for tariff and trade purposes, schedule cefoxitin sodium under hs 29419000 and sitc 54139. as of q4 2014, cefoxitin sodium remains us fdas preferred term for this commodity. cefoxitin sodium bears us nlm identifiers umls id c0701380 and nci concept code c28915. smiles: co[c@@]1([c@@h]2n(c1=o)c(=c(cs2)coc(=o)n)c(=o)[o-])nc(=o)cc3cccs3.[na+].. "
"cephamycins. this classification denotes naturally occurring antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms.. flomoxef sodium. this classification denotes a cephalosporin antibiotic with the molecular structure c15h17f2n6o7s2.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 445hib8xnf chemically known as 5-oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((((difluoromethyl)thio)acetyl)amino)-3-(((1-(2-hydroxyethyl)-1h-tetrazol-5-yl)thio)methyl)-7-methoxy-8-oxo-, sodium salt (1:1), (6r,7r)-, but more commonly known as flomoxef sodium, which bears us nih compound identifier 443982. european medicines agency schedules flomoxef sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02203mig. most nations, for tariff and trade purposes, schedule flomoxef sodium under hs 29419000 and sitc 54139. as of q4 2014, flomoxef sodium remains us fdas preferred term for this commodity. smiles: co[c@@]1([c@@h]2n(c1=o)c(=c(co2)csc3nnnn3cco)c(=o)[o-])nc(=o)csc(f)f.[na+].. "
"erythromycins. this classification denotes an antibiotic variety based on a bacteriostatic produced from streptomyces erythreus, hence the name erythromycin, and of which erythromycin a is the major active component. in sensitive organisms, it inhibits protein synthesis by binding to 50s ribosomal subunits. this binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. . "
"erythromycins. this classification denotes an antibiotic variety based on a bacteriostatic produced from streptomyces erythreus, hence the name erythromycin, and of which erythromycin a is the major active component. in sensitive organisms, it inhibits protein synthesis by binding to 50s ribosomal subunits. this binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. azithromycin. this classification denotes a macrolide antibiotic with the molecular formula c38h72n2o12, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier j2klz20u1m, chemically known as 11-(4-dimethylamino-3-hydroxy-6-methyl-oxan-2-yl)oxy-2-ethyl-3,4,10-trihydroxy-13-(5-hydroxy-4-methoxy-4,6-dimethyl-oxan-2-yl)oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one but generally known as azithromycin, which bears us nih compound identifier 55185. azithromycin most often comes in base and hydrate forms. european medicines agency schedules azithromycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05660mig. the term azithromycin is an international non-proprietary name or inn (see who inn reference publication, volume 2, no. 3, 1988, list 28). world health organization schedules azithromycin in its anatomical therapeutic chemical (atc) classification. azithromycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule azithromycin under hs 29419000 and sitc 54139. azithromycin bears us nlm identifiers umls id c0678143 and nci concept code c28844. smiles: o(c1c(c(oc2oc(c(o)c(oc)(c2)c)c)c(c(=o)oc(c(o)(c(o)c(n(cc(cc1(o)c)c)c)c)c)cc)c)c)c1oc(cc(n(c)c)c1o)c.. "
"erythromycins. this classification denotes an antibiotic variety based on a bacteriostatic produced from streptomyces erythreus, hence the name erythromycin, and of which erythromycin a is the major active component. in sensitive organisms, it inhibits protein synthesis by binding to 50s ribosomal subunits. this binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. clarithromycin. this classification denotes a macrolide antibiotic with the molecular formula c38h69no13, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h1250jik0a, chemically known as erythromycin, 6-o-methyl- but generally known as clarithromycin, which bears us nih compound identifier 54688. european medicines agency schedules clarithromycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06641mig. the term clarithromycin is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). world health organization schedules clarithromycin in its anatomical therapeutic chemical (atc) classification. clarithromycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule clarithromycin under hs 29415000 and sitc 54139. as of q4 2014, clarithromycin remains the us fda preferred term for this commodity. clarithromycin bears us nlm identifiers umls id c0055856 and nci concept code c1054. smiles: o(c1c(c(oc2oc(c(o)c(oc)(c2)c)c)c(c(=o)oc(c(o)(c(o)c(c(=o)c(cc1(oc)c)c)c)c)cc)c)c)c1oc(cc(n(c)c)c1o)c.. "
"erythromycins. this classification denotes an antibiotic variety based on a bacteriostatic produced from streptomyces erythreus, hence the name erythromycin, and of which erythromycin a is the major active component. in sensitive organisms, it inhibits protein synthesis by binding to 50s ribosomal subunits. this binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. dirithromycin. this classification denotes a macrolide antibiotic with the molecular formula c42h78n2o14, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1801d76stl, chemically known as erythromycin, 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethylidene)oxy)-, (9s(r))- but generally known as dirithromycin, which bears us nih compound identifier 5464388. european medicines agency schedules dirithromycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07232mig. the term dirithromycin is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). world health organization schedules dirithromycin in its anatomical therapeutic chemical (atc) classification. dirithromycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dirithromycin under hs 29415000 and sitc 54139. as of q4 2014, dirithromycin remains the us fda preferred term for this commodity. dirithromycin bears us nlm identifiers umls id c0058445 and nci concept code c47496. smiles: o1c2c(c(nc1coccoc)c(cc(o)(c(oc1oc(cc(n(c)c)c1o)c)c(c(oc1oc(c(o)c(oc)(c1)c)c)c(c(=o)oc(c2(o)c)cc)c)c)c)c)c.. "
"erythromycins. this classification denotes an antibiotic variety based on a bacteriostatic produced from streptomyces erythreus, hence the name erythromycin, and of which erythromycin a is the major active component. in sensitive organisms, it inhibits protein synthesis by binding to 50s ribosomal subunits. this binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. erythromycin. this classification denotes a macrolide antibiotic with the molecular formula c37h67no13, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 63937kv33d, chemically known as sulfuric acid, monododecyl ester, sodium salt, compd. with erythromycin but generally known as erythromycin, which bears us nih compound identifier 3255. european medicines agency schedules erythromycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06605mig. the term erythromycin is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules erythromycin in its anatomical therapeutic chemical (atc) classification. erythromycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule erythromycin under hs 29415000 and sitc 54139. as of q4 2014, erythromycin remains the us fda preferred term for this commodity. erythromycin bears us nlm identifiers umls id c0014806 and nci concept code c476. smiles: o(c1c(c(oc2oc(c(o)c(oc)(c2)c)c)c(c(=o)oc(c(o)(c(o)c(c(=o)c(cc1(o)c)c)c)c)cc)c)c)c1oc(cc(n(c)c)c1o)c.. "
"erythromycins. this classification denotes an antibiotic variety based on a bacteriostatic produced from streptomyces erythreus, hence the name erythromycin, and of which erythromycin a is the major active component. in sensitive organisms, it inhibits protein synthesis by binding to 50s ribosomal subunits. this binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. erythromycin ethylcarbonate. this classification denotes a macrolide antibiotic with the molecular formula c37h67no13.c3h6o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier d2jue6gd5a. most nations schedule erythromycin ethylcarbonate under hs 29415000 and sitc 54139. as of q4 2014, erythromycin ethylcarbonate remains the us fda preferred term for this commodity. erythromycin ethylcarbonate bears us nlm identifiers umls id c2700011 and nci concept code c76762. smiles: ccc1c(c(c(c(=o)c(cc(c(c(c(c(c(=o)o1)c)oc2cc(c(c(o2)c)o)(c)oc)c)oc3c(c(cc(o3)c)n(c)c)oc(=o)occ)(c)o)c)c)o)(c)o.. "
"erythromycins. this classification denotes an antibiotic variety based on a bacteriostatic produced from streptomyces erythreus, hence the name erythromycin, and of which erythromycin a is the major active component. in sensitive organisms, it inhibits protein synthesis by binding to 50s ribosomal subunits. this binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. flurithromycin. this classification denotes a macrolide antibiotic with the molecular formula c37h66fno13, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 56c9dte69v, chemically known as erythromycin, 8-fluoro- but generally known as flurithromycin, which bears us nih compound identifier 71260. european medicines agency schedules flurithromycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07747mig. the term flurithromycin is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24). world health organization schedules flurithromycin in its anatomical therapeutic chemical (atc) classification. flurithromycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule flurithromycin under hs 29415000 and sitc 54139. as of q4 2014, flurithromycin remains the us fda preferred term for this commodity. flurithromycin bears us nlm identifiers umls id c0060591 and nci concept code c65735. smiles: fc1(cc(o)(c(oc2oc(cc(n(c)c)c2o)c)c(c(oc2oc(c(o)c(oc)(c2)c)c)c(c(=o)oc(c(o)(c(o)c(c1=o)c)c)cc)c)c)c)c.. "
"erythromycins. this classification denotes an antibiotic variety based on a bacteriostatic produced from streptomyces erythreus, hence the name erythromycin, and of which erythromycin a is the major active component. in sensitive organisms, it inhibits protein synthesis by binding to 50s ribosomal subunits. this binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. lexithromycin. this classification denotes a macrolide antibiotic with the molecular formula c38h70n2o13, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7qko29734u, chemically known as erythromycin, 9-(o-methyloxime) but generally known as lexithromycin, which bears us nih compound identifier 9570610. european medicines agency schedules lexithromycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08499mig. the term lexithromycin is an international non-proprietary name or inn (see who inn reference publication, volume 6, no, 3 1992, list 32). lexithromycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule lexithromycin under hs 29415000 and sitc 54139. as of q4 2014, lexithromycin remains the us fda preferred term for this commodity. lexithromycin bears us nlm identifiers umls id c2981357 and nci concept code c87760. smiles: o(c1c(c(oc2oc(c(o)c(oc)(c2)c)c)c(c(=o)oc(c(o)(c(o)c(c(=n\\oc)\\c(cc1(o)c)c)c)c)cc)c)c)c1oc(cc(n(c)c)c1o)c.. "
"erythromycins. this classification denotes an antibiotic variety based on a bacteriostatic produced from streptomyces erythreus, hence the name erythromycin, and of which erythromycin a is the major active component. in sensitive organisms, it inhibits protein synthesis by binding to 50s ribosomal subunits. this binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. roxithromycin. this classification denotes a macrolide antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 21kof230fa. european medicines agency schedules roxithromycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10400mig. roxithromycin generally arises in the molecular formula c41h76n2o15. the term roxithromycin is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26.) roxithromycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule roxithromycin under hs 29415000 and sitc 54139. as of q4 2014, roxithromycin remains the us fda preferred term for this commodity. roxithromycin bears us nlm identifiers umls id c0035891 and nci concept code c818. smiles: o(c1c(c(oc2oc(c(o)c(oc)(c2)c)c)c(c(=o)oc(c(o)(c(o)c(c(=n\\ococcoc)/c(cc1(o)c)c)c)c)cc)c)c)c1oc(cc(n(c)c)c1o)c.. "
"erythromycins. this classification denotes an antibiotic variety based on a bacteriostatic produced from streptomyces erythreus, hence the name erythromycin, and of which erythromycin a is the major active component. in sensitive organisms, it inhibits protein synthesis by binding to 50s ribosomal subunits. this binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. azithromycin anhydrous. this classification denotes a macrolide antibiotic with the molecular formula c38h72n2o12, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier j2klz20u1m, chemically known as 11-(4-dimethylamino-3-hydroxy-6-methyl-oxan-2-yl)oxy-2-ethyl-3,4,10-trihydroxy-13-(5-hydroxy-4-methoxy-4,6-dimethyl-oxan-2-yl)oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one but more generally known as azithromycin, which bears us nih compound identifier 55185. azithromycin most often comes in base and hydrate forms. european medicines agency schedules azithromycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05660mig. the term azithromycin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 2, no. 3, 1988, list 28). world health organization schedules azithromycin in its anatomical therapeutic chemical (atc) classification. azithromycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule azithromycin anhydrous under hs 29419000. as of q4 2014, azithromycin anhydrous remains us fdas preferred term for this commodity. azithromycin anhydrous bears us nlm identifiers umls id c2698292 and nci concept code c76213. smiles: cc[c@@h]1[c@@]([c@@h]([c@h](n(c[c@@h](c[c@@]([c@@h]([c@h]([c@@h]([c@h](c(=o)o1)c)o[c@h]2c[c@@]([c@h]([c@@h](o2)c)o)(c)oc)c)o[c@h]3[c@@h]([c@h](c[c@h](o3)c)n(c)c)o)(c)o)c)c)c)o)(c)o.. "
"erythromycins. this classification denotes an antibiotic variety based on a bacteriostatic produced from streptomyces erythreus, hence the name erythromycin, and of which erythromycin a is the major active component. in sensitive organisms, it inhibits protein synthesis by binding to 50s ribosomal subunits. this binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. azithromycin dihydrate. this classification denotes a macrolide antibiotic with the molecular formula c38h72n2o12.2h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5fd1131i7s, chemically known as 11-(4-dimethylamino-3-hydroxy-6-methyl-oxan-2-yl)oxy-2-ethyl-3,4,10-trihydroxy-13-(5-hydroxy-4-methoxy-4,6-dimethyl-oxan-2-yl)oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one but more generally known as azithromycin dihydrate, which bears us nih compound identifier 55185. european medicines agency schedules azithromycin dihydrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub16399mig. most nations, for tariff and trade purposes, schedule azithromycin dihydrate under hs 29419000 and sitc 54139. as of q4 2014, azithromycin dihydrate remains us fdas preferred term for this commodity. azithromycin dihydrate bears us nlm identifiers umls id c0795582 and nci concept code c76214. smiles: cc[c@@h]1[c@@]([c@@h]([c@h](n(c[c@@h](c[c@@]([c@@h]([c@h]([c@@h]([c@h](c(=o)o1)c)o[c@h]2c[c@@]([c@h]([c@@h](o2)c)o)(c)oc)c)o[c@h]3[c@@h]([c@h](c[c@h](o3)c)n(c)c)o)(c)o)c)c)c)o)(c)o.o.o.. "
"erythromycins. this classification denotes an antibiotic variety based on a bacteriostatic produced from streptomyces erythreus, hence the name erythromycin, and of which erythromycin a is the major active component. in sensitive organisms, it inhibits protein synthesis by binding to 50s ribosomal subunits. this binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. clarithromycin lactobionate. this classification denotes a macrolide antibiotic c38h69no13.c12h22o12, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4108jki097, chemically known as erythromycin, 6-o-methyl-, 4-o-.beta.-d-galactopyranosyl-d-gluconate (1:1), but more generally known as clarithromycin lactobionate, which bears us nih compound identifier 178265. european medicines agency schedules clarithromycin lactobionate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20333. most nations, for tariff and trade purposes, schedule clarithromycin lactobionate under hs 29415000 and sitc 54139. smiles: as of q4 2014, clarithromycin lactobionate remains us fdas preferred term for this commodity.. "
"erythromycins. this classification denotes an antibiotic variety based on a bacteriostatic produced from streptomyces erythreus, hence the name erythromycin, and of which erythromycin a is the major active component. in sensitive organisms, it inhibits protein synthesis by binding to 50s ribosomal subunits. this binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. erythromycin a. this classification denotes a macrolide antibiotic with the molecular formula c37h67no13, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 63937kv33d, chemically known as erythromycin estolate impurity, free erythromycin-, but more generally known as erythromycin a, which bears us nih compound identifier 3255. european medicines agency schedules erythromycin a or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06605mig. most nations, for tariff purposes, schedule erythromycin a under hs 29415000. smiles: cc[c@@h]1[c@@]([c@@h]([c@h](c(=o)[c@@h](c[c@@]([c@@h]([c@h]([c@@h]([c@h](c(=o)o1)c)o[c@h]2c[c@@]([c@h]([c@@h](o2)c)o)(c)oc)c)o[c@h]3[c@@h]([c@h](c[c@h](o3)c)n(c)c)o)(c)o)c)c)o)(c)o.. "
"erythromycins. this classification denotes an antibiotic variety based on a bacteriostatic produced from streptomyces erythreus, hence the name erythromycin, and of which erythromycin a is the major active component. in sensitive organisms, it inhibits protein synthesis by binding to 50s ribosomal subunits. this binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. erythromycin aspartate. this classification denotes a macrolide antibiotic with the molecular formula c37h67no13.c4h7no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier da04yx38da, chemically known as aspartic acid, l-, compd. with erythromycin (1:1), but more generally known as erythromycin aspartate, which bears us nih compound identifier 83953. european medicines agency schedules erythromycin aspartate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06605mig. most nations, for tariff purposes, schedule erythromycin aspartate under hs 29415000. smiles: cc[c@@h]1[c@@]([c@@h]([c@h](c(=o)[c@@h](c[c@@]([c@@h]([c@h]([c@@h]([c@h](c(=o)o1)c)o[c@h]2c[c@@]([c@h]([c@@h](o2)c)o)(c)oc)c)o[c@h]3[c@@h]([c@h](c[c@h](o3)c)n(c)c)o)(c)o)c)c)o)(c)o.c([c@@h](c(=o)o)n)c(=o)o.. "
"erythromycins. this classification denotes an antibiotic variety based on a bacteriostatic produced from streptomyces erythreus, hence the name erythromycin, and of which erythromycin a is the major active component. in sensitive organisms, it inhibits protein synthesis by binding to 50s ribosomal subunits. this binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. erythromycin e. this classification denotes a macrolide antibiotic with the molecular formula c37h65no14, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 39v2di8xox, chemically known as erythromycin, 1,16-epoxy-, but more generally known as erythromycin e, which bears us nih compound identifier 5462331. european medicines agency schedules erythromycin e or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06605mig. most nations, for tariff purposes, schedule erythromycin e under hs 29415000. smiles: cc[c@@h]1[c@@]([c@@h]([c@h](c(=o)[c@@h](c[c@@]([c@@h]([c@h]([c@h]2[c@@h](co[c@]3(o2)c[c@@]([c@h]([c@@h](o3)c)o)(c)oc)c(=o)o1)c)o[c@h]4[c@@h]([c@h](c[c@h](o4)c)n(c)c)o)(c)o)c)c)o)(c)o.. "
"erythromycins. this classification denotes an antibiotic variety based on a bacteriostatic produced from streptomyces erythreus, hence the name erythromycin, and of which erythromycin a is the major active component. in sensitive organisms, it inhibits protein synthesis by binding to 50s ribosomal subunits. this binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. erythromycin enol ether. this classification denotes a macrolide antibiotic with the molecular formula c37h65no12, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 32b40i7v7b, chemically known as erythromycin, 8,9-didehydro-9-deoxo-6-deoxy-6,9-epoxy-, but more generally known as erythromycin enol ether, which bears us nih compound identifier 6426642. european medicines agency schedules erythromycin enol ether or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06605mig. most nations, for tariff purposes, schedule erythromycin enol ether under hs 29415000. smiles: cc[c@@h]1[c@@]([c@@h]([c@h](c2=c(c[c@@](o2)([c@@h]([c@h]([c@@h]([c@h](c(=o)o1)c)o[c@h]3c[c@@]([c@h]([c@@h](o3)c)o)(c)oc)c)o[c@h]4[c@@h]([c@h](c[c@h](o4)c)n(c)c)o)c)c)c)o)(c)o.. "
"erythromycins. this classification denotes an antibiotic variety based on a bacteriostatic produced from streptomyces erythreus, hence the name erythromycin, and of which erythromycin a is the major active component. in sensitive organisms, it inhibits protein synthesis by binding to 50s ribosomal subunits. this binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. erythromycin estolate. this classification denotes a macrolide antibiotic with the molecular formula c40h71no14.c12h26o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier xrj2p631hp, chemically known as erythromycin, n-demethyl-n-(methyl-11c)- but more generally known as erythromycin estolate, which bears us nih compound identifier 12560. european medicines agency schedules erythromycin estolate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01941mig. most nations, for tariff and trade purposes, schedule erythromycin estolate under hs 29415000 and sitc 54139. as of q4 2014, erythromycin estolate remains us fdas preferred term for this commodity. erythromycin estolate bears us nlm identifiers umls id c0014809 and nci concept code c47986. smiles: ccccccccccccos(=o)(=o)o.cc[c@@h]1[c@@]([c@@h]([c@h](c(=o)[c@@h](c[c@@]([c@@h]([c@h]([c@@h]([c@h](c(=o)o1)c)o[c@h]2c[c@@]([c@h]([c@@h](o2)c)o)(c)oc)c)o[c@h]3[c@@h]([c@h](c[c@h](o3)c)n(c)c)oc(=o)cc)(c)o)c)c)o)(c)o.. "
"erythromycins. this classification denotes an antibiotic variety based on a bacteriostatic produced from streptomyces erythreus, hence the name erythromycin, and of which erythromycin a is the major active component. in sensitive organisms, it inhibits protein synthesis by binding to 50s ribosomal subunits. this binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. erythromycin ethyl succinate. this classification denotes a macrolide antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1014ksj86f. european medicines agency schedules erythromycin ethyl succinate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01942mig. erythromycin ethyl succinate generally arises in the molecular formula c43h75no16. the term erythromycin ethyl succinate is a u.s. pharmacopeial convention designation. most nations, for tariff and trade purposes, schedule erythromycin ethyl succinate under hs 29415000. smiles: cc[c@@h]1[c@@]([c@@h]([c@h](c(=o)[c@@h](c[c@@]([c@@h]([c@h]([c@@h]([c@h](c(=o)o1)c)o[c@h]2c[c@@]([c@h]([c@@h](o2)c)o)(c)oc)c)o[c@h]3[c@@h]([c@h](c[c@h](o3)c)n(c)c)oc(=o)ccc(=o)occ)(c)o)c)c)o)(c)o.. "
"erythromycins. this classification denotes an antibiotic variety based on a bacteriostatic produced from streptomyces erythreus, hence the name erythromycin, and of which erythromycin a is the major active component. in sensitive organisms, it inhibits protein synthesis by binding to 50s ribosomal subunits. this binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. erythromycin ethylsuccinate. this classification denotes a macrolide antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1014ksj86f. european medicines agency schedules erythromycin ethyl succinate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01942mig. erythromycin ethylsuccinate generally arises in the molecular formula c43h75no16. the term erythromycin ethylsuccinate is a u.s. pharmacopeial convention designation. most nations, for tariff and trade purposes, schedule erythromycin ethylsuccinate under hs 29415000 and sitc 54139. as of q4 2014, erythromycin ethylsuccinate remains us fdas preferred term for this commodity. erythromycin ethylsuccinate bears us nlm identifiers umls id c0014810 and nci concept code c47987. smiles: cc[c@@h]1[c@@]([c@@h]([c@h](c(=o)[c@@h](c[c@@]([c@@h]([c@h]([c@@h]([c@h](c(=o)o1)c)o[c@h]2c[c@@]([c@h]([c@@h](o2)c)o)(c)oc)c)o[c@h]3[c@@h]([c@h](c[c@h](o3)c)n(c)c)oc(=o)ccc(=o)occ)(c)o)c)c)o)(c)o.. "
"erythromycins. this classification denotes an antibiotic variety based on a bacteriostatic produced from streptomyces erythreus, hence the name erythromycin, and of which erythromycin a is the major active component. in sensitive organisms, it inhibits protein synthesis by binding to 50s ribosomal subunits. this binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. erythromycin f. this classification denotes a macrolide antibiotic with the molecular formula c37h67no14, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier nm325t380n, chemically known as erythromycin, 16-hydroxy-, but more generally known as erythromycin f, which bears us nih compound identifier 6426644. european medicines agency schedules erythromycin f or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06605mig. most nations, for tariff purposes, schedule erythromycin f under hs 29415000. smiles: cc[c@@h]1[c@@]([c@@h]([c@h](c(=o)[c@@h](c[c@@]([c@@h]([c@h]([c@@h]([c@h](c(=o)o1)co)o[c@h]2c[c@@]([c@h]([c@@h](o2)c)o)(c)oc)c)o[c@h]3[c@@h]([c@h](c[c@h](o3)c)n(c)c)o)(c)o)c)c)o)(c)o.. "
"erythromycins. this classification denotes an antibiotic variety based on a bacteriostatic produced from streptomyces erythreus, hence the name erythromycin, and of which erythromycin a is the major active component. in sensitive organisms, it inhibits protein synthesis by binding to 50s ribosomal subunits. this binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. erythromycin gluceptate. this classification denotes a macrolide antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2ay21r0u64. european medicines agency schedules erythromycin gluceptate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01943mig. erythromycin glucoheptonate generally arises in the molecular formula c37h67no13.c7h14o8. the term erythromycin glucoheptonate is a u.s. pharmacopeial convention designation. most nations, for tariff and trade purposes, schedule erythromycin gluceptate under hs 29415000 and sitc 54139. as of q4 2014, erythromycin gluceptate remains us fdas preferred term for this commodity. erythromycin gluceptate bears us nlm identifiers umls id c0059561 and nci concept code c65533. smiles: cc[c@@h]1[c@@]([c@@h]([c@h](c(=o)[c@@h](c[c@@]([c@@h]([c@h]([c@@h]([c@h](c(=o)o1)c)o[c@h]2c[c@@]([c@h]([c@@h](o2)c)o)(c)oc)c)o[c@h]3[c@@h]([c@h](c[c@h](o3)c)n(c)c)o)(c)o)c)c)o)(c)o.c([c@h]([c@h]([c@@h]([c@h]([c@h](c(=o)o)o)o)o)o)o)o.. "
"erythromycins. this classification denotes an antibiotic variety based on a bacteriostatic produced from streptomyces erythreus, hence the name erythromycin, and of which erythromycin a is the major active component. in sensitive organisms, it inhibits protein synthesis by binding to 50s ribosomal subunits. this binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. erythromycin glucoheptonate. this classification denotes a macrolide antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2ay21r0u64. european medicines agency schedules erythromycin gluceptate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01943mig. erythromycin glucoheptonate generally arises in the molecular formula c37h67no13.c7h14o8. the term erythromycin glucoheptonate is a u.s. pharmacopeial convention designation. most nations, for tariff and trade purposes, schedule erythromycin glucoheptonate under hs 29415000 and sitc 54139. smiles: cc[c@@h]1[c@@]([c@@h]([c@h](c(=o)[c@@h](c[c@@]([c@@h]([c@h]([c@@h]([c@h](c(=o)o1)c)o[c@h]2c[c@@]([c@h]([c@@h](o2)c)o)(c)oc)c)o[c@h]3[c@@h]([c@h](c[c@h](o3)c)n(c)c)o)(c)o)c)c)o)(c)o.c([c@h]([c@h]([c@@h]([c@h]([c@h](c(=o)o)o)o)o)o)o)o.. "
"erythromycins. this classification denotes an antibiotic variety based on a bacteriostatic produced from streptomyces erythreus, hence the name erythromycin, and of which erythromycin a is the major active component. in sensitive organisms, it inhibits protein synthesis by binding to 50s ribosomal subunits. this binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. erythromycin lactobionate. this classification denotes a macrolide antibiotic with the molecular formula c37h67no13.c12h22o12, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 33h58i7glq, chemically known as erythromycin, n-demethyl-n-(methyl-11c)- but more generally known as erythromycin lactobionate, which bears us nih compound identifier 12560. european medicines agency schedules erythromycin lactobionate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01944mig. most nations, for tariff and trade purposes, schedule erythromycin lactobionate under hs 29415000 and sitc 54139. erythromycin lactobionate bears us nlm identifiers umls id c0059562 and nci concept code c47988. smiles: as of q4 2014, erythromycin lactobionate remains us fdas preferred term for this commodity.. "
"erythromycins. this classification denotes an antibiotic variety based on a bacteriostatic produced from streptomyces erythreus, hence the name erythromycin, and of which erythromycin a is the major active component. in sensitive organisms, it inhibits protein synthesis by binding to 50s ribosomal subunits. this binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. erythromycin oxime. this classification denotes a macrolide antibiotic c37h68n2o13, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 10w452cmtz, chemically known as erythromycin, 9-oxime, but more generally known as erythromycin oxime, which bears us nih compound identifier 6537896. most nations, for tariff and trade purposes, schedule erythromycin oxime under hs 29415000 and sitc 54139. as of q4 2014, erythromycin oxime remains us fdas preferred term for this commodity. erythromycin oxime bears us nlm identifiers umls id c0207096 and nci concept code c87758. smiles: cc[c@@h]1[c@@]([c@@h]([c@h](c(=no)[c@@h](c[c@@]([c@@h]([c@h]([c@@h]([c@h](c(=o)o1)c)o[c@h]2c[c@@]([c@h]([c@@h](o2)c)o)(c)oc)c)o[c@h]3[c@@h]([c@h](c[c@h](o3)c)n(c)c)o)(c)o)c)c)o)(c)o.. "
"erythromycins. this classification denotes an antibiotic variety based on a bacteriostatic produced from streptomyces erythreus, hence the name erythromycin, and of which erythromycin a is the major active component. in sensitive organisms, it inhibits protein synthesis by binding to 50s ribosomal subunits. this binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. erythromycin phosphate. this classification denotes a macrolide antibiotic with the molecular formula c37h67no13.h3o4p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier i8t8ku14x7, chemically known as erythromycin, phosphate but more generally known as erythromycin phosphate, which bears us nih compound identifier 83935. most nations, for tariff and trade purposes, schedule erythromycin phosphate under hs 29415000 and sitc 54139. as of q4 2014, erythromycin phosphate remains us fdas preferred term for this commodity. erythromycin phosphate bears us nlm identifiers umls id c0014813 and nci concept code c87759. smiles: cc[c@@h]1[c@@]([c@@h]([c@h](c(=o)[c@@h](c[c@@]([c@@h]([c@h]([c@@h]([c@h](c(=o)o1)c)o[c@h]2c[c@@]([c@h]([c@@h](o2)c)o)(c)oc)c)o[c@h]3[c@@h]([c@h](c[c@h](o3)c)n(c)c)o)(c)o)c)c)o)(c)o.op(=o)(o)o.. "
"erythromycins. this classification denotes an antibiotic variety based on a bacteriostatic produced from streptomyces erythreus, hence the name erythromycin, and of which erythromycin a is the major active component. in sensitive organisms, it inhibits protein synthesis by binding to 50s ribosomal subunits. this binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. erythromycin propionate. this classification denotes a macrolide antibiotic with the molecular formula c40h71no14, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hb75cit999, chemically known as erythromycin, 2-propionate but more generally known as erythromycin propionate, which bears us nih compound identifier 3258. european medicines agency schedules erythromycin propionate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01945mig. most nations, for tariff and trade purposes, schedule erythromycin propionate under hs 29415000 and sitc 54139. as of q4 2014, erythromycin propionate remains us fdas preferred term for this commodity. smiles: cc[c@@h]1[c@@]([c@@h]([c@h](c(=o)[c@@h](c[c@@]([c@@h]([c@h]([c@@h]([c@h](c(=o)o1)c)o[c@h]2c[c@@]([c@h]([c@@h](o2)c)o)(c)oc)c)o[c@h]3[c@@h]([c@h](c[c@h](o3)c)n(c)c)oc(=o)cc)(c)o)c)c)o)(c)o.. "
"erythromycins. this classification denotes an antibiotic variety based on a bacteriostatic produced from streptomyces erythreus, hence the name erythromycin, and of which erythromycin a is the major active component. in sensitive organisms, it inhibits protein synthesis by binding to 50s ribosomal subunits. this binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. erythromycin salnacedin. this classification denotes a macrolide antibiotic with the molecular formula c37h67no13.c12h13no5s.2h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier vma8f29a76, chemically known as erythromycin, compound with n-acetyl-l-cysteine 2-hydroxybenzoate (ester) (1:1), dihydrate, but more generally known as erythromycin salnacedin, which bears us nih compound identifier 60940. european medicines agency schedules erythromycin salnacedin or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06605mig. most nations, for tariff purposes, schedule erythromycin salnacedin under hs 29415000. smiles: cc[c@@h]1[c@@]([c@@h]([c@h](c(=o)[c@@h](c[c@@]([c@@h]([c@h]([c@@h]([c@h](c(=o)o1)c)o[c@h]2c[c@@]([c@h]([c@@h](o2)c)o)(c)oc)c)o[c@h]3[c@@h]([c@h](c[c@h](o3)c)n(c)c)o)(c)o)c)c)o)(c)o.cc(=o)n[c@@h](csc(=o)c1ccccc1o)c(=o)o.o.o.. "
"erythromycins. this classification denotes an antibiotic variety based on a bacteriostatic produced from streptomyces erythreus, hence the name erythromycin, and of which erythromycin a is the major active component. in sensitive organisms, it inhibits protein synthesis by binding to 50s ribosomal subunits. this binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. erythromycin stearate. this classification denotes a macrolide antibiotic with the molecular formula c37h67no13.c18h36o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier lxw024x05m, chemically known as stearic acid, compd. with erythromycin (1:1) but more generally known as erythromycin stearate, which bears us nih compound identifier 12559. european medicines agency schedules erythromycin stearate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01946mig. most nations, for tariff and trade purposes, schedule erythromycin stearate under hs 29415000 and sitc 54139. as of q4 2014, erythromycin stearate remains us fdas preferred term for this commodity. erythromycin stearate bears us nlm identifiers umls id c0059566 and nci concept code c47989. smiles: cccccccccccccccccc(=o)o.cc[c@@h]1[c@@]([c@@h]([c@h](c(=o)[c@@h](c[c@@]([c@@h]([c@h]([c@@h]([c@h](c(=o)o1)c)o[c@h]2c[c@@]([c@h]([c@@h](o2)c)o)(c)oc)c)o[c@h]3[c@@h]([c@h](c[c@h](o3)c)n(c)c)o)(c)o)c)c)o)(c)o.. "
"erythromycins. this classification denotes an antibiotic variety based on a bacteriostatic produced from streptomyces erythreus, hence the name erythromycin, and of which erythromycin a is the major active component. in sensitive organisms, it inhibits protein synthesis by binding to 50s ribosomal subunits. this binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. erythromycin succinate. this classification denotes a macrolide antibiotic with the molecular formula c41h71no16, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 831sf5m65l. most nations, for tariff and trade purposes, schedule erythromycin succinate under hs 29415000 and sitc 54139. as of q4 2014, erythromycin succinate remains us fdas preferred term for this commodity. smiles: cc[c@@h]1[c@@]([c@@h]([c@h](c(=o)[c@@h](c[c@@]([c@@h]([c@h]([c@@h]([c@h](c(=o)o1)c)o[c@h]2c[c@@]([c@h]([c@@h](o2)c)o)(c)oc)c)o[c@h]3[c@@h]([c@h](c[c@h](o3)c)n(c)c)oc(=o)ccc(=o)o)(c)o)c)c)o)(c)o.. "
"erythromycins. this classification denotes an antibiotic variety based on a bacteriostatic produced from streptomyces erythreus, hence the name erythromycin, and of which erythromycin a is the major active component. in sensitive organisms, it inhibits protein synthesis by binding to 50s ribosomal subunits. this binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. erythromycin thiocyanate. this classification denotes a macrolide antibiotic c37h67no13.chns, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier y7a95yri88, chemically known as thiocyanic acid, compd. with erythromycin (1:1), but more generally known as erythromycin thiocyanate, which bears us nih compound identifier 83938. most nations, for tariff and trade purposes, schedule erythromycin thiocyanate under hs 29415000 and sitc 54139. as of q4 2014, erythromycin thiocyanate remains us fdas preferred term for this commodity. smiles: cc[c@@h]1[c@@]([c@@h]([c@h](c(=o)[c@@h](c[c@@]([c@@h]([c@h]([c@@h]([c@h](c(=o)o1)c)o[c@h]2c[c@@]([c@h]([c@@h](o2)c)o)(c)oc)c)o[c@h]3[c@@h]([c@h](c[c@h](o3)c)n(c)c)o)(c)o)c)c)o)(c)o.c(#n)s.. "
"extended-spectrum penicillins. this classification denotes penicillin-derived antibiotics with wide antibacterial spectrum, hence the designation extended-spectrum penicillins.. . "
"extended-spectrum penicillins. this classification denotes penicillin-derived antibiotics with wide antibacterial spectrum, hence the designation extended-spectrum penicillins.. amdinocillin or mecillinam. this classification denotes a penicillin antibiotic with the molecular formula c15h23n3o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier v10579p3qz, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((hexahydro-1h-azepin-1-yl)methylene)amino)-3,3-dimethyl-7-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (2s-(2alpha,5alpha,6beta))- but generally known as amdinocillin, which bears us nih compound identifier 36272. amdinocillin most often comes in mecillinam and pivoxil forms. european medicines agency schedules amdinocillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08675mig. the term mecillinam is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15). world health organization schedules amdinocillin in its anatomical therapeutic chemical (atc) classification. amdinocillin or mecillinam bears us nlm identifiers umls id c0002435 and nci concept code c65229. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2/n=c/n1cccccc1.. "
"extended-spectrum penicillins. this classification denotes penicillin-derived antibiotics with wide antibacterial spectrum, hence the designation extended-spectrum penicillins.. pivmecillinam or amdinocillin pivoxil. this classification denotes a penicillin antibiotic with the molecular formula c21h33n3o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1wam1oq30b, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((hexahydro-1h-azepin-1-yl)methylene)amino)-3,3-dimethyl-7-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (2s-(2alpha,5alpha,6beta))- but generally known as amdinocillin pivoxil, which bears us nih compound identifier 36272. european medicines agency schedules amdinocillin pivoxil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub36043. world health organization schedules amdinocillin pivoxil in its anatomical therapeutic chemical (atc) classification. pivmecillinam or amdinocillin pivoxil bears us nlm identifiers umls id c0002436 and nci concept code c76216. smiles: s1c2n(c(c1(c)c)c(=o)ococ(=o)c(c)(c)c)c(=o)c2/n=c/n1cccccc1.. "
"extended-spectrum penicillins. this classification denotes penicillin-derived antibiotics with wide antibacterial spectrum, hence the designation extended-spectrum penicillins.. azlocillin. this classification denotes a penicillin antibiotic with the molecular formula c20h23n5o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hum6h389w0, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(((((2-oxo-1-imidazolidinyl)carbonyl)amino)phenylacetyl)amino)-, (2s-(2alpha,5alpha,6beta(s*)))- but generally known as azlocillin, which bears us nih compound identifier 37625. azlocillin most often comes in base and sodium forms. european medicines agency schedules azlocillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05661mig. the term azlocillin is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17). world health organization schedules azlocillin in its anatomical therapeutic chemical (atc) classification. azlocillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule azlocillin under hs 29411090 and sitc 54131. as of q4 2014, azlocillin remains the us fda preferred term for this commodity. azlocillin bears us nlm identifiers umls id c0004499 and nci concept code c293. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2nc(=o)c(nc(=o)n1ccnc1=o)c1ccccc1.. "
"extended-spectrum penicillins. this classification denotes penicillin-derived antibiotics with wide antibacterial spectrum, hence the designation extended-spectrum penicillins.. carbenicillin. this classification denotes an extended spectrum penicillin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g42zu72n5g. european medicines agency schedules carbenicillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06122mig. carbenicillin generally arises in the molecular formula c17h18n2o6s. the term carbenicillin is an international non-proprietary name or inn. carbenicillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule carbenicillin under hs 29411090 and sitc 54131. as of q4 2014, carbenicillin remains the us fda preferred term for this commodity. carbenicillin bears us nlm identifiers umls id c0006976 and nci concept code c343. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2nc(=o)c(c1ccccc1)c(=o)o.. "
"extended-spectrum penicillins. this classification denotes penicillin-derived antibiotics with wide antibacterial spectrum, hence the designation extended-spectrum penicillins.. carindacillin. this classification denotes an anti-bacterial agent with the molecular formula c26h26n2o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5v278481ke, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((3-((2,3-dihydro-1h-inden-5-yl)oxy)-1,3-dioxo-2-phenylpropyl)amino)-3,3-dimethyl-7-oxo-, (2s-(2-alpha,5-alpha,6-beta))- but generally known as carindacillin, which bears us nih compound identifier 93184. carindacillin most often comes in base and sodium forms. european medicines agency schedules carindacillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06629mig. world health organization schedules carindacillin in its anatomical therapeutic chemical (atc) classification. carindacillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule carindacillin under hs 29411090 and sitc 54131. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2nc(=o)c(c1ccccc1)c(=o)oc1cc2cccc2cc1.. "
"extended-spectrum penicillins. this classification denotes penicillin-derived antibiotics with wide antibacterial spectrum, hence the designation extended-spectrum penicillins.. fuzlocillin. this classification denotes a penicillin antibiotic with the molecular formula c25h26n6o8s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier j6uqp7jhot, chemically known as (2s,5r,6r)-6-((2r)-2-(3-((e)-furfurylideneamino)-2-oxo-1-imidazolidinecarboxamido)-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid but generally known as fuzlocillin, which bears us nih compound identifier 9571079. european medicines agency schedules fuzlocillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07855mig. the term fuzlocillin is an international non-proprietary name. fuzlocillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule fuzlocillin under hs 29411090 and sitc 54131. as of q4 2014, fuzlocillin remains the us fda preferred term for this commodity. fuzlocillin bears us nlm identifiers umls id c0060856 and nci concept code c65794. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2nc(=o)c(nc(=o)n1ccn(/n=c/c2occc2)c1=o)c1ccc(o)cc1.. "
"extended-spectrum penicillins. this classification denotes penicillin-derived antibiotics with wide antibacterial spectrum, hence the designation extended-spectrum penicillins.. mezlocillin. this classification denotes an extended spectrum penicillin antibiotic with the molecular formula c21h25n5o8s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier oh2o403d1g, chemically known as 1h-indole-3-acetic acid, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl- (9ci) but generally known as mezlocillin, which bears us nih compound identifier 3715. european medicines agency schedules mezlocillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08938mig. the term mezlocillin is an international non-proprietary name or inn (see who inn reference publication, volume 30, no. 10 1976, list 16). world health organization schedules mezlocillin in its anatomical therapeutic chemical (atc) classification. mezlocillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mezlocillin under hs 29411090 and sitc 54131. as of q4 2014, mezlocillin remains the us fda preferred term for this commodity. mezlocillin bears us nlm identifiers umls id c0025893 and nci concept code c653. smiles: clc1ccc(c(=o)n2c3c(c(c2c)cc(=o)o)cc(oc)cc3)cc1.. "
"extended-spectrum penicillins. this classification denotes penicillin-derived antibiotics with wide antibacterial spectrum, hence the designation extended-spectrum penicillins.. mezlocillin sodium. this classification denotes an extended spectrum penicillin antibiotic with the molecular formula c21h24n5o8s2.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier rx227tp94u, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-6-(((((((3-(methylsulfonyl)-2-oxo-1-imidazolidinyl)carbonyl)amino)carbonyl)amino)phenylacetyl)amino)-7-oxo-, monosodium salt, (2s-(2alpha,5alpha,6beta(s*)))- but generally known as mezlocillin sodium, which bears us nih compound identifier 43084. european medicines agency schedules mezlocillin sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03282mig. most nations schedule mezlocillin sodium under hs 29411090 and sitc 54131. as of q4 2014, mezlocillin sodium remains the us fda preferred term for this commodity. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2nc(=o)c(nc(=o)n1ccn(s(=o)(=o)c)c1=o)c1ccccc1.[na].. "
"extended-spectrum penicillins. this classification denotes penicillin-derived antibiotics with wide antibacterial spectrum, hence the designation extended-spectrum penicillins.. piperacillin. this classification denotes an extended spectrum penicillin antibiotic with the molecular formula c23h27n5o7s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9i628532gx, chemically known as 6-(d-(-)-alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)phenylacetamido)penicillanic acid but generally known as piperacillin, which bears us nih compound identifier 43672. european medicines agency schedules piperacillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09867mig. the term piperacillin anhydrous is an international non-proprietary name. world health organization schedules piperacillin in its anatomical therapeutic chemical (atc) classification. piperacillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule piperacillin under hs 29411090 and sitc 54131. as of q4 2014, piperacillin remains the us fda preferred term for this commodity. piperacillin bears us nlm identifiers umls id c0031955 and nci concept code c62069. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2nc(=o)c(nc(=o)n1ccn(c(=o)c1=o)cc)c1ccccc1.. "
"extended-spectrum penicillins. this classification denotes penicillin-derived antibiotics with wide antibacterial spectrum, hence the designation extended-spectrum penicillins.. temocillin. this classification denotes a penicillin antibiotic with the molecular formula c16h18n2o7s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 03qb156w6i, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((carboxy-3-thienylacetyl)amino)-6-methoxy-3,3-dimethyl-7-oxo-, (2s-(2alpha,5alpha,6alpha))- but generally known as temocillin, which bears us nih compound identifier 171758. european medicines agency schedules temocillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10886mig. the term temocillin is an international non-proprietary name. world health organization schedules temocillin in its anatomical therapeutic chemical (atc) classification. temocillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule temocillin under hs 29411090 and sitc 54131. as of q4 2014, temocillin remains the us fda preferred term for this commodity. temocillin bears us nlm identifiers umls id c0076079 and nci concept code c76858. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2(oc)nc(=o)c(c1ccsc1)c(=o)o.. "
"extended-spectrum penicillins. this classification denotes penicillin-derived antibiotics with wide antibacterial spectrum, hence the designation extended-spectrum penicillins.. ticarcillin. this classification denotes an extended spectrum penicillin antibiotic with the molecular formula c15h16n2o6s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f93ujx4swt, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((carboxy-3-thienylacetyl)amino)-3,3-dimethyl-7-oxo-, (2s-(2alpha,5alpha,6beta(s*)))- but generally known as ticarcillin, which bears us nih compound identifier 36921. european medicines agency schedules ticarcillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15567mig. the term ticarcillin is an international non-proprietary name or inn (see who inn reference publication, volume 14, no. 1, 2000, list 43). world health organization schedules ticarcillin in its anatomical therapeutic chemical (atc) classification. ticarcillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ticarcillin under hs 29411090 and sitc 54131. as of q4 2014, ticarcillin remains the us fda preferred term for this commodity. ticarcillin bears us nlm identifiers umls id c0040193 and nci concept code c889. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2nc(=o)c(c1ccsc1)c(=o)o.. "
"extended-spectrum penicillins. this classification denotes penicillin-derived antibiotics with wide antibacterial spectrum, hence the designation extended-spectrum penicillins.. azlocillin sodium. this classification denotes a penicillin antibiotic with the molecular formula c20h22n5o6s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier dwv1efw947, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(((((2-oxo-1-imidazolidinyl)carbonyl)amino)phenylacetyl)amino)-, monosodium salt, (2s-(2alpha,5alpha,6beta(s*)))- but more generally known as azlocillin sodium, which bears us nih compound identifier 37623. european medicines agency schedules azlocillin sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00645mig. most nations, for tariff and trade purposes, schedule azlocillin sodium under hs 29411090 and sitc 54131. as of q4 2014, azlocillin sodium remains us fdas preferred term for this commodity. azlocillin sodium bears us nlm identifiers umls id c0701436 and nci concept code c65243. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)[c@@h](c3ccccc3)nc(=o)n4ccnc4=o)c(=o)[o-])c.[na+].. "
"extended-spectrum penicillins. this classification denotes penicillin-derived antibiotics with wide antibacterial spectrum, hence the designation extended-spectrum penicillins.. carbenicillin disodium. this classification denotes an extended spectrum penicillin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9ts4b3h261. european medicines agency schedules carbenicillin disodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01041mig. carbenicillin disodium generally arises in the molecular formula c17h16n2na2o6s. the term carbenicillin disodium is a japanese accepted name designation. most nations, for tariff and trade purposes, schedule carbenicillin disodium under hs 29411090 and sitc 54131. as of q4 2014, carbenicillin disodium remains us fdas preferred term for this commodity. carbenicillin disodium bears us nlm identifiers umls id c0813202 and nci concept code c65285. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)c(c3ccccc3)c(=o)[o-])c(=o)[o-])c.[na+].[na+].. "
"extended-spectrum penicillins. this classification denotes penicillin-derived antibiotics with wide antibacterial spectrum, hence the designation extended-spectrum penicillins.. carbenicillin indanyl. this classification denotes an extended spectrum penicillin antibiotic with the molecular formula c26h26n2o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5v278481ke, chemically known as 1-(5-indanyl)(2s,5r,6r)-n-(2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl)-2-phenylmalonamate, but more generally known as carbenicillin indanyl, which bears us nih compound identifier 93184. european medicines agency schedules carbenicillin indanyl or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06122mig. most nations, for tariff purposes, schedule carbenicillin indanyl under hs 29411090. as of q4 2014, carbenicillin indanyl remains us fdas preferred term for this commodity. carbenicillin indanyl bears us nlm identifiers umls id c0054667 and nci concept code c76219. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)c(c3ccccc3)c(=o)oc4ccc5c(c4)ccc5)c(=o)o)c.. "
"extended-spectrum penicillins. this classification denotes penicillin-derived antibiotics with wide antibacterial spectrum, hence the designation extended-spectrum penicillins.. carbenicillin indanyl sodium. this classification denotes an extended spectrum penicillin antibiotic with the molecular formula c26h25n2o6s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4oul81k2rt, chemically known as 1-(5-indanyl)(2s,5r,6r)-n-(2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl)-2-phenylmalonamate monosodium salt, but more generally known as carbenicillin indanyl sodium, which bears us nih compound identifier 33554. european medicines agency schedules carbenicillin indanyl sodium or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06122mig. most nations, for tariff purposes, schedule carbenicillin indanyl sodium under hs 29411090. as of q4 2014, carbenicillin indanyl sodium remains us fdas preferred term for this commodity. carbenicillin indanyl sodium bears us nlm identifiers umls id c0142817 and nci concept code c1409. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)c(c3ccccc3)c(=o)oc4ccc5c(c4)ccc5)c(=o)[o-])c.[na+].. "
"extended-spectrum penicillins. this classification denotes penicillin-derived antibiotics with wide antibacterial spectrum, hence the designation extended-spectrum penicillins.. carbenicillin phenyl. this classification denotes an extended spectrum penicillin antibiotic with the molecular formula c23h22n2o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9uu4xdb74x, chemically known as n-(2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl)-2-phenylmalonamic acid 1-phenyl ester, but more generally known as carbenicillin phenyl, which bears us nih compound identifier 33672. european medicines agency schedules carbenicillin phenyl or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06122mig. most nations, for tariff purposes, schedule carbenicillin phenyl under hs 29411090. as of q4 2014, carbenicillin phenyl remains us fdas preferred term for this commodity. carbenicillin phenyl bears us nlm identifiers umls id c2698988 and nci concept code c79761. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)c(c3ccccc3)c(=o)oc4ccccc4)c(=o)o)c.. "
"extended-spectrum penicillins. this classification denotes penicillin-derived antibiotics with wide antibacterial spectrum, hence the designation extended-spectrum penicillins.. carbenicillin phenyl sodium. this classification denotes an extended spectrum penicillin antibiotic with the molecular formula c23h21n2o6s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 18n5jp36gy, chemically known as n-(2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl)-2-phenylmalonamic acid 1-phenyl ester sodium salt, but more generally known as carbenicillin phenyl sodium, which bears us nih compound identifier 30728. european medicines agency schedules carbenicillin phenyl sodium or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06122mig. most nations, for tariff purposes, schedule carbenicillin phenyl sodium under hs 29411090. as of q4 2014, carbenicillin phenyl sodium remains us fdas preferred term for this commodity. carbenicillin phenyl sodium bears us nlm identifiers umls id c0085959 and nci concept code c79421. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)c(c3ccccc3)c(=o)oc4ccccc4)c(=o)[o-])c.[na+].. "
"extended-spectrum penicillins. this classification denotes penicillin-derived antibiotics with wide antibacterial spectrum, hence the designation extended-spectrum penicillins.. carbenicillin sodium. this classification denotes an extended spectrum penicillin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9ts4b3h261. european medicines agency schedules carbenicillin disodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01041mig. carbenicillin disodium generally arises in the molecular formula c17h16n2na2o6s. the term carbenicillin disodium is a japanese accepted name designation. most nations, for tariff and trade purposes, schedule carbenicillin sodium under hs 29411090. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)c(c3ccccc3)c(=o)[o-])c(=o)[o-])c.[na+].[na+].. "
"extended-spectrum penicillins. this classification denotes penicillin-derived antibiotics with wide antibacterial spectrum, hence the designation extended-spectrum penicillins.. carindacillin sodium. this classification denotes an extended spectrum penicillin antibiotic with the molecular formula c26h25n2o6s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4oul81k2rt, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((3-((2,3-dihydro-1h-inden-5-yl)oxy)-1,3-dioxo-2-phenylpropyl)amino)-3,3-dimethyl-7-oxo-, monosodium salt, (2s-(2alpha,5alpha,6beta))- but more generally known as carbenicillin indanyl sodium, which bears us nih compound identifier 33554. the base compound, carbenicillin, comes in many other forms, including base, disodium, indanyl, indanyl potassium, phenyl, phenyl ester, phenyl sodium, potassium, and sodium. european medicines agency schedules carindacillin sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01061mig. most nations, for tariff and trade purposes, schedule carindacillin sodium under hs 29411090 and sitc 54131. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)c(c3ccccc3)c(=o)oc4ccc5c(c4)ccc5)c(=o)[o-])c.[na+].. "
"extended-spectrum penicillins. this classification denotes penicillin-derived antibiotics with wide antibacterial spectrum, hence the designation extended-spectrum penicillins.. mezlocillin sodium monohydrate. this classification denotes an extended spectrum penicillin antibiotic c21h24n5o8s2.na.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3cww8b5904, chemically known as sodium (2s,5r,6r)-3,3-dimethyl-6-((r)-2-(3-(methylsulfonyl)-2-oxo-1-imidazolidinecarboxamido)-2-phenylacetamido)-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate, monohydrate, but more generally known as mezlocillin sodium monohydrate, which bears us nih compound identifier 23677831. most nations, for tariff and trade purposes, schedule mezlocillin sodium monohydrate under hs 29411090 and sitc 54131. as of q4 2014, mezlocillin sodium monohydrate remains us fdas preferred term for this commodity. mezlocillin sodium monohydrate bears us nlm identifiers umls id c2828283 and nci concept code c87369. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)[c@@h](c3ccccc3)nc(=o)n4ccn(c4=o)s(=o)(=o)c)c(=o)[o-])c.o.[na+].. "
"extended-spectrum penicillins. this classification denotes penicillin-derived antibiotics with wide antibacterial spectrum, hence the designation extended-spectrum penicillins.. piperacillin anhydrous. this classification denotes an extended spectrum penicillin antibiotic with the molecular formula c23h27n5o7s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9i628532gx, chemically known as piperacillin, anhydrous, but more generally known as piperacillin anhydrous, which bears us nih compound identifier 43672. european medicines agency schedules piperacillin anhydrous or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09867mig. most nations, for tariff purposes, schedule piperacillin anhydrous under hs 29411090. piperacillin anhydrous bears us nlm identifiers umls id c1882383 and nci concept code c61891. smiles: ccn1ccn(c(=o)c1=o)c(=o)n[c@h](c2ccccc2)c(=o)n[c@h]3[c@@h]4n(c3=o)[c@h](c(s4)(c)c)c(=o)o.. "
"extended-spectrum penicillins. this classification denotes penicillin-derived antibiotics with wide antibacterial spectrum, hence the designation extended-spectrum penicillins.. piperacillin hydrate. this classification denotes an extended spectrum penicillin antibiotic with the molecular formula c23h27n5o7s.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x00b0d5o0e, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((2r)-(((4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)phenylacetyl)amino)-3,3-dimethyl-7-oxo-, monohydrate, (2s,5r,6r)-, but more generally known as piperacillin hydrate, which bears us nih compound identifier 73246. european medicines agency schedules piperacillin hydrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09867mig. most nations, for tariff purposes, schedule piperacillin hydrate under hs 29411090. smiles: ccn1ccn(c(=o)c1=o)c(=o)n[c@h](c2ccccc2)c(=o)n[c@h]3[c@@h]4n(c3=o)[c@h](c(s4)(c)c)c(=o)o.o.. "
"extended-spectrum penicillins. this classification denotes penicillin-derived antibiotics with wide antibacterial spectrum, hence the designation extended-spectrum penicillins.. piperacillin sodium. this classification denotes an extended spectrum penicillin antibiotic with the molecular formula c23h26n5o7s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m98t69q7hp, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((((4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)phenylacetyl)amino)-3,3-dimethyl-7-oxo-, monosodium salt, (2s-(2alpha,5alpha,6beta(s*)))- but more generally known as piperacillin sodium, which bears us nih compound identifier 43066. european medicines agency schedules piperacillin sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03840mig. most nations, for tariff and trade purposes, schedule piperacillin sodium under hs 29411090 and sitc 54131. as of q4 2014, piperacillin sodium remains us fdas preferred term for this commodity. piperacillin sodium bears us nlm identifiers umls id c0700463 and nci concept code c749. smiles: ccn1ccn(c(=o)c1=o)c(=o)n[c@h](c2ccccc2)c(=o)n[c@h]3[c@@h]4n(c3=o)[c@h](c(s4)(c)c)c(=o)[o-].[na+].. "
"extended-spectrum penicillins. this classification denotes penicillin-derived antibiotics with wide antibacterial spectrum, hence the designation extended-spectrum penicillins.. pivmecillinam hydrochloride. this classification denotes a penicillin antibiotic with the molecular structure c21h33n3o5s.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 48fx7n21h2 chemically known as hydroxymethyl (2s,5r,6r)-6-(((hexahydro-1h-azepin-1-yl)methylene)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate pivalate (ester) hydrochloride, but more commonly known as pivmecillinam hydrochloride, which bears us nih compound identifier 115162. european medicines agency schedules pivmecillinam hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03884mig. most nations, for tariff and trade purposes, schedule pivmecillinam hydrochloride under hs 29419000. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)n=cn3cccccc3)c(=o)ococ(=o)c(c)(c)c)c.cl.. "
"extended-spectrum penicillins. this classification denotes penicillin-derived antibiotics with wide antibacterial spectrum, hence the designation extended-spectrum penicillins.. temocillin sodium. this classification denotes a penicillin antibiotic with the molecular formula c16h16n2o7s2.2na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 96iip39odh, chemically known as n-((2s,5r,6s)-2-carboxy-6-methoxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl)-3-thiophenemalonamic acid disodium salt, but more generally known as temocillin sodium, which bears us nih compound identifier 6917850. european medicines agency schedules temocillin sodium or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10886mig. most nations, for tariff purposes, schedule temocillin sodium under hs 29411090. smiles: cc1([c@@h](n2[c@h](s1)[c@@](c2=o)(nc(=o)c(c3ccsc3)c(=o)[o-])oc)c(=o)[o-])c.[na+].[na+].. "
"extended-spectrum penicillins. this classification denotes penicillin-derived antibiotics with wide antibacterial spectrum, hence the designation extended-spectrum penicillins.. ticarcillin cresyl sodium. this classification denotes an extended spectrum penicillin antibiotic with the molecular formula c22h21n2o6s2.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0evr7q3336, chemically known as p-tolyl (r)-n-((2s,5r,6r)-(2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl))-3-thiophenemalonamate sodium salt, but more generally known as ticarcillin cresyl sodium, which bears us nih compound identifier 42946. european medicines agency schedules ticarcillin cresyl sodium or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15567mig. most nations, for tariff purposes, schedule ticarcillin cresyl sodium under hs 29411090. smiles: cc1ccc(cc1)oc(=o)[c@h](c2ccsc2)c(=o)n[c@h]3[c@@h]4n(c3=o)[c@h](c(s4)(c)c)c(=o)[o-].[na+].. "
"extended-spectrum penicillins. this classification denotes penicillin-derived antibiotics with wide antibacterial spectrum, hence the designation extended-spectrum penicillins.. ticarcillin disodium. this classification denotes an extended spectrum penicillin antibiotic with the molecular formula c15h14n2o6s2.2na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g8tvv6dsyg, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((carboxy-3-thienylacetyl)amino)-3,3-dimethyl-7-oxo-, disodium salt, (2s-(2alpha,5alpha,6beta(s*)))- but more generally known as ticarcillin disodium, which bears us nih compound identifier 20823. european medicines agency schedules ticarcillin disodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04857mig. most nations, for tariff and trade purposes, schedule ticarcillin disodium under hs 29411090 and sitc 54131. as of q4 2014, ticarcillin disodium remains us fdas preferred term for this commodity. ticarcillin disodium bears us nlm identifiers umls id c0546880 and nci concept code c65205. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)[c@@h](c3ccsc3)c(=o)[o-])c(=o)[o-])c.[na+].[na+].. "
"extended-spectrum penicillins. this classification denotes penicillin-derived antibiotics with wide antibacterial spectrum, hence the designation extended-spectrum penicillins.. ticarcillin sodium. this classification denotes an extended spectrum penicillin antibiotic with the molecular formula c15h14n2o6s2.2na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g8tvv6dsyg, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((carboxy-3-thienylacetyl)amino)-3,3-dimethyl-7-oxo-, disodium salt, (2s-(2alpha,5alpha,6beta(s*)))- but more generally known as ticarcillin disodium, which bears us nih compound identifier 20823. european medicines agency schedules ticarcillin disodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04857mig. most nations, for tariff and trade purposes, schedule ticarcillin sodium under hs 29411090. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)[c@@h](c3ccsc3)c(=o)[o-])c(=o)[o-])c.[na+].[na+].. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. . "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefacetrile or cephacetrile. this classification denotes an anti-bacterial agent with the molecular formula c13h13n3o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fdm21qq344, chemically known as (6r,7r)-3-acetoxymethyl-7-(2-cyanacetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure but generally known as cefacetrile, which bears us nih compound identifier 91562. cefacetrile most often comes in base and sodium forms. european medicines agency schedules cefacetrile in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06162mig. world health organization schedules cefacetrile in its anatomical therapeutic chemical (atc) classification. cefacetrile is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. cefacetrile or cephacetrile bears us nlm identifiers umls id c0007714 and nci concept code c81037. smiles: cc(=o)occ1=c(n2c(c(c2=o)nc(=o)cc#n)sc1)c(=o)[o-].[na+].. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefadroxil. this classification denotes a cephalosporin antibiotic with the molecular formula c16h17n3o5s.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 280111g160, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, (6r-(6-alpha,7-beta(r*)))- but generally known as cefadroxil, which bears us nih compound identifier 2610. cefadroxil most often comes in base, hydrate, and hemihydrate forms. european medicines agency schedules cefadroxil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06164mig. world health organization schedules cefadroxil in its anatomical therapeutic chemical (atc) classification. cefadroxil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefadroxil under hs 29419000 and sitc 54139. as of q4 2014, cefadroxil remains the us fda preferred term for this commodity. cefadroxil bears us nlm identifiers umls id c0007538 and nci concept code c28912. smiles: s1c2n(c(=o)c2nc(=o)c(n)c2ccc(o)cc2)c(=c(c1)c)c(=o)o.. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefalexin or cephalexin. this classification denotes a cephalosporin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier obn7uds42y. european medicines agency schedules cefalexin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06165mig. cefalexin generally arises in the molecular formula c16h17n3o4s. the term cefalexin is an international non-proprietary name or inn. cefalexin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. cefalexin or cephalexin bears us nlm identifiers umls id c0007716 and nci concept code c356. smiles: s1c2n(c(=o)c2nc(=o)c(n)c2ccccc2)c(=c(c1)c)c(=o)o.. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefaloglycin or cephaloglycin. this classification denotes a cephalosporin antibiotic with the molecular structure c18h19n3o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, hd2d469w6u chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-carboxylic acid, 3-((acetyloxy)methyl)-7-((aminophenylacetyl)amino)-8-oxo-, (6r-(6.alpha.,7.beta.(r*))) but generally known as cefaloglycin, which bears us nih compound identifier 19150. european medicines agency schedules cefaloglycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06166mig. the term cefaloglycin is an international non-proprietary name or inn. cefaloglycin or cephaloglycin bears us nlm identifiers umls id c0007721 and nci concept code c65307. smiles: s1c2n(c(=o)c2nc(=o)c(n)c2ccccc2)c(=c(c1)coc(=o)c)c(=o)o.. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefaloridine or cephaloridine. this classification denotes a cephalosporin antibiotic with the molecular formula c19h17n3o4s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier lvz1vc61hb, chemically known as pyridinium, 1-((2-carboxy-8-oxo-7-((2-thienylacetyl)amino)-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, (6r-trans)- but generally known as cefaloridine, which bears us nih compound identifier 5773. european medicines agency schedules cefaloridine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06169mig. the term cefaloridine is an international non-proprietary name. world health organization schedules cefaloridine in its anatomical therapeutic chemical (atc) classification. cefaloridine or cephaloridine bears us nlm identifiers umls id c0007727 and nci concept code c76594. smiles: s1c2n(c(=o)c2nc(=o)cc2sccc2)c(=c(c1)c[n]1ccccc1)c(=o)o.. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefalotin or cephalothin. this classification denotes a cephalosporin antibiotic with the molecular formula c16h16n2o6s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier r72lw146e6, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(hydroxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-, acetate (ester) but generally known as cefalotin, which bears us nih compound identifier 6024. european medicines agency schedules cefalotin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06170mig. the term cefalotin is an international non-proprietary name. world health organization schedules cefalotin in its anatomical therapeutic chemical (atc) classification. cefalotin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. cefalotin or cephalothin bears us nlm identifiers umls id c0007735 and nci concept code c62021. smiles: cc(=o)occ1=c(n2c(c(c2=o)nc(=o)cc3=cc=cs3)sc1)c(=o)[o-].[na+].. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefroxadine. this classification denotes a cephalosporin antibiotic with the molecular formula c16h19n3o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier b908c4mv2r, chemically known as 7-(d-2-amino-2-(1,4-cyclohexadienyl)acetamide)-3-methoxy-3-cephem-4-carboxylic acid but generally known as cefroxadine, which bears us nih compound identifier 40117. european medicines agency schedules cefroxadine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07419mig. the term cefroxadine is an international non-proprietary name or inn (see who inn reference publication, volume 34, no. 10 1980, list 20). world health organization schedules cefroxadine in its anatomical therapeutic chemical (atc) classification. cefroxadine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefroxadine under hs 29419000 and sitc 54139. as of q4 2014, cefroxadine remains the us fda preferred term for this commodity. cefroxadine bears us nlm identifiers umls id c0108941 and nci concept code c81033. smiles: s1c2n(c(=o)c2nc(=o)c(n)c2c=ccc=c2)c(=c(oc)c1)c(=o)o.. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefatrizine. this classification denotes a cephalosporin antibiotic with the molecular formula c18h18n6o5s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8p4w949t8k, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-8-oxo-3-((1h-1,2,3-triazol-4-ylthio)methyl)-, (6r-(6alpha,7beta(r*)))- but generally known as cefatrizine, which bears us nih compound identifier 40073. european medicines agency schedules cefatrizine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07376mig. the term cefatrizine is an international non-proprietary name. world health organization schedules cefatrizine in its anatomical therapeutic chemical (atc) classification. cefatrizine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefatrizine under hs 29419000 and sitc 54139. as of q4 2014, cefatrizine remains the us fda preferred term for this commodity. cefatrizine bears us nlm identifiers umls id c0007545 and nci concept code c81027. smiles: s1c2n(c(=o)c2nc(=o)c(n)c2ccc(o)cc2)c(=c(c1)csc1n[nh]nc1)c(=o)o.. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefazaflur. this classification denotes a cephalosporin antibiotic with the molecular formula c13h13f3n6o4s3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 97i0692rnt chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-7-((((trifluoromethyl)thio)acetyl)amino)-, (6r-trans)- but generally known as cefazaflur, which bears us nih compound identifier 40239. european medicines agency schedules cefazaflur in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07377mig. the term cefazaflur is an international non-proprietary name or inn. most nations schedule cefazaflur under hs 29419000 and sitc 54139. as of q4 2014, cefazaflur remains the us fda preferred term for this commodity. cefazaflur bears us nlm identifiers umls id c0054998 and nci concept code c79419. smiles: cn1c(=nn=n1)scc2=c(n3c(c(c3=o)nc(=o)csc(f)(f)f)sc2)c(=o)[o-].[na+].. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefazedone. this classification denotes a cephalosporin antibiotic with the molecular formula c18h15cl2n5o5s3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7y86x0d799, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((3,5-dichloro-4-oxo-1(4h)-pyridinyl)acetyl)amino)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-, (6r-trans)- but generally known as cefazedone, which bears us nih compound identifier 71736. european medicines agency schedules cefazedone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07378mig. the term cefazedone is an international non-proprietary name or inn (see who inn reference publication, volume 32, no 10 1978, list 18). world health organization schedules cefazedone in its anatomical therapeutic chemical (atc) classification. cefazedone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefazedone under hs 29419000 and sitc 54139. as of q4 2014, cefazedone remains the us fda preferred term for this commodity. cefazedone bears us nlm identifiers umls id c0054999 and nci concept code c76157. smiles: clc1cn(cc(=o)nc2c3scc(=c(n3c2=o)c(=o)o)csc2sc(nn2)c)cc(cl)c1=o.. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefazolin or cefazoline or cephazolin. this classification denotes a cephalosporin antibiotic with the molecular formula c14h14n8o4s3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ihs69l0y4t, chemically known as 7-(1-(1h-)-tetrazolylacetamido)-3-(2-(5-methyl-1,3,4-thiadiazolyl)thiomethyl)delta3-cephem-4-carboxylic acid but generally known as cefazolin, which bears us nih compound identifier 33255. european medicines agency schedules cefazolin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07379mig. the term cefazolin is an international non-proprietary name. world health organization schedules cefazolin in its anatomical therapeutic chemical (atc) classification. cefazolin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s1c2n(c(=o)c2nc(=o)cn2nnnc2)c(=c(c1)csc1sc(nn1)c)c(=o)o.. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. ceftezole. this classification denotes a cephalosporin antibiotic with the molecular formula c13h12n8o4s3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2z86syp11w, chemically known as (6r,7r)-8-oxo-7-(2-(1h-tetrazol-1-yl)acetamido)-3-((1,3,4-thiadiazol-2-ylthio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid but generally known as ceftezole, which bears us nih compound identifier 65755. european medicines agency schedules ceftezole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07424mig. the term ceftezole is an international non-proprietary name. world health organization schedules ceftezole in its anatomical therapeutic chemical (atc) classification. ceftezole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ceftezole under hs 29419000 and sitc 54139. as of q4 2014, ceftezole remains the us fda preferred term for this commodity. ceftezole bears us nlm identifiers umls id c0055013 and nci concept code c76038. smiles: s1c2n(c(=o)c2nc(=o)cn2nnnc2)c(=c(c1)csc1scnn1)c(=o)o.. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cephalexin. this classification denotes a cephalosporin antibiotic with the molecular structure c16h17n3o4s.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, obn7uds42y chemically known as (6r,7r)-7-((r)-2-amino-2-phenylacetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid monohydrate but generally known as cephalexin, which bears us nih compound identifier 2666. european medicines agency schedules cephalexin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06165mig. as of q4 2014, cephalexin remains the us fda preferred term for this commodity. cephalexin bears us nlm identifiers umls id c0007716 and nci concept code c356. smiles: s1c2n(c(=o)c2nc(=o)c(n)c2ccccc2)c(=c(c1)c)c(=o)o.. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefapirin or cephapirin. this classification denotes a cephalosporin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 89b59h32vn. european medicines agency schedules cefapirin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07375mig. cefapirin generally arises in the molecular formula c17h17n3o6s2. the term cefapirin is a hazardous substances data bank designation. cefapirin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. cefapirin or cephapirin bears us nlm identifiers umls id c0007737 and nci concept code c61670. smiles: s1c2n(c(=o)c2nc(=o)csc2ccncc2)c(=c(c1)coc(=o)c)c(=o)o.. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefradine or cephradine. this classification denotes a cephalosporin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f1bc02i72w. european medicines agency schedules cefradine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07417mig. cefradine generally arises in the molecular formula c16h19n3o4s. the term cefradine is an international non-proprietary name or inn (see who inn reference publication, volume 26, no. 10 1972, list 12.) cefradine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. cefradine or cephradine bears us nlm identifiers umls id c0007738 and nci concept code c47441. smiles: s1c2n(c(=o)c2nc(=o)c(n)c2=ccc=cc2)c(=c(c1)c)c(=o)o.. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefmepidium. this classification denotes a cephalosporin antibiotic with the molecular formula c23h25n6o8s3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier xlc35939wj, chemically known as 4-((((6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)thio)-1-methylpyridinium 72-(z)-(o-(1-carboxy-1-methylethyl)oxime) s-oxide. but generally known as cefmepidium, which bears us nih compound identifier 9589472. european medicines agency schedules cefmepidium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07398mig. the term cefmepidium is an international non-proprietary name. as of q4 2014, cefmepidium remains the us fda preferred term for this commodity. cefmepidium bears us nlm identifiers umls id c2827106 and nci concept code c83603. smiles: cc(c)(c(=o)o)on=c(c1=csc(=n1)n)c(=o)nc2c3n(c2=o)c(=c(cs3=o)csc4=cc=[n+](c=c4)c)c(=o)o.. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefacetrile sodium. this classification denotes a cephalosporin antibiotic with the molecular formula c13h12n3o6s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 87th1fjy1n, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(2-cyanoacetamido)-3-(hydroxymethyl)-8-oxo-, acetate (ester), monosodium salt but more generally known as cefacetrile sodium, which bears us nih compound identifier 31725. european medicines agency schedules cefacetrile sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01094mig. most nations, for tariff and trade purposes, schedule cefacetrile sodium under hs 29419000. smiles: cc(=o)occ1=c(n2[c@@h]([c@@h](c2=o)nc(=o)cc#n)sc1)c(=o)[o-].[na+].. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefadroxil hemihydrate. this classification denotes a cephalosporin antibiotic with the molecular formula 2c16h17n3o5s.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier j9cmf6461m, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, monohydrate, (6r-(6alpha,7beta(r*)))- but more generally known as cefadroxil hemihydrate, which bears us nih compound identifier 47964. most nations, for tariff and trade purposes, schedule cefadroxil hemihydrate under hs 29419000 and sitc 54139. as of q4 2014, cefadroxil hemihydrate remains us fdas preferred term for this commodity. cefadroxil hemihydrate bears us nlm identifiers umls id c1707321 and nci concept code c47965. smiles: cc1=c(n2[c@@h]([c@@h](c2=o)nc(=o)[c@@h](c3ccc(cc3)o)n)sc1)c(=o)o.cc1=c(n2[c@@h]([c@@h](c2=o)nc(=o)[c@@h](c3ccc(cc3)o)n)sc1)c(=o)o.o.. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefadroxil monohydrate. this classification denotes a cephalosporin antibiotic with the molecular formula c16h17n3o5s.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 280111g160, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, (6r-(6-alpha,7-beta(r*)))- but more generally known as cefadroxil, which bears us nih compound identifier 2610. cefadroxil most often comes in base, hydrate, and hemihydrate forms. european medicines agency schedules cefadroxil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06164mig. world health organization schedules cefadroxil in its anatomical therapeutic chemical (atc) classification. cefadroxil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule cefadroxil monohydrate under hs 29419000 and sitc 54139. smiles: cc1=c(n2[c@@h]([c@@h](c2=o)nc(=o)[c@@h](c3ccc(cc3)o)n)sc1)c(=o)o.o.. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefalexin hydrochloride. this classification denotes a cephalosporin antibiotic with the molecular formula c16h17n3o4s.clh.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6vje5g3d98. european medicines agency schedules cefalexin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01097mig. the term cefalexin hydrochloride is a u.s. fda designation. most nations, for tariff and trade purposes, schedule cefalexin hydrochloride under hs 29419000. smiles: cc1=c(n2[c@@h]([c@@h](c2=o)nc(=o)[c@@h](c3ccccc3)n)sc1)c(=o)o.o.cl.. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefalexin monohydrate. this classification denotes a cephalosporin antibiotic with the molecular structure c16h17n3o4s.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, obn7uds42y chemically known as (6r,7r)-7-((r)-2-amino-2-phenylacetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid monohydrate, but more commonly known as cephalexin, which bears us nih compound identifier 2666. european medicines agency schedules cephalexin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06165mig. most nations, for tariff and trade purposes, schedule cefalexin monohydrate under hs 29419000. smiles: cc1=c(n2[c@@h]([c@@h](c2=o)nc(=o)[c@@h](c3ccccc3)n)sc1)c(=o)o.o.. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefalexin sodium. this classification denotes a cephalosporin antibiotic with the molecular structure c16h16n3o4s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, f78yjg0wxk chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2r)-2-amino-2-phenylacetyl)amino)-3-methyl-8-oxo-, sodium salt (1:1), (6r,7r)-, but more commonly known as cefalexin sodium, which bears us nih compound identifier 27447. european medicines agency schedules cefalexin sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13273mig. most nations, for tariff and trade purposes, schedule cefalexin sodium under hs 29419000. smiles: cc1=c(n2[c@@h]([c@@h](c2=o)nc(=o)[c@@h](c3ccccc3)n)sc1)c(=o)[o-].[na+].. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefalotin sodium. this classification denotes a cephalosporin antibiotic with the molecular formula c16h15n2o6s2.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier c22g6eyp8b, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(hydroxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-, acetate, monosodium salt but more generally known as cefalotin sodium, which bears us nih compound identifier 6023. european medicines agency schedules cefalotin sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01100mig. most nations, for tariff and trade purposes, schedule cefalotin sodium under hs 29419000. smiles: cc(=o)occ1=c(n2[c@@h]([c@@h](c2=o)nc(=o)cc3cccs3)sc1)c(=o)[o-].[na+].. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefapirin sodium. this classification denotes a cephalosporin antibiotic with the molecular formula c17h16n3o6s2.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 431lff7i7j, chemically known as 5-thia-1-azabicyclo(4,2,0)oct-2-ene-2-carboxylic acid, 3-(hydroxymethyl)-8-oxo-7-(2-(4-pyridylthio)acetamido)-, acetate (ester), monosodium salt but more generally known as cefapirin sodium, which bears us nih compound identifier 32325. european medicines agency schedules cefapirin sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01103mig. most nations, for tariff and trade purposes, schedule cefapirin sodium under hs 29419000. smiles: cc(=o)occ1=c(n2[c@@h]([c@@h](c2=o)nc(=o)csc3ccncc3)sc1)c(=o)[o-].[na+].. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefatrizine compd with propylene glycol. this classification denotes a cephalosporin antibiotic with the molecular formula c18h18n6o5s2.c3h8o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3731ia5gi9, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2r)-2-amino-2-(4-hydroxyphenyl)acetyl)amino)-8-oxo-3-((1h-1,2,3-triazol-5-ylthio)methyl)-, (6r,7r)-, compd. with 1,2-propanediol (1:1), but more generally known as cefatrizine compd with propylene glycol, which bears us nih compound identifier 6410506. european medicines agency schedules cefatrizine compd with propylene glycol or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07376mig. most nations, for tariff purposes, schedule cefatrizine compd with propylene glycol under hs 29419000. smiles: cc(co)o.c1cc(ccc1[c@h](c(=o)n[c@h]2[c@@h]3n(c2=o)c(=c(cs3)csc4cnn[nh]4)c(=o)o)n)o.. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefatrizine propylene glycol. this classification denotes a cephalosporin antibiotic with the molecular formula c18h18n6o5s2.c3h8o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3731ia5gi9, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2r)-2-amino-2-(4-hydroxyphenyl)acetyl)amino)-8-oxo-3-((1h-1,2,3-triazol-5-ylthio)methyl)-, (6r,7r)-, compd. with 1,2-propanediol (1:1), but more generally known as cefatrizine propylene glycol, which bears us nih compound identifier 6410757. european medicines agency schedules cefatrizine propylene glycol or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07376mig. most nations, for tariff purposes, schedule cefatrizine propylene glycol under hs 29419000. smiles: cc(co)o.c1cc(ccc1[c@h](c(=o)n[c@h]2[c@@h]3n(c2=o)c(=c(cs3)csc4cnn[nh]4)c(=o)o)n)o.. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefazaflur sodium. this classification denotes the sodium form of a cephalosporin antibiotic with the molecular structure c13h13f3n6o4s3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 97i0692rnt chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-7-((((trifluoromethyl)thio)acetyl)amino)-, (6r-trans)-, but more commonly known as cefazaflur, which bears us nih compound identifier 40239. european medicines agency schedules cefazaflur in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07377mig. the term cefazaflur is an international non-proprietary name or inn. most nations, for tariff and trade purposes, schedule cefazaflur sodium under hs 29419000 and sitc 54139. as of q4 2014, cefazaflur sodium remains us fdas preferred term for this commodity. cefazaflur sodium bears us nlm identifiers umls id c2825417 and nci concept code c81028. smiles: cn1c(nnn1)scc2=c(n3[c@@h]([c@@h](c3=o)nc(=o)csc(f)(f)f)sc2)c(=o)[o-].[na+].. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefazedone sodium. this classification denotes a cephalosporin antibiotic with the molecular formula c18h14cl2n5o5s3.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 658x66lf6y. european medicines agency schedules cefazedone sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01106mig. the term cefazedone sodium is a u.s. fda designation. most nations, for tariff and trade purposes, schedule cefazedone sodium under hs 29419000 and sitc 54139. as of q4 2014, cefazedone sodium remains us fdas preferred term for this commodity. cefazedone sodium bears us nlm identifiers umls id c0140149 and nci concept code c98216. smiles: cc1nnc(s1)scc2=c(n3[c@@h]([c@@h](c3=o)nc(=o)cn4cc(c(=o)c(c4)cl)cl)sc2)c(=o)[o-].[na+].. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefazolin benzathine. this classification denotes a cephalosporin antibiotic c16h20n2.c14h14n8o4s3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier bjn67huz04, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-((1h-tetrazol-1-ylacetyl)amino)-, (6r-trans)-, compd. with n,n-bis(phenylmethyl)-1,2-ethanediamine (2:1), but more generally known as cefazolin benzathine, which bears us nih compound identifier 71300925. most nations, for tariff and trade purposes, schedule cefazolin benzathine under hs 29419000 and sitc 54139. as of q4 2014, cefazolin benzathine remains us fdas preferred term for this commodity. smiles: cc1nnc(s1)scc2=c(n3[c@@h]([c@@h](c3=o)nc(=o)cn4cnnn4)sc2)c(=o)o.c1ccc(cc1)cnccncc2ccccc2.. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefazolin sodium. this classification denotes a cephalosporin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier p380m0454z. european medicines agency schedules cefazolin sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01107mig. cefazolin sodium generally arises in the molecular formula c14h13n8nao4s3. the term cefazolin sodium is a united states adopted name designation. most nations, for tariff and trade purposes, schedule cefazolin sodium under hs 29419000. as of q4 2014, cefazolin sodium remains us fdas preferred term for this commodity. cefazolin sodium bears us nlm identifiers umls id c0700526 and nci concept code c47968. smiles: cc1nnc(s1)scc2=c(n3[c@@h]([c@@h](c3=o)nc(=o)cn4cnnn4)sc2)c(=o)[o-].[na+].. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefmepidium chloride. this classification denotes a cephalosporin antibiotic with the molecular formula c23h25n6o8s3.cl, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 726233n8l3, chemically known as 4-((((6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)thio)-1-methylpyridinium chloride 7,2-(z)-(o-(1-carboxy-1-methylethyl)oxime) s-oxide. but more generally known as cefmepidium chloride, which bears us nih compound identifier 9589472. european medicines agency schedules cefmepidium chloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07398mig. the term cefmepidium chloride is an international non-proprietary name. most nations, for tariff and trade purposes, schedule cefmepidium chloride under hs 29419000 and sitc 54139. as of q4 2014, cefmepidium chloride remains us fdas preferred term for this commodity. cefmepidium chloride bears us nlm identifiers umls id c2825418 and nci concept code c81030. smiles: cc(c)(c(=o)o)o/n=c(/c1csc(n1)n)\\c(=o)n[c@h]2[c@@h]3n(c2=o)c(=c(c[s+]3[o-])csc4cc[n+](cc4)c)c(=o)o.[cl-].. "
"first generation cephalosporins. this classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. ceftezole sodium. this classification denotes a cephalosporin antibiotic with the molecular formula c13h11n8o4s3.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3nhz4y117h, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 8-oxo-7-((1h-tetrazol-1-ylacetyl)amino)-3-((1,3,4-thiadiazol-2-ylthio)methyl)-, monosodium salt, (6r-trans)- but more generally known as ceftezole sodium, which bears us nih compound identifier 170470. european medicines agency schedules ceftezole sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01136mig. most nations, for tariff and trade purposes, schedule ceftezole sodium under hs 29419000 and sitc 54139. as of q4 2014, ceftezole sodium remains us fdas preferred term for this commodity. ceftezole sodium bears us nlm identifiers umls id c0970035 and nci concept code c98231. smiles: c1nnnn1cc(=o)n[c@h]2[c@@h]3n(c2=o)c(=c(cs3)csc4nncs4)c(=o)[o-].[na+].. "
"fourth generation cephalosporins. this classification denotes the fourth variety or generation of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. . "
"fourth generation cephalosporins. this classification denotes the fourth variety or generation of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefpirome. this classification denotes a cephalosporin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier s72q2f09hy. european medicines agency schedules cefpirome in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07413mig. cefpirome generally arises in the molecular formula c22h22n6o5s2. the term cefpirome is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24.) cefpirome is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefpirome under hs 29419000 and sitc 54139. as of q4 2014, cefpirome remains the us fda preferred term for this commodity. cefpirome bears us nlm identifiers umls id c0062986 and nci concept code c79563. smiles: s1c2n(c(=o)c2nc(=o)/c(=n\\oc)c2nc(sc2)n)c(=c(c1)c[n]1c2cccc2ccc1)c(=o)o.. "
"fourth generation cephalosporins. this classification denotes the fourth variety or generation of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefepime. this classification denotes a cephalosporin antibiotic with the molecular formula c19h24n6o5s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 807pw4vqe3, chemically known as 1-(((6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-methylpyrrolidinium hydroxide, inner salt, 7(sup 2)-(z)-(o-methyloxime) but generally known as cefepime, which bears us nih compound identifier 5479537. european medicines agency schedules cefepime in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07390mig. the term cefepime is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). world health organization schedules cefepime in its anatomical therapeutic chemical (atc) classification. cefepime is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefepime under hs 29419000 and sitc 54139. as of q4 2014, cefepime remains the us fda preferred term for this commodity. cefepime bears us nlm identifiers umls id c0055003 and nci concept code c65294. smiles: s1c2n(c(=c(c[n]3(cccc3)c)c1)c(=o)o)c(=o)c2nc(=o)/c(=n\\oc)c1nc(sc1)n.. "
"fourth generation cephalosporins. this classification denotes the fourth variety or generation of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefluprenam. this classification denotes a cephalosporin antibiotic with the molecular formula c20h25fn8o6s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 098633q42p, chemically known as 2-propen-1-aminium, n-(2-amino-2-oxoethyl)-3-(7-(((5-amino-1,2,4-thiadiazol-3-yl)((fluoromethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)-n-ethyl-n-methyl-, inner salt, (6r-(3(e),6-alpha,7-beta(z)))- but generally known as cefluprenam, which bears us nih compound identifier 6536774. european medicines agency schedules cefluprenam in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07396mig. the term cefluprenam is an international non-proprietary name or inn (see who inn reference publication, volume 9, no. 3, 1995, list 35). cefluprenam is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefluprenam under hs 29419000 and sitc 54139. as of q4 2014, cefluprenam remains the us fda preferred term for this commodity. cefluprenam bears us nlm identifiers umls id c0652447 and nci concept code c76034. smiles: s1c2n(c(=o)c2nc(=o)/c(=n\\ocf)c2nc(sn2)n)c(=c(c1)/c=c/c[n](cc)(cc(=o)n)c)c(=o)o.. "
"fourth generation cephalosporins. this classification denotes the fourth variety or generation of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefoselis. this classification denotes a cephalosporin antibiotic with the molecular formula c19h22n8o6s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0b50mlu3h1, chemically known as (-)-5-amino-2-(((6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-(2-hydroxyethyl)pyrazolium hydroxide, inner salt, 7,2-(z)-(o-methyloxime). but generally known as cefoselis, which bears us nih compound identifier 9589475. european medicines agency schedules cefoselis in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07404mig. the term cefoselis is an international non-proprietary name or inn (see who inn reference publication, volume 9, no. 3, 1995, list 35). cefoselis is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefoselis under hs 29419000 and sitc 54139. as of q4 2014, cefoselis remains the us fda preferred term for this commodity. cefoselis bears us nlm identifiers umls id c0965645 and nci concept code c79420. smiles: s1c2n(c(=o)c2nc(=o)/c(=n/oc)c2nc(sc2)n)c(=c(c1)c[n]1n(c(n)cc1)cco)c(=o)o.. "
"fourth generation cephalosporins. this classification denotes the fourth variety or generation of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefozopran. this classification denotes a cephalosporin antibiotic with the molecular formula c19h17n9o5s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1lg87k28lw, chemically known as imidazo(1,2-b)pyridazinium, 1-((7-(((5-amino-1,2,4-thiadiazol-3-yl)(methoxyimino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, (6r-(6alpha,7beta(z)))- but generally known as cefozopran, which bears us nih compound identifier 9571080. european medicines agency schedules cefozopran in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07410mig. the term cefozopran is an international non-proprietary name or inn (see who inn reference publication, volume 6, no, 3 1992, list 32). world health organization schedules cefozopran in its anatomical therapeutic chemical (atc) classification. cefozopran is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefozopran under hs 29419000 and sitc 54139. as of q4 2014, cefozopran remains the us fda preferred term for this commodity. cefozopran bears us nlm identifiers umls id c0246584 and nci concept code c76172. smiles: s1c2n(c(=o)c2nc(=o)/c(=n\\oc)c2nc(sn2)n)c(=c(c1)cn1c2[n](nccc2)cc1)c(=o)o.. "
"fourth generation cephalosporins. this classification denotes the fourth variety or generation of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefquinome. this classification denotes a cephalosporin antibiotic with the molecular formula c23h24n6o5s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, z74s078cwp chemically known as 1-(((6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-5,6,7,8-tetrahydroquinolinium hydroxide, inner salt, 72-(z)-(o-methyloxime) but generally known as cefquinome, which bears us nih compound identifier 9571084. european medicines agency schedules cefquinome in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07416mig. the term cefquinome is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29. ). most nations schedule cefquinome under hs 29419000 and sitc 54139. as of q4 2014, cefquinome remains the us fda preferred term for this commodity. cefquinome bears us nlm identifiers umls id c0108939 and nci concept code c79564. smiles: con=c(c1=csc(=n1)n)c(=o)nc2c3n(c2=o)c(=c(cs3)c[n+]4=cc=cc5=c4cccc5)c(=o)[o-].. "
"fourth generation cephalosporins. this classification denotes the fourth variety or generation of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefovecin. this classification denotes a cephalosporin antibiotic with the molecular formula c17h19n5o6s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0d1ol46zie, che,ically known as (7r)-7-[[(2z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-8-oxo-3-[(2s)-tetrahydrofuran-2-yl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid but generally known cefovecin, as which bears us nih compound identifier 9578573. the term cefovecin is an international non-proprietary name. most nations schedule cefovecin under hs 29419000 and sitc 54139. as of q4 2014, cefovecin remains the us fda preferred term for this commodity. cefovecin bears us nlm identifiers umls id c1869686 and nci concept code c76035. smiles: con=c(c1=csc(=n1)n)c(=o)nc2c3n(c2=o)c(=c(cs3)c4ccco4)c(=o)o.. "
"fourth generation cephalosporins. this classification denotes the fourth variety or generation of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefepime dihydrochloride. this classification denotes a cephalosporin antibiotic with the molecular formula c19h24n6o5s2.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2a1o4f5n0c, chemically known as (6r,7r)-7-(((2e)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl)amino)-3-((1-methylpyrrolidin-1-ium-1-yl)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid chloride hydrochloride, but more generally known as cefepime dihydrochloride, which bears us nih compound identifier 9571075. european medicines agency schedules cefepime dihydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07390mig. most nations, for tariff purposes, schedule cefepime dihydrochloride under hs 29419000. smiles: c[n+]1(cccc1)cc2=c(n3[c@@h]([c@@h](c3=o)nc(=o)/c(=n\\oc)/c4csc(n4)n)sc2)c(=o)[o-].cl.cl.. "
"fourth generation cephalosporins. this classification denotes the fourth variety or generation of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefepime dihydrochloride monohydrate. this classification denotes a cephalosporin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier i8x1o0607p. european medicines agency schedules cefepime dihydrochloride monohydrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub26333. cefepime dihydrochloride monohydrate generally arises in the molecular formula c19h24n6o5s2.2clh.h2o. the term cefepime dihydrochloride monohydrate is a european pharmacopoeia designation. most nations, for tariff and trade purposes, schedule cefepime dihydrochloride monohydrate under hs 29419000. smiles: c[n+]1(cccc1)cc2=c(n3[c@@h]([c@@h](c3=o)nc(=o)/c(=n\\oc)/c4csc(n4)n)sc2)c(=o)[o-].o.cl.cl.. "
"fourth generation cephalosporins. this classification denotes the fourth variety or generation of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefepime hydrochloride. this classification denotes a cephalosporin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier i8x1o0607p. european medicines agency schedules cefepime dihydrochloride monohydrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub26333. cefepime hydrochloride generally arises in the molecular formula c19h24n6o5s2.2clh.h2o. the term cefepime hydrochloride is a european pharmacopoeia designation. most nations, for tariff and trade purposes, schedule cefepime hydrochloride under hs 29419000 and sitc 54139. as of q4 2014, cefepime hydrochloride remains us fdas preferred term for this commodity. cefepime hydrochloride bears us nlm identifiers umls id c0771284 and nci concept code c1041. smiles: c[n+]1(cccc1)cc2=c(n3[c@@h]([c@@h](c3=o)nc(=o)/c(=n\\oc)/c4csc(n4)n)sc2)c(=o)[o-].o.cl.cl.. "
"fourth generation cephalosporins. this classification denotes the fourth variety or generation of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefoselis sulfate. this classification denotes a cephalosporin antibiotic with the molecular formula c19h22n8o6s2.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6ey42207vs, chemically known as 5-amino-2-(((6r,7r)-7-(((z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl)-amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-(2-hydroxyethyl)-1h-pyrazolium hydroxide sulfate, but more generally known as cefoselis sulfate, which bears us nih compound identifier 9690118. european medicines agency schedules cefoselis sulfate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07404mig. most nations, for tariff purposes, schedule cefoselis sulfate under hs 29419000. smiles: co/n=c(/c1csc(n1)n)\\c(=o)n[c@h]2[c@@h]3n(c2=o)c(=c(cs3)cn4ccc(=n)n4cco)c(=o)o.os(=o)(=o)o.. "
"fourth generation cephalosporins. this classification denotes the fourth variety or generation of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefovecin sodium. this classification denotes a cephalosporin antibiotic with the molecular formula c17h18n5o6s2.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier dl8q24959p. the term cefovecin sodium is a united states adopted name designation. most nations, for tariff and trade purposes, schedule cefovecin sodium under hs 29419000 and sitc 54139. as of q4 2014, cefovecin sodium remains us fdas preferred term for this commodity. cefovecin sodium bears us nlm identifiers umls id c2699141 and nci concept code c76036. smiles: co/n=c(/c1csc(n1)n)\\c(=o)n[c@h]2[c@@h]3n(c2=o)c(=c(cs3)[c@@h]4ccco4)c(=o)[o-].[na+].. "
"fourth generation cephalosporins. this classification denotes the fourth variety or generation of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefozopran hydrochloride. this classification denotes a cephalosporin antibiotic with the molecular formula c19h17n9o5s2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 060i5c0grc. european medicines agency schedules cefozopran hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13278mig. the term cefozopran hydrochloride is a u.s. fda designation. most nations, for tariff and trade purposes, schedule cefozopran hydrochloride under hs 29419000 and sitc 54139. as of q4 2014, cefozopran hydrochloride remains us fdas preferred term for this commodity. cefozopran hydrochloride bears us nlm identifiers umls id c0141689 and nci concept code c92168. smiles: co/n=c(/c1nc(sn1)n)\\c(=o)n[c@h]2[c@@h]3n(c2=o)c(=c(cs3)c[n+]4ccn5c4cccn5)c(=o)[o-].cl.. "
"fourth generation cephalosporins. this classification denotes the fourth variety or generation of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefpirome sulfate. this classification denotes a cephalosporin antibiotic with the molecular formula c22h22n6o5s2.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ba5alu2zt9, chemically known as 5h-1-pyrindinium, 1-((7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-6,7-dihydro-, hydroxide, inner salt, (6r-(6alpha,7beta(z)))-, sulfate (1:1) but more generally known as cefpirome sulfate, which bears us nih compound identifier 9570928. european medicines agency schedules cefpirome sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01131mig. most nations, for tariff and trade purposes, schedule cefpirome sulfate under hs 29419000 and sitc 54139. as of q4 2014, cefpirome sulfate remains us fdas preferred term for this commodity. cefpirome sulfate bears us nlm identifiers umls id c0771341 and nci concept code c87463. smiles: co/n=c(/c1csc(n1)n)\\c(=o)n[c@h]2[c@@h]3n(c2=o)c(=c(cs3)c[n+]4cccc5c4ccc5)c(=o)[o-].os(=o)(=o)o.. "
"fourth generation cephalosporins. this classification denotes the fourth variety or generation of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefquinome sulfate. this classification denotes a cephalosporin antibiotic with the molecular formula c23h24n6o5s2.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3858k104dq. the term cefquinome sulfate is a united states adopted name designation. most nations, for tariff and trade purposes, schedule cefquinome sulfate under hs 29419000 and sitc 54139. as of q4 2014, cefquinome sulfate remains us fdas preferred term for this commodity. cefquinome sulfate bears us nlm identifiers umls id c2825422 and nci concept code c81032. smiles: co/n=c(/c1csc(n1)n)\\c(=o)n[c@h]2[c@@h]3n(c2=o)c(=c(cs3)c[n+]4cccc5c4cccc5)c(=o)[o-].os(=o)(=o)o.. "
"glycopeptides. glycopeptides. . "
"glycopeptides. glycopeptides. teicoplanin. this classification denotes an antibiotic with the molecular formula c58h42cl2n7o18(r1)(r2)(r3), a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4u3d3yy81m, more generally known as teicoplanin. european medicines agency schedules teicoplanin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04714mig. the term teicoplanin is an international non-proprietary name or inn. see who inn reference publication, volume 37, no. 6, 1983, list 23. teicoplanin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule teicoplanin under hs 29419000 and sitc 54139. as of q4 2014, teicoplanin remains the us fda preferred term for this commodity. teicoplanin bears us nlm identifiers umls id c0145106 and nci concept code c1412. smiles: cccccc=cccc(=o)nc1c(c(c(oc1oc2=c3c=c4c=c2oc5=c(c=c(c=c5)c(c6c(=o)nc(c7=cc(=cc(=c7c8=c(c=cc(=c8)c(c(=o)n6)nc(=o)c4nc(=o)c9c1=cc(=cc(=c1)o)oc1=c(c=cc(=c1)c(c(=o)nc(cc1=cc(=c(o3)c=c1)cl)c(=o)n9)n)o)o)oc1c(c(c(c(o1)co)o)o)o)o)c(=o)o)oc1c(c(c(c(o1)co)o)o)nc(=o)c)cl)co)o)o.. "
"glycopeptides. glycopeptides. vancomycin. this classification denotes an antibiotic with the molecular formula c66h75cl2n9o24, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6q205eh1vu, chemically known as (s(sub a))-(3s,6r,7r,22r,23s,26s,36r,38ar)-44-((2-o-(3-amino-2,3,6-trideoxy-3-c-methyl-alpha-l-lyxo-hexopyranosyl)-beta-d-glucopyranosyl)oxy)-3-(carbamoylmethyl)-10,19-dichloro-2,3,4,5,6,7,23,24,25,26,36,37,38,38a-tetradecahydro-7,22,28,30,32-pentahydroxy-6-((2r)-4-methyl-2-(methylamino)valeramido)-2,5,24,38,39-pentaoxo-22h-8,11:18,21-dietheno-23,36-(iminomethano)-13,16:31,35- but generally known as vancomycin, which bears us nih compound identifier 14969. european medicines agency schedules vancomycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05076mig. the term vancomycin is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules vancomycin in its anatomical therapeutic chemical (atc) classification. vancomycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule vancomycin under hs 29419000 and sitc 54139. as of q4 2014, vancomycin remains the us fda preferred term for this commodity. vancomycin bears us nlm identifiers umls id c0042313 and nci concept code c925. smiles: clc1c2oc3c(oc4oc(c(o)c(o)c4oc4oc(c(o)c(n)(c4)c)c)co)c4oc5c(cl)cc(c(o)c6nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc)cc(c)c)c(o)c(c1)cc2)cc(=o)n)c(c3)c4)c1cc(c2c(c(nc6=o)c(=o)o)cc(o)cc2o)c(o)cc1)cc5.. "
"glycopeptides. glycopeptides. vancomycin hydrochloride. this classification denotes an antibiotic with the molecular formula c66h75cl2n9o24.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 71wo621tjd, chemically known as vancomycin, monohydrochloride but generally known as vancomycin hydrochloride, which bears us nih compound identifier 14970. european medicines agency schedules vancomycin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05077mig. most nations schedule vancomycin hydrochloride under hs 29419000 and sitc 54139. as of q4 2014, vancomycin hydrochloride remains the us fda preferred term for this commodity. vancomycin hydrochloride bears us nlm identifiers umls id c0205992 and nci concept code c65207. smiles: clc1c2oc3c(oc4oc(c(o)c(o)c4oc4oc(c(o)c(n)(c4)c)c)co)c4oc5c(cl)cc(c(o)c6nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc)cc(c)c)c(o)c(c1)cc2)cc(=o)n)c(c3)c4)c1cc(c2c(c(nc6=o)c(=o)o)cc(o)cc2o)c(o)cc1)cc5.cl.. "
"glycopeptides. glycopeptides. dalbavancin. this classification denotes an antibacterial with the molecular formula c88h100cl2n10o28, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 808ui9ms5k, chemically known as ristomycin a aglycone,5,31-dichloro-38-de(methoxycarbonyl)-7-demethyl-19-deoxy-56-o-(2-deoxy-2-((10-methyl-1-oxoundecyl)amino)-.beta.-d-glucopyranuronosyl)-38-(((3-(dimethylamino)propyl)amino)carbonyl)-42-o-.alpha.-d-mannopyranosyl-n(sup 15)-methyl- but generally known as dalbavancin, which bears us nih compound identifier 23724878. the term dalbavancin is an international non-proprietary name or inn sub26697. most nations schedule dalbavancin under hs 29419000 and sitc 54139. as of q4 2014, dalbavancin remains the us fda preferred term for this commodity. smiles: cc(c)ccccccccc(=o)nc1c(c(c(oc1oc2=c3c=c4c=c2oc5=c(c=c(c=c5)c(c6c(=o)nc(c7=cc(=cc(=c7c8=c(c=cc(=c8)c(c(=o)n6)nc(=o)c4nc(=o)c9c1=cc(=cc(=c1cl)o)oc1=c(c=cc(=c1)c(c(=o)nc(cc1=cc=c(o3)c=c1)c(=o)n9)nc)o)o)oc1c(c(c(c(o1)co)o)o)o)o)c(=o)ncccn(c)c)o)cl)c(=o)o)o)o.. "
"glycopeptides. glycopeptides. vancomycin monohydrochloride. this classification denotes an antibiotic with the molecular formula c66h75cl2n9o24.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 71wo621tjd, chemically known as vancomycin, monohydrochloride, but more generally known as vancomycin monohydrochloride, which bears us nih compound identifier 14970. european medicines agency schedules vancomycin monohydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05076mig. most nations, for tariff purposes, schedule vancomycin monohydrochloride under hs 29419000. smiles:.. "
"glycopeptides. glycopeptides. oritavancin. a type of lipoglycopeptide antibacterial drug indicated for the treatment of adult patients with acute bacterial skin and skin structure infections caused or suspected to be caused by susceptible isolates of designated gram-positive microorganisms.. "
"imidazoles. this classification denotes antibiotics containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. . "
"imidazoles. this classification denotes antibiotics containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. tinidazole. this classification denotes an antiprotozoal agent with the molecular formula c8h13n3o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 033kf7v46h, chemically known as 1h-imidazole, 1-(2-(ethylsulfonyl)ethyl)-2-methyl-5-nitro- but generally known as tinidazole, which bears us nih compound identifier 5479. european medicines agency schedules tinidazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11074mig. the term tinidazole is an international non-proprietary name or inn (see who inn reference publication, volume 23, no. 10 1969, list 9). world health organization schedules tinidazole in its anatomical therapeutic chemical (atc) classification. tinidazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tinidazole under hs 29332990 and sitc 51573. as of q4 2014, tinidazole remains the us fda preferred term for this commodity. tinidazole bears us nlm identifiers umls id c0040263 and nci concept code c890. smiles: s(=o)(=o)(ccn1c(ncc1[n](=o)o)c)cc.. "
"imidazoles. this classification denotes antibiotics containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. coumamycin. this classification denotes an antibiotic with the molecular formula c55h59n5o20, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, pch9qz1iih chemically known as 5-methylpyyrole-2-carboxylic acid, diester with 3,3-((3-methylpyrrole-2,4-diyl)bis(carbonylimino))bis(4-hydroxy-8-methyl-7-((tetrahydro-3,4-dihydroxy-5-methoxy-6,6-dimethylpyran-2-yl)oxy)coumarin) but generally known as coumamycin, which bears us nih compound identifier 20494. european medicines agency schedules coumamycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06814mig. the term coumamycin is an international non-proprietary name or inn. most nations schedule coumamycin under hs 29419000 and sitc 54139. smiles: cc1=cc=c(n1)c(=o)oc2c(c(oc(c2oc)(c)c)oc3=c(c4=c(c=c3)c(=o)c(=c(o4)o)nc(=o)c5=cnc(=c5c)c(=o)nc6=c(oc7=c(c6=o)c=cc(=c7c)oc8c(c(c(c(o8)(c)c)oc)oc(=o)c9=cc=c(n9)c)o)o)c)o.. "
"imidazoles. this classification denotes antibiotics containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. ornidazole. this classification denotes an amebicide, antitrichomonal agent, and radiation-sensitizing agent with the molecular formula c7h10cln3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 62xck0g93t, chemically known as 1h-imidazole-1-ethanol, alpha-(chloromethyl)-2-methyl-5-nitro- but generally known as ornidazole, which bears us nih compound identifier 28061. european medicines agency schedules ornidazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09464mig. world health organization schedules ornidazole in its anatomical therapeutic chemical (atc) classification. ornidazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ornidazole under hs 29332990 and sitc 51573. as of q4 2014, ornidazole remains the us fda preferred term for this commodity. smiles: clcc(o)cn1c(ncc1[n](=o)o)c.. "
"imidazoles. this classification denotes antibiotics containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. secnidazole. this classification denotes an antiprotozoal agent with the molecular formula c7h11n3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier r3459k699k, chemically known as imidazole-1-ethanol, alpha,2-dimethyl-5-nitro- but generally known as secnidazole, which bears us nih compound identifier 71815. european medicines agency schedules secnidazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10467mig. the term secnidazole is an international non-proprietary name or inn (see who inn reference publication, volume 28, no. 10 1974, list 14). world health organization schedules secnidazole in its anatomical therapeutic chemical (atc) classification. secnidazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule secnidazole under hs 29332990 and sitc 51573. as of q4 2014, secnidazole remains the us fda preferred term for this commodity. secnidazole bears us nlm identifiers umls id c0074246 and nci concept code c66529. smiles: oc(cn1c(ncc1[n](=o)o)c)c.. "
"imidazoles. this classification denotes antibiotics containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. propenidazole. this classification denotes an antiprotozoal agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f0o89mb7qe. european medicines agency schedules propenidazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10101mig. propenidazole generally arises in the molecular formula c11h13n3o5. the term propenidazole is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21.) propenidazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule propenidazole under hs 29332990 and sitc 51573. as of q4 2014, propenidazole remains the us fda preferred term for this commodity. propenidazole bears us nlm identifiers umls id c1882489 and nci concept code c66480. smiles: ccoc(=o)/c(=c/c1=nc=c(n1c)[n+](=o)[o-])/c(=o)c.. "
"imidazoles. this classification denotes antibiotics containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. dimetridazole. this classification denotes an antiprotozoal agent with the molecular formula c5h7n3o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k59p7xnb8x, chemically known as 1,2-dimethyl-5-nitroimidazole but generally known as dimetridazole, which bears us nih compound identifier 3090. european medicines agency schedules dimetridazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07183mig. the term dimetridazole is an international non-proprietary name. dimetridazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dimetridazole under hs 29332990 and sitc 51573. as of q4 2014, dimetridazole remains the us fda preferred term for this commodity. dimetridazole bears us nlm identifiers umls id c0012444 and nci concept code c76419. smiles: o[n](=o)c1n(c(nc1)c)c.. "
"imidazoles. this classification denotes antibiotics containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. telithromycin. this classification denotes a macrolide antibiotic with the molecular formula c43h65n5o10, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ki8h7h19wl, chemically known as erythromycin, 3-de((2,6-dideoxy-3-c-methyl-3-o-methyl-alpha-l-ribo-hexopyranosyl)oxy)-11,12-dideoxy-6-o-methyl-3-oxo-12,11-(oxycarbonyl((4-(4-(3-pyridinyl)-1h-imidazol-1-yl)butyl)imino))- but generally known as telithromycin, which bears us nih compound identifier 3002190. european medicines agency schedules telithromycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12606mig. the term telithromycin is an international non-proprietary name or inn (see who inn reference publication, volume 13 no. 3, 1999, list 42). world health organization schedules telithromycin in its anatomical therapeutic chemical (atc) classification. most nations schedule telithromycin under hs 29419000 and sitc 54139. as of q4 2014, telithromycin remains the us fda preferred term for this commodity. telithromycin bears us nlm identifiers umls id c1452484 and nci concept code c61963. smiles: o1c2(c(n(c1=o)ccccn1cc(nc1)c1cccnc1)c(c(=o)c(cc(oc)(c(oc1oc(cc(n(c)c)c1o)c)c(c(=o)c(c(=o)oc2cc)c)c)c)c)c)c.. "
"imidazoles. this classification denotes antibiotics containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. metronidazole. this classification denotes a trichomonacide agent and protein synthesis inhibitor with the molecular formula c6h9n3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 140qmo216e, chemically known as 1h-imidazole-1-ethanol, 2-methyl-5-nitro- but generally known as metronidazole, which bears us nih compound identifier 4173. european medicines agency schedules metronidazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08922mig. the term metronidazole is an international non-proprietary name. world health organization schedules metronidazole in its anatomical therapeutic chemical (atc) classification. metronidazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule metronidazole under hs 29332990 and sitc 51573. as of q4 2014, metronidazole remains the us fda preferred term for this commodity. metronidazole bears us nlm identifiers umls id c0025872 and nci concept code c651. smiles: occn1c(ncc1[n](=o)o)c.. "
"imidazoles. this classification denotes antibiotics containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. nimorazole. this classification denotes an antiprotozoal agent with the molecular formula c9h14n4o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 469ulx0h4g, chemically known as morpholine, 4-(2-(5-nitroimidazol-1-yl)ethyl)- but generally known as nimorazole, which bears us nih compound identifier 23009. european medicines agency schedules nimorazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09298mig. the term nimorazole is an international non-proprietary name or inn (see who inn reference publication, volume 26, no. 10 1972, list 12). world health organization schedules nimorazole in its anatomical therapeutic chemical (atc) classification. nimorazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nimorazole under hs 29349990 and sitc 51579. as of q4 2014, nimorazole remains the us fda preferred term for this commodity. nimorazole bears us nlm identifiers umls id c0028095 and nci concept code c76425. smiles: o1ccn(ccn2c([n](=o)o)cnc2)cc1.. "
"imidazoles. this classification denotes antibiotics containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. metronidazole benzoate. this classification denotes a trichomonacide agent and protein synthesis inhibitor with the molecular formula c13h13n3o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier a355c835xc, chemically known as 2-(2-methyl-5-nitroimidazol-1-yl)ethyl benzoate, but more generally known as metronidazole benzoate, which bears us nih compound identifier 4173. european medicines agency schedules metronidazole benzoate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08922mig. most nations, for tariff purposes, schedule metronidazole benzoate under hs 29332990. metronidazole benzoate bears us nlm identifiers umls id c0353490 and nci concept code c87387. smiles: cc1ncc(n1ccoc(=o)c2ccccc2)[n+](=o)[o-].. "
"imidazoles. this classification denotes antibiotics containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. metronidazole hydrochloride. this classification denotes a trichomonacide agent and protein synthesis inhibitor with the molecular formula c6h9n3o3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 76jc1633uf, chemically known as 1h-imidazole-1-ethanol, 2-methyl-5-nitro-, hydrochloride but more generally known as metronidazole hydrochloride, which bears us nih compound identifier 68592. european medicines agency schedules metronidazole hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14570mig. most nations, for tariff and trade purposes, schedule metronidazole hydrochloride under hs 29332990 and sitc 51573. as of q4 2014, metronidazole hydrochloride remains us fdas preferred term for this commodity. metronidazole hydrochloride bears us nlm identifiers umls id c0282239 and nci concept code c48005. smiles: cc1ncc(n1cco)[n+](=o)[o-].cl.. "
"imidazoles. this classification denotes antibiotics containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. metronidazole phosphate. this classification denotes an antiprotozoal agent and antimicrobial with the molecular formula c6h10n3o6p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l500pr95qa, chemically known as 1h-imidazole-1-ethanol, 2-methyl-5-nitro-, dihydrogen phosphate (ester) but more generally known as metronidazole phosphate, which bears us nih compound identifier 51794. most nations, for tariff and trade purposes, schedule metronidazole phosphate under hs 29332990 and sitc 51573. as of q4 2014, metronidazole phosphate remains us fdas preferred term for this commodity. metronidazole phosphate bears us nlm identifiers umls id c0887130 and nci concept code c90619. smiles: cc1ncc(n1ccop(=o)(o)o)[n+](=o)[o-].. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. . "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. cinoxacin. this classification denotes a quinolone antibiotic with the molecular formula c12h10n2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier lmk22vuh23, chemically known as 1-ethyl-6,7-methylenedioxy-4(1h)-oxocinnoline-3-carboxylic acid but generally known as cinoxacin, which bears us nih compound identifier 2762. european medicines agency schedules cinoxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06309mig. the term cinoxacin is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15). world health organization schedules cinoxacin in its anatomical therapeutic chemical (atc) classification. cinoxacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cinoxacin under hs 29349990 and sitc 51579. as of q4 2014, cinoxacin remains the us fda preferred term for this commodity. cinoxacin bears us nlm identifiers umls id c0008806 and nci concept code c65333. smiles: ccn1c2=cc3=c(c=c2c(=o)c(=n1)c(=o)o)oco3.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. alatrofloxacin. this classification denotes a quinolone antibiotic and antimicrobial solution with the molecular formula c26h25f3n6o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7qvv6i50dt, chemically known as l-alaninamide, l-alanyl-n-(3-(6-carboxy-8-(2,4-difluorophenyl)-3-fluoro-5,8-dihydro-5-oxo-1,8-naphthyridin-2-yl)-3-azabicyclo(3.1.0)hex-6-yl)-, (1alpha,5alpha,6alpha)- but generally known as alatrofloxacin, which bears us nih compound identifier 3086677. alatrofloxacin most often comes in base and mesylate forms. european medicines agency schedules alatrofloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05293mig. the term alatrofloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 11, no. 11997, list 37). alatrofloxacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule alatrofloxacin under hs 29339990 and sitc 51577. as of q4 2014, alatrofloxacin remains the us fda preferred term for this commodity. alatrofloxacin bears us nlm identifiers umls id c0540776 and nci concept code c79898. smiles: fc1c(n2cc3c(c3nc(=o)c(nc(=o)c(n)c)c)c2)nc2n(cc(c(=o)c2c1)c(=o)o)c1c(f)cc(f)cc1.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. amifloxacin. this classification denotes a quinolone antibiotic with the molecular formula c16h19fn4o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5tu5227kyq, chemically known as 6-fluoro-1,4-dihydro-1-(methylamino)-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid but generally known as amifloxacin, which bears us nih compound identifier 55492. amifloxacin most often comes in mesylate and n-oxide forms. european medicines agency schedules amifloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05430mig. the term amifloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24). amifloxacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule amifloxacin under hs 29335995 and sitc 51576. as of q4 2014, amifloxacin remains the us fda preferred term for this commodity. amifloxacin bears us nlm identifiers umls id c0051596 and nci concept code c72696. smiles: fc1c(n2ccn(cc2)c)cc2n(nc)cc(c(=o)c2c1)c(=o)o.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. balofloxacin. this classification denotes a quinolone antibiotic with the molecular formula c20h24fn3o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q022b63jpm, chemically known as 3-quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-(methylamino)-1-piperidinyl)-4-oxo- but generally known as balofloxacin, which bears us nih compound identifier 65958. balofloxacin most often comes in base and hydrate forms. european medicines agency schedules balofloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06091mig. the term balofloxacin is an international non-proprietary name. balofloxacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule balofloxacin under hs 29334910 and sitc 51575. as of q4 2014, balofloxacin remains the us fda preferred term for this commodity. balofloxacin bears us nlm identifiers umls id c0173239 and nci concept code c72631. smiles: fc1c(n2cc(nc)ccc2)c(oc)c2n(c3cc3)cc(c(=o)c2c1)c(=o)o.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. besifloxacin. this classification denotes a quinolone antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier bfe2nbz7nx. european medicines agency schedules besifloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub33064. besifloxacin generally arises in the molecular formula c19h21clfn3o3. the term besifloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 22, no. 3, 2008, list 60.) most nations schedule besifloxacin under hs 29334900 and sitc 51575. as of q4 2014, besifloxacin remains the us fda preferred term for this commodity. besifloxacin bears us nlm identifiers umls id c2351042 and nci concept code c83553. smiles: c1ccn(c[c@@h](c1)n)c2=c(c=c3c(=c2cl)n(c=c(c3=o)c(=o)o)c4cc4)f.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. besifloxacin hydrochloride. this classification denotes a quinolone antibiotic with the molecular formula c19h21clfn3o3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7506a6j57t. the term besifloxacin hydrochloride is a united states adopted name designation. most nations schedule besifloxacin hydrochloride under hs 29334900 and sitc 51575. as of q4 2014, besifloxacin hydrochloride remains the us fda preferred term for this commodity. besifloxacin hydrochloride bears us nlm identifiers umls id c2710017 and nci concept code c76228. smiles: c1ccn(c[c@@h](c1)n)c2=c(c=c3c(=c2cl)n(c=c(c3=o)c(=o)o)c4cc4)f.cl.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. binfloxacin. this classification denotes a quinolone antibiotic with the molecular formula c19h22fn3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 78vm28za2h, chemically known as 7-(1,4-diazabicyclo(3.2.2)non-4-yl)-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid but generally known as binfloxacin, which bears us nih compound identifier 166565. european medicines agency schedules binfloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05836mig. the term binfloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). binfloxacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule binfloxacin under hs 29334990 and sitc 51575. as of q4 2014, binfloxacin remains the us fda preferred term for this commodity. binfloxacin bears us nlm identifiers umls id c2347020 and nci concept code c72632. smiles: fc1c(n2c3ccn(cc3)cc2)cc2n(cc)cc(c(=o)c2c1)c(=o)o.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. cadrofloxacin. this classification denotes a quinolone antibiotic with the molecular formula c19h20f3n3o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1yoq7j9acy, chemically known as 128427-55-4 (monohydrochloride, s isomer) but generally known as cadrofloxacin, which bears us nih compound identifier 189912. the term cadrofloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 14, no. 1, 2000, list 43). most nations schedule cadrofloxacin under hs 29335995 and sitc 51576. as of q4 2014, cadrofloxacin remains the us fda preferred term for this commodity. cadrofloxacin bears us nlm identifiers umls id c1454081 and nci concept code c76229. smiles: cc1cn(ccn1)c2=c(c=c3c(=c2oc(f)f)n(c=c(c3=o)c(=o)o)c4cc4)f.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. ciprofloxacin. this classification denotes a quinolone antibiotic and antitubercular agent with the molecular formula c17h18fn3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5e8k9i0o4u, chemically known as 86393-32-0 (hydrochloride, monohydrate) but generally known as ciprofloxacin, which bears us nih compound identifier 2764. european medicines agency schedules ciprofloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07470mig. the term ciprofloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24). world health organization schedules ciprofloxacin in its anatomical therapeutic chemical (atc) classification. ciprofloxacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ciprofloxacin under hs 29335995 and sitc 51576. as of q4 2014, ciprofloxacin remains the us fda preferred term for this commodity. ciprofloxacin bears us nlm identifiers umls id c0008809 and nci concept code c375. smiles: fc1c(n2ccncc2)cc2n(c3cc3)cc(c(=o)c2c1)c(=o)o.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. clinafloxacin. this classification denotes a quinolone antibiotic with the molecular formula c17h17clfn3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8n86xtf9qd, chemically known as 3-quinolinecarboxylic acid, 7-(3-amino-1-pyrrolidinyl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-, monohydrochloride, (+-)- but generally known as clinafloxacin, which bears us nih compound identifier 60062. european medicines agency schedules clinafloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06664mig. the term clinafloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 7, no3, 1993, list 33). clinafloxacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule clinafloxacin under hs 29334910 and sitc 51575. as of q4 2014, clinafloxacin remains the us fda preferred term for this commodity. clinafloxacin bears us nlm identifiers umls id c0070191 and nci concept code c74372. smiles: clc1c2n(c3cc3)cc(c(=o)c2cc(f)c1n1cc(n)cc1)c(=o)o.cl.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. danofloxacin. this classification denotes a quinolone antibiotic with the molecular formula c19h20fn3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 24cu1ys91d chemically known as 1-cyclopropyl-6-fluoro-1,4-dihydro-7-((1s,4s)-5-methyl-2,5-diazabicyclo(2.2.1)hept-2-yl)-4-oxo-3-quinolinecarboxylic acid but generally known as danofloxacin, which bears us nih compound identifier 71335. european medicines agency schedules danofloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06901mig. the term danofloxacin is an international non-proprietary name or inn. most nations schedule danofloxacin under hs 29335995 and sitc 51576. as of q4 2014, danofloxacin remains the us fda preferred term for this commodity. danofloxacin bears us nlm identifiers umls id c0112317 and nci concept code c72731. smiles: cn1cc2cc1cn2c3=c(c=c4c(=c3)n(c=c(c4=o)c(=o)o)c5cc5)f.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. dequalinium. this classification denotes a quinolone antibiotic with the molecular formula c30h40n4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier e7qc7v26b8, chemically known as quinolinium, 1,1-(1,10-decanediyl)bis(4-amino-2-methyl- but generally known as dequalinium, which bears us nih compound identifier 2993. european medicines agency schedules dequalinium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01590mig. world health organization schedules dequalinium in its anatomical therapeutic chemical (atc) classification. dequalinium is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, dequalinium remains the us fda preferred term for this commodity. dequalinium bears us nlm identifiers umls id c0011588 and nci concept code c83661. smiles: [n]1(cccccccccc[n]2c3c(c(n)cc2c)cccc3)c2c(c(n)cc1c)cccc2.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. difloxacin. this classification denotes a quinolone antibiotic with the molecular formula c21h19f2n3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5z7oo9fnfd, chemically known as 6-fluoro-1-(4-fluorophenyl)-7-(4-methyl-1-piperazinyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid but generally known as difloxacin, which bears us nih compound identifier 56206. the term difloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). difloxacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule difloxacin under hs 29335995 and sitc 51576. as of q4 2014, difloxacin remains the us fda preferred term for this commodity. difloxacin bears us nlm identifiers umls id c0057993 and nci concept code c65382. smiles: cn1ccn(cc1)c2=c(c=c3c(=c2)n(c=c(c3=o)c(=o)o)c4=cc=c(c=c4)f)f.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. gemifloxacin. this classification denotes a quinolone antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier okr68y0e4t. european medicines agency schedules gemifloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub27752. gemifloxacin generally arises in the molecular formula c18h20fn5o4. the term gemifloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 14, no. 1, 2000, list 43.) most nations schedule gemifloxacin under hs 29339990 and sitc 51577. as of q4 2014, gemifloxacin remains the us fda preferred term for this commodity. gemifloxacin bears us nlm identifiers umls id c0533545 and nci concept code c61775. smiles: fc1c(n2cc(/c(=n\\oc)c2)cn)nc2n(c3cc3)cc(c(=o)c2c1)c(=o)o.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. ecenofloxacin. this classification denotes a quinolone antibiotic with the molecular formula c19h21fn4o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3613zy362l, chemically known as 1,8-naphthyridine-3-carboxylic acid, 7-((1r,5s,6s)-6-amino-1-methyl-3-azabicyclo(3.2.0)hept-3-yl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-, rel-( )- but generally known as ecenofloxacin, which bears us nih compound identifier 178066. european medicines agency schedules ecenofloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06445mig. the term ecenofloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 2 1999, list 40). most nations schedule ecenofloxacin under hs 29339990 and sitc 51577. as of q4 2014, ecenofloxacin remains the us fda preferred term for this commodity. ecenofloxacin bears us nlm identifiers umls id c2348374 and nci concept code c72661. smiles: fc1c(n2cc3(c(c(n)c3)c2)c)nc2n(c3cc3)cc(c(=o)c2c1)c(=o)o.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. enrofloxacin. this classification denotes a quinolone antibiotic with the molecular formula c19h22fn3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3dx3xek1bn, chemically known as 1,4-dihydro-1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-4-oxo-3-quinolinecarboxylic acid but generally known as enrofloxacin, which bears us nih compound identifier 71188. european medicines agency schedules enrofloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06550mig. the term enrofloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). enrofloxacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule enrofloxacin under hs 29335995 and sitc 51576. as of q4 2014, enrofloxacin remains the us fda preferred term for this commodity. enrofloxacin bears us nlm identifiers umls id c0059374 and nci concept code c72660. smiles: fc1c(n2ccn(cc2)cc)cc2n(c3cc3)cc(c(=o)c2c1)c(=o)o.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. fandofloxacin. this classification denotes a quinolone antibiotic with the molecular formula c20h18f2n4o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, i6406oc637 chemically known as 6-fluoro-1-(5-fluoro-2-pyridyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid but generally known as fandofloxacin, which bears us nih compound identifier 178087. european medicines agency schedules fandofloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07508mig. the term fandofloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 2 1999, list 40. ). most nations schedule fandofloxacin under hs 29335995 and sitc 51576. as of q4 2014, fandofloxacin remains the us fda preferred term for this commodity. fandofloxacin bears us nlm identifiers umls id c1880732 and nci concept code c65618. smiles: fc1c(n2ccn(cc2)c)cc2n(cc(c(=o)c2c1)c(=o)o)c1ncc(f)cc1.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. fleroxacin. this classification denotes a quinolone antibiotic with the molecular formula c17h18f3n3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier n804ldh51k, chemically known as 6,8-difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methylpiperazino)-4-oxo-3-quinolinecarboxylic acid but generally known as fleroxacin, which bears us nih compound identifier 3357. european medicines agency schedules fleroxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07639mig. the term fleroxacin is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). world health organization schedules fleroxacin in its anatomical therapeutic chemical (atc) classification. fleroxacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule fleroxacin under hs 29335995 and sitc 51576. as of q4 2014, fleroxacin remains the us fda preferred term for this commodity. fleroxacin bears us nlm identifiers umls id c0085161 and nci concept code c72657. smiles: fc1c(n2ccn(cc2)c)c(f)cc2c1n(ccf)cc(c2=o)c(=o)o.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. flumequine. this classification denotes a quinolone antibiotic with the molecular formula c14h12fno3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier uvg8vsp2sj, chemically known as 6,7-dihydro-9-fluoro-5-methyl-1-oxo-1h,5h-quinolizine-2-carboxylic acid but generally known as flumequine, which bears us nih compound identifier 3374. european medicines agency schedules flumequine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07696mig. the term flumequine is an international non-proprietary name or inn (see who inn reference publication, volume 30, no. 10 1976, list 16). world health organization schedules flumequine in its anatomical therapeutic chemical (atc) classification. flumequine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule flumequine under hs 29339990 and sitc 51577. as of q4 2014, flumequine remains the us fda preferred term for this commodity. flumequine bears us nlm identifiers umls id c0060493 and nci concept code c80639. smiles: fc1cc2ccc(n3c2c(c(=o)c(c3)c(=o)o)c1)c.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. garenoxacin. this classification denotes a quinolone antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier v72h9867wb. european medicines agency schedules garenoxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25475. garenoxacin generally arises in the molecular formula c23h20f2n2o4. the term garenoxacin is an international non-proprietary name or inn (see who inn reference publication, volume 17, no. 2, 2003, list 49.) most nations schedule garenoxacin under hs 29334990 and sitc 51575. as of q4 2014, garenoxacin remains the us fda preferred term for this commodity. garenoxacin bears us nlm identifiers umls id c1507354 and nci concept code c65800. smiles: fc(f)oc1c2n(c3cc3)cc(c(=o)c2ccc1c1cc2c(c(nc2)c)cc1)c(=o)o.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. gatifloxacin. this classification denotes a quinolone antibiotic with the molecular formula 2c19h22fn3o4.3h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, l4618bd7kj chemically known as (+/-)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid, sesquihydrate but generally known as gatifloxacin, which bears us nih compound identifier 5379. european medicines agency schedules gatifloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13952mig. the term gatifloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 10, no. 3, 1996, list 36. ). most nations schedule gatifloxacin under hs 29335995 and sitc 51576. as of q4 2014, gatifloxacin remains the us fda preferred term for this commodity. gatifloxacin bears us nlm identifiers umls id c1258065 and nci concept code c29070. smiles: fc1c(n2cc(ncc2)c)c(oc)c2n(c3cc3)cc(c(=o)c2c1)c(=o)o.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. merafloxacin. this classification denotes a quinolone antibiotic with the molecular formula c19h23f2n3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g6u51t1k77, chemically known as 3-quinolinecarboxylic acid, 1-ethyl-7-(3-((ethylamino)methyl)-1-pyrrolidinyl)-6,8-difluoro-1,4-dihydro-4-oxo- but generally known as merafloxacin, which bears us nih compound identifier 121833. european medicines agency schedules merafloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08767mig. the term merafloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 8 no. 3 1994, list 34). merafloxacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule merafloxacin under hs 29334910 and sitc 51575. as of q4 2014, merafloxacin remains the us fda preferred term for this commodity. merafloxacin bears us nlm identifiers umls id c0089342 and nci concept code c83932. smiles: fc1c(n2cc(cc2)cncc)c(f)cc2c1n(cc)cc(c2=o)c(=o)o.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. grepafloxacin. this classification denotes a quinolone antibiotic with the molecular formula c19h22fn3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l1m1u2hc31, chemically known as 3-quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo- but generally known as grepafloxacin, which bears us nih compound identifier 72474. european medicines agency schedules grepafloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07965mig. the term grepafloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 7, no3, 1993, list 33). world health organization schedules grepafloxacin in its anatomical therapeutic chemical (atc) classification. most nations schedule grepafloxacin under hs 29335995 and sitc 51576. as of q4 2014, grepafloxacin remains the us fda preferred term for this commodity. grepafloxacin bears us nlm identifiers umls id c0287721 and nci concept code c65817. smiles: fc1c(n2cc(ncc2)c)cc2n(c3cc3)cc(c(=o)c2c1c)c(=o)o.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. ibafloxacin. this classification denotes a quinolone antibiotic with the molecular formula c15h14fno3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 53vpk9r0t5, chemically known as 9-fluoro-6,7-dihydro-5,8-dimethyl-1-oxo-1h,5h-benzo(ij)quinolizine-2-carboxylic acid but generally known as ibafloxacin, which bears us nih compound identifier 71186. european medicines agency schedules ibafloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08091mig. the term ibafloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). ibafloxacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ibafloxacin under hs 29339990 and sitc 51577. as of q4 2014, ibafloxacin remains the us fda preferred term for this commodity. ibafloxacin bears us nlm identifiers umls id c0098834 and nci concept code c83772. smiles: fc1c(c2ccc(n3c2c(c(=o)c(c3)c(=o)o)c1)c)c.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. irloxacin. this classification denotes a quinolone antibiotic with the molecular formula c16h13fn2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 36sg77d21b, chemically known as 1,4-dihydro-1-ethyl-6-fluoro-4-oxo-7-(1h-pyrrol-1-yl)-3-quinolinecarboxylic acid but generally known as irloxacin, which bears us nih compound identifier 65828. european medicines agency schedules irloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08296mig. the term irloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). irloxacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule irloxacin under hs 29334990 and sitc 51575. as of q4 2014, irloxacin remains the us fda preferred term for this commodity. irloxacin bears us nlm identifiers umls id c0071133 and nci concept code c65961. smiles: fc1c(n2cccc2)cc2n(cc)cc(c(=o)c2c1)c(=o)o.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. levofloxacin. this classification denotes a quinolone antibiotic with the molecular formula 2c18h20fn3o4.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6gnt3y5lmf, chemically known as 7h-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 2,3-dihydro-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (s)- but generally known as levofloxacin, which bears us nih compound identifier 149096. european medicines agency schedules levofloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08471mig. world health organization schedules levofloxacin in its anatomical therapeutic chemical (atc) classification. most nations schedule levofloxacin under hs 29349990 and sitc 51579. as of q4 2014, levofloxacin remains the us fda preferred term for this commodity. levofloxacin bears us nlm identifiers umls id c0282386 and nci concept code c1586. smiles: cc1coc2=c3n1c=c(c(=o)c3=cc(=c2n4ccn(cc4)c)f)c(=o)o.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. lomefloxacin. this classification denotes a quinolone antibiotic with the molecular formula c17h19f2n3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l6br2wjd8v, chemically known as 1,4-dihydro-6,8-difluoro-1-ethyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid but generally known as lomefloxacin, which bears us nih compound identifier 3948. european medicines agency schedules lomefloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08561mig. the term lomefloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 2, no. 3, 1988, list 28). world health organization schedules lomefloxacin in its anatomical therapeutic chemical (atc) classification. lomefloxacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule lomefloxacin under hs 29335995 and sitc 51576. as of q4 2014, lomefloxacin remains the us fda preferred term for this commodity. lomefloxacin bears us nlm identifiers umls id c0065162 and nci concept code c61814. smiles: fc1c(n2cc(ncc2)c)c(f)cc2c1n(cc)cc(c2=o)c(=o)o.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. marbofloxacin. this classification denotes a quinolone antibiotic with the molecular formula c17h19fn4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8x09wu898t, chemically known as 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7h-pyrido(3,2,1-ij)(4,1,2)benzoxadiazine-6-carboxylic acid but generally known as marbofloxacin, which bears us nih compound identifier 60651. european medicines agency schedules marbofloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08648mig. the term marbofloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 6, no, 3 1992, list 32). marbofloxacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule marbofloxacin under hs 29349990 and sitc 51579. as of q4 2014, marbofloxacin remains the us fda preferred term for this commodity. marbofloxacin bears us nlm identifiers umls id c0214439 and nci concept code c80640. smiles: fc1c(n2ccn(cc2)c)c2ocn(n3c2c(c1)c(=o)c(c3)c(=o)o)c.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. pefloxacin. this classification denotes a quinolone antibiotic with the molecular formula c17h20fn3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2h52z9f2q5, chemically known as 3-quinolinecarboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo- but generally known as pefloxacin, which bears us nih compound identifier 51081. european medicines agency schedules pefloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09645mig. the term pefloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21). world health organization schedules pefloxacin in its anatomical therapeutic chemical (atc) classification. pefloxacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pefloxacin under hs 29335995 and sitc 51576. as of q4 2014, pefloxacin remains the us fda preferred term for this commodity. pefloxacin bears us nlm identifiers umls id c0030771 and nci concept code c728. smiles: fc1c(n2ccn(cc2)c)cc2n(cc)cc(c(=o)c2c1)c(=o)o.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. miloxacin. this classification denotes an antibiotic with the molecular formula c12h9no6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier vm4w7043sn, chemically known as 5,8-dihydro-5-methoxy-8-oxo-2h-1,3-dioxolo(4,5-g)quinoline-7-carboxylic acid but generally known as miloxacin, which bears us nih compound identifier 37614. european medicines agency schedules miloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08967mig. the term miloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 33, no. 10 1979, list 19). miloxacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule miloxacin under hs 29349990 and sitc 51579. as of q4 2014, miloxacin remains the us fda preferred term for this commodity. miloxacin bears us nlm identifiers umls id c0066553 and nci concept code c66154. smiles: o1c2c(oc1)cc1c(n(oc)cc(c1=o)c(=o)o)c2.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. moxifloxacin. this classification denotes a quinolone antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u188xyd42p. european medicines agency schedules moxifloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09086mig. moxifloxacin generally arises in the molecular formula c21h24fn3o4. the term moxifloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 2 1999, list 40.) moxifloxacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule moxifloxacin under hs 29334910 and sitc 51575. as of q4 2014, moxifloxacin remains the us fda preferred term for this commodity. moxifloxacin bears us nlm identifiers umls id c0536495 and nci concept code c62052. smiles: fc1c(n2cc3c(nccc3)c2)c(oc)c2n(c3cc3)cc(c(=o)c2c1)c(=o)o.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. norfloxacin. this classification denotes a quinolone antibiotic with the molecular formula c16h18fn3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier n0f8p22l1p, chemically known as 1,4-dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid but generally known as norfloxacin, which bears us nih compound identifier 4539. european medicines agency schedules norfloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09365mig. the term norfloxacin is an international non-proprietary name. world health organization schedules norfloxacin in its anatomical therapeutic chemical (atc) classification. norfloxacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule norfloxacin under hs 29335995 and sitc 51576. as of q4 2014, norfloxacin remains the us fda preferred term for this commodity. norfloxacin bears us nlm identifiers umls id c0028365 and nci concept code c47638. smiles: fc1c(n2ccncc2)cc2n(cc)cc(c(=o)c2c1)c(=o)o.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. olamufloxacin. this classification denotes a quinolone antibiotic with the molecular formula c20h23fn4o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ljg8kl1435, chemically known as 3-quinolinecarboxylic acid, 5-amino-7-(7-amino-5-azaspiro(2,4)hept-5-yl)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methyl-4-oxo-, (s)- but generally known as olamufloxacin, which bears us nih compound identifier 477670. european medicines agency schedules olamufloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03495mig. the term olamufloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 13 no. 1, 1999, list 41). most nations schedule olamufloxacin under hs 29334910 and sitc 51575. as of q4 2014, olamufloxacin remains the us fda preferred term for this commodity. olamufloxacin bears us nlm identifiers umls id c0965382 and nci concept code c84030. smiles: fc1c(n2cc3(cc3)c(n)c2)c(c2n(c3cc3)cc(c(=o)c2c1n)c(=o)o)c.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. orbifloxacin. this classification denotes a quinolone antibiotic with the molecular formula c19h20f3n3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 660932tpy6, chemically known as 1-cyclopropyl-7-(cis-3,5-dimethyl-1-piperazinyl)-5,6,8-trifluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid but generally known as orbifloxacin, which bears us nih compound identifier 60605. european medicines agency schedules orbifloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09454mig. the term orbifloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 7, no3, 1993, list 33). orbifloxacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule orbifloxacin under hs 29335995 and sitc 51576. as of q4 2014, orbifloxacin remains the us fda preferred term for this commodity. orbifloxacin bears us nlm identifiers umls id c0300903 and nci concept code c72635. smiles: fc1c2n(c3cc3)cc(c(=o)c2c(f)c(f)c1n1cc(nc(c1)c)c)c(=o)o.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. oxolinic acid. this classification denotes a quinolone antibiotic with the molecular formula c13h11no5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l0a22b22ft, chemically known as 1,3-dioxolo(4,5-g)quinoline-7-carboxylic acid, 5-ethyl-5,8-dihydro-8-oxo- but generally known as oxolinic acid, which bears us nih compound identifier 4628. european medicines agency schedules oxolinic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09548mig. the term oxolinic acid is an international non-proprietary name. world health organization schedules oxolinic acid in its anatomical therapeutic chemical (atc) classification. most nations schedule oxolinic acid under hs 29349990 and sitc 51579. as of q4 2014, oxolinic acid remains the us fda preferred term for this commodity. oxolinic acid bears us nlm identifiers umls id c0030031 and nci concept code c76921. smiles: o1c2cc3n(cc)cc(c(=o)c3cc2oc1)c(=o)o.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. pazufloxacin. this classification denotes a quinolone antibiotic with the molecular formula c16h15fn2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4cz1r38ndi, chemically known as 7h-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 2,3-dihydro-10-(1-aminocyclopropyl)-9-fluoro-3-methyl-7-oxo-, (s)- but generally known as pazufloxacin, which bears us nih compound identifier 65957. european medicines agency schedules pazufloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09641mig. the term pazufloxacin is an international non-proprietary name. world health organization schedules pazufloxacin in its anatomical therapeutic chemical (atc) classification. pazufloxacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pazufloxacin under hs 29349990 and sitc 51579. as of q4 2014, pazufloxacin remains the us fda preferred term for this commodity. pazufloxacin bears us nlm identifiers umls id c0175022 and nci concept code c66331. smiles: fc1c(c2(n)cc2)c2occ(n3c2c(c1)c(=o)c(c3)c(=o)o)c.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. sitafloxacin. this classification denotes a quinolone antibiotic with the molecular formula c19h18clf2n3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3gjc60u4q8, chemically known as 7-((7s)-amino-5-azaspiro(2,4)heptan-5-yl)-8-chloro-6-fluoro-1-((1r,2r)-cis-2-fluoro-1-cyclopropyl)-1,4-dihydro-4-oxoquinolone-3-carboxylic acid but generally known as sitafloxacin, which bears us nih compound identifier 73011. european medicines agency schedules sitafloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10539mig. the term sitafloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 11, no. 11997, list 37). world health organization schedules sitafloxacin in its anatomical therapeutic chemical (atc) classification. most nations schedule sitafloxacin under hs 29334910 and sitc 51575. as of q4 2014, sitafloxacin remains the us fda preferred term for this commodity. sitafloxacin bears us nlm identifiers umls id c0171447 and nci concept code c76922. smiles: clc1c(n2cc3(cc3)c(n)c2)c(f)cc2c1n(c1c(f)c1)cc(c2=o)c(=o)o.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. pipemidic acid. this classification denotes a urinary anti-infective agent and quinolone antibiotic with the molecular formula c14h17n5o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier lt12j5hvr8, chemically known as 5,8-dihydro-8-ethyl-5-oxo-2-(1-piperazinyl)pyrido(2,3-d)pyrimidine-6-carboxylic acid but generally known as pipemidic acid, which bears us nih compound identifier 4831. european medicines agency schedules pipemidic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09863mig. the term pipemidic acid is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15). world health organization schedules pipemidic acid in its anatomical therapeutic chemical (atc) classification. most nations schedule pipemidic acid under hs 29335995 and sitc 51576. as of q4 2014, pipemidic acid remains the us fda preferred term for this commodity. pipemidic acid bears us nlm identifiers umls id c0031953 and nci concept code c66394. smiles: o=c1c2c(n(cc)cc1c(=o)o)nc(n1ccncc1)nc2.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. piromidic acid. this classification denotes a urinary anti-infective agent and quinolone antibiotic with the molecular formula c14h16n4o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3i12wh4ewf, chemically known as 8-ethyl-5-oxo-2-(1-pyrrolidinyl)-5,8-dihydropyrido(2,3-d)pyrimidine-6-carboxylic acid but generally known as piromidic acid, which bears us nih compound identifier 4855. european medicines agency schedules piromidic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09934mig. the term piromidic acid is an international non-proprietary name or inn (see who inn reference publication, volume 26, no. 10 1972, list 12). world health organization schedules piromidic acid in its anatomical therapeutic chemical (atc) classification. most nations schedule piromidic acid under hs 29335995 and sitc 51576. as of q4 2014, piromidic acid remains the us fda preferred term for this commodity. piromidic acid bears us nlm identifiers umls id c0031987 and nci concept code c66433. smiles: o=c1c2c(n(cc)cc1c(=o)o)nc(n1cccc1)nc2.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. premafloxacin. this classification denotes a quinolone antibiotic with the molecular formula c21h26fn3o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier uom2hmo524, chemically known as 3-quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-(1-(methylamino)ethyl)-1-pyrrolidinyl)-4-oxo-, (s-(r*,s*))- but generally known as premafloxacin, which bears us nih compound identifier 71455. european medicines agency schedules premafloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10025mig. the term premafloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 9, no. 3, 1995, list 35). most nations schedule premafloxacin under hs 29334910 and sitc 51575. as of q4 2014, premafloxacin remains the us fda preferred term for this commodity. premafloxacin bears us nlm identifiers umls id c0537079 and nci concept code c66464. smiles: fc1c(n2cc(cc2)c(nc)c)c(oc)c2n(c3cc3)cc(c(=o)c2c1)c(=o)o.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. prulifloxacin. this classification denotes a quinolone antibiotic with the molecular formula c21h20fn3o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier j42298iesw, chemically known as 1h,4h-(1,3)thiazeto(3,2-a)quinoline-3-carboxylic acid, 6-fluoro-1-methyl-7-(4-((5-methyl-2-oxo-1,3-dioxol-4-yl)methyl)-1-piperazinyl)-4-oxo- but generally known as prulifloxacin, which bears us nih compound identifier 65947. european medicines agency schedules prulifloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10156mig. the term prulifloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 9, no. 3, 1995, list 35). world health organization schedules prulifloxacin in its anatomical therapeutic chemical (atc) classification. prulifloxacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule prulifloxacin under hs 29349990 and sitc 51579. as of q4 2014, prulifloxacin remains the us fda preferred term for this commodity. prulifloxacin bears us nlm identifiers umls id c0527129 and nci concept code c72637. smiles: s1c(n2c3cc(n4ccn(cc4)cc4oc(=o)oc4c)c(f)cc3c(=o)c(c12)c(=o)o)c.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. rosoxacin. this classification denotes a quinolone antibiotic with the molecular formula c17h14n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3y1ot3j4nw, chemically known as 3-quinolinecarboxylic acid, 1-ethyl-1,4-dihydro-4-oxo-7-(4-pyridinyl)- but generally known as rosoxacin, which bears us nih compound identifier 287180. european medicines agency schedules rosoxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10389mig. the term rosoxacin is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17). world health organization schedules rosoxacin in its anatomical therapeutic chemical (atc) classification. most nations schedule rosoxacin under hs 29334910 and sitc 51575. as of q4 2014, rosoxacin remains the us fda preferred term for this commodity. rosoxacin bears us nlm identifiers umls id c0073591 and nci concept code c76232. smiles: o=c1c2c(n(cc)cc1c(=o)o)cc(cc2)c1ccncc1.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. rufloxacin. this classification denotes a quinolone antibiotic with the molecular formula c17h18fn3o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier y521xm2900, chemically known as 9-fluoro-2,3-dihydro-10-(4-methyl-1-piperazinyl)-7-oxo-7h-pyrido(1,2,3-de)-1,4-benzothiazine-6-carboxylic acid but generally known as rufloxacin, which bears us nih compound identifier 58258. european medicines agency schedules rufloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10404mig. the term rufloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). world health organization schedules rufloxacin in its anatomical therapeutic chemical (atc) classification. rufloxacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule rufloxacin under hs 29349990 and sitc 51579. as of q4 2014, rufloxacin remains the us fda preferred term for this commodity. rufloxacin bears us nlm identifiers umls id c0073704 and nci concept code c72638. smiles: s1c2c(n3ccn(cc3)c)c(f)cc3c2n(cc1)cc(c3=o)c(=o)o.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. sparfloxacin. this classification denotes a quinolone antibiotic and antitubercular agent with the molecular formula c19h22f2n4o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q90aga787l, chemically known as 5-amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid, but generally known as sparfloxacin, which bears us nih compound identifier 5257. european medicines agency schedules sparfloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10610mig. the term sparfloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). world health organization schedules sparfloxacin in its anatomical therapeutic chemical (atc) classification. sparfloxacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sparfloxacin under hs 29335995 and sitc 51576. as of q4 2014, sparfloxacin remains the us fda preferred term for this commodity. sparfloxacin bears us nlm identifiers umls id c0052585 and nci concept code c61950. smiles: fc1c2n(c3cc3)cc(c(=o)c2c(n)c(f)c1n1cc(nc(c1)c)c)c(=o)o.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. temafloxacin. this classification denotes a quinolone antibiotic with the molecular formula c21h18f3n3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1wz12gtt67, chemically known as 3-quinolinecarboxylic acid, 1,4-dihydro-1-(2,4-difluorophenyl)-6-fluoro-7- (3-methyl-1-piperazinyl)-4-oxo- but generally known as temafloxacin, which bears us nih compound identifier 60021. european medicines agency schedules temafloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10877mig. the term temafloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). world health organization schedules temafloxacin in its anatomical therapeutic chemical (atc) classification. temafloxacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule temafloxacin under hs 29335995 and sitc 51576. as of q4 2014, temafloxacin remains the us fda preferred term for this commodity. temafloxacin bears us nlm identifiers umls id c0076075 and nci concept code c87391. smiles: fc1c(n2cc(ncc2)c)cc2n(cc(c(=o)c2c1)c(=o)o)c1c(f)cc(f)cc1.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. temafloxacin hydrochloride. this classification denotes a quinolone antibiotic with the molecular formula c21h18f3n3o3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier oc5igj7j6i, chemically known as 3-quinolinecarboxylic acid, 1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-, monohydrochloride, (+-)- but generally known as temafloxacin hydrochloride, which bears us nih compound identifier 60020. european medicines agency schedules temafloxacin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04715mig. most nations schedule temafloxacin hydrochloride under hs 29335995 and sitc 51576. as of q4 2014, temafloxacin hydrochloride remains the us fda preferred term for this commodity. temafloxacin hydrochloride bears us nlm identifiers umls id c0957500 and nci concept code c72858. smiles: cl.fc1c(n2cc(ncc2)c)cc2n(cc(c(=o)c2c1)c(=o)o)c1c(f)cc(f)cc1.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. tioxacin. this classification denotes a quinolone antibiotic with the molecular formula c14h12n2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0k40cnm74k, chemically known as 6-ethyl-2,3,6,9-tetrahydro-3-methyl-2,9-dioxothiazolo(5,4-f)quinoline-8-carboxylic acid but generally known as tioxacin, which bears us nih compound identifier 65788. european medicines agency schedules tioxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11096mig. the term tioxacin is an international non-proprietary name or inn (see who inn reference publication, volume 30, no. 10 1976, list 16). tioxacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tioxacin under hs 29349990 and sitc 51579. as of q4 2014, tioxacin remains the us fda preferred term for this commodity. tioxacin bears us nlm identifiers umls id c0076712 and nci concept code c76924. smiles: s1c2c3c(n(cc)cc(c3=o)c(=o)o)ccc2n(c1=o)c.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. tosufloxacin. this classification denotes a quinolone antibiotic with the molecular formula c19h15f3n4o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ghj553kqps, chemically known as 1,8-naphthyridine-3-carboxylic acid, 1,4-dihydro-7-(3-amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo- but generally known as tosufloxacin, which bears us nih compound identifier 5517. european medicines agency schedules tosufloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11201mig. the term tosufloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). tosufloxacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tosufloxacin under hs 29339990 and sitc 51577. as of q4 2014, tosufloxacin remains the us fda preferred term for this commodity. tosufloxacin bears us nlm identifiers umls id c0076843 and nci concept code c80642. smiles: fc1c(n2cc(n)cc2)nc2n(cc(c(=o)c2c1)c(=o)o)c1c(f)cc(f)cc1.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. trovafloxacin. this classification denotes a quinolone antibiotic with the molecular formula c20h15f3n4o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9f388j00uk, chemically known as cp-99,219 but generally known as trovafloxacin, which bears us nih compound identifier 62959. european medicines agency schedules trovafloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11350mig. the term trovafloxacin is an international non-proprietary name or inn (see who inn reference publication, volume 10, no. 3, 1996, list 36). world health organization schedules trovafloxacin in its anatomical therapeutic chemical (atc) classification. most nations schedule trovafloxacin under hs 29339990 and sitc 51577. as of q4 2014, trovafloxacin remains the us fda preferred term for this commodity. trovafloxacin bears us nlm identifiers umls id c0379881 and nci concept code c66644. smiles: fc1c(n2cc3c(c3n)c2)nc2n(cc(c(=o)c2c1)c(=o)o)c1c(f)cc(f)cc1.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. sarafloxacin. this classification denotes a quinolone antibiotic with the molecular formula c20h17f2n3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier rc3wj907xy, chemically known as 6-fluoro-1-(4-fluorophenyl)-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid but generally known as sarafloxacin, which bears us nih compound identifier 56208. most nations schedule sarafloxacin under hs 29335995 and sitc 51576. as of q4 2014, sarafloxacin remains the us fda preferred term for this commodity. sarafloxacin bears us nlm identifiers umls id c0050308 and nci concept code c84143. smiles: c1cn(ccn1)c2=c(c=c3c(=c2)n(c=c(c3=o)c(=o)o)c4=cc=c(c=c4)f)f.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. nalidixic acid. this classification denotes a urinary anti-infective agent and quinolone antibiotic with the molecular formula c12h12n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3b91hwa56m, chemically known as 1,8-naphthyridine-3-carboxylic acid, 1-ethyl-1,4-dihydro-7-methyl-4-oxo- but generally known as nalidixic acid, which bears us nih compound identifier 4421. european medicines agency schedules nalidixic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09138mig. the term nalidixic acid is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules nalidixic acid in its anatomical therapeutic chemical (atc) classification. most nations schedule nalidixic acid under hs 29339990 and sitc 51577. as of q4 2014, nalidixic acid remains the us fda preferred term for this commodity. nalidixic acid bears us nlm identifiers umls id c0027353 and nci concept code c47630. smiles: ccn1c=c(c(=o)c2=c1n=c(c=c2)c)c(=o)o.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. decoquinate. this classification denotes a quinolone antibiotic with the molecular formula c24h35no5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 534i52pvwh, chemically known as 3-quinolinecarboxylic acid, 6-(decyloxy)-7-ethoxy-4-hydroxy-, ethyl ester but more generally known as decoquinate, which bears us nih compound identifier 29112. european medicines agency schedules decoquinate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06938mig. the term decoquinate is an international non-proprietary name or inn (see world health organization inn reference publication, volume 23, no. 10 1969, list 9). decoquinate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: o(cccccccccc)c1c(occ)cc2[nh]cc(c(=o)c2c1)c(=o)occ.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. enoxacin. this classification denotes an anti-infective agent with the molecular formula c15h17fn4o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 325ogw249p, chemically known as 1,8-naphthyridine-3-carboxylic acid, 6-fluoro-1,4-dihydro- 4-oxo-7-piperazinyl but more generally known as enoxacin, which bears us nih compound identifier 3229. european medicines agency schedules enoxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06540mig. the term enoxacin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 40, no. 6, 1986, list 26). the world health organization schedules enoxacin in its anatomical therapeutic chemical (atc) classification. enoxacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: fc1c(n2ccncc2)nc2n(cc)cc(c(=o)c2c1)c(=o)o.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. enoxacin sesquihydrate. this classification denotes an anti-infective agent 2c15h17fn4o3.3h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier i9cd31n8wb, chemically known as 1,8-naphthyridine-3-carboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, hydrate (2:3), but more generally known as enoxacin sesquihydrate, which bears us nih compound identifier 3229. european medicines agency schedules sub13675migin its extended eudravigilance medicinal product dictionary or xevmpd under index sub13675mig. most nations schedule enoxacin sesquihydrate under hs 29335995 and sitc 51576. as of q4 2014, enoxacin sesquihydrate remains the us fda preferred term for this commodity. smiles: ccn1cc(c(=o)c2c1nc(c(c2)f)n3ccncc3)c(=o)o.ccn1cc(c(=o)c2c1nc(c(c2)f)n3ccncc3)c(=o)o.o.o.o.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. esafloxacin. this classification denotes a quinolone antibiotic with the molecular formula c15h17fn4o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier a6nt0i9x0k, chemically known as 1,8-naphthyridine-3-carboxylic acid, 7-(3-amino-1-pyrrolidinyl)-1-ethyl-6-fluoro-1,4-dihydro-4-oxo- but more generally known as esafloxacin, which bears us nih compound identifier 208933. european medicines agency schedules esafloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06606mig. the term esafloxacin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 3, no. 3, 1989, list 29). esafloxacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: fc1c(n2cc(n)cc2)nc2n(cc)cc(c(=o)c2c1)c(=o)o.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. ofloxacin. this classification denotes a quinolone antibiotic with the molecular formula c18h20fn3o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) a4p49jaz9h, chemically known as 86393-32-0 (hydrochloride, monohydrate) but more generally known as ofloxacin, which bears u.s. national institutes of health compound identifier 2764. european medicines agency schedules ofloxacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09422mig. the term ofloxacin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 38, no. 6, 1984, list 24). world health organization schedules ofloxacin in its anatomical therapeutic chemical (atc) classification. ofloxacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ofloxacin under hs 29349990 and sitc 51579. as of q4 2014, ofloxacin remains the us fda preferred term for this commodity. ofloxacin bears us nlm identifiers umls id c0028902 and nci concept code c712. smiles: fc1c(n2ccncc2)cc2n(c3cc3)cc(c(=o)c2c1)c(=o)o.. "
"quinolone antibacterials. this classification denotes broad-spectrum antibacterials based on a group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or nalidixic acid (a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum), hence the name quinolones.. ofloxacin hydrochloride. this classification denotes a quinolone antibiotic with the molecular formula c18h20fn3o4.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier i2uwv315wa. european medicines agency schedules ofloxacin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03494mig. the term ofloxacin hydrochloride is a u.s. fda designation. most nations schedule ofloxacin hydrochloride under hs 29349990. as of q4 2014, ofloxacin hydrochloride remains the us fda preferred term for this commodity. smiles: cc1coc2c3n1cc(c(=o)c3cc(c2n4ccn(cc4)c)f)c(=o)o.cl.. "
"lincosamides. this classification denotes antibiotics belonging to a family of lincomycin-related glycosides that contain a pyrrolidine ring linked via an amide-bond to a pyranose moiety, hence the names lincos-amide, lincosamide, and lincosamides. individual members of this family are defined by the arrangement of specific constituent groups on the lyncomycin molecule.. . "
"lincosamides. this classification denotes antibiotics belonging to a family of lincomycin-related glycosides that contain a pyrrolidine ring linked via an amide-bond to a pyranose moiety, hence the names lincos-amide, lincosamide, and lincosamides. individual members of this family are defined by the arrangement of specific constituent groups on the lyncomycin molecule.. pirlimycin. this classification denotes a lincosamide antibiotic with the molecular formula c17h31cln2o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier lm19jt6g5k, chemically known as l-threo-alpha-d-galacto-octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((4-ethyl-2-piperidinyl)carbonyl)amino)-1-thio-, monohydrochloride, (2s-cis)- but generally known as pirlimycin, which bears us nih compound identifier 115329. european medicines agency schedules pirlimycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09922mig. the term pirlimycin is an international non-proprietary name. pirlimycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pirlimycin under hs 29419000 and sitc 54139. as of q4 2014, pirlimycin remains the us fda preferred term for this commodity. pirlimycin bears us nlm identifiers umls id c0071142 and nci concept code c84066. smiles: clc(c(nc(=o)c1nccc(c1)cc)c1oc(sc)c(o)c(o)c1o)c.cl.. "
"lincosamides. this classification denotes antibiotics belonging to a family of lincomycin-related glycosides that contain a pyrrolidine ring linked via an amide-bond to a pyranose moiety, hence the names lincos-amide, lincosamide, and lincosamides. individual members of this family are defined by the arrangement of specific constituent groups on the lyncomycin molecule.. clindamycin. this classification denotes a lincosamide antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3u02el437c. european medicines agency schedules clindamycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06665mig. clindamycin generally arises in the molecular formula c18h33cln2o5s. the term clindamycin is an international non-proprietary name or inn (see who inn reference publication, volume 23, no. 10 1969, list 9.) clindamycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule clindamycin under hs 29419000 and sitc 54139. as of q4 2014, clindamycin remains the us fda preferred term for this commodity. clindamycin bears us nlm identifiers umls id c0008947 and nci concept code c377. smiles: clc(c(nc(=o)c1n(cc(c1)ccc)c)c1oc(sc)c(o)c(o)c1o)c.. "
"lincosamides. this classification denotes antibiotics belonging to a family of lincomycin-related glycosides that contain a pyrrolidine ring linked via an amide-bond to a pyranose moiety, hence the names lincos-amide, lincosamide, and lincosamides. individual members of this family are defined by the arrangement of specific constituent groups on the lyncomycin molecule.. clindamycin hydrochloride. this classification denotes a lincosamide antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t20oq1yn1w. european medicines agency schedules clindamycin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01342mig. clindamycin hydrochloride generally arises in the molecular formula c18h33cln2o5s.clh. the term clindamycin hydrochloride is a u.s. pharmacopeial convention designation. most nations, for tariff and trade purposes, schedule clindamycin hydrochloride under hs 29419000 and sitc 54139. as of q4 2014, clindamycin hydrochloride remains us fdas preferred term for this commodity. clindamycin hydrochloride bears us nlm identifiers umls id c0282105 and nci concept code c47977. smiles: ccc[c@@h]1c[c@h](n(c1)c)c(=o)n[c@@h]([c@@h]2[c@@h]([c@@h]([c@h]([c@h](o2)sc)o)o)o)[c@h](c)cl.cl.. "
"lincosamides. this classification denotes antibiotics belonging to a family of lincomycin-related glycosides that contain a pyrrolidine ring linked via an amide-bond to a pyranose moiety, hence the names lincos-amide, lincosamide, and lincosamides. individual members of this family are defined by the arrangement of specific constituent groups on the lyncomycin molecule.. clindamycin palmitate. this classification denotes a lincosamide antibiotic with the molecular formula c34h63cln2o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier c501z28afg, chemically known as methyl (2s-trans)-7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-l-threo-alpha-d-galacto-octopyranoside, monopalmitate (ester) but more generally known as clindamycin palmitate, which bears us nih compound identifier 83855. most nations, for tariff and trade purposes, schedule clindamycin palmitate under hs 29419000 and sitc 54139. as of q4 2014, clindamycin palmitate remains us fdas preferred term for this commodity. smiles: cccccccccccccccc(=o)o[c@@h]1[c@h]([c@h]([c@h](o[c@@h]1sc)[c@@h]([c@h](c)cl)nc(=o)[c@@h]2c[c@h](cn2c)ccc)o)o.. "
"lincosamides. this classification denotes antibiotics belonging to a family of lincomycin-related glycosides that contain a pyrrolidine ring linked via an amide-bond to a pyranose moiety, hence the names lincos-amide, lincosamide, and lincosamides. individual members of this family are defined by the arrangement of specific constituent groups on the lyncomycin molecule.. clindamycin palmitate hydrochloride. this classification denotes a lincosamide antibiotic with the molecular formula c34h63cln2o6s.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier vn9a8jm7m7, chemically known as methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-l-2-pyrrolidinecarboxamido)-1-thio-l-threo-alpha-d-galacto-octopyranoside 2-palmitate monohydrochloride but more generally known as clindamycin palmitate hydrochloride, which bears us nih compound identifier 33030. european medicines agency schedules clindamycin palmitate hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01343mig. most nations, for tariff and trade purposes, schedule clindamycin palmitate hydrochloride under hs 29419000 and sitc 54139. as of q4 2014, clindamycin palmitate hydrochloride remains us fdas preferred term for this commodity. clindamycin palmitate hydrochloride bears us nlm identifiers umls id c0304311 and nci concept code c61683. smiles: cccccccccccccccc(=o)o[c@@h]1[c@h]([c@h]([c@h](o[c@@h]1sc)[c@@h]([c@h](c)cl)nc(=o)[c@@h]2c[c@h](cn2c)ccc)o)o.cl.. "
"lincosamides. this classification denotes antibiotics belonging to a family of lincomycin-related glycosides that contain a pyrrolidine ring linked via an amide-bond to a pyranose moiety, hence the names lincos-amide, lincosamide, and lincosamides. individual members of this family are defined by the arrangement of specific constituent groups on the lyncomycin molecule.. clindamycin phosphate. this classification denotes a lincosamide antibiotic with the molecular formula c18h34cln2o8ps, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier eh6d7113i8, chemically known as l-threo-.alpha.-d-galacto-octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, 2-(dihydrogen phosphate), (2s-trans)-, but more generally known as clindamycin phosphate, which bears us nih compound identifier 29029. european medicines agency schedules clindamycin phosphate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06665mig. most nations, for tariff purposes, schedule clindamycin phosphate under hs 29419000. clindamycin phosphate bears us nlm identifiers umls id c0055881 and nci concept code c47978. smiles: ccc[c@@h]1c[c@h](n(c1)c)c(=o)n[c@@h]([c@@h]2[c@@h]([c@@h]([c@h]([c@h](o2)sc)op(=o)(o)o)o)o)[c@h](c)cl.. "
"lincosamides. this classification denotes antibiotics belonging to a family of lincomycin-related glycosides that contain a pyrrolidine ring linked via an amide-bond to a pyranose moiety, hence the names lincos-amide, lincosamide, and lincosamides. individual members of this family are defined by the arrangement of specific constituent groups on the lyncomycin molecule.. pirlimycin hydrochloride. this classification denotes a lincosamide antibiotic with the molecular formula c17h31cln2o5s.clh.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8s09o559aq, chemically known as l-threo-.alpha.-d-galacto-octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((4-ethyl-2-piperidinyl)carbonyl)amino)-1-thio-, monohydrochloride, monohydrate, (2s-cis)-, but more generally known as pirlimycin hydrochloride, which bears us nih compound identifier 71997. european medicines agency schedules pirlimycin hydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09922mig. most nations, for tariff purposes, schedule pirlimycin hydrochloride under hs 29419000. pirlimycin hydrochloride bears us nlm identifiers umls id c0521904 and nci concept code c73846. smiles: cc[c@@h]1ccn[c@@h](c1)c(=o)n[c@@h]([c@@h]2[c@@h]([c@@h]([c@h]([c@h](o2)sc)o)o)o)[c@h](c)cl.o.cl.. "
"lipopeptides. this classification denotes antibiotics based on lipids and compounds consisting of a short peptide chain conjugated with an acyl chain, hence the names lipo-peptide, lipo-peptides, and lipopeptides.. . "
"lipopeptides. this classification denotes antibiotics based on lipids and compounds consisting of a short peptide chain conjugated with an acyl chain, hence the names lipo-peptide, lipo-peptides, and lipopeptides.. anidulafungin. this classification denotes an antifungal agent with the molecular formula c58h73n7o17, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9hlm53094i, chemically known as echinocandin b, 1-((4r,5r)-4,5-dihydroxy-n2-((4-(pentyloxy)(1,1:4,1-terphenyl)-4-yl)carbonyl)-l-ornithine) but generally known as anidulafungin, which bears us nih compound identifier 166548. european medicines agency schedules anidulafungin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub22240. the term anidulafungin is an international non-proprietary name or inn (see who inn reference publication, volume 14, no. 1, 2000, list 43). world health organization schedules anidulafungin in its anatomical therapeutic chemical (atc) classification. most nations schedule anidulafungin under hs 29419000 and sitc 54139. as of q4 2014, anidulafungin remains the us fda preferred term for this commodity. anidulafungin bears us nlm identifiers umls id c1142738 and nci concept code c38716. smiles: oc1c(cn2c1c(=o)nc(o)c(o)cc(nc(=o)c1ccc(cc1)c1ccc(cc1)c1ccc(occccc)cc1)c(=o)nc(c(=o)n1c(cc(o)c1)c(=o)nc(c(=o)nc(c2=o)c(o)c)c(o)c(o)c1ccc(o)cc1)c(o)c)c.. "
"lipopeptides. this classification denotes antibiotics based on lipids and compounds consisting of a short peptide chain conjugated with an acyl chain, hence the names lipo-peptide, lipo-peptides, and lipopeptides.. caspofungin. this classification denotes an antifungal agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f0xdi6zl63. european medicines agency schedules caspofungin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub16405mig. caspofungin generally arises in the molecular formula c52h88n10o15. the term caspofungin is an international non-proprietary name or inn (see who inn reference publication, volume 13 no. 3, 1999, list 42.) most nations schedule caspofungin under hs 29419000 and sitc 54139. as of q4 2014, caspofungin remains the us fda preferred term for this commodity. caspofungin bears us nlm identifiers umls id c0537894 and nci concept code c28910. smiles: oc1c2n(cc1)c(=o)c(nc(=o)c(nc(=o)c1n(cc(o)c1)c(=o)c(nc(=o)c(nc(=o)ccccccccc(cc(cc)c)c)cc(o)c(nc2=o)nccn)c(o)c)c(o)c(o)c1ccc(o)cc1)c(o)ccn.. "
"lipopeptides. this classification denotes antibiotics based on lipids and compounds consisting of a short peptide chain conjugated with an acyl chain, hence the names lipo-peptide, lipo-peptides, and lipopeptides.. cilofungin. this classification denotes an antifungal agent with the molecular formula c49h71n7o17, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8zjc54a39x, chemically known as 1-((4r,5r)-4,5-dihydroxy-n(sup 2)-(p-(octyloxy)benzoyl)-l-ornithine)echinocandin b but generally known as cilofungin, which bears us nih compound identifier 71762. european medicines agency schedules cilofungin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06271mig. the term cilofungin is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). cilofungin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cilofungin under hs 29419000 and sitc 54139. as of q4 2014, cilofungin remains the us fda preferred term for this commodity. cilofungin bears us nlm identifiers umls id c0055726 and nci concept code c83623. smiles: oc1c(cn2c1c(=o)nc(o)c(o)cc(nc(=o)c1ccc(occcccccc)cc1)c(=o)nc(c(=o)n1c(cc(o)c1)c(=o)nc(c(=o)nc(c2=o)c(o)c)c(o)c(o)c1ccc(o)cc1)c(o)c)c.. "
"lipopeptides. this classification denotes antibiotics based on lipids and compounds consisting of a short peptide chain conjugated with an acyl chain, hence the names lipo-peptide, lipo-peptides, and lipopeptides.. colistimethate. this classification denotes an antimicrobial solution, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier xw0e5ys77g. european medicines agency schedules colistimethate sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06801mig. colistimethate sodium generally arises in the molecular formula c57h103n16na5o28s5. the term colistimethate sodium is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24.) as of q4 2014, colistimethate remains the us fda preferred term for this commodity. colistimethate bears us nlm identifiers umls id c0009315 and nci concept code c72729. smiles: ccc(c)ccccc(=o)nc(ccncs(=o)(=o)[o-])c(=o)nc(c(c)o)c(=o)nc(ccncs(=o)(=o)[o-])c(=o)nc1ccnc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc1=o)ccncs(=o)(=o)[o-])cc(c)c)cc(c)c)ccncs(=o)(=o)[o-])ccncs(=o)(=o)[o-])c(c)o.. "
"lipopeptides. this classification denotes antibiotics based on lipids and compounds consisting of a short peptide chain conjugated with an acyl chain, hence the names lipo-peptide, lipo-peptides, and lipopeptides.. micafungin. this classification denotes an antifungal agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier r10h71bswg. european medicines agency schedules micafungin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub16444mig. micafungin generally arises in the molecular formula c56h71n9o23s. the term micafungin is an international non-proprietary name or inn (see who inn reference publication, volume 15 no. 3-4, 2001, list 46.) most nations schedule micafungin under hs 29419000 and sitc 54139. as of q4 2014, micafungin remains the us fda preferred term for this commodity. micafungin bears us nlm identifiers umls id c1120386 and nci concept code c1850. smiles: s(=o)(=o)(oc1cc(c(o)c(o)c2nc(=o)c3n(cc(o)c3)c(=o)c(nc(=o)c(nc(=o)c3ccc(cc3)c3noc(c3)c3ccc(occccc)cc3)cc(o)c(o)nc(=o)c3n(cc(c3o)c)c(=o)c(nc2=o)c(o)cc(=o)n)c(o)c)ccc1o)o.. "
"lipopeptides. this classification denotes antibiotics based on lipids and compounds consisting of a short peptide chain conjugated with an acyl chain, hence the names lipo-peptide, lipo-peptides, and lipopeptides.. polymyxin b. this classification denotes a polymyxin antibiotic with the molecular formula c55h95n16o13r, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier j2vz07j96k, more generally known as polymyxin b. european medicines agency schedules polymyxin b in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03937mig. the term polymyxin b is an international non-proprietary name or inn. see who inn reference publication, volume 13, no. 12, 1959, list 3. most nations schedule polymyxin b under hs 29419000 and sitc 54139. as of q4 2014, polymyxin b remains the us fda preferred term for this commodity. polymyxin b bears us nlm identifiers umls id c0032535 and nci concept code c61894. smiles: ccc(c)ccccc(=o)nc(ccn)c(=o)nc(c(c)o)c(=o)nc(ccn)c(=o)nc1ccnc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc1=o)ccn)cc2=cc=cc=c2)cc(c)c)ccn)ccn)c(c)o.. "
"lipopeptides. this classification denotes antibiotics based on lipids and compounds consisting of a short peptide chain conjugated with an acyl chain, hence the names lipo-peptide, lipo-peptides, and lipopeptides.. caspofungin acetate. this classification denotes an antifungal agent with the molecular formula c52h88n10o15.2c2h4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier vuw370o5qe, chemically known as pneumocandin b0, 1-((4r,5s)-5-((2-aminoethyl)amino)-n2-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-l-ornithine)-5-((3r)-3-hydroxy-l-ornithine)-, diacetate (salt) but more generally known as caspofungin acetate, which bears us nih compound identifier 123623. the base compound, caspofungin, most often comes in base and acetate forms. european medicines agency schedules caspofungin acetate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12476mig. most nations, for tariff and trade purposes, schedule caspofungin acetate under hs 29419000 and sitc 54139. as of q4 2014, caspofungin acetate remains us fdas preferred term for this commodity. caspofungin acetate bears us nlm identifiers umls id c0935942 and nci concept code c1724. smiles: ccc(c)cc(c)ccccccccc(=o)n[c@h]1c[c@h]([c@h](nc(=o)[c@@h]2[c@h](ccn2c(=o)[c@@h](nc(=o)[c@@h](nc(=o)[c@@h]3c[c@h](cn3c(=o)[c@@h](nc1=o)[c@@h](c)o)o)[c@@h]([c@h](c4ccc(cc4)o)o)o)[c@@h](ccn)o)o)nccn)o.cc(=o)o.cc(=o)o.. "
"lipopeptides. this classification denotes antibiotics based on lipids and compounds consisting of a short peptide chain conjugated with an acyl chain, hence the names lipo-peptide, lipo-peptides, and lipopeptides.. colistimethate sodium. this classification denotes an antimicrobial solution, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier xw0e5ys77g. european medicines agency schedules colistimethate sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06801mig. colistimethate sodium generally arises in the molecular formula c57h103n16na5o28s5. the term colistimethate sodium is an international non-proprietary name or inn (see world health organization inn reference publication, volume 38, no. 6, 1984, list 24.) most nations, for tariff and trade purposes, schedule colistimethate sodium under hs 29419000 and sitc 54139. colistimethate sodium bears us nlm identifiers umls id c0110462 and nci concept code c65349. smiles: as of q4 2014, colistimethate sodium remains us fdas preferred term for this commodity.. "
"lipopeptides. this classification denotes antibiotics based on lipids and compounds consisting of a short peptide chain conjugated with an acyl chain, hence the names lipo-peptide, lipo-peptides, and lipopeptides.. micafungin sodium. this classification denotes an antifungal agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier is1up79r56. european medicines agency schedules micafungin sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20666. micafungin sodium generally arises in the molecular formula c56h70n9o23s.na. the term micafungin sodium is a united states adopted name designation. most nations, for tariff and trade purposes, schedule micafungin sodium under hs 29419000 and sitc 54139. as of q4 2014, micafungin sodium remains us fdas preferred term for this commodity. micafungin sodium bears us nlm identifiers umls id c1576821 and nci concept code c66145. smiles: cccccoc1ccc(cc1)c2cc(no2)c3ccc(cc3)c(=o)n[c@h]4c[c@h]([c@h](nc(=o)[c@@h]5[c@h]([c@h](cn5c(=o)[c@@h](nc(=o)[c@@h](nc(=o)[c@@h]6c[c@h](cn6c(=o)[c@@h](nc4=o)[c@@h](c)o)o)[c@@h]([c@h](c7ccc(c(c7)os(=o)(=o)[o-])o)o)o)[c@@h](cc(=o)n)o)c)o)o)o.[na+].. "
"lipopeptides. this classification denotes antibiotics based on lipids and compounds consisting of a short peptide chain conjugated with an acyl chain, hence the names lipo-peptide, lipo-peptides, and lipopeptides.. clofazimine. this classification denotes an antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier d959ae5usf. european medicines agency schedules clofazimine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06694mig. clofazimine generally arises in the molecular formula c27h22cl2n4. the term clofazimine is an international non-proprietary name or inn. clofazimine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: cc(c)n=c1c=c2c(=nc3=cc=cc=c3n2c4=cc=c(c=c4)cl)c=c1nc5=cc=c(c=c5)cl.. "
"lipopeptides. this classification denotes antibiotics based on lipids and compounds consisting of a short peptide chain conjugated with an acyl chain, hence the names lipo-peptide, lipo-peptides, and lipopeptides.. cuprimyxin. this classification denotes a topical anti-infective agent with the molecular formula 2c13h9n2o4.cu, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q728680892, chemically known as copper, bis(6-methoxy-1-phenazinol 5,10-dioxidato-o(sup1),o(sup10))- but more generally known as cuprimyxin, which bears us nih compound identifier 421620. european medicines agency schedules cuprimyxin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06833mig. the term cuprimyxin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 28, no. 10 1974, list 14). cuprimyxin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: coc1=cc=cc2=c1n(c3=cc=cc(=o)c3=[n+]2[o-])o.coc1=cc=cc2=c1n(c3=cc=cc(=o)c3=[n+]2[o-])o.[cu].. "
"lipopeptides. this classification denotes antibiotics based on lipids and compounds consisting of a short peptide chain conjugated with an acyl chain, hence the names lipo-peptide, lipo-peptides, and lipopeptides.. gramicidin. this classification denotes an anti-infective agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5ie62321p4. european medicines agency schedules gramicidin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02403mig. gramicidin generally arises in the molecular formula c60h92n12o10. the term gramicidin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 26, no. 10 1972, list 12.) gramicidin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: cc(c)cc(c(=o)nc(c)c(=o)nc(c(c)c)c(=o)nc(c(c)c)c(=o)nc(c(c)c)c(=o)nc(cc1=cnc2=cc=cc=c21)c(=o)nc(cc(c)c)c(=o)nc(cc3=cnc4=cc=cc=c43)c(=o)nc(cc(c)c)c(=o)nc(cc5=cnc6=cc=cc=c65)c(=o)nc(cc(c)c)c(=o)nc(cc7=cnc8=cc=cc=c87)c(=o)ncco)nc(=o)c(c)nc(=o)cnc(=o)c(c(c)c)nc=o.. "
"macrolides. this classification denotes bacteriostatic, broad-spectrum antibiotics based on a group of often glycosylated macrocyclic compounds formed by chain extension of multiple propionates cyclized into a large (typically 12, 14, or 16)-membered lactone, and having of a macrolide ring, hence the names macro-lide, macro-lide and macrolides. macrolides belong to the polyketides class of natural product.. . "
"macrolides. this classification denotes bacteriostatic, broad-spectrum antibiotics based on a group of often glycosylated macrocyclic compounds formed by chain extension of multiple propionates cyclized into a large (typically 12, 14, or 16)-membered lactone, and having of a macrolide ring, hence the names macro-lide, macro-lide and macrolides. macrolides belong to the polyketides class of natural product.. filipin. this classification denotes a macrolide antibiotic with the molecular formula c35h58o11, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 87z59r7d14 chemically known as oxacyclooctacosa-17,19,21,23,25-pentaen-2-one, 4,6,8,10,12,14,16,27-octahydroxy-3-(1-hydroxyhexyl)-17,28-dimethyl- but generally known as filipin, which bears us nih compound identifier 5351457. european medicines agency schedules filipin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07628mig. the term filipin is an international non-proprietary name or inn. most nations schedule filipin under hs 29419000 and sitc 54139. as of q4 2014, filipin remains the us fda preferred term for this commodity. smiles: oc1c(c(o)ccccc)c(=o)oc(c(o)c=cc=cc=cc=cc=c(c(o)cc(o)cc(o)cc(o)cc(o)cc(o)c1)c)c.. "
"macrolides. this classification denotes bacteriostatic, broad-spectrum antibiotics based on a group of often glycosylated macrocyclic compounds formed by chain extension of multiple propionates cyclized into a large (typically 12, 14, or 16)-membered lactone, and having of a macrolide ring, hence the names macro-lide, macro-lide and macrolides. macrolides belong to the polyketides class of natural product.. filipin iii. this classification denotes a macrolide antibiotic with the molecular formula c35h58o11, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 87z59r7d14 chemically known as oxacyclooctacosa-17,19,21,23,25-pentaen-2-one, 4,6,8,10,12,14,16,27-octahydroxy-3-(1-hydroxyhexyl)-17,28-dimethyl- but generally known as filipin, which bears us nih compound identifier 5351457. european medicines agency schedules filipin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07628mig. the term filipin is an international non-proprietary name or inn. most nations schedule filipin iii under hs 29419000 and sitc 54139. filipin iii bears us nlm identifiers umls id c0016095 and nci concept code c80959. smiles: oc1c(c(o)ccccc)c(=o)oc(c(o)c=cc=cc=cc=cc=c(c(o)cc(o)cc(o)cc(o)cc(o)cc(o)c1)c)c.. "
"macrolides. this classification denotes bacteriostatic, broad-spectrum antibiotics based on a group of often glycosylated macrocyclic compounds formed by chain extension of multiple propionates cyclized into a large (typically 12, 14, or 16)-membered lactone, and having of a macrolide ring, hence the names macro-lide, macro-lide and macrolides. macrolides belong to the polyketides class of natural product.. josamycin. this classification denotes a macrolide antibiotic with the molecular formula c42h69no15, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hv13hfs217, chemically known as stereoisomer of 7-(formylmethyl)-4,10-dihydroxy-5-methoxy-9,16-dimethyl-2-oxooxacyclohexadeca-11,13-dien-6-yl 3,6-dideoxy-4-o-(2,6-dideoxy-3-c-methyl-alpha-l-ribo-hexopyranosyl)-3-(dimethylamino)-beta-d-glucopyranoside 4-acetate 4-isovalerate but generally known as josamycin, which bears us nih compound identifier 5282165. european medicines agency schedules josamycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12091mig. the term josamycin is an international non-proprietary name or inn (see who inn reference publication, volume 24, no. 11 1970, list 10). world health organization schedules josamycin in its anatomical therapeutic chemical (atc) classification. josamycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule josamycin under hs 29419000 and sitc 54139. as of q4 2014, josamycin remains the us fda preferred term for this commodity. josamycin bears us nlm identifiers umls id c0022419 and nci concept code c83851. smiles: o(c1c(n(c)c)c(o)c(oc1c)oc1c(cc(c(o)c=cc=ccc(oc(=o)cc(oc(=o)c)c1oc)c)c)cc=o)c1oc(c(oc(=o)cc(c)c)c(o)(c1)c)c.. "
"macrolides. this classification denotes bacteriostatic, broad-spectrum antibiotics based on a group of often glycosylated macrocyclic compounds formed by chain extension of multiple propionates cyclized into a large (typically 12, 14, or 16)-membered lactone, and having of a macrolide ring, hence the names macro-lide, macro-lide and macrolides. macrolides belong to the polyketides class of natural product.. tylosin. this classification denotes a macrolide antibiotic with the molecular formula c46h77no17, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier yef4jxn031. the term tylosin is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7. ). tylosin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tylosin under hs 29419000 and sitc 54139. as of q4 2014, tylosin remains the us fda preferred term for this commodity. tylosin bears us nlm identifiers umls id c0041441 and nci concept code c84234. smiles: ccc1c(c=c(c=cc(=o)c(cc(c(c(c(cc(=o)o1)o)c)oc2c(c(c(c(o2)c)oc3cc(c(c(o3)c)o)(c)o)n(c)c)o)cc=o)c)c)coc4c(c(c(c(o4)c)o)oc)oc.. "
"macrolides. this classification denotes bacteriostatic, broad-spectrum antibiotics based on a group of often glycosylated macrocyclic compounds formed by chain extension of multiple propionates cyclized into a large (typically 12, 14, or 16)-membered lactone, and having of a macrolide ring, hence the names macro-lide, macro-lide and macrolides. macrolides belong to the polyketides class of natural product.. oleandomycin. this classification denotes a macrolide antibiotic with the molecular formula c35h61no12, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier p8zq646136, chemically known as 12-((2,6-didesoxy-3-o-methyl-alpha-k-arabino-hexopyranosyl)oxy)-8-hydroxy-5,7,8,11,13,15-hexamethyl-14-((3,4,6-tridesoxy-3-dimethylamino-beta-d-xylo-hexopyranosyl)oxy)-1,9-dioxaspiro(2.13)hexadecan-4,10-dion but generally known as oleandomycin, which bears us nih compound identifier 19822. european medicines agency schedules oleandomycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09428mig. world health organization schedules oleandomycin in its anatomical therapeutic chemical (atc) classification. oleandomycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule oleandomycin under hs 29419000 and sitc 54139. as of q4 2014, oleandomycin remains the us fda preferred term for this commodity. oleandomycin bears us nlm identifiers umls id c0028923 and nci concept code c61864. smiles: o1c2(cc(c(oc3oc(cc(n(c)c)c3o)c)c(c(oc3oc(c(o)c(oc)c3)c)c(c(=o)oc(c(c(o)c(c2=o)c)c)c)c)c)c)c1.. "
"macrolides. this classification denotes bacteriostatic, broad-spectrum antibiotics based on a group of often glycosylated macrocyclic compounds formed by chain extension of multiple propionates cyclized into a large (typically 12, 14, or 16)-membered lactone, and having of a macrolide ring, hence the names macro-lide, macro-lide and macrolides. macrolides belong to the polyketides class of natural product.. rokitamycin. this classification denotes a miocamycin analog and leucomycin with the molecular formula c42h69no15, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier zpt03uem0e, chemically known as leucomycin v, 4(sup b)-butanoate 3(sup b)-propanoate but generally known as rokitamycin, which bears us nih compound identifier 5282211. european medicines agency schedules rokitamycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10361mig. world health organization schedules rokitamycin in its anatomical therapeutic chemical (atc) classification. rokitamycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule rokitamycin under hs 29419000 and sitc 54139. as of q4 2014, rokitamycin remains the us fda preferred term for this commodity. smiles: o(c1c(n(c)c)c(o)c(oc1c)oc1c(cc(c(o)c=cc=ccc(oc(=o)cc(o)c1oc)c)c)cc=o)c1oc(c(oc(=o)ccc)c(oc(=o)cc)(c1)c)c.. "
"macrolides. this classification denotes bacteriostatic, broad-spectrum antibiotics based on a group of often glycosylated macrocyclic compounds formed by chain extension of multiple propionates cyclized into a large (typically 12, 14, or 16)-membered lactone, and having of a macrolide ring, hence the names macro-lide, macro-lide and macrolides. macrolides belong to the polyketides class of natural product.. sedecamycin. this classification denotes a macrolide antibiotic with the molecular formula c27h35no8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier wlk252z51f, chemically known as pyruvamide, n-(7,13-dihydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo(13.2.2)nonadeca-3,5,9,11-tetraen-2-yl)-, 13-acetate, (all-e)-(1s,2r,7s,13s,15r,19r)-(-)- but generally known as sedecamycin, which bears us nih compound identifier 5382567. european medicines agency schedules sedecamycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10471mig. the term sedecamycin is an international non-proprietary name. sedecamycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sedecamycin under hs 29419000 and sitc 54139. as of q4 2014, sedecamycin remains the us fda preferred term for this commodity. sedecamycin bears us nlm identifiers umls id c0074263 and nci concept code c72589. smiles: o1c2c(c(=o)c(c(nc(=o)c(=o)c)c=c(c)c=cc(o)cc=c(c=cc(oc(=o)c)c2)c)(c1=o)c)c.. "
"macrolides. this classification denotes bacteriostatic, broad-spectrum antibiotics based on a group of often glycosylated macrocyclic compounds formed by chain extension of multiple propionates cyclized into a large (typically 12, 14, or 16)-membered lactone, and having of a macrolide ring, hence the names macro-lide, macro-lide and macrolides. macrolides belong to the polyketides class of natural product.. spiramycin. this classification denotes a macrolide antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 71ody0v87h. european medicines agency schedules spiramycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04526mig. spiramycin generally arises in the molecular formula c43h74n2o14. the term spiramycin is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3.) spiramycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule spiramycin under hs 29419000 and sitc 54139. as of q4 2014, spiramycin remains the us fda preferred term for this commodity. spiramycin bears us nlm identifiers umls id c0037962 and nci concept code c839. smiles: cc1c/c=c/c=c/c(c(cc(c(c(c(cc(=o)o1)o)oc)oc2c(c(c(c(o2)c)oc3cc(c(c(o3)c)o)(c)o)n(c)c)o)cc=o)c)oc4ccc(c(o4)c)n(c)c.. "
"macrolides. this classification denotes bacteriostatic, broad-spectrum antibiotics based on a group of often glycosylated macrocyclic compounds formed by chain extension of multiple propionates cyclized into a large (typically 12, 14, or 16)-membered lactone, and having of a macrolide ring, hence the names macro-lide, macro-lide and macrolides. macrolides belong to the polyketides class of natural product.. tilmicosin. this classification denotes a macrolide antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier xl4103x2e3. european medicines agency schedules tilmicosin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11054mig. tilmicosin generally arises in the molecular formula c46h80n2o13. the term tilmicosin is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27.) most nations schedule tilmicosin under hs 29419000 and sitc 54139. as of q4 2014, tilmicosin remains the us fda preferred term for this commodity. tilmicosin bears us nlm identifiers umls id c0076681 and nci concept code c84213. smiles: o(c1c(ccn2cc(cc(c2)c)c)cc(c)c(=o)c=cc(=cc(c(oc(=o)cc(o)c1c)cc)coc1oc(c(o)c(oc)c1oc)c)c)c1oc(c(o)c(n(c)c)c1o)c.. "
"macrolides. this classification denotes bacteriostatic, broad-spectrum antibiotics based on a group of often glycosylated macrocyclic compounds formed by chain extension of multiple propionates cyclized into a large (typically 12, 14, or 16)-membered lactone, and having of a macrolide ring, hence the names macro-lide, macro-lide and macrolides. macrolides belong to the polyketides class of natural product.. troleandomycin. this classification denotes a macrolide antibiotic with the molecular formula c41h67no15, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier c4dz64560d, chemically known as oleandomycin, triacetyl- but generally known as triacetyloleandomycin, which bears us nih compound identifier 17675. european medicines agency schedules troleandomycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11333mig. the term triacetyloleandomycin is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules triacetyloleandomycin in its anatomical therapeutic chemical (atc) classification. most nations schedule troleandomycin under hs 29419000 and sitc 54139. as of q4 2014, troleandomycin remains the us fda preferred term for this commodity. troleandomycin bears us nlm identifiers umls id c0702222 and nci concept code c66643. smiles: cc1cc(c(c(o1)oc2c(cc3(co3)c(=o)c(c(c(c(oc(=o)c(c(c2c)oc4cc(c(c(o4)c)oc(=o)c)oc)c)c)c)oc(=o)c)c)c)oc(=o)c)n(c)c.. "
"macrolides. this classification denotes bacteriostatic, broad-spectrum antibiotics based on a group of often glycosylated macrocyclic compounds formed by chain extension of multiple propionates cyclized into a large (typically 12, 14, or 16)-membered lactone, and having of a macrolide ring, hence the names macro-lide, macro-lide and macrolides. macrolides belong to the polyketides class of natural product.. fidaxomicin. this classification denotes a macrolide antibiotic with the molecular formula c52h74cl2o18, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier z5n076g8yq, chemically known as [(2r,3s,4s,5s,6r)-6-[[(3e,5e,8s,9e,11s,12r,13e,15e,18s)-12-[(2r,3s,4r,5s)-3,4-dihydroxy-6,6-dimethyl-5-(2-methylpropanoyloxy)oxan-2-yl]oxy-11-ethyl-8-hydroxy-18-[(1r)-1-hydroxyethyl]-9,13,15-trimethyl-2-oxo-1-oxacyclooctadeca-3,5,9,13,15-pentaen-3-yl]methoxy]-4-hydroxy-5-methoxy-2-methyloxan-3-yl]3,5-dichloro-2-ethyl-4,6-dihydroxybenzoate but generally known as fidaxomicin, which bears us nih compound identifier 10034073. european medicines agency schedules fidaxomicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub31455. the term fidaxomicin is an international non-proprietary name or inn (see who inn reference publication, vol 23, no. 3, 2009, list 62.). as of q4 2014, fidaxomicin remains the us fda preferred term for this commodity. fidaxomicin bears us nlm identifiers umls id c0065023 and nci concept code c66979. smiles: ccc1c=c(c(cc=cc=c(c(=o)oc(cc=c(c=c(c1oc2c(c(c(c(o2)(c)c)oc(=o)c(c)c)o)o)c)c)c(c)o)coc3c(c(c(c(o3)c)oc(=o)c4=c(c(=c(c(=c4o)cl)o)cl)cc)o)oc)o)c.. "
"macrolides. this classification denotes bacteriostatic, broad-spectrum antibiotics based on a group of often glycosylated macrocyclic compounds formed by chain extension of multiple propionates cyclized into a large (typically 12, 14, or 16)-membered lactone, and having of a macrolide ring, hence the names macro-lide, macro-lide and macrolides. macrolides belong to the polyketides class of natural product.. mepartricin. this classification denotes a macrolide antibiotic with the molecular formula c60h88n2o19, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier b7fbw3y74g, chemically known as (4e,6e,8e,10z,12z,14e,16e)-3-[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-23,27,29,31,33,35,37-heptahydroxy-19-[5-hydroxy-7-[4-(methylamino)phenyl]-7-oxoheptan-2-yl]-18-methyl-21,25-dioxo-20,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,12,14,16-heptaene-38-carboxylate but generally known as mepartricin, which bears us nih compound identifier 6479653. european medicines agency schedules mepartricin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03153mig. the term mepartricin is an international non-proprietary name or inn (see who inn reference publication, volume 30, no. 10 1976, list 1). world health organization schedules azithromycin in its anatomical therapeutic chemical (atc) classification. mepartricin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mepartricin under hs 29419000 and sitc 54139. as of q4 2014, mepartricin remains the us fda preferred term for this commodity. smiles: cc1c=cc=cc=cc=cc=cc=cc=cc(cc2c(c(cc(o2)(cc(cc(cc(cc(cc(=o)cc(cc(=o)oc1c(c)ccc(cc(=o)c3=cc=c(c=c3)nc)o)o)o)o)o)o)o)o)c(=o)oc)oc4c(c(c(c(o4)c)o)n)o.. "
"macrolides. this classification denotes bacteriostatic, broad-spectrum antibiotics based on a group of often glycosylated macrocyclic compounds formed by chain extension of multiple propionates cyclized into a large (typically 12, 14, or 16)-membered lactone, and having of a macrolide ring, hence the names macro-lide, macro-lide and macrolides. macrolides belong to the polyketides class of natural product.. mirosamicin. this classification denotes a macrolide antibiotic with the molecular formula c37h61no13, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k7g02hkm1x, chemically known as 4,17-dioxabicyclo(14.1.0)heptadeca-6,14-diene-5,13-dione, 2-(((6-deoxy-2,3-di-o-methyl-beta-d-allopyranosyl)oxy)methyl)-3-ethyl-2-hydroxy-8,10,12-trimethyl-9-((3,4,6-trideoxy-3-(dimethylamino)-beta-d-xylo-hexopyranosyl)oxy)-, (1r,2s,3r,6e,8s,9s,10s,12r,14e,16s)- but generally known as mirosamicin, which bears us nih compound identifier 6436150. european medicines agency schedules mirosamicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08995mig. the term mirosamicin is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). mirosamicin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mirosamicin under hs 29419000 and sitc 54139. as of q4 2014, mirosamicin remains the us fda preferred term for this commodity. mirosamicin bears us nlm identifiers umls id c0245985 and nci concept code c90878. smiles: o1c2c(o)(c(oc(=o)c=cc(c(oc3oc(cc(n(c)c)c3o)c)c(cc(c(=o)c=cc12)c)c)c)cc)coc1oc(c(o)c(oc)c1oc)c.. "
"macrolides. this classification denotes bacteriostatic, broad-spectrum antibiotics based on a group of often glycosylated macrocyclic compounds formed by chain extension of multiple propionates cyclized into a large (typically 12, 14, or 16)-membered lactone, and having of a macrolide ring, hence the names macro-lide, macro-lide and macrolides. macrolides belong to the polyketides class of natural product.. josamycin propionate. this classification denotes a macrolide antibiotic with the molecular formula c45h73no16, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 053va4b06y, chemically known as leucomycin v, 3-acetate 4b-(3-methylbutanoate) 9-propanoate but more generally known as josamycin propionate, which bears us nih compound identifier 5353696. european medicines agency schedules josamycin propionate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02814mig. most nations, for tariff and trade purposes, schedule josamycin propionate under hs 29419000 and sitc 54139. as of q4 2014, josamycin propionate remains us fdas preferred term for this commodity. smiles: ccc(=o)o[c@h]1/c=c/c=c/c[c@h](oc(=o)c[c@h]([c@@h]([c@h]([c@h](c[c@h]1c)cc=o)o[c@h]2[c@@h]([c@h]([c@@h]([c@h](o2)c)o[c@h]3c[c@@]([c@h]([c@@h](o3)c)oc(=o)cc(c)c)(c)o)n(c)c)o)oc)oc(=o)c)c.. "
"macrolides. this classification denotes bacteriostatic, broad-spectrum antibiotics based on a group of often glycosylated macrocyclic compounds formed by chain extension of multiple propionates cyclized into a large (typically 12, 14, or 16)-membered lactone, and having of a macrolide ring, hence the names macro-lide, macro-lide and macrolides. macrolides belong to the polyketides class of natural product.. relomycin. this classification denotes a macrolide antibiotic with the molecular formula c46h79no17, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier e70cpl81iy. the term relomycin is an international non-proprietary name or inn. relomycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: ccc1c(c=c(c=cc(=o)c(cc(c(c(c(cc(=o)o1)o)c)oc2c(c(c(c(o2)c)oc3cc(c(c(o3)c)o)(c)o)n(c)c)o)cco)c)c)coc4c(c(c(c(o4)c)o)oc)oc.. "
"macrolides. this classification denotes bacteriostatic, broad-spectrum antibiotics based on a group of often glycosylated macrocyclic compounds formed by chain extension of multiple propionates cyclized into a large (typically 12, 14, or 16)-membered lactone, and having of a macrolide ring, hence the names macro-lide, macro-lide and macrolides. macrolides belong to the polyketides class of natural product.. triacetyloleandomycin or troleandomycin. this classification denotes a macrolide antibiotic with the molecular formula c41h67no15, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier c4dz64560d, chemically known as oleandomycin, triacetyl- but more generally known as triacetyloleandomycin, which bears u.s. national institutes of health compound identifier 17675. the european medicines agency schedules troleandomycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11333mig. the term triacetyloleandomycin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 16, no. 3 1962, list 4). the world health organization schedules triacetyloleandomycin in its anatomical therapeutic chemical (atc) classification. smiles: cc1cc(c(c(o1)oc2c(cc3(co3)c(=o)c(c(c(c(oc(=o)c(c(c2c)oc4cc(c(c(o4)c)oc(=o)c)oc)c)c)c)oc(=o)c)c)c)oc(=o)c)n(c)c.. "
"macrolides. this classification denotes bacteriostatic, broad-spectrum antibiotics based on a group of often glycosylated macrocyclic compounds formed by chain extension of multiple propionates cyclized into a large (typically 12, 14, or 16)-membered lactone, and having of a macrolide ring, hence the names macro-lide, macro-lide and macrolides. macrolides belong to the polyketides class of natural product.. josamycin tartrate. this classification denotes a macrolide antibiotic with the molecular formula c42h69no15.c4h6o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ph728k04hs, chemically known as leucomycin v, 3-acetate 4b-(3-methylbutanoate), (2r,3r)-2,3-dihydroxybutanedioate (1:1) (salt), but more generally known as josamycin tartrate, which bears us nih compound identifier 6445955. european medicines agency schedules josamycin tartrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12091mig. most nations, for tariff purposes, schedule josamycin tartrate under hs 29419000. smiles: c[c@@h]1c/c=c/c=c/[c@@h]([c@@h](c[c@@h]([c@@h]([c@h]([c@@h](cc(=o)o1)oc(=o)c)oc)o[c@h]2[c@@h]([c@h]([c@@h]([c@h](o2)c)o[c@h]3c[c@@]([c@h]([c@@h](o3)c)oc(=o)cc(c)c)(c)o)n(c)c)o)cc=o)c)o.[c@@h]([c@h](c(=o)o)o)(c(=o)o)o.. "
"macrolides. this classification denotes bacteriostatic, broad-spectrum antibiotics based on a group of often glycosylated macrocyclic compounds formed by chain extension of multiple propionates cyclized into a large (typically 12, 14, or 16)-membered lactone, and having of a macrolide ring, hence the names macro-lide, macro-lide and macrolides. macrolides belong to the polyketides class of natural product.. mepartricin a. this classification denotes a macrolide antibiotic with the molecular formula c60h88n2o19, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l13v8793fq, chemically known as candicidin d, 40-demethyl-3,7-dideoxo-3,7-dihydroxy-n47-methyl-5-oxo-, methyl ester, cyclic 15,19-hemiacetal, but more generally known as mepartricin a, which bears us nih compound identifier 3009010. european medicines agency schedules mepartricin a or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03153mig. most nations, for tariff purposes, schedule mepartricin a under hs 29419000. smiles: c[c@h]1[c@@h]([c@h]([c@h]([c@h](o1)oc\\2cc3c(c(cc(o3)(cc(cc(cc(cc(cc(=o)cc(cc(=o)oc(c(/c=c/c=c/c=c/c=c/c=c/c=c/c=c2)c)c(c)ccc(cc(=o)c4ccc(cc4)nc)o)o)o)o)o)o)o)o)c(=o)oc)o)n)o.. "
"macrolides. this classification denotes bacteriostatic, broad-spectrum antibiotics based on a group of often glycosylated macrocyclic compounds formed by chain extension of multiple propionates cyclized into a large (typically 12, 14, or 16)-membered lactone, and having of a macrolide ring, hence the names macro-lide, macro-lide and macrolides. macrolides belong to the polyketides class of natural product.. mepartricin b. this classification denotes a macrolide antibiotic with the molecular formula c59h86n2o19, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 21g4vmn6c9, chemically known as candicidin d, 40-demethyl-3,7-dideoxo-3,7-dihydroxy-5-oxo-, methyl ester, cyclic 15,19-hemiacetal, but more generally known as mepartricin b, which bears us nih compound identifier 6450330. european medicines agency schedules mepartricin b or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03153mig. most nations, for tariff purposes, schedule mepartricin b under hs 29419000. smiles: c[c@h]1[c@@h]([c@h]([c@h]([c@h](o1)oc\\2cc3c(c(cc(o3)(cc(cc(cc(cc(cc(=o)cc(cc(=o)oc(c(/c=c/c=c/c=c/c=c/c=c/c=c/c=c2)c)c(c)ccc(cc(=o)c4ccc(cc4)n)o)o)o)o)o)o)o)o)c(=o)oc)o)n)o.. "
"macrolides. this classification denotes bacteriostatic, broad-spectrum antibiotics based on a group of often glycosylated macrocyclic compounds formed by chain extension of multiple propionates cyclized into a large (typically 12, 14, or 16)-membered lactone, and having of a macrolide ring, hence the names macro-lide, macro-lide and macrolides. macrolides belong to the polyketides class of natural product.. oleandomycin phosphate. this classification denotes a macrolide antibiotic with the molecular formula c35h61no12.h3o4p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8681h0c27p, chemically known as oleandomycin, phosphate (1:1) (salt) but more generally known as oleandomycin phosphate, which bears us nih compound identifier 72492. european medicines agency schedules oleandomycin phosphate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03497mig. most nations, for tariff and trade purposes, schedule oleandomycin phosphate under hs 29419000 and sitc 54139. as of q4 2014, oleandomycin phosphate remains us fdas preferred term for this commodity. oleandomycin phosphate bears us nlm identifiers umls id c0282269 and nci concept code c61865. smiles: c[c@@h]1c[c@@h]([c@h]([c@@h](o1)o[c@h]2[c@h](c[c@@]3(co3)c(=o)[c@@h]([c@h]([c@h]([c@h](oc(=o)[c@@h]([c@h]([c@@h]2c)o[c@h]4c[c@@h]([c@h]([c@@h](o4)c)o)oc)c)c)c)o)c)c)o)n(c)c.op(=o)(o)o.. "
"macrolides. this classification denotes bacteriostatic, broad-spectrum antibiotics based on a group of often glycosylated macrocyclic compounds formed by chain extension of multiple propionates cyclized into a large (typically 12, 14, or 16)-membered lactone, and having of a macrolide ring, hence the names macro-lide, macro-lide and macrolides. macrolides belong to the polyketides class of natural product.. spiramycin adipate. this classification denotes a macrolide antibiotic with the molecular formula c49h84n2o18, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l9knt101ok, chemically known as hexanedioic acid, compd. with spiramycin (1:1), but more generally known as spiramycin adipate, which bears us nih compound identifier 6450354. european medicines agency schedules spiramycin adipate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04526mig. most nations, for tariff purposes, schedule spiramycin adipate under hs 29419000. smiles:.. "
"macrolides. this classification denotes bacteriostatic, broad-spectrum antibiotics based on a group of often glycosylated macrocyclic compounds formed by chain extension of multiple propionates cyclized into a large (typically 12, 14, or 16)-membered lactone, and having of a macrolide ring, hence the names macro-lide, macro-lide and macrolides. macrolides belong to the polyketides class of natural product.. spiramycin i. this classification denotes a macrolide antibiotic c43h74n2o14, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 033ech6ifg, chemically known as leucomycin v, 9-o-((2r,5s,6r)-5-(dimethylamino)tetrahydro-6-methyl-2h-pyran-2-yl)-, but more generally known as spiramycin i, which bears us nih compound identifier 158334. most nations, for tariff and trade purposes, schedule spiramycin i under hs 29419000 and sitc 54139. as of q4 2014, spiramycin i remains us fdas preferred term for this commodity. smiles: c[c@@h]1c/c=c/c=c/[c@@h]([c@@h](c[c@@h]([c@@h]([c@h]([c@@h](cc(=o)o1)o)oc)o[c@h]2[c@@h]([c@h]([c@@h]([c@h](o2)c)o[c@h]3c[c@@]([c@h]([c@@h](o3)c)o)(c)o)n(c)c)o)cc=o)c)o[c@h]4cc[c@@h]([c@@h](o4)c)n(c)c.. "
"macrolides. this classification denotes bacteriostatic, broad-spectrum antibiotics based on a group of often glycosylated macrocyclic compounds formed by chain extension of multiple propionates cyclized into a large (typically 12, 14, or 16)-membered lactone, and having of a macrolide ring, hence the names macro-lide, macro-lide and macrolides. macrolides belong to the polyketides class of natural product.. tilmicosin phosphate. this classification denotes a macrolide antibiotic with the molecular formula c46h80n2o13.h3o4p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier smh7u1s683. the term tilmicosin phosphate is a united states adopted name designation. most nations, for tariff and trade purposes, schedule tilmicosin phosphate under hs 29419000 and sitc 54139. as of q4 2014, tilmicosin phosphate remains us fdas preferred term for this commodity. tilmicosin phosphate bears us nlm identifiers umls id c0521892 and nci concept code c84214. smiles: cc[c@@h]1[c@h](/c=c(/c=c/c(=o)[c@@h](c[c@@h]([c@@h]([c@h]([c@@h](cc(=o)o1)o)c)o[c@h]2[c@@h]([c@h]([c@@h]([c@h](o2)c)o)n(c)c)o)ccn3c[c@@h](c[c@@h](c3)c)c)c)\\c)co[c@h]4[c@@h]([c@@h]([c@@h]([c@h](o4)c)o)oc)oc.op(=o)(o)o.. "
"macrolides. this classification denotes bacteriostatic, broad-spectrum antibiotics based on a group of often glycosylated macrocyclic compounds formed by chain extension of multiple propionates cyclized into a large (typically 12, 14, or 16)-membered lactone, and having of a macrolide ring, hence the names macro-lide, macro-lide and macrolides. macrolides belong to the polyketides class of natural product.. tylosin phosphate. this classification denotes a macrolide antibiotic with the molecular formula c46h77no17.h3o4p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier nr75x12aff. the term tylosin phosphate is a u.s. fda green book designation. most nations, for tariff and trade purposes, schedule tylosin phosphate under hs 29419000. as of q4 2014, tylosin phosphate remains us fdas preferred term for this commodity. tylosin phosphate bears us nlm identifiers umls id c0060065 and nci concept code c84235. smiles: cc[c@@h]1[c@h](/c=c(/c=c/c(=o)[c@@h](c[c@@h]([c@@h]([c@h]([c@@h](cc(=o)o1)o)c)o[c@h]2[c@@h]([c@h]([c@@h]([c@h](o2)c)o[c@h]3c[c@@]([c@h]([c@@h](o3)c)o)(c)o)n(c)c)o)cc=o)c)\\c)co[c@h]4[c@@h]([c@@h]([c@@h]([c@h](o4)c)o)oc)oc.op(=o)(o)o.. "
"macrolides. this classification denotes bacteriostatic, broad-spectrum antibiotics based on a group of often glycosylated macrocyclic compounds formed by chain extension of multiple propionates cyclized into a large (typically 12, 14, or 16)-membered lactone, and having of a macrolide ring, hence the names macro-lide, macro-lide and macrolides. macrolides belong to the polyketides class of natural product.. tylosin tartrate. this classification denotes a macrolide antibiotic with the molecular formula c46h77no17.c4h6o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5p4625c51t, chemically known as tylosin, tartrate but more generally known as tylosin tartrate, which bears us nih compound identifier 6433274. most nations, for tariff and trade purposes, schedule tylosin tartrate under hs 29419000 and sitc 54139. tylosin tartrate bears us nlm identifiers umls id c0041442 and nci concept code c84236. smiles: as of q4 2014, tylosin tartrate remains us fdas preferred term for this commodity.. "
"oxazolidinones. this classification denotes antibiotics which are derivatives of oxazolidin-2-one (hence the name oxazolidin-one, oxazolidin-ones, and oxazolidinones) and are oxazoles and azoles.. . "
"oxazolidinones. this classification denotes antibiotics which are derivatives of oxazolidin-2-one (hence the name oxazolidin-one, oxazolidin-ones, and oxazolidinones) and are oxazoles and azoles.. cycloserine. this classification denotes an antitubercular agent with the molecular formula c3h6n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 95ik5ki84z, chemically known as 3-isoxazolidinone, 4-amino-, (s)- but generally known as cycloserine, which bears us nih compound identifier 401. european medicines agency schedules cycloserine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06863mig. the term cycloserine is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules cycloserine in its anatomical therapeutic chemical (atc) classification. cycloserine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cycloserine under hs 29419000 and sitc 54139. as of q4 2014, cycloserine remains the us fda preferred term for this commodity. cycloserine bears us nlm identifiers umls id c0010590 and nci concept code c47466. smiles: o1nc(=o)c(n)c1.. "
"oxazolidinones. this classification denotes antibiotics which are derivatives of oxazolidin-2-one (hence the name oxazolidin-one, oxazolidin-ones, and oxazolidinones) and are oxazoles and azoles.. eperezolid. this classification denotes an antibiotic with the molecular formula c18h23fn4o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier c460zsu1ow, chemically known as acetamide, n-((3-(3-fluoro-4-(4-(hydroxyacetyl)-1-piperazynyl)phenyl)- 2-oxo-5-oxazolidinyl)methyl)-, (s)- but generally known as eperezolid, which bears us nih compound identifier 73214. european medicines agency schedules eperezolid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06559mig. the term eperezolid is an international non-proprietary name. eperezolid is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule eperezolid under hs 29349990 and sitc 51579. as of q4 2014, eperezolid remains the us fda preferred term for this commodity. eperezolid bears us nlm identifiers umls id c0663242 and nci concept code c81444. smiles: fc1c(n2ccn(cc2)c(=o)co)ccc(n2cc(oc2=o)cnc(=o)c)c1.. "
"oxazolidinones. this classification denotes antibiotics which are derivatives of oxazolidin-2-one (hence the name oxazolidin-one, oxazolidin-ones, and oxazolidinones) and are oxazoles and azoles.. linezolid. this classification denotes an antibiotic with the molecular formula c16h20fn3o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier isq9i6j12j, chemically known as acetamide, n-(((5s)-3-(3-fluoro-4-(4-morpholinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl)- but generally known as linezolid, which bears us nih compound identifier 73180. european medicines agency schedules linezolid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08520mig. the term linezolid is an international non-proprietary name or inn (see who inn reference publication, volume 11, no. 3 1997, list 38). world health organization schedules linezolid in its anatomical therapeutic chemical (atc) classification. linezolid is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule linezolid under hs 29349990 and sitc 51579. as of q4 2014, linezolid remains the us fda preferred term for this commodity. linezolid bears us nlm identifiers umls id c0663241 and nci concept code c29158. smiles: fc1c(n2ccocc2)ccc(n2cc(oc2=o)cnc(=o)c)c1.. "
"oxazolidinones. this classification denotes antibiotics which are derivatives of oxazolidin-2-one (hence the name oxazolidin-one, oxazolidin-ones, and oxazolidinones) and are oxazoles and azoles.. cycloserine tartrate. this classification denotes an antitubercular agent with the molecular formula c4h6o6.c3h6n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 24ez3l1e6s. most nations, for tariff and trade purposes, schedule cycloserine tartrate under hs 29419000. as of q4 2014, cycloserine tartrate remains us fdas preferred term for this commodity. smiles: c1[c@h](c(=o)no1)n.[c@@h]([c@h](c(=o)o)o)(c(=o)o)o.. "
"oxazolidinones. this classification denotes antibiotics which are derivatives of oxazolidin-2-one (hence the name oxazolidin-one, oxazolidin-ones, and oxazolidinones) and are oxazoles and azoles.. levofuraltadone. this classification denotes an antimicrobial solution, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier v6h66n6udu. european medicines agency schedules levofuraltadone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08472mig. levofuraltadone generally arises in the molecular formula c13h16n4o6. the term levofuraltadone is an international non-proprietary name or inn (see world health organization inn reference publication, volume 21 no. 12 1967, list 7.) levofuraltadone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: o1c(cn2ccocc2)cn(/n=c/c2oc([n](=o)o)cc2)c1=o.. "
"oxazolidinones. this classification denotes antibiotics which are derivatives of oxazolidin-2-one (hence the name oxazolidin-one, oxazolidin-ones, and oxazolidinones) and are oxazoles and azoles.. levofuraltadone hydrochloride. this classification denotes an antimicrobial solution c13h16n4o6.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier zia9bc2jjr, chemically known as furaltadone hydrochloride, l-, but more generally known as levofuraltadone hydrochloride, which bears us nih compound identifier 56840909. most nations schedule levofuraltadone hydrochloride under hs 29349990 and sitc 51579. as of q4 2014, levofuraltadone hydrochloride remains the us fda preferred term for this commodity. smiles: c1cc(oc1/c=n/n2c[c@@h](oc2=o)cn3ccocc3)[n+](=o)[o-].cl.. "
"oxazolidinones. this classification denotes antibiotics which are derivatives of oxazolidin-2-one (hence the name oxazolidin-one, oxazolidin-ones, and oxazolidinones) and are oxazoles and azoles.. tedizolid. a type of antibacterial drug indicated for treatment of acute bacterial skin and skin structure infections by susceptible bacteria.. "
"penicillins. this classification denotes a group of antibiotics that contain 6-aminopenicillanic acid (hence the name penicillin) with a side chain attached to the 6-amino group. the penicillin nucleus is the chief structural requirement for biological activity. the side-chain structure determines many of the antibacterial and pharmacological characteristics.. . "
"penicillins. this classification denotes a group of antibiotics that contain 6-aminopenicillanic acid (hence the name penicillin) with a side chain attached to the 6-amino group. the penicillin nucleus is the chief structural requirement for biological activity. the side-chain structure determines many of the antibacterial and pharmacological characteristics.. penicillin o. this classification denotes a penicillin antibiotic with the molecular formula c13h18n2o4s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6246wh0s1o, chemically known as sodium (2s-(2alpha,5alpha,6beta))-6-((allylthio)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate but generally known as almecillin, which bears us nih compound identifier 23569. european medicines agency schedules almecillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05345mig. the term almecillin is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 2 1999, list 40). almecillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2nc(=o)cscc=c.[na].. "
"penicillins. this classification denotes a group of antibiotics that contain 6-aminopenicillanic acid (hence the name penicillin) with a side chain attached to the 6-amino group. the penicillin nucleus is the chief structural requirement for biological activity. the side-chain structure determines many of the antibacterial and pharmacological characteristics.. adicillin or penicillin n. this classification denotes a penicillin antibiotic with the molecular formula c14h21n3o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier nof9u9eyq4, chemically known as 6-(5-amino-5-carboxyvaleramido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid but generally known as adicillin, which bears us nih compound identifier 71724. european medicines agency schedules adicillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05269mig. the term adicillin is an international non-proprietary name. adicillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. adicillin or penicillin n bears us nlm identifiers umls id c0070233 and nci concept code c72659. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2nc(=o)cccc(n)c(=o)o.. "
"penicillins. this classification denotes a group of antibiotics that contain 6-aminopenicillanic acid (hence the name penicillin) with a side chain attached to the 6-amino group. the penicillin nucleus is the chief structural requirement for biological activity. the side-chain structure determines many of the antibacterial and pharmacological characteristics.. apalcillin. this classification denotes a penicillin antibiotic with the molecular formula c25h23n5o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3373rt9u7a, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((((4-hydroxy-1,5-naphthyridin-3-yl)carbonyl)amino)phenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2s-(2-alpha,5-alpha,6-beta(s*)))- but generally known as apalcillin, which bears us nih compound identifier 107947. apalcillin most often comes in base and sodium forms. european medicines agency schedules apalcillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05535mig. the term apalcillin is an international non-proprietary name. apalcillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule apalcillin under hs 29411090 and sitc 54131. as of q4 2014, apalcillin remains the us fda preferred term for this commodity. apalcillin bears us nlm identifiers umls id c0052145 and nci concept code c76217. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2nc(=o)c(nc(=o)c1c(=o)c2ncccc2[nh]c1)c1ccccc1.. "
"penicillins. this classification denotes a group of antibiotics that contain 6-aminopenicillanic acid (hence the name penicillin) with a side chain attached to the 6-amino group. the penicillin nucleus is the chief structural requirement for biological activity. the side-chain structure determines many of the antibacterial and pharmacological characteristics.. carfecillin. this classification denotes a urinary anti-infective agent and penicillin with the molecular formula c23h22n2o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9uu4xdb74x, chemically known as 6-((1,3-dioxo-3-phenoxy-2-phenylpropyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid (2s-(2alpha,5alpha,6beta))- but generally known as carfecillin, which bears us nih compound identifier 33672. carfecillin most often comes in base, phenyl, phenyl sodium, and sodium forms. european medicines agency schedules carfecillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06624mig. world health organization schedules carfecillin in its anatomical therapeutic chemical (atc) classification. most nations schedule carfecillin under hs 29411090 and sitc 54131. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2nc(=o)c(c1ccccc1)c(=o)oc1ccccc1.. "
"penicillins. this classification denotes a group of antibiotics that contain 6-aminopenicillanic acid (hence the name penicillin) with a side chain attached to the 6-amino group. the penicillin nucleus is the chief structural requirement for biological activity. the side-chain structure determines many of the antibacterial and pharmacological characteristics.. benzylpenicillin or penicillin g. this classification denotes a penicillin antibiotic with the molecular formula c16h18n2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q42t66vg0c, chemically known as penicillin, (phenylmethyl)- but generally known as benzylpenicillin, which bears us nih compound identifier 2349. benzylpenicillin comes in many forms, including base, benzathine, benzathine hydrate, beta-diethylaminoethyl ester, dibenzylethylenediamine salt, g, novocaine salt, potassium, procaine, procaine monohydrate, and sodium. european medicines agency schedules benzylpenicillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05772mig. the term benzylpenicillin is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). world health organization schedules benzylpenicillin in its anatomical therapeutic chemical (atc) classification. benzylpenicillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. benzylpenicillin or penicillin g bears us nlm identifiers umls id c0030827 and nci concept code c61883. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2nc(=o)cc1ccccc1.. "
"penicillins. this classification denotes a group of antibiotics that contain 6-aminopenicillanic acid (hence the name penicillin) with a side chain attached to the 6-amino group. the penicillin nucleus is the chief structural requirement for biological activity. the side-chain structure determines many of the antibacterial and pharmacological characteristics.. penicillin v or phenoxymethylpenicillin. this classification denotes a penicillin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier z61i075u2w. european medicines agency schedules penicillin v in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09779mig. penicillin v generally arises in the molecular formula c16h18n2o5s. the term penicillin v is a european pharmacopoeia designation. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2nc(=o)coc1ccccc1.. "
"penicillins. this classification denotes a group of antibiotics that contain 6-aminopenicillanic acid (hence the name penicillin) with a side chain attached to the 6-amino group. the penicillin nucleus is the chief structural requirement for biological activity. the side-chain structure determines many of the antibacterial and pharmacological characteristics.. pheneticillin or phenethicillin. this classification denotes a penicillin v analog and anti-bacterial agent with the molecular formula c17h20n2o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier efa30x554h, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(2-phenoxypropionamido)- but generally known as pheneticillin, which bears us nih compound identifier 4759. european medicines agency schedules pheneticillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09759mig. world health organization schedules pheneticillin in its anatomical therapeutic chemical (atc) classification. pheneticillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2nc(=o)c(oc1ccccc1)c.. "
"penicillins. this classification denotes a group of antibiotics that contain 6-aminopenicillanic acid (hence the name penicillin) with a side chain attached to the 6-amino group. the penicillin nucleus is the chief structural requirement for biological activity. the side-chain structure determines many of the antibacterial and pharmacological characteristics.. prazocillin. this classification denotes a penicillin antibiotic with the molecular formula c19h18cl2n4o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier irz1462xxf, chemically known as 6-(1-(2,6-dichlorophenyl)-4-methylpyrazole-5-carboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid but generally known as prazocillin, which bears us nih compound identifier 65622. european medicines agency schedules prazocillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10010mig. the term prazocillin is an international non-proprietary name or inn (see who inn reference publication, volume 28, no. 10 1974, list 14). prazocillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule prazocillin under hs 29411090 and sitc 54131. as of q4 2014, prazocillin remains the us fda preferred term for this commodity. prazocillin bears us nlm identifiers umls id c0071817 and nci concept code c72832. smiles: clc1c(n2ncc(c2c(=o)nc2c3sc(c(n3c2=o)c(=o)o)(c)c)c)c(cl)ccc1.. "
"penicillins. this classification denotes a group of antibiotics that contain 6-aminopenicillanic acid (hence the name penicillin) with a side chain attached to the 6-amino group. the penicillin nucleus is the chief structural requirement for biological activity. the side-chain structure determines many of the antibacterial and pharmacological characteristics.. procaine benzylpenicillin or procaine penicillin g. this classification denotes a penicillin antibiotic with the molecular formula c16h18n2o4s.c13h20n2o2.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 17r794esyn. european medicines agency schedules procaine benzylpenicillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub26570. the term penicillin g procaine is a u.s. fda designation. smiles: ccn(cc)ccoc(=o)c1=cc=c(c=c1)n.cc1(c(n2c(s1)c(c2=o)nc(=o)cc3=cc=cc=c3)c(=o)o)c.o.. "
"penicillins. this classification denotes a group of antibiotics that contain 6-aminopenicillanic acid (hence the name penicillin) with a side chain attached to the 6-amino group. the penicillin nucleus is the chief structural requirement for biological activity. the side-chain structure determines many of the antibacterial and pharmacological characteristics.. sarpicillin. this classification denotes a penicillin antibiotic with the molecular formula c21h27n3o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier o70j1ge4yb, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2,2-dimethyl-5-oxo-4-phenyl-1-imidazolidinyl)-3,3-dimethyl-7-oxo-, (2s-(2alpha,5alpha,6beta))-, methoxymethyl ester but generally known as sarpicillin, which bears us nih compound identifier 65429. european medicines agency schedules sarpicillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10454mig. the term sarpicillin is an international non-proprietary name. sarpicillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sarpicillin under hs 29411090 and sitc 54131. as of q4 2014, sarpicillin remains the us fda preferred term for this commodity. sarpicillin bears us nlm identifiers umls id c0074076 and nci concept code c90914. smiles: s1c2n(c(c1(c)c)c(=o)ococ)c(=o)c2n1c(nc(c1=o)c1ccccc1)(c)c.. "
"penicillins. this classification denotes a group of antibiotics that contain 6-aminopenicillanic acid (hence the name penicillin) with a side chain attached to the 6-amino group. the penicillin nucleus is the chief structural requirement for biological activity. the side-chain structure determines many of the antibacterial and pharmacological characteristics.. piroxicillin. this classification denotes a penicillin antibiotic with the molecular formula c27h28n8o9s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hpi5a94gd9, chemically known as (2s,5r,6r)-6-((r)-2-(p-hydroxyphenyl)-2-(3-(4-hydroxy-2-(p-sulfamoylanilino)-5-pyrimidinyl)ureido)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid but generally known as piroxicillin, which bears us nih compound identifier 3047855. european medicines agency schedules piroxicillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09937mig. the term piroxicillin is an international non-proprietary name. piroxicillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule piroxicillin under hs 29411090 and sitc 54131. as of q4 2014, piroxicillin remains the us fda preferred term for this commodity. piroxicillin bears us nlm identifiers umls id c2698824 and nci concept code c76857. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2nc(=o)c(nc(=o)nc1c(=o)[nh]c(nc1)nc1ccc(s(=o)(=o)n)cc1)c1ccc(o)cc1.. "
"penicillins. this classification denotes a group of antibiotics that contain 6-aminopenicillanic acid (hence the name penicillin) with a side chain attached to the 6-amino group. the penicillin nucleus is the chief structural requirement for biological activity. the side-chain structure determines many of the antibacterial and pharmacological characteristics.. apalcillin sodium. this classification denotes a penicillin antibiotic with the molecular formula c25h22n5o6s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3xq12nyc0q, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((((4-hydroxy-1,5-naphthyridin-3-yl)carbonyl)amino)phenylacetyl)amino)-3,3-dimethyl-7-oxo-, monosodium salt, (2s-(2alpha,5alpha,6beta(s*)))- but more generally known as apalcillin sodium, which bears us nih compound identifier 42834. european medicines agency schedules apalcillin sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00556mig. most nations, for tariff and trade purposes, schedule apalcillin sodium under hs 29411090 and sitc 54131. as of q4 2014, apalcillin sodium remains us fdas preferred term for this commodity. apalcillin sodium bears us nlm identifiers umls id c0771721 and nci concept code c76218. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)[c@@h](c3ccccc3)nc(=o)c4cnc5cccnc5c4o)c(=o)[o-])c.[na+].. "
"penicillins. this classification denotes a group of antibiotics that contain 6-aminopenicillanic acid (hence the name penicillin) with a side chain attached to the 6-amino group. the penicillin nucleus is the chief structural requirement for biological activity. the side-chain structure determines many of the antibacterial and pharmacological characteristics.. rotamicillin. this classification denotes a penicillin antibiotic with the molecular formula c28h31n5o5s, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier js13873052, chemically known as (2s,5r,6r)-3,3-dimethyl-7-oxo-6-((r)-2-phenyl-2-(2-(4-(1,4,5,6-tetrahydro-2-pyrimidinyl)phenyl)acetamido(acetamido-4-thia-1-azabicyclo(3.2.0)heptan-2-carboxylic acid but more generally known as rotamicillin, which bears u.s. national institutes of health compound identifier 3058737. the european medicines agency schedules rotamicillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10391mig. the term rotamicillin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 30, no. 10 1976, list 16). rotamicillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2nc(=o)c(nc(=o)cc1ccc(c2=ncccn2)cc1)c1ccccc1.. "
"penicillins. this classification denotes a group of antibiotics that contain 6-aminopenicillanic acid (hence the name penicillin) with a side chain attached to the 6-amino group. the penicillin nucleus is the chief structural requirement for biological activity. the side-chain structure determines many of the antibacterial and pharmacological characteristics.. benzylpenicillin potassium. this classification denotes a penicillin antibiotic with the molecular formula c16h17n2o4s.k, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier vl775zth4c. european medicines agency schedules benzylpenicillin potassium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13036mig. the term benzylpenicillin potassium is a european pharmacopoeia designation. most nations, for tariff and trade purposes, schedule benzylpenicillin potassium under hs 29411090. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)cc3ccccc3)c(=o)[o-])c.[k+].. "
"penicillins. this classification denotes a group of antibiotics that contain 6-aminopenicillanic acid (hence the name penicillin) with a side chain attached to the 6-amino group. the penicillin nucleus is the chief structural requirement for biological activity. the side-chain structure determines many of the antibacterial and pharmacological characteristics.. tobicillin. this classification denotes a penicillin antibiotic, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 2p43z53esb. the european medicines agency schedules tobicillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11132mig. tobicillin generally arises in the molecular formula c27h30n2o6s. the term tobicillin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 12 no. 2 1999, list 40.) tobicillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s1c2n(c(c1(c)c)c(=o)oc1cc(ccc1)coc(=o)c(c)c)c(=o)c2nc(=o)cc1ccccc1.. "
"penicillins. this classification denotes a group of antibiotics that contain 6-aminopenicillanic acid (hence the name penicillin) with a side chain attached to the 6-amino group. the penicillin nucleus is the chief structural requirement for biological activity. the side-chain structure determines many of the antibacterial and pharmacological characteristics.. benzylpenicillin sodium. this classification denotes a penicillin antibiotic with the molecular formula c16h17n2o4s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ys5ly7jf4n, chemically known as penicillin, (phenylmethyl)- but more generally known as benzylpenicillin sodium, which bears us nih compound identifier 2349. european medicines agency schedules benzylpenicillin sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13038mig. most nations, for tariff and trade purposes, schedule benzylpenicillin sodium under hs 29411090. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)cc3ccccc3)c(=o)[o-])c.[na+].. "
"penicillins. this classification denotes a group of antibiotics that contain 6-aminopenicillanic acid (hence the name penicillin) with a side chain attached to the 6-amino group. the penicillin nucleus is the chief structural requirement for biological activity. the side-chain structure determines many of the antibacterial and pharmacological characteristics.. carfecillin sodium. this classification denotes a penicillin antibiotic with the molecular formula c23h21n2o6s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 18n5jp36gy, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((1,3-dioxo-3-phenoxy-2-phenylpropyl)amino)-3,3-dimethyl-7-oxo-, monosodium salt, (2s-(2alpha,5alpha,6beta))- but more generally known as carbenicillin phenyl sodium, which bears us nih compound identifier 30728. the base compound, carbenicillin, comes in many other forms, including base, disodium, indanyl, indanyl potassium, indanyl sodium, phenyl, phenyl ester, potassium, and sodium. european medicines agency schedules carfecillin sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01058mig. most nations, for tariff and trade purposes, schedule carfecillin sodium under hs 29411090 and sitc 54131. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)c(c3ccccc3)c(=o)oc4ccccc4)c(=o)[o-])c.[na+].. "
"penicillins. this classification denotes a group of antibiotics that contain 6-aminopenicillanic acid (hence the name penicillin) with a side chain attached to the 6-amino group. the penicillin nucleus is the chief structural requirement for biological activity. the side-chain structure determines many of the antibacterial and pharmacological characteristics.. pheneticillin potassium. this classification denotes a penicillin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 70978wuk7c. european medicines agency schedules pheneticillin potassium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03742mig. pheneticillin potassium generally arises in the molecular formula c17h20n2o5s.k. the term pheneticillin potassium is a hazardous substances data bank designation. most nations, for tariff and trade purposes, schedule pheneticillin potassium under hs 29411090. smiles: cc(c(=o)n[c@h]1[c@@h]2n(c1=o)[c@h](c(s2)(c)c)c(=o)[o-])oc3ccccc3.[k+].. "
"penicillins. this classification denotes a group of antibiotics that contain 6-aminopenicillanic acid (hence the name penicillin) with a side chain attached to the 6-amino group. the penicillin nucleus is the chief structural requirement for biological activity. the side-chain structure determines many of the antibacterial and pharmacological characteristics.. phenoxymethylpenicillin calcium. this classification denotes a penicillin antibiotic 2c16h17n2o5s.ca, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3750yh4nm7, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenoxyacetyl)amino)-, calcium salt (2:1), (2s,5r,6r)-, but more generally known as phenoxymethylpenicillin calcium, which bears us nih compound identifier 46174101. european medicines agency schedules phenoxymethylpenicillin calcium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03764mig. most nations, for tariff and trade purposes, schedule phenoxymethylpenicillin calcium under hs 29411090 and sitc 54131. as of q4 2014, phenoxymethylpenicillin calcium remains us fdas preferred term for this commodity. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)coc3ccccc3)c(=o)[o-])c.cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)coc3ccccc3)c(=o)[o-])c.[ca+2].. "
"penicillins. this classification denotes a group of antibiotics that contain 6-aminopenicillanic acid (hence the name penicillin) with a side chain attached to the 6-amino group. the penicillin nucleus is the chief structural requirement for biological activity. the side-chain structure determines many of the antibacterial and pharmacological characteristics.. phenoxymethylpenicillin potassium. this classification denotes a penicillin antibiotic with the molecular formula c16h17n2o5s.k, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 146t0tu1jb. european medicines agency schedules phenoxymethylpenicillin potassium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03766mig. the term penicillin v potassium is a european pharmacopoeia designation. most nations, for tariff and trade purposes, schedule phenoxymethylpenicillin potassium under hs 29411090. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)coc3ccccc3)c(=o)[o-])c.[k+].. "
"penicillins. this classification denotes a group of antibiotics that contain 6-aminopenicillanic acid (hence the name penicillin) with a side chain attached to the 6-amino group. the penicillin nucleus is the chief structural requirement for biological activity. the side-chain structure determines many of the antibacterial and pharmacological characteristics.. fenbenicillin. this classification denotes a penicillin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 641eda6x6l. european medicines agency schedules fenbenicillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07542mig. fenbenicillin generally arises in the molecular formula c22h22n2o5s. the term fenbenicillin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5.) fenbenicillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2nc(=o)c(oc1ccccc1)c1ccccc1.. "
"penicillins. this classification denotes a group of antibiotics that contain 6-aminopenicillanic acid (hence the name penicillin) with a side chain attached to the 6-amino group. the penicillin nucleus is the chief structural requirement for biological activity. the side-chain structure determines many of the antibacterial and pharmacological characteristics.. fumoxicillin. this classification denotes a penicillin antibiotic with the molecular formula c21h21n3o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier c7h9m9492j, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((((2-furanylmethylene)amino)(4-hydroxyphenyl)acetyl)amino)-3,3-dimethyl-7-oxo-, (2s-(2alpha,5alpha,6beta(s*)))- but more generally known as fumoxicillin, which bears us nih compound identifier 72000. european medicines agency schedules fumoxicillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07826mig. the term fumoxicillin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 38, no. 6, 1984, list 24). fumoxicillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2nc(=o)c(/n=c/c1occc1)c1ccc(o)cc1.. "
"penicillins. this classification denotes a group of antibiotics that contain 6-aminopenicillanic acid (hence the name penicillin) with a side chain attached to the 6-amino group. the penicillin nucleus is the chief structural requirement for biological activity. the side-chain structure determines many of the antibacterial and pharmacological characteristics.. oxetacillin. this classification denotes a penicillin antibiotic with the molecular formula c19h23n3o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 47udj8ga54, chemically known as (2s,5r,6r)-6-((r)-(4-(p-hydroxyphenyl)-2,2-dimethyl-5-oxo-1-imidazolidinyl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid but more generally known as oxetacillin, which bears us nih compound identifier 6367080. european medicines agency schedules oxetacillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09517mig. the term oxetacillin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 29, no. 10 1975, list 15). oxetacillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2[nh]1c(nc(c1=o)c1ccc(o)cc1)(c)c.. "
"penicillinase-resistant penicillins. this classification denotes highly-target-specific, second-generation penicillins chiefly employed against staphylococcal infections, especially against staphylococcus aureus, and which are not rendered inactive by penicillinas, a beta-lactamase or bacteria-produced enzyme preferentially cleaving penicillins.. . "
"penicillinase-resistant penicillins. this classification denotes highly-target-specific, second-generation penicillins chiefly employed against staphylococcal infections, especially against staphylococcus aureus, and which are not rendered inactive by penicillinas, a beta-lactamase or bacteria-produced enzyme preferentially cleaving penicillins.. cloxacillin. this classification denotes a penicillin antibiotic with the molecular formula c19h18cln3o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier o6x5qgc2vb, chemically known as 6-(((3-(2-chlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid but generally known as cloxacillin, which bears us nih compound identifier 6098. european medicines agency schedules cloxacillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06780mig. the term cloxacillin is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules cloxacillin in its anatomical therapeutic chemical (atc) classification. cloxacillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cloxacillin under hs 29411090 and sitc 54131. as of q4 2014, cloxacillin remains the us fda preferred term for this commodity. cloxacillin bears us nlm identifiers umls id c0009077 and nci concept code c61688. smiles: clc1c(c2noc(c2c(=o)nc2c3sc(c(n3c2=o)c(=o)o)(c)c)c)cccc1.. "
"penicillinase-resistant penicillins. this classification denotes highly-target-specific, second-generation penicillins chiefly employed against staphylococcal infections, especially against staphylococcus aureus, and which are not rendered inactive by penicillinas, a beta-lactamase or bacteria-produced enzyme preferentially cleaving penicillins.. dicloxacillin. this classification denotes a penicillin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier cof19h7wbk. european medicines agency schedules dicloxacillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07099mig. dicloxacillin generally arises in the molecular formula c19h17cl2n3o5s. the term dicloxacillin is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7.) dicloxacillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dicloxacillin under hs 29411090 and sitc 54131. as of q4 2014, dicloxacillin remains the us fda preferred term for this commodity. dicloxacillin bears us nlm identifiers umls id c0012093 and nci concept code c28986. smiles: clc1c(c2noc(c2c(=o)nc2c3sc(c(n3c2=o)c(=o)o)(c)c)c)c(cl)ccc1.. "
"penicillinase-resistant penicillins. this classification denotes highly-target-specific, second-generation penicillins chiefly employed against staphylococcal infections, especially against staphylococcus aureus, and which are not rendered inactive by penicillinas, a beta-lactamase or bacteria-produced enzyme preferentially cleaving penicillins.. methicillin or meticillin. this classification denotes a penicillin antibiotic with the molecular formula c17h20n2o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q91fh1328a, chemically known as 6-(2,6-dimethoxybenzamido)penicillanic acid but generally known as methicillin, which bears us nih compound identifier 6087. european medicines agency schedules meticillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08885mig. the term meticillin is an international non-proprietary name or inn (see who inn reference publication, volume 14, no. 1, 2000, list 43). world health organization schedules methicillin in its anatomical therapeutic chemical (atc) classification. methicillin or meticillin bears us nlm identifiers umls id c0025643 and nci concept code c61842. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)c3=c(c=cc=c3oc)oc)c(=o)o)c.. "
"penicillinase-resistant penicillins. this classification denotes highly-target-specific, second-generation penicillins chiefly employed against staphylococcal infections, especially against staphylococcus aureus, and which are not rendered inactive by penicillinas, a beta-lactamase or bacteria-produced enzyme preferentially cleaving penicillins.. nafcillin. this classification denotes a beta-lactam antibiotic with the molecular formula c21h22n2o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4cnz27m7rv, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-ethoxy-1-naphthamido)-3,3-dimethyl-7-oxo- but generally known as nafcillin, which bears us nih compound identifier 8982. european medicines agency schedules nafcillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09118mig. the term nafcillin is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). nafcillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nafcillin under hs 29411090 and sitc 54131. as of q4 2014, nafcillin remains the us fda preferred term for this commodity. nafcillin bears us nlm identifiers umls id c0027324 and nci concept code c62053. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2nc(=o)c1c2c(ccc1occ)cccc2.. "
"penicillinase-resistant penicillins. this classification denotes highly-target-specific, second-generation penicillins chiefly employed against staphylococcal infections, especially against staphylococcus aureus, and which are not rendered inactive by penicillinas, a beta-lactamase or bacteria-produced enzyme preferentially cleaving penicillins.. oxacillin. this classification denotes a penicillin antibiotic with the molecular formula c19h19n3o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier uh95vd7v76, chemically known as 5-methyl-3-phenyl-4-isoxazolyl penicillin, sodium but generally known as oxacillin, which bears us nih compound identifier 4608. european medicines agency schedules oxacillin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09484mig. the term oxacillin is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24). world health organization schedules oxacillin in its anatomical therapeutic chemical (atc) classification. oxacillin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule oxacillin under hs 29411090 and sitc 54131. as of q4 2014, oxacillin remains the us fda preferred term for this commodity. oxacillin bears us nlm identifiers umls id c0029983 and nci concept code c62063. smiles: s1c2n(c(c1(c)c)c(=o)o)c(=o)c2nc(=o)c1c(noc1c)c1ccccc1.. "
"penicillinase-resistant penicillins. this classification denotes highly-target-specific, second-generation penicillins chiefly employed against staphylococcal infections, especially against staphylococcus aureus, and which are not rendered inactive by penicillinas, a beta-lactamase or bacteria-produced enzyme preferentially cleaving penicillins.. cloxacillin benzathine. this classification denotes a penicillin antibiotic with the molecular formula 2c19h18cln3o5s.c16h20n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ac79l7pv2g, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((3-(2-chlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, (2s-(2.alpha.,5.alpha.,6.beta.))-, compd. with n,n-bis(phenylmethyl)-1,2-ethanediamine (2:1), but more generally known as cloxacillin benzathine, which bears us nih compound identifier 64706. european medicines agency schedules cloxacillin benzathine or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06780mig. most nations, for tariff purposes, schedule cloxacillin benzathine under hs 29411090. cloxacillin benzathine bears us nlm identifiers umls id c0053154 and nci concept code c76854. smiles: cc1c(c(no1)c2ccccc2cl)c(=o)n[c@h]3[c@@h]4n(c3=o)[c@h](c(s4)(c)c)c(=o)o.cc1c(c(no1)c2ccccc2cl)c(=o)n[c@h]3[c@@h]4n(c3=o)[c@h](c(s4)(c)c)c(=o)o.c1ccc(cc1)cnccncc2ccccc2.. "
"penicillinase-resistant penicillins. this classification denotes highly-target-specific, second-generation penicillins chiefly employed against staphylococcal infections, especially against staphylococcus aureus, and which are not rendered inactive by penicillinas, a beta-lactamase or bacteria-produced enzyme preferentially cleaving penicillins.. cloxacillin sodium. this classification denotes a penicillin antibiotic with the molecular formula c19h17cln3o5s.na.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 65lcb00b4y, chemically known as 6-(((3-(2-chlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid but more generally known as cloxacillin sodium, which bears us nih compound identifier 6098. european medicines agency schedules cloxacillin sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13400mig. most nations, for tariff and trade purposes, schedule cloxacillin sodium under hs 29411090 and sitc 54131. as of q4 2014, cloxacillin sodium remains us fdas preferred term for this commodity. cloxacillin sodium bears us nlm identifiers umls id c0037496 and nci concept code c47460. smiles: cc1c(c(no1)c2ccccc2cl)c(=o)n[c@h]3[c@@h]4n(c3=o)[c@h](c(s4)(c)c)c(=o)[o-].o.[na+].. "
"penicillinase-resistant penicillins. this classification denotes highly-target-specific, second-generation penicillins chiefly employed against staphylococcal infections, especially against staphylococcus aureus, and which are not rendered inactive by penicillinas, a beta-lactamase or bacteria-produced enzyme preferentially cleaving penicillins.. cloxacillin sodium anhydrous. this classification denotes a penicillin antibiotic c19h17cln3o5s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier mwq645mkmf, chemically known as cloxacillin sodium, anhydrous, but more generally known as cloxacillin sodium anhydrous, which bears us nih compound identifier 23675320. most nations, for tariff and trade purposes, schedule cloxacillin sodium anhydrous under hs 29411090 and sitc 54131. as of q4 2014, cloxacillin sodium anhydrous remains us fdas preferred term for this commodity. cloxacillin sodium anhydrous bears us nlm identifiers umls id c2699387 and nci concept code c76222. smiles: cc1c(c(no1)c2ccccc2cl)c(=o)n[c@h]3[c@@h]4n(c3=o)[c@h](c(s4)(c)c)c(=o)[o-].[na+].. "
"penicillinase-resistant penicillins. this classification denotes highly-target-specific, second-generation penicillins chiefly employed against staphylococcal infections, especially against staphylococcus aureus, and which are not rendered inactive by penicillinas, a beta-lactamase or bacteria-produced enzyme preferentially cleaving penicillins.. dicloxacillin sodium. this classification denotes a penicillin antibiotic with the molecular formula c19h16cl2n3o5s.na.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4hzt2v9kx0, chemically known as monosodium (2s,5r,6r)-6-(3-(2,6-dichlorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate monohydrate, but more generally known as dicloxacillin sodium, which bears us nih compound identifier 6098. european medicines agency schedules dicloxacillin sodium or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07099mig. most nations, for tariff purposes, schedule dicloxacillin sodium under hs 29411090. as of q4 2014, dicloxacillin sodium remains us fdas preferred term for this commodity. dicloxacillin sodium bears us nlm identifiers umls id c0887422 and nci concept code c47985. smiles: cc1c(c(no1)c2c(cccc2cl)cl)c(=o)n[c@h]3[c@@h]4n(c3=o)[c@h](c(s4)(c)c)c(=o)[o-].o.[na+].. "
"penicillinase-resistant penicillins. this classification denotes highly-target-specific, second-generation penicillins chiefly employed against staphylococcal infections, especially against staphylococcus aureus, and which are not rendered inactive by penicillinas, a beta-lactamase or bacteria-produced enzyme preferentially cleaving penicillins.. dicloxacillin sodium anhydrous. this classification denotes a penicillin antibiotic with the molecular formula c19h16cl2n3o5s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4cks6mol6z, chemically known as monosodium (2s,5r,6r)-6-(3-(2,6-dichlorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate, but more generally known as dicloxacillin sodium anhydrous, which bears us nih compound identifier 64688. european medicines agency schedules dicloxacillin sodium anhydrous or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07099mig. most nations, for tariff purposes, schedule dicloxacillin sodium anhydrous under hs 29411090. smiles: cc1c(c(no1)c2c(cccc2cl)cl)c(=o)n[c@h]3[c@@h]4n(c3=o)[c@h](c(s4)(c)c)c(=o)[o-].[na+].. "
"penicillinase-resistant penicillins. this classification denotes highly-target-specific, second-generation penicillins chiefly employed against staphylococcal infections, especially against staphylococcus aureus, and which are not rendered inactive by penicillinas, a beta-lactamase or bacteria-produced enzyme preferentially cleaving penicillins.. dicloxacillin sodium monohydrate. this classification denotes a penicillin antibiotic with the molecular formula c19h16cl2n3o5s.na.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4hzt2v9kx0, chemically known as 6-(((3-(2-chlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid but more generally known as dicloxacillin sodium, which bears us nih compound identifier 6098. european medicines agency schedules dicloxacillin sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11900mig. most nations, for tariff and trade purposes, schedule dicloxacillin sodium monohydrate under hs 29411090 and sitc 54131. smiles: cc1c(c(no1)c2c(cccc2cl)cl)c(=o)n[c@h]3[c@@h]4n(c3=o)[c@h](c(s4)(c)c)c(=o)[o-].o.[na+].. "
"penicillinase-resistant penicillins. this classification denotes highly-target-specific, second-generation penicillins chiefly employed against staphylococcal infections, especially against staphylococcus aureus, and which are not rendered inactive by penicillinas, a beta-lactamase or bacteria-produced enzyme preferentially cleaving penicillins.. meticillin sodium. this classification denotes a penicillin antibiotic with the molecular formula c17h19n2o6s.na.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ao9yf4mn30, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((2,6-dimethoxybenzoyl)amino)-3,3-dimethyl-7-oxo-, monosodium salt, monohydrate, (2s-(2alpha,5alpha,6beta))- but more generally known as methicillin sodium, which bears us nih compound identifier 23675. european medicines agency schedules meticillin sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03264mig. most nations, for tariff and trade purposes, schedule meticillin sodium under hs 29411090. smiles: cc1([c@@h](n2[c@h](s1)[c@@h](c2=o)nc(=o)c3c(cccc3oc)oc)c(=o)[o-])c.[na+].. "
"penicillinase-resistant penicillins. this classification denotes highly-target-specific, second-generation penicillins chiefly employed against staphylococcal infections, especially against staphylococcus aureus, and which are not rendered inactive by penicillinas, a beta-lactamase or bacteria-produced enzyme preferentially cleaving penicillins.. nafcillin sodium. this classification denotes an anti-bacterial agent with the molecular formula c21h21n2o5s.na.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 49g3001bck, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-ethoxy-1-naphthamido)-3,3-dimethyl-7-oxo- but more generally known as nafcillin sodium, which bears us nih compound identifier 8982. european medicines agency schedules nafcillin sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03375mig. most nations, for tariff and trade purposes, schedule nafcillin sodium under hs 29411090 and sitc 54131. as of q4 2014, nafcillin sodium remains us fdas preferred term for this commodity. nafcillin sodium bears us nlm identifiers umls id c0037531 and nci concept code c29281. smiles: ccoc1ccc2ccccc2c1c(=o)n[c@h]3[c@@h]4n(c3=o)[c@h](c(s4)(c)c)c(=o)[o-].o.[na+].. "
"penicillinase-resistant penicillins. this classification denotes highly-target-specific, second-generation penicillins chiefly employed against staphylococcal infections, especially against staphylococcus aureus, and which are not rendered inactive by penicillinas, a beta-lactamase or bacteria-produced enzyme preferentially cleaving penicillins.. nafcillin sodium anhydrous. this classification denotes a beta-lactam antibiotic with the molecular formula c21h21n2o5s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier sy07234tts, chemically known as sodium 6-(2-ethoxy-1-naphthamido)penicillanate, but more generally known as nafcillin sodium anhydrous, which bears us nih compound identifier 64712. european medicines agency schedules nafcillin sodium anhydrous or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09118mig. most nations, for tariff purposes, schedule nafcillin sodium anhydrous under hs 29411090. nafcillin sodium anhydrous bears us nlm identifiers umls id c2698426 and nci concept code c76224. smiles: ccoc1ccc2ccccc2c1c(=o)n[c@h]3[c@@h]4n(c3=o)[c@h](c(s4)(c)c)c(=o)[o-].[na+].. "
"penicillinase-resistant penicillins. this classification denotes highly-target-specific, second-generation penicillins chiefly employed against staphylococcal infections, especially against staphylococcus aureus, and which are not rendered inactive by penicillinas, a beta-lactamase or bacteria-produced enzyme preferentially cleaving penicillins.. nafcillin sodium monohydrate. this classification denotes a beta-lactam antibiotic with the molecular formula c21h21n2o5s.na.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 49g3001bck, chemically known as monosodium (2s,5r,6r)-6-(2-ethoxy-1-naphthamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate monohydrate, but more generally known as nafcillin sodium monohydrate, which bears us nih compound identifier 5282391. european medicines agency schedules nafcillin sodium monohydrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09118mig. most nations, for tariff purposes, schedule nafcillin sodium monohydrate under hs 29411090. smiles: ccoc1ccc2ccccc2c1c(=o)n[c@h]3[c@@h]4n(c3=o)[c@h](c(s4)(c)c)c(=o)[o-].o.[na+].. "
"penicillinase-resistant penicillins. this classification denotes highly-target-specific, second-generation penicillins chiefly employed against staphylococcal infections, especially against staphylococcus aureus, and which are not rendered inactive by penicillinas, a beta-lactamase or bacteria-produced enzyme preferentially cleaving penicillins.. oxacillin sodium. this classification denotes an anti-bacterial agent with the molecular formula c19h18n3o5s.na.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g0v6c994q5, chemically known as 5-methyl-3-phenyl-4-isoxazolyl penicillin, sodium but more generally known as oxacillin sodium, which bears us nih compound identifier 4608. european medicines agency schedules oxacillin sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03559mig. most nations, for tariff and trade purposes, schedule oxacillin sodium under hs 29411090 and sitc 54131. as of q4 2014, oxacillin sodium remains us fdas preferred term for this commodity. oxacillin sodium bears us nlm identifiers umls id c0037536 and nci concept code c720. smiles: cc1c(c(no1)c2ccccc2)c(=o)n[c@h]3[c@@h]4n(c3=o)[c@h](c(s4)(c)c)c(=o)[o-].o.[na+].. "
"penicillinase-resistant penicillins. this classification denotes highly-target-specific, second-generation penicillins chiefly employed against staphylococcal infections, especially against staphylococcus aureus, and which are not rendered inactive by penicillinas, a beta-lactamase or bacteria-produced enzyme preferentially cleaving penicillins.. oxacillin sodium anhydrous. this classification denotes a penicillin antibiotic with the molecular formula c19h18n3o5s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4twd2995up, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-6-(((5-methyl-3-phenyl-4-isoxazolyl)carbonyl)amino)-7-oxo-, sodium salt (1:1), (2s,5r,6r)-, but more generally known as oxacillin sodium anhydrous, which bears us nih compound identifier 64714. european medicines agency schedules oxacillin sodium anhydrous or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09484mig. most nations, for tariff purposes, schedule oxacillin sodium anhydrous under hs 29411090. oxacillin sodium anhydrous bears us nlm identifiers umls id c2698675 and nci concept code c76225. smiles: cc1c(c(no1)c2ccccc2)c(=o)n[c@h]3[c@@h]4n(c3=o)[c@h](c(s4)(c)c)c(=o)[o-].[na+].. "
"rifamycin antibacterials. this classification denotes a group of anti-bacterial agents characterized by a chromophoric naphthohydroquinone group spanned by an aliphatic bridge not previously found in other known anti-bacterial agents, and they have been isolated from fermentation broths of streptomyces mediterranei.. . "
"rifamycin antibacterials. this classification denotes a group of anti-bacterial agents characterized by a chromophoric naphthohydroquinone group spanned by an aliphatic bridge not previously found in other known anti-bacterial agents, and they have been isolated from fermentation broths of streptomyces mediterranei.. rifampicin or rifampin. this classification denotes a rna polymerase inhibitor and antitubercular agent with the molecular formula c43h58n4o12, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier vjt6j7r4tr, chemically known as 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(n-(4-methyl-1-piperazinyl)formimidoyl)-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2h)-dione 21-acetate but generally known as rifampicin, which bears us nih compound identifier 5381226. european medicines agency schedules rifampicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10309mig. the term rifampicin is an international non-proprietary name or inn (see who inn reference publication, volume 22, no. 10, 1968, list 8). world health organization schedules rifampicin in its anatomical therapeutic chemical (atc) classification. rifampicin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. rifampicinn or rifampin bears us nlm nci c811. smiles: o(c1c(c(o)c(c(o)c(c)c=cc=c(c(=o)nc2=c(o)c3c(c4c(=o)c(oc=cc(oc)c1c)(oc4c(c3o)c)c)c(=o)/c2=c/nn1ccn(cc1)c)c)c)c)c(=o)c.. "
"rifamycin antibacterials. this classification denotes a group of anti-bacterial agents characterized by a chromophoric naphthohydroquinone group spanned by an aliphatic bridge not previously found in other known anti-bacterial agents, and they have been isolated from fermentation broths of streptomyces mediterranei.. rifamycin. this classification denotes an antitubercular agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier du69t8zzpa. european medicines agency schedules rifamycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10310mig. rifamycin generally arises in the molecular formula c37h47no12. the term rifamycin is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5.) rifamycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule rifamycin under hs 29419000 and sitc 54139. as of q4 2014, rifamycin remains the us fda preferred term for this commodity. rifamycin bears us nlm identifiers umls id c0035609 and nci concept code c29406. smiles: o([n](=o)o)c1c(c(o)c(c(o)c(c)c=cc=c(c(=o)cc2c(o)c3c(c4c(oc(oc=cc(oc)c1c)(c4=o)c)c(c3c)c)c(o)c2)c)c)c.. "
"rifamycin antibacterials. this classification denotes a group of anti-bacterial agents characterized by a chromophoric naphthohydroquinone group spanned by an aliphatic bridge not previously found in other known anti-bacterial agents, and they have been isolated from fermentation broths of streptomyces mediterranei.. rifapentine. this classification denotes an antitubercular agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier xjm390a33u. european medicines agency schedules rifapentine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10311mig. rifapentine generally arises in the molecular formula c47h64n4o12. the term rifapentine is an international non-proprietary name or inn (see who inn reference publication, volume 34, no. 10 1980, list 20.) rifapentine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule rifapentine under hs 29419000 and sitc 54139. as of q4 2014, rifapentine remains the us fda preferred term for this commodity. rifapentine bears us nlm identifiers umls id c0073372 and nci concept code c66516. smiles: o(c1c(c(o)c(c(o)c(c)c=cc=c(c(=o)nc2=c(o)c3c(c(=o)/c2=c/nn2ccn(c4cccc4)cc2)c2c(oc(oc=cc(oc)c1c)(c2=o)c)c(c3o)c)c)c)c)c(=o)c.. "
"rifamycin antibacterials. this classification denotes a group of anti-bacterial agents characterized by a chromophoric naphthohydroquinone group spanned by an aliphatic bridge not previously found in other known anti-bacterial agents, and they have been isolated from fermentation broths of streptomyces mediterranei.. rifaximin. this classification denotes an antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l36o5t016n. european medicines agency schedules rifaximin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10312mig. rifaximin generally arises in the molecular formula c43h51n3o11. the term rifaximin is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23.) rifaximin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule rifaximin under hs 29419000 and sitc 54139. as of q4 2014, rifaximin remains the us fda preferred term for this commodity. rifaximin bears us nlm identifiers umls id c0073374 and nci concept code c61926. smiles: o(c1c(c(o)c(c(o)c(c)c=cc=c(c(=o)nc2c3n4c(nc3c3c5c(oc(oc=cc(oc)c1c)(c5=o)c)c(c(o)c3c2o)c)cc(cc4)c)c)c)c)c(=o)c.. "
"rifamycin antibacterials. this classification denotes a group of anti-bacterial agents characterized by a chromophoric naphthohydroquinone group spanned by an aliphatic bridge not previously found in other known anti-bacterial agents, and they have been isolated from fermentation broths of streptomyces mediterranei.. rifametane. this classification denotes an antitubercular agent with the molecular formula c44h60n4o12, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 1pug6262hx, chemically known as rifamycin, 3-(((1-(diethylamino)ethylidene)hydrazono)methyl)- but more generally known as rifametane, which bears u.s. national institutes of health compound identifier 9571071. the european medicines agency schedules rifametane in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10306mig. the term rifametane is an international non-proprietary name or inn (see world health organization inn reference publication, volume 4, no. 3 1990, list 30). rifametane is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: o(c1c(c(o)c(c(o)c(c)c=cc=c(c(=o)nc2=c(o)c3c(c4c(=o)c(oc=cc(oc)c1c)(oc4c(c3o)c)c)c(=o)/c2=c/n/n=c(\\n(cc)cc)c)c)c)c)c(=o)c.. "
"rifamycin antibacterials. this classification denotes a group of anti-bacterial agents characterized by a chromophoric naphthohydroquinone group spanned by an aliphatic bridge not previously found in other known anti-bacterial agents, and they have been isolated from fermentation broths of streptomyces mediterranei.. rifamycin amp. this classification denotes an antitubercular agent with the molecular formula c43h58n4o12, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier vjt6j7r4tr, chemically known as rifamycin, 3-(((4-methyl-1-piperazinyl)imino)methyl)-, but more generally known as rifamycin amp, which bears us nih compound identifier 5381226. european medicines agency schedules rifamycin amp or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10310mig. most nations, for tariff purposes, schedule rifamycin amp under hs 29419000. smiles: cc1c(c2c3c4c1o[c@@](c4=o)(o/c=c/[c@@h]([c@h]([c@h]([c@@h]([c@@h]([c@@h]([c@h]([c@h](/c=c/c=c(\\c(=o)nc(c2o)c(c3o)c=nn5ccn(cc5)c)/c)c)o)c)o)c)oc(=o)c)c)oc)c)o.. "
"rifamycin antibacterials. this classification denotes a group of anti-bacterial agents characterized by a chromophoric naphthohydroquinone group spanned by an aliphatic bridge not previously found in other known anti-bacterial agents, and they have been isolated from fermentation broths of streptomyces mediterranei.. rifamycin b. this classification denotes an antitubercular agent with the molecular formula c39h49no14, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8ddb535dji, chemically known as 4-o-(carboxymethyl)rifamycin, but more generally known as rifamycin b, which bears us nih compound identifier 5459948. european medicines agency schedules rifamycin b or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10310mig. most nations, for tariff purposes, schedule rifamycin b under hs 29419000. smiles: cc1c(c2c3c(cc(c2o)nc(=o)/c(=c\\c=c\\[c@@h]([c@@h]([c@h]([c@h]([c@h]([c@@h]([c@@h]([c@h](/c=c/o[c@@]4(c(=o)c3c1o4)c)oc)c)oc(=o)c)c)o)c)o)c)/c)occ(=o)o)o.. "
"rifamycin antibacterials. this classification denotes a group of anti-bacterial agents characterized by a chromophoric naphthohydroquinone group spanned by an aliphatic bridge not previously found in other known anti-bacterial agents, and they have been isolated from fermentation broths of streptomyces mediterranei.. rifamycin b diethylamide. this classification denotes an antitubercular agent with the molecular formula c43h58n2o13, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ts121h7u7e, chemically known as rifamycin, 4-o-(2-(diethylamino)-2-oxoethyl)-, but more generally known as rifamycin b diethylamide, which bears us nih compound identifier 5382104. european medicines agency schedules rifamycin b diethylamide or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10310mig. most nations, for tariff purposes, schedule rifamycin b diethylamide under hs 29419000. smiles: ccn(cc)c(=o)coc1cc2c(c3c1c4c(c(c3o)c)o[c@@](c4=o)(o/c=c/[c@@h]([c@h]([c@h]([c@@h]([c@@h]([c@@h]([c@h]([c@h](/c=c/c=c(\\c(=o)n2)/c)c)o)c)o)c)oc(=o)c)c)oc)c)o.. "
"rifamycin antibacterials. this classification denotes a group of anti-bacterial agents characterized by a chromophoric naphthohydroquinone group spanned by an aliphatic bridge not previously found in other known anti-bacterial agents, and they have been isolated from fermentation broths of streptomyces mediterranei.. rifamycin o. this classification denotes an antitubercular agent with the molecular formula c39h47no14, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier z67lem9p1w, chemically known as 4-o-(carboxymethyl)-1-deoxy-1,4-dihydro-4-hydroxy-1-oxorifamycin .gamma.-lactone, but more generally known as rifamycin o, which bears us nih compound identifier 5280468. european medicines agency schedules rifamycin o or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10310mig. most nations, for tariff purposes, schedule rifamycin o under hs 29419000. smiles: cc1c(c2c3c4c1o[c@@](c4=o)(o/c=c/[c@@h]([c@h]([c@h]([c@@h]([c@@h]([c@@h]([c@h]([c@h](/c=c/c=c(\\c(=o)nc(=cc35occ(=o)o5)c2=o)/c)c)o)c)o)c)oc(=o)c)c)oc)c)o.. "
"rifamycin antibacterials. this classification denotes a group of anti-bacterial agents characterized by a chromophoric naphthohydroquinone group spanned by an aliphatic bridge not previously found in other known anti-bacterial agents, and they have been isolated from fermentation broths of streptomyces mediterranei.. rifamycin s. this classification denotes an antitubercular agent with the molecular formula c37h45no12, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier pi53n820jv, chemically known as 1,4-dideoxy-1,4-dihydro-1,4-dioxorifamycin, but more generally known as rifamycin s, which bears us nih compound identifier 5475445. european medicines agency schedules rifamycin s or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10310mig. most nations, for tariff purposes, schedule rifamycin s under hs 29419000. smiles: cc1c(c2c3c4c1o[c@@](c4=o)(o/c=c/[c@@h]([c@h]([c@h]([c@@h]([c@@h]([c@@h]([c@h]([c@h](/c=c/c=c(\\c(=o)nc(=cc3=o)c2=o)/c)c)o)c)o)c)oc(=o)c)c)oc)c)o.. "
"rifamycin antibacterials. this classification denotes a group of anti-bacterial agents characterized by a chromophoric naphthohydroquinone group spanned by an aliphatic bridge not previously found in other known anti-bacterial agents, and they have been isolated from fermentation broths of streptomyces mediterranei.. rifamycin sodium. this classification denotes an antitubercular agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 32086gs35z. european medicines agency schedules rifamycin sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04246mig. rifamycin sodium generally arises in the molecular formula c37h46no12.na. the term rifamycin sodium is a united states adopted name designation. most nations, for tariff and trade purposes, schedule rifamycin sodium under hs 29419000 and sitc 54139. as of q4 2014, rifamycin sodium remains us fdas preferred term for this commodity. rifamycin sodium bears us nlm identifiers umls id c0771754 and nci concept code c95605. smiles: cc1c(c2c3c(cc(c2o)nc(=o)/c(=c\\c=c\\[c@@h]([c@@h]([c@h]([c@h]([c@h]([c@@h]([c@@h]([c@h](/c=c/o[c@@]4(c(=o)c3c1o4)c)oc)c)oc(=o)c)c)o)c)o)c)/c)[o-])o.[na+].. "
"rifamycin antibacterials. this classification denotes a group of anti-bacterial agents characterized by a chromophoric naphthohydroquinone group spanned by an aliphatic bridge not previously found in other known anti-bacterial agents, and they have been isolated from fermentation broths of streptomyces mediterranei.. rifamycin sv. this classification denotes an antitubercular agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier du69t8zzpa. european medicines agency schedules rifamycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10310mig. rifamycin generally arises in the molecular formula c37h47no12. the term rifamycin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5.) rifamycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule rifamycin sv under hs 29419000. smiles: cc1c(c2c3c(cc(c2o)nc(=o)/c(=c\\c=c\\[c@@h]([c@@h]([c@h]([c@h]([c@h]([c@@h]([c@@h]([c@h](/c=c/o[c@@]4(c(=o)c3c1o4)c)oc)c)oc(=o)c)c)o)c)o)c)/c)o)o.. "
"second generation cephalosporins. this classification denotes the second variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. . "
"second generation cephalosporins. this classification denotes the second variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefaclor. this classification denotes a cephalosporin antibiotic with the molecular formula c15h14cln3o4s.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 69k7k19h4l, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-chloro-8-oxo-, (6r-(6-alpha,7-beta(r*)))- but generally known as cefaclor, which bears us nih compound identifier 40958. cefaclor most often comes in base, anhydrous, and hydrate forms. european medicines agency schedules cefaclor in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06163mig. world health organization schedules cefaclor in its anatomical therapeutic chemical (atc) classification. cefaclor is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefaclor under hs 29419000 and sitc 54139. as of q4 2014, cefaclor remains the us fda preferred term for this commodity. cefaclor bears us nlm identifiers umls id c0007537 and nci concept code c28911. smiles: clc1=c(n2c(sc1)c(nc(=o)c(n)c1ccccc1)c2=o)c(=o)o.. "
"second generation cephalosporins. this classification denotes the second variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefamandole. this classification denotes a cephalosporin antibiotic with the molecular formula c18h18n6o5s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5ckp8c2lli, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((hydroxyphenylacetyl)amino)-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r-(6alpha,7beta(r*)))- but generally known as cefamandole, which bears us nih compound identifier 36831. european medicines agency schedules cefamandole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07373mig. the term cefamandole is an international non-proprietary name or inn (see who inn reference publication, volume 28, no. 10 1974, list 14). world health organization schedules cefamandole in its anatomical therapeutic chemical (atc) classification. cefamandole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefamandole under hs 29419000 and sitc 54139. as of q4 2014, cefamandole remains the us fda preferred term for this commodity. cefamandole bears us nlm identifiers umls id c0007541 and nci concept code c353. smiles: s1c2n(c(=o)c2nc(=o)c(o)c2ccccc2)c(=c(c1)csc1n(nnn1)c)c(=o)o.. "
"second generation cephalosporins. this classification denotes the second variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefbuperazone. this classification denotes a cephalosporin antibiotic with the molecular formula c22h29n9o9s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t0785j3x40, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((2-(((4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)-3-hydroxy-1-oxobutyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r-(6alpha,7alpha,7(2r*,3s*)))- but generally known as cefbuperazone, which bears us nih compound identifier 53522. european medicines agency schedules cefbuperazone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07380mig. the term cefbuperazone is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). cefbuperazone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefbuperazone under hs 29419000 and sitc 54139. as of q4 2014, cefbuperazone remains the us fda preferred term for this commodity. cefbuperazone bears us nlm identifiers umls id c0055000 and nci concept code c81029. smiles: s1c2n(c(=o)c2(oc)nc(=o)c(nc(=o)n2ccn(c(=o)c2=o)cc)c(o)c)c(=c(c1)csc1n(nnn1)c)c(=o)o.. "
"second generation cephalosporins. this classification denotes the second variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefetrizole. this classification denotes a cephalosporin antibiotic with the molecular formula c16h15n5o4s3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 61k37e446t, chemically known as (6r,7r)-8-oxo-7-(2-(2-thienyl)acetamido)-3-((s-triazol-3-ylthio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carboxylic acid. but generally known as cefetrizole, which bears us nih compound identifier 193956. european medicines agency schedules cefetrizole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07393mig. the term cefetrizole is an international non-proprietary name. cefetrizole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefetrizole under hs 29419000 and sitc 54139. as of q4 2014, cefetrizole remains the us fda preferred term for this commodity. cefetrizole bears us nlm identifiers umls id c2699139 and nci concept code c76166. smiles: s1c2n(c(=o)c2nc(=o)cc2sccc2)c(=c(c1)csc1[nh]ncn1)c(=o)o.. "
"second generation cephalosporins. this classification denotes the second variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefminox. this classification denotes a cephalosporin antibiotic with the molecular formula c16h21n7o7s3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier pw08y13465, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((((2s)-2-amino-2-carboxyethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r,7s)- but generally known as cefminox, which bears us nih compound identifier 71141. european medicines agency schedules cefminox in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07400mig. the term cefminox is an international non-proprietary name. cefminox is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefminox under hs 29419000 and sitc 54139. as of q4 2014, cefminox remains the us fda preferred term for this commodity. cefminox bears us nlm identifiers umls id c0055006 and nci concept code c76169. smiles: s1c2n(c(=o)c2(oc)nc(=o)cscc(n)c(=o)o)c(=c(c1)csc1n(nnn1)c)c(=o)o.. "
"second generation cephalosporins. this classification denotes the second variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefonicid. this classification denotes a cephalosporin antibiotic with the molecular formula c18h18n6o8s3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6532b86wfg, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((hydroxyphenylacetyl)amino)-8-oxo-3-(((1-sulfomethyl)-1h-tetrazol-5-yl)thio)methyl)-, (6r-(6-alpha,7-beta(r*)))- but generally known as cefonicid, which bears us nih compound identifier 43592. european medicines agency schedules cefonicid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12429mig. the term cefonicid is an international non-proprietary name or inn (see who inn reference publication, volume 34, no. 10 1980, list 20). world health organization schedules cefonicid in its anatomical therapeutic chemical (atc) classification. cefonicid is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefonicid under hs 29419000 and sitc 54139. as of q4 2014, cefonicid remains the us fda preferred term for this commodity. cefonicid bears us nlm identifiers umls id c0007551 and nci concept code c65299. smiles: s1c2n(c(=o)c2nc(=o)c(o)c2ccccc2)c(=c(c1)csc1n(nnn1)cs(=o)(=o)o)c(=o)o.. "
"second generation cephalosporins. this classification denotes the second variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. ceforanide. this classification denotes a cephalosporin antibiotic with the molecular formula c20h21n7o6s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8m1yf8951v, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-(aminomethyl)phenyl)acetyl)amino)-3-(((1-(carboxymethyl)-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r-trans)- but generally known as ceforanide, which bears us nih compound identifier 43507. european medicines agency schedules ceforanide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07403mig. the term ceforanide is an international non-proprietary name or inn (see who inn reference publication, volume 32, no 10 1978, list 18). world health organization schedules ceforanide in its anatomical therapeutic chemical (atc) classification. ceforanide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ceforanide under hs 29419000 and sitc 54139. as of q4 2014, ceforanide remains the us fda preferred term for this commodity. ceforanide bears us nlm identifiers umls id c0055008 and nci concept code c47436. smiles: s1c2n(c(=o)c2nc(=o)cc2c(cn)cccc2)c(=c(c1)csc1n(nnn1)cc(=o)o)c(=o)o.. "
"second generation cephalosporins. this classification denotes the second variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefotiam. this classification denotes a cephalosporin antibiotic with the molecular formula c18h23n9o4s3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 91w6z2n718, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)acetyl)amino)-3-(((1-(2-(dimethylamino)ethyl)-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r-trans)- but generally known as cefotiam, which bears us nih compound identifier 43708. european medicines agency schedules cefotiam in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07407mig. the term cefotiam is an international non-proprietary name or inn (see who inn reference publication, volume 33, no. 10 1979, list 19). world health organization schedules cefotiam in its anatomical therapeutic chemical (atc) classification. cefotiam is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefotiam under hs 29419000 and sitc 54139. as of q4 2014, cefotiam remains the us fda preferred term for this commodity. cefotiam bears us nlm identifiers umls id c0007556 and nci concept code c65301. smiles: s1c2n(c(=o)c2nc(=o)cc2nc(sc2)n)c(=c(c1)csc1n(nnn1)ccn(c)c)c(=o)o.. "
"second generation cephalosporins. this classification denotes the second variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefprozil. this classification denotes a cephalosporin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4w0459za4v. european medicines agency schedules cefprozil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07415mig. cefprozil generally arises in the molecular formula c18h19n3o5s.h2o. the term cefprozil is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29.) cefprozil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefprozil under hs 29419000 and sitc 54139. as of q4 2014, cefprozil remains the us fda preferred term for this commodity. cefprozil bears us nlm identifiers umls id c0053882 and nci concept code c28917. smiles: cc=cc1=c(n2c(c(c2=o)nc(=o)c(c3=cc=c(c=c3)o)n)sc1)c(=o)o.. "
"second generation cephalosporins. this classification denotes the second variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefuzonam. this classification denotes a cephalosporin antibiotic with the molecular formula c16h15n7o5s4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 860mt00t7t, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-3-((1,2,3-thiadiazol-5-ylthio)methyl)-, (6r-(6alpha,7beta(z)))- but generally known as cefuzonam, which bears us nih compound identifier 6336505. european medicines agency schedules cefuzonam in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07434mig. the term cefuzonam is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). cefuzonam is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefuzonam under hs 29419000 and sitc 54139. as of q4 2014, cefuzonam remains the us fda preferred term for this commodity. cefuzonam bears us nlm identifiers umls id c0055017 and nci concept code c76179. smiles: s1c2n(c(=o)c2nc(=o)/c(=n\\oc)c2nc(sc2)n)c(=c(c1)csc1snnc1)c(=o)o.. "
"second generation cephalosporins. this classification denotes the second variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. loracarbef. this classification denotes a cephalosporin antibiotic with the molecular formula c16h16cln3o4.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3x11evm5su, chemically known as 1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-chloro-8-oxo-, (6r-(6alpha,7beta(r*)))- but generally known as loracarbef, which bears us nih compound identifier 3956. european medicines agency schedules loracarbef in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08578mig. world health organization schedules loracarbef in its anatomical therapeutic chemical (atc) classification. loracarbef is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule loracarbef under hs 29419000 and sitc 54139. as of q4 2014, loracarbef remains the us fda preferred term for this commodity. loracarbef bears us nlm identifiers umls id c0721422 and nci concept code c47588. smiles: clc1=c(n2c(c(nc(=o)c(n)c3ccccc3)c2=o)cc1)c(=o)o.. "
"second generation cephalosporins. this classification denotes the second variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefuroxime. this classification denotes a cephalosporin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier o1r9fj93ed. european medicines agency schedules cefuroxime in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07433mig. cefuroxime generally arises in the molecular formula c16h16n4o8s. the term cefuroxime is an international non-proprietary name or inn (see who inn reference publication, volume 30, no. 10 1976, list 16.) cefuroxime is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefuroxime under hs 29419000 and sitc 54139. as of q4 2014, cefuroxime remains the us fda preferred term for this commodity. cefuroxime bears us nlm identifiers umls id c0007562 and nci concept code c61669. smiles: s1c2n(c(=o)c2nc(=o)/c(=n/oc)c2occc2)c(=c(c1)coc(=o)n)c(=o)o.. "
"second generation cephalosporins. this classification denotes the second variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefaclor anhydrous. this classification denotes a cephalosporin antibiotic with the molecular formula c15h14cln3o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3z6fs3ik0k, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2r)-2-amino-2-phenylacetyl)amino)-3-chloro-8-oxo-, (6r,7r)-, but more generally known as cefaclor anhydrous, which bears us nih compound identifier 40958. european medicines agency schedules cefaclor anhydrous or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06163mig. most nations, for tariff purposes, schedule cefaclor anhydrous under hs 29419000. cefaclor anhydrous bears us nlm identifiers umls id c2699131 and nci concept code c76033. smiles: c1ccc(cc1)[c@h](c(=o)n[c@h]2[c@@h]3n(c2=o)c(=c(cs3)cl)c(=o)o)n.. "
"second generation cephalosporins. this classification denotes the second variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefamandole nafate. this classification denotes a cephalosporin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8hdo7941do. european medicines agency schedules cefamandole nafate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01101mig. cefamandole nafate generally arises in the molecular formula c19h17n6nao6s2. the term cefamandole nafate is a united states adopted name designation. most nations, for tariff and trade purposes, schedule cefamandole nafate under hs 29419000 and sitc 54139. as of q4 2014, cefamandole nafate remains us fdas preferred term for this commodity. cefamandole nafate bears us nlm identifiers umls id c0054995 and nci concept code c47966. smiles: cn1c(nnn1)scc2=c(n3[c@@h]([c@@h](c3=o)nc(=o)[c@@h](c4ccccc4)oc=o)sc2)c(=o)[o-].[na+].. "
"second generation cephalosporins. this classification denotes the second variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefamandole sodium. this classification denotes a cephalosporin antibiotic with the molecular formula c18h17n6o5s2.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier iy6234odvr, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-mandelamido-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, monosodium salt, d- but more generally known as cefamandole sodium, which bears us nih compound identifier 34779. european medicines agency schedules cefamandole sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub35548. most nations, for tariff and trade purposes, schedule cefamandole sodium under hs 29419000 and sitc 54139. as of q4 2014, cefamandole sodium remains us fdas preferred term for this commodity. cefamandole sodium bears us nlm identifiers umls id c1707322 and nci concept code c47967. smiles: cn1c(nnn1)scc2=c(n3[c@@h]([c@@h](c3=o)nc(=o)[c@@h](c4ccccc4)o)sc2)c(=o)[o-].[na+].. "
"second generation cephalosporins. this classification denotes the second variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefbuperazone sodium. this classification denotes a cephalosporin antibiotic with the molecular structure c22h28n9o9s2.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 1vx59v96bs chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(2-((2,3-dioxo-4-ethyl-1-piperazinyl)formamido)-3-hydroxybutyramido)-7-methoxy- 3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, monosodium salt, (6r-(6-alpha,7-alpha,7(2r*,3s*)))-, but more commonly known as cefbuperazone sodium, which bears us nih compound identifier 127526. european medicines agency schedules cefbuperazone sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01109mig. most nations, for tariff and trade purposes, schedule cefbuperazone sodium under hs 29419000 and sitc 54139. as of q4 2014, cefbuperazone sodium remains us fdas preferred term for this commodity. cefbuperazone sodium bears us nlm identifiers umls id c0144299 and nci concept code c98217. smiles: ccn1ccn(c(=o)c1=o)c(=o)n[c@h]([c@h](c)o)c(=o)n[c@]2([c@@h]3n(c2=o)c(=c(cs3)csc4nnnn4c)c(=o)[o-])oc.[na+].. "
"second generation cephalosporins. this classification denotes the second variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefminox sodium. this classification denotes the sodium form of a cephalosporin antibiotic with the molecular formula c16h21n7o7s3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier pw08y13465, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((((2s)-2-amino-2-carboxyethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r,7s)- but more generally known as cefminox, which bears us nih compound identifier 71141. european medicines agency schedules cefminox in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07400mig. the term cefminox is an international non-proprietary name. cefminox is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule cefminox sodium under hs 29419000 and sitc 54139. as of q4 2014, cefminox sodium remains us fdas preferred term for this commodity. cefminox sodium bears us nlm identifiers umls id c1529767 and nci concept code c98223. smiles: cn1c(nnn1)scc2=c(n3[c@@h]([c@@](c3=o)(nc(=o)csc[c@h](c(=o)o)n)oc)sc2)c(=o)[o-].[na+].. "
"second generation cephalosporins. this classification denotes the second variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefonicid monosodium. this classification denotes a cephalosporin antibiotic c18h17n6o8s3.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier qd9g66c5uf, chemically known as (6r,7r)-7-((r)-mandelamido)-8-oxo-3-(((1-(sulfomethyl)-1h-tetrazol-5-yl)thio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, s-sodium salt, but more generally known as cefonicid monosodium, which bears us nih compound identifier 6336979. most nations, for tariff and trade purposes, schedule cefonicid monosodium under hs 29419000 and sitc 54139. as of q4 2014, cefonicid monosodium remains us fdas preferred term for this commodity. cefonicid monosodium bears us nlm identifiers umls id cl386475 and nci concept code c76170. smiles: c1ccc(cc1)[c@h](c(=o)n[c@h]2[c@@h]3n(c2=o)c(=c(cs3)csc4nnnn4cs(=o)(=o)[o-])c(=o)o)o.[na+].. "
"second generation cephalosporins. this classification denotes the second variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefonicid sodium. this classification denotes a cephalosporin antibiotic with the molecular formula c18h16n6o8s3.2na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f74mfl78a1, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((hydroxyphenylacetyl)amino)-8-oxo-3-(((1-(sulfomethyl)-1h-tetrazol-5-yl)thio)methyl)disodium salt, (6r-(6alpha,7beta(r*))) but more generally known as cefonicid sodium, which bears us nih compound identifier 43593. most nations, for tariff and trade purposes, schedule cefonicid sodium under hs 29419000 and sitc 54139. as of q4 2014, cefonicid sodium remains us fdas preferred term for this commodity. cefonicid sodium bears us nlm identifiers umls id c0886812 and nci concept code c65300. smiles: c1ccc(cc1)[c@h](c(=o)n[c@h]2[c@@h]3n(c2=o)c(=c(cs3)csc4nnnn4cs(=o)(=o)[o-])c(=o)[o-])o.[na+].[na+].. "
"second generation cephalosporins. this classification denotes the second variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefotiam dihydrochloride. this classification denotes a cephalosporin antibiotic with the molecular formula c18h23n9o4s3.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h7v12wdz93, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)acetyl)-amino)-3-(((1-(2-(dimethylamino)ethyl)-1h-tetrazol-5-yl)-thio)methyl)-8-oxo-, hydrochloride, (6r-trans)-, but more generally known as cefotiam dihydrochloride, which bears us nih compound identifier 47896. european medicines agency schedules cefotiam dihydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07407mig. most nations, for tariff purposes, schedule cefotiam dihydrochloride under hs 29419000. smiles: cn(c)ccn1c(nnn1)scc2=c(n3[c@@h]([c@@h](c3=o)nc(=o)cc4csc(n4)n)sc2)c(=o)o.cl.cl.. "
"second generation cephalosporins. this classification denotes the second variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefotiam hexetil hydrochloride. this classification denotes a cephalosporin antibiotic c27h37n9o7s3.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3n1x7e8cle, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((2-(2-amino-4-thiazolyl)acetyl)amino)-3-(((1-(2-(dimethylamino)ethyl)-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, 1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester, hydrochloride (1:2), (6r,7r)-, but more generally known as cefotiam hexetil hydrochloride, which bears us nih compound identifier 175647. european medicines agency schedules cefotiam hexetil hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01125mig. most nations, for tariff and trade purposes, schedule cefotiam hexetil hydrochloride under hs 29419000 and sitc 54139. as of q4 2014, cefotiam hexetil hydrochloride remains us fdas preferred term for this commodity. cefotiam hexetil hydrochloride bears us nlm identifiers umls id c3273886 and nci concept code c98226. smiles: cc(oc(=o)c1=c(cs[c@h]2n1c(=o)[c@h]2nc(=o)cc3csc(n3)n)csc4nnnn4ccn(c)c)oc(=o)oc5ccccc5.cl.cl.. "
"second generation cephalosporins. this classification denotes the second variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefotiam hydrochloride. this classification denotes a cephalosporin antibiotic with the molecular formula c18h23n9o4s3.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h7v12wdz93, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)acetyl)amino)-3-(((1-(2-(dimethylamino)ethyl)-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r-trans)- but more generally known as cefotiam hydrochloride, which bears us nih compound identifier 43708. european medicines agency schedules cefotiam hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01126mig. most nations, for tariff and trade purposes, schedule cefotiam hydrochloride under hs 29419000 and sitc 54139. as of q4 2014, cefotiam hydrochloride remains us fdas preferred term for this commodity. cefotiam hydrochloride bears us nlm identifiers umls id c0771454 and nci concept code c65302. smiles: cn(c)ccn1c(nnn1)scc2=c(n3[c@@h]([c@@h](c3=o)nc(=o)cc4csc(n4)n)sc2)c(=o)o.cl.cl.. "
"second generation cephalosporins. this classification denotes the second variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefprozil anhydrous. this classification denotes a cephalosporin antibiotic with the molecular formula c18h19n3o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1m698f4h4e, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-8-oxo-3-(1-propenyl)-, (6r-(6.alpha.,7.beta.(r*)))-, but more generally known as cefprozil anhydrous, which bears us nih compound identifier 5281006. european medicines agency schedules cefprozil anhydrous or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07415mig. most nations, for tariff purposes, schedule cefprozil anhydrous under hs 29419000. smiles:. cefprozil anhydrous bears us nlm identifiers umls id c2699143 and nci concept code c79994.. "
"second generation cephalosporins. this classification denotes the second variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefuroxime axetil. this classification denotes a cephalosporin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier z49qdt0j8z. european medicines agency schedules cefuroxime axetil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01139mig. cefuroxime axetil generally arises in the molecular formula c20h22n4o10s. the term cefuroxime axetil is a united states adopted name designation. most nations, for tariff and trade purposes, schedule cefuroxime axetil under hs 29419000 and sitc 54139. as of q4 2014, cefuroxime axetil remains us fdas preferred term for this commodity. cefuroxime axetil bears us nlm identifiers umls id c0055015 and nci concept code c28918. smiles: cc(oc(=o)c)oc(=o)c1=c(cs[c@h]2n1c(=o)[c@h]2nc(=o)/c(=n\\oc)/c3ccco3)coc(=o)n.. "
"second generation cephalosporins. this classification denotes the second variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefuroxime pivoxetil. this classification denotes a cephalosporin antibiotic c23h28n4o11s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier lr90117565, chemically known as 1-hydroxyethyl (6r,7r)-7-(2-(2-furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7^2-(z)-(o-methyloxime), 3-carbamate 1-(2-methoxy-2-methylpropionate), but more generally known as cefuroxime pivoxetil, which bears us nih compound identifier 9595289. most nations, for tariff and trade purposes, schedule cefuroxime pivoxetil under hs 29419000 and sitc 54139. as of q4 2014, cefuroxime pivoxetil remains us fdas preferred term for this commodity. cefuroxime pivoxetil bears us nlm identifiers umls id c2699152 and nci concept code c76178. smiles: cc(oc(=o)c1=c(cs[c@h]2n1c(=o)[c@h]2nc(=o)/c(=n\\oc)/c3ccco3)coc(=o)n)oc(=o)c(c)(c)oc.. "
"second generation cephalosporins. this classification denotes the second variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefuroxime sodium. this classification denotes a cephalosporin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier r8a7m9my61. european medicines agency schedules cefuroxime sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01140mig. cefuroxime sodium generally arises in the molecular formula c16h15n4nao8s. the term cefuroxime sodium is a u.s. pharmacopeial convention designation. most nations, for tariff and trade purposes, schedule cefuroxime sodium under hs 29419000 and sitc 54139. as of q4 2014, cefuroxime sodium remains us fdas preferred term for this commodity. cefuroxime sodium bears us nlm identifiers umls id c0701852 and nci concept code c47439. smiles: co/n=c(/c1ccco1)\\c(=o)n[c@h]2[c@@h]3n(c2=o)c(=c(cs3)coc(=o)n)c(=o)[o-].[na+].. "
"second generation cephalosporins. this classification denotes the second variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefuzonam sodium. this classification denotes a cephalosporin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6sou25l22c. european medicines agency schedules cefuzonam sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01141mig. cefuzonam sodium generally arises in the molecular formula c16h14n7o5s4.na. the term cefuzonam sodium is a japanese accepted name designation. most nations, for tariff and trade purposes, schedule cefuzonam sodium under hs 29419000 and sitc 54139. as of q4 2014, cefuzonam sodium remains us fdas preferred term for this commodity. cefuzonam sodium bears us nlm identifiers umls id c0124795 and nci concept code c98232. smiles: co/n=c(/c1csc(n1)n)\\c(=o)n[c@h]2[c@@h]3n(c2=o)c(=c(cs3)csc4cnns4)c(=o)[o-].[na+].. "
"second generation cephalosporins. this classification denotes the second variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. loracarbef monohydrate. this classification denotes a cephalosporin antibiotic with the molecular formula c16h16cln3o4.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3x11evm5su, chemically known as 1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-chloro-8-oxo-, monohydrate, (6r-(6.alpha.,7.beta.(r*)))-, but more generally known as loracarbef monohydrate, which bears us nih compound identifier 60746. european medicines agency schedules loracarbef monohydrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08578mig. most nations, for tariff purposes, schedule loracarbef monohydrate under hs 29419000. smiles: c1ccc(cc1)[c@h](c(=o)n[c@h]2[c@h]3ccc(=c(n3c2=o)c(=o)o)cl)n.o.. "
"streptogramins. this classification denotes a class of natural cyclic peptide antibiotics produced by certain subspecies of streptomyces, hence the name strepto-gramin, strepto-gramins, and streptogramins. they include two structurally unrelated components, streptogramin group a and streptogramin group b, which generally act synergistically to inhibit bacterial growth.. . "
"streptogramins. this classification denotes a class of natural cyclic peptide antibiotics produced by certain subspecies of streptomyces, hence the name strepto-gramin, strepto-gramins, and streptogramins. they include two structurally unrelated components, streptogramin group a and streptogramin group b, which generally act synergistically to inhibit bacterial growth.. dalfopristin. this classification denotes an antibiotic with the molecular formula c34h50n4o9s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier r9m4fje48e, chemically known as virginiamycin m1, 26-((2-(diethylamino)ethyl)sulfonyl)-26,27-dihydro-, (26r,27s)- but generally known as dalfopristin, which bears us nih compound identifier 6323289. european medicines agency schedules dalfopristin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06892mig. the term dalfopristin is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). dalfopristin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dalfopristin under hs 29349990 and sitc 51579. as of q4 2014, dalfopristin remains the us fda preferred term for this commodity. dalfopristin bears us nlm identifiers umls id c0756085 and nci concept code c47468. smiles: s(=o)(=o)(c1c2n(cc1)c(=o)c1nc(oc1)cc(=o)cc(o)c=c(c=ccnc(=o)c=cc(c(oc2=o)c(c)c)c)c)ccn(cc)cc.. "
"streptogramins. this classification denotes a class of natural cyclic peptide antibiotics produced by certain subspecies of streptomyces, hence the name strepto-gramin, strepto-gramins, and streptogramins. they include two structurally unrelated components, streptogramin group a and streptogramin group b, which generally act synergistically to inhibit bacterial growth.. pristinamycin or pristinamycine. this classification denotes an antibiotic with the molecular formula c34h50n4o9s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier r9m4fje48e, chemically known as virginiamycin m1, 26-((2-(diethylamino)ethyl)sulfonyl)-26,27-dihydro-, (26r,27s)- but generally known as dalfopristin, which bears us nih compound identifier 6323289. european medicines agency schedules dalfopristin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06892mig. the term dalfopristin is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). dalfopristin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s(=o)(=o)(c1c2n(cc1)c(=o)c1nc(oc1)cc(=o)cc(o)c=c(c=ccnc(=o)c=cc(c(oc2=o)c(c)c)c)c)ccn(cc)cc.. "
"streptogramins. this classification denotes a class of natural cyclic peptide antibiotics produced by certain subspecies of streptomyces, hence the name strepto-gramin, strepto-gramins, and streptogramins. they include two structurally unrelated components, streptogramin group a and streptogramin group b, which generally act synergistically to inhibit bacterial growth.. quinupristin. this classification denotes an antibiotic with the molecular formula c53h67n9o10s, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 23ow28rs7p, chemically known as virginiamycin s1, 4-(4-(dimethylamino)-n-methyl-l-phenylalanine)-5-(5-((1-azabicyclo(2.2.2)oct-3-ylthio)methyl)-4-oxo-l-2-piperidinecarboxylic acid)-, (s)- but more generally known as quinupristin, which bears u.s. national institutes of health compound identifier 71338. the european medicines agency schedules quinupristin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10226mig. the term quinupristin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 5, no. 3 1991, list 31). quinupristin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s(c1c2ccn(c1)cc2)cc1cn2c(cc1=o)c(=o)nc(c1ccccc1)c(=o)oc(c(nc(=o)c1ncccc1o)c(=o)nc(c(=o)n1c(ccc1)c(=o)n(c(c2=o)cc1ccc(n(c)c)cc1)c)cc)c.. "
"streptogramins. this classification denotes a class of natural cyclic peptide antibiotics produced by certain subspecies of streptomyces, hence the name strepto-gramin, strepto-gramins, and streptogramins. they include two structurally unrelated components, streptogramin group a and streptogramin group b, which generally act synergistically to inhibit bacterial growth.. volpristin. this classification denotes an antibiotic with the molecular formula c28h37n3o7, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 18uan5144e. the term volpristin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 13 no. 3, 1999, list 42. ). smiles: cc1c=cc(=o)ncc=cc(=cc(cc(=o)cc2=nc(=co2)c(=o)n3ccc(c3)c(=o)oc1c(c)c)o)c.. "
"streptogramins. this classification denotes a class of natural cyclic peptide antibiotics produced by certain subspecies of streptomyces, hence the name strepto-gramin, strepto-gramins, and streptogramins. they include two structurally unrelated components, streptogramin group a and streptogramin group b, which generally act synergistically to inhibit bacterial growth.. virginiamycin. this classification denotes a depsipeptide antibiotic with the molecular formula c43h49n7o10, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier c49ws9n75l, more generally known as virginiamycin. european medicines agency schedules virginiamycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05111mig. the term virginiamycin is an international non-proprietary name or inn. see world health organization inn reference publication, volume 22, no. 10, 1968, list 8. virginiamycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. . "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfacetamide. this classification denotes a sulfonamide anti-infective agent with the molecular formula c8h10n2o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4965g3j0f5, chemically known as sulfanilamide, n(sup 1)-acetyl- but generally known as sulfacetamide, which bears us nih compound identifier 5320. european medicines agency schedules sulfacetamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10687mig. world health organization schedules sulfacetamide in its anatomical therapeutic chemical (atc) classification. sulfacetamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sulfacetamide under hs 29350090 and sitc 51580. as of q4 2014, sulfacetamide remains the us fda preferred term for this commodity. sulfacetamide bears us nlm identifiers umls id c0038670 and nci concept code c62077. smiles: s(=o)(=o)(nc(=o)c)c1ccc(n)cc1.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. mafenide. this classification denotes an anti-infective agent with the molecular formula c7h10n2o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 58447s8p4l, chemically known as p-toluenesulfonamide, .alpha.-amino-, monohydrochloride but generally known as mafenide, which bears us nih compound identifier 3998. european medicines agency schedules mafenide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08633mig. the term mafenide is an international non-proprietary name or inn (see who inn reference publication, volume 32, no 10 1978, list 18). world health organization schedules mafenide in its anatomical therapeutic chemical (atc) classification. mafenide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mafenide under hs 29350090 and sitc 51580. as of q4 2014, mafenide remains the us fda preferred term for this commodity. mafenide bears us nlm identifiers umls id c0024452 and nci concept code c61819. smiles: s(=o)(=o)(n)c1ccc(cc1)cn.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. phthalylsulfathiazole. this classification denotes a sulfonamide anti-infective agent with the molecular formula c17h13n3o5s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6875l5852v, chemically known as sulfanilamide, n(sup 4)-(o-carboxybenzoyl)-n-2-thiazolyl- but generally known as phthalylsulfathiazole, which bears us nih compound identifier 4806. european medicines agency schedules phthalylsulfathiazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09799mig. the term phthalylsulfathiazole is an international non-proprietary name. world health organization schedules phthalylsulfathiazole in its anatomical therapeutic chemical (atc) classification. phthalylsulfathiazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule phthalylsulfathiazole under hs 29350090 and sitc 51580. as of q4 2014, phthalylsulfathiazole remains the us fda preferred term for this commodity. phthalylsulfathiazole bears us nlm identifiers umls id c0070975 and nci concept code c80790. smiles: s(=o)(=o)(nc1sccn1)c1ccc(nc(=o)c2c(cccc2)c(=o)o)cc1.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. silvadene or silver sulfadiazine. this classification denotes a topical anti-infective agent and sulfonamide anti-infective agent with the molecular formula c10h9n4o2s.ag, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w46jy43ejr, chemically known as sulfanilamide, n(sup 1)-2-pyrimidinyl-, monosilver(1+) salt but generally known as silver sulfadiazine, which bears us nih compound identifier 31011. european medicines agency schedules silver sulfadiazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04622mig. world health organization schedules silver sulfadiazine in its anatomical therapeutic chemical (atc) classification. silvadene or silver sulfadiazine bears us nlm identifiers umls id c0723179 and nci concept code c66567. smiles: c1=cn=c(n=c1)[n-]s(=o)(=o)c2=cc=c(c=c2)n.[ag+].. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. succinylsulfathiazole. this classification denotes an intestinal antimicrobial agent with the molecular formula c13h13n3o5s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier rss8647o4s, chemically known as succinanilic acid, 4- (2-thiazolylsulfamoyl)- but generally known as succinylsulfathiazole, which bears us nih compound identifier 5315. european medicines agency schedules succinylsulfathiazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10664mig. world health organization schedules succinylsulfathiazole in its anatomical therapeutic chemical (atc) classification. succinylsulfathiazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule succinylsulfathiazole under hs 29350090 and sitc 51580. as of q4 2014, succinylsulfathiazole remains the us fda preferred term for this commodity. smiles: s(=o)(=o)(nc1sccn1)c1ccc(nc(=o)ccc(=o)o)cc1.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfabenzamide. this classification denotes a sulfonamide anti-infective agent with the molecular formula c13h12n2o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g58f8opl4i, chemically known as sulfanilamide, n(sup1)-benzoyl- but generally known as sulfabenzamide, which bears us nih compound identifier 5319. european medicines agency schedules sulfabenzamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10684mig. the term sulfabenzamide is an international non-proprietary name or inn (see who inn reference publication, volume 26, no. 10 1972, list 12). sulfabenzamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sulfabenzamide under hs 29350090 and sitc 51580. as of q4 2014, sulfabenzamide remains the us fda preferred term for this commodity. sulfabenzamide bears us nlm identifiers umls id c0075504 and nci concept code c87216. smiles: s(=o)(=o)(nc(=o)c1ccccc1)c1ccc(n)cc1.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfacitine or sulfacytine. this classification denotes a sulfonamide anti-infective agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t795873ajp. european medicines agency schedules sulfacitine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10690mig. sulfacitine generally arises in the molecular formula c12h14n4o3s. the term sulfacitine is an international non-proprietary name or inn. sulfacitine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. sulfacitine or sulfacytine bears us nlm identifiers umls id c0262960 and nci concept code c47734. smiles: ccn1c=cc(=nc1=o)ns(=o)(=o)c2=cc=c(c=c2)n.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfadiazine. this classification denotes a sulfonamide anti-infective agent with the molecular formula c10h10n4o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0n7609k889, chemically known as trisulfapyrimidine, oral suspension but generally known as sulfadiazine, which bears us nih compound identifier 5215. european medicines agency schedules sulfadiazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10695mig. the term sulfadiazine is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules sulfadiazine in its anatomical therapeutic chemical (atc) classification. sulfadiazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sulfadiazine under hs 29350090 and sitc 51580. as of q4 2014, sulfadiazine remains the us fda preferred term for this commodity. sulfadiazine bears us nlm identifiers umls id c0038675 and nci concept code c29468. smiles: c1=cn=c(n=c1)ns(=o)(=o)c2=cc=c(c=c2)n.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfadimethoxine. this classification denotes a sulfonamide anti-infective agent with the molecular formula c12h14n4o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 30cpc5ldex, chemically known as 2,6-dimethoxy-4-sulfanilamidopyrimidine but generally known as sulfadimethoxine, which bears us nih compound identifier 5323. european medicines agency schedules sulfadimethoxine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10698mig. the term sulfadimethoxine is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules sulfadimethoxine in its anatomical therapeutic chemical (atc) classification. sulfadimethoxine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sulfadimethoxine under hs 29350090 and sitc 51580. as of q4 2014, sulfadimethoxine remains the us fda preferred term for this commodity. sulfadimethoxine bears us nlm identifiers umls id c0038676 and nci concept code c76975. smiles: coc1=nc(=nc(=c1)ns(=o)(=o)c2=cc=c(c=c2)n)oc.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfadimethazine or sulfadimidine or sulfamidine. this classification denotes a sulfonamide anti-infective agent with the molecular formula c12h14n4o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 48u51w007f, chemically known as 4,6-dimethylsulfadiazine but generally known as sulfadimidine, which bears us nih compound identifier 5327. european medicines agency schedules sulfadimidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10699mig. world health organization schedules sulfadimidine in its anatomical therapeutic chemical (atc) classification. sulfadimidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: cc1=cc(=nc(=n1)ns(=o)(=o)c2=cc=c(c=c2)n)c.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfadoxine or sulphadoxine. this classification denotes an antimalarial agent with the molecular formula c12h14n4o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 88463u4sm5, chemically known as 6-(4-aminobenzenesulfonamido)-4,5-dimethoxypyrimidine but generally known as sulfadoxine, which bears us nih compound identifier 17134. european medicines agency schedules sulfadoxine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10700mig. the term sulfadoxine is an international non-proprietary name or inn (see who inn reference publication, volume 23, no. 10 1969, list 9). sulfadoxine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. sulfadoxine or sulphadoxine bears us nlm identifiers umls id c0038679 and nci concept code c47735. smiles: coc1=c(n=cn=c1oc)ns(=o)(=o)c2=cc=c(c=c2)n.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfafurazole or sulfisoxazole or sulphafurazole. this classification denotes a sulfonamide anti-infective agent with the molecular formula c11h13n3o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 740t4c525w, chemically known as 3,4-dimethylisoxazole-5-sulphanilamide but generally known as sulfafurazole, which bears us nih compound identifier 5344. european medicines agency schedules sulfafurazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10702mig. world health organization schedules sulfafurazole in its anatomical therapeutic chemical (atc) classification. sulfafurazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: cc1=c(on=c1c)ns(=o)(=o)c2=cc=c(c=c2)n.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfametoxydiazine or sulfamethoxydiazine sulfameter. this classification denotes a sulfonamide anti-infective agent with the molecular formula c11h12n4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3l179f09d6, chemically known as sulfanilamide, n(sup 1)-(5-methoxy-2-pyrimidinyl)- but generally known as sulfameter, which bears us nih compound identifier 5326. european medicines agency schedules sulfametoxydiazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10714mig. the term sulfametoxydiazine is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7). world health organization schedules sulfameter in its anatomical therapeutic chemical (atc) classification. smiles: coc1=cn=c(n=c1)ns(=o)(=o)c2=cc=c(c=c2)n.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfaguanidine. this classification denotes a sulfonamide anti-infective agent with the molecular formula c7h10n4o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 15xq8043fn, chemically known as sulfanilamide, n(sup1)-amidino- but generally known as sulfaguanidine, which bears us nih compound identifier 5324. european medicines agency schedules sulfaguanidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10703mig. the term sulfaguanidine is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules sulfaguanidine in its anatomical therapeutic chemical (atc) classification. sulfaguanidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sulfaguanidine under hs 29350090 and sitc 51580. as of q4 2014, sulfaguanidine remains the us fda preferred term for this commodity. sulfaguanidine bears us nlm identifiers umls id c0038681 and nci concept code c76977. smiles: s(=o)(=o)(/n=c(/n)n)c1ccc(n)cc1.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfalene or sulfamethopyrazine. this classification denotes a sulfonamide anti-infective agent with the molecular formula c11h12n4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t6bl4zc15g, chemically known as sulfanilamide, n(sup 1)-(3-methoxypyrazinyl)- but generally known as sulfalene, which bears us nih compound identifier 9047. european medicines agency schedules sulfalene in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10705mig. the term sulfalene is an international non-proprietary name. world health organization schedules sulfalene in its anatomical therapeutic chemical (atc) classification. sulfalene is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. sulfalene or sulfamethopyrazine bears us nlm identifiers umls id c0038683 and nci concept code c80793. smiles: coc1=nc=cn=c1ns(=o)(=o)c2=cc=c(c=c2)n.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfamazone. this classification denotes a sulfonamide anti-infective agent with the molecular formula c23h24n6o7s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier d7b8u8va9j, chemically known as alpha-(4-((6-methoxy-3-pyridazinyl)sulfamoyl)anilino)-2,3-dimethyl-5-oxo-1-phenyl-3-pyrazolin-4-methanesulfonsaeure but generally known as sulfamazone, which bears us nih compound identifier 187764. european medicines agency schedules sulfamazone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10707mig. the term sulfamazone is an international non-proprietary name or inn (see who inn reference publication, volume 15 no. 1, 2001, list 45). world health organization schedules sulfamazone in its anatomical therapeutic chemical (atc) classification. sulfamazone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sulfamazone under hs 29350090 and sitc 51580. as of q4 2014, sulfamazone remains the us fda preferred term for this commodity. sulfamazone bears us nlm identifiers umls id c2348596 and nci concept code c73102. smiles: s(=o)(=o)(o)c(nc1ccc(s(=o)(=o)nc2nnc(oc)cc2)cc1)c1c(n(n(c1=o)c1ccccc1)c)c.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfamerazine. this classification denotes a sulfonamide anti-infective agent with the molecular formula c11h12n4o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ur1sab295f, chemically known as sulfanilamide, n(sup 1)-(4-methyl-2-pyrimidinyl)- but generally known as sulfamerazine, which bears us nih compound identifier 5325. european medicines agency schedules sulfamerazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10708mig. the term sulfamerazine is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules sulfamerazine in its anatomical therapeutic chemical (atc) classification. sulfamerazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sulfamerazine under hs 29350090 and sitc 51580. as of q4 2014, sulfamerazine remains the us fda preferred term for this commodity. sulfamerazine bears us nlm identifiers umls id c0038684 and nci concept code c61959. smiles: cc1=nc(=nc=c1)ns(=o)(=o)c2=cc=c(c=c2)n.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfamethizole. this classification denotes a sulfonamide anti-infective agent with the molecular formula c9h10n4o2s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 25w8454h16, chemically known as 5-methyl-2-sulfanilamido-1,3,4-thiadiazole but generally known as sulfamethizole, which bears us nih compound identifier 5328. european medicines agency schedules sulfamethizole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10710mig. the term sulfamethizole is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17). world health organization schedules sulfamethizole in its anatomical therapeutic chemical (atc) classification. sulfamethizole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sulfamethizole under hs 29350090 and sitc 51580. as of q4 2014, sulfamethizole remains the us fda preferred term for this commodity. sulfamethizole bears us nlm identifiers umls id c0038687 and nci concept code c47736. smiles: s(=o)(=o)(nc1sc(nn1)c)c1ccc(n)cc1.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfamethoxazole. this classification denotes a sulfonamide anti-infective agent with the molecular formula c10h11n3o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier je42381tnv, chemically known as 4-amino-n-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide but generally known as sulfamethoxazole, which bears us nih compound identifier 5329. european medicines agency schedules sulfamethoxazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10711mig. the term sulfamethoxazole is an international non-proprietary name. world health organization schedules sulfamethoxazole in its anatomical therapeutic chemical (atc) classification. sulfamethoxazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sulfamethoxazole under hs 29350090 and sitc 51580. as of q4 2014, sulfamethoxazole remains the us fda preferred term for this commodity. sulfamethoxazole bears us nlm identifiers umls id c0038689 and nci concept code c47737. smiles: cc1=cc(=no1)ns(=o)(=o)c2=cc=c(c=c2)n.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfamethoxypyridazine. this classification denotes a sulfonamide anti-infective agent with the molecular formula c11h12n4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t034e4ns2z, chemically known as sulfanilamide, n(sup 1)-(6-methoxy-3-pyridazinyl)- but generally known as sulfamethoxypyridazine, which bears us nih compound identifier 5330. european medicines agency schedules sulfamethoxypyridazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10712mig. the term sulfamethoxypyridazine is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules sulfamethoxypyridazine in its anatomical therapeutic chemical (atc) classification. sulfamethoxypyridazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sulfamethoxypyridazine under hs 29350090 and sitc 51580. as of q4 2014, sulfamethoxypyridazine remains the us fda preferred term for this commodity. sulfamethoxypyridazine bears us nlm identifiers umls id c0038693 and nci concept code c80795. smiles: coc1=nn=c(c=c1)ns(=o)(=o)c2=cc=c(c=c2)n.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfametomidine or sulfamethomidine. this classification denotes a sulfonamide anti-infective agent with the molecular formula c12h14n4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 940zl3ahkb, chemically known as sulfanilamide, n(sup 1)-(6-methoxy-2-methyl-4-pyrimidinyl)- but generally known as sulfamethomidine, which bears us nih compound identifier 19596. european medicines agency schedules sulfametomidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10713mig. the term sulfametomidine is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules sulfamethomidine in its anatomical therapeutic chemical (atc) classification. sulfametomidine or sulfamethomidine bears us nlm identifiers umls id c0075510 and nci concept code c72851. smiles: cc1=nc(=cc(=n1)oc)ns(=o)(=o)c2=cc=c(c=c2)n.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfathiourea. this classification denotes a sulfonamide anti-infective agent with the molecular formula c7h9n3o2s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier mxf9g4i1v5, chemically known as urea, 1-sulfanilyl-2-thio- but generally known as sulfathiourea, which bears us nih compound identifier 3000579. european medicines agency schedules sulfathiourea in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10732mig. the term sulfathiourea is an international non-proprietary name. world health organization schedules sulfathiourea in its anatomical therapeutic chemical (atc) classification. sulfathiourea is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sulfathiourea under hs 29350090 and sitc 51580. as of q4 2014, sulfathiourea remains the us fda preferred term for this commodity. sulfathiourea bears us nlm identifiers umls id c0075539 and nci concept code c76982. smiles: s(=o)(=o)(nc(=s)n)c1ccc(n)cc1.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfametrole. this classification denotes a sulfonamide anti-infective agent with the molecular formula c9h10n4o3s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f5ak41ipqg, chemically known as 4-amino-n-(5-methoxy-2,1,3-thiadiazol-4-yl)benzolsulfonamid but generally known as sulfametrole, which bears us nih compound identifier 64939. european medicines agency schedules sulfametrole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10715mig. the term sulfametrole is an international non-proprietary name or inn (see who inn reference publication, volume 28, no. 10 1974, list 14). sulfametrole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sulfametrole under hs 29350090 and sitc 51580. as of q4 2014, sulfametrole remains the us fda preferred term for this commodity. sulfametrole bears us nlm identifiers umls id c0075512 and nci concept code c72852. smiles: s(=o)(=o)(nc1nsnc1oc)c1ccc(n)cc1.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfamoxole. this classification denotes an anti-infective agent and sulfanilamide with the molecular formula c11h13n3o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hgg82xe020, chemically known as 4,5-dimethyl-2-sulfanilamidooxazole but generally known as sulfamoxole, which bears us nih compound identifier 12894. european medicines agency schedules sulfamoxole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10717mig. world health organization schedules sulfamoxole in its anatomical therapeutic chemical (atc) classification. sulfamoxole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sulfamoxole under hs 29350090 and sitc 51580. as of q4 2014, sulfamoxole remains the us fda preferred term for this commodity. smiles: cc1=c(oc(=n1)ns(=o)(=o)c2=cc=c(c=c2)n)c.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfaperin or sulfaperine. this classification denotes a sulfonamide anti-infective agent with the molecular formula c11h12n4o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w5e840uv9p, chemically known as sulfanilamide, n(sup 1)-(5-methyl-2-pyrimidinyl)- but generally known as sulfaperin, which bears us nih compound identifier 68933. european medicines agency schedules sulfaperin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10720mig. the term sulfaperine is an international non-proprietary name. world health organization schedules sulfaperin in its anatomical therapeutic chemical (atc) classification. sulfaperin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. sulfaperin or sulfaperine bears us nlm identifiers umls id c0075523 and nci concept code c72854. smiles: cc1=cn=c(n=c1)ns(=o)(=o)c2=cc=c(c=c2)n.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfaphenazole. this classification denotes a sulfonamide anti-infective agent with the molecular formula c15h14n4o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0j8l4v3f81, chemically known as sulfanilamide, n(sup 1)-(1-phenylpyrazol-5-yl)- (8ci) but generally known as sulfaphenazole, which bears us nih compound identifier 5335. european medicines agency schedules sulfaphenazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10721mig. the term sulfaphenazole is an international non-proprietary name. world health organization schedules sulfaphenazole in its anatomical therapeutic chemical (atc) classification. sulfaphenazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sulfaphenazole under hs 29350090 and sitc 51580. as of q4 2014, sulfaphenazole remains the us fda preferred term for this commodity. sulfaphenazole bears us nlm identifiers umls id c0038706 and nci concept code c66569. smiles: s(=o)(=o)(nc1n(ncc1)c1ccccc1)c1ccc(n)cc1.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfapyridine. this classification denotes a sulfonamide anti-infective agent with the molecular formula c11h11n3o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier y5v2n1ke8u, chemically known as sulfanilamide, n(sup 1)-2-pyridyl- but generally known as sulfapyridine, which bears us nih compound identifier 5336. european medicines agency schedules sulfapyridine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10724mig. the term sulfapyridine is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17). world health organization schedules sulfapyridine in its anatomical therapeutic chemical (atc) classification. sulfapyridine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sulfapyridine under hs 29350090 and sitc 51580. as of q4 2014, sulfapyridine remains the us fda preferred term for this commodity. sulfapyridine bears us nlm identifiers umls id c0038710 and nci concept code c66570. smiles: c1=cc=nc(=c1)ns(=o)(=o)c2=cc=c(c=c2)n.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfaquinoxaline. this classification denotes a sulfonamide anti-infective agent with the molecular formula c14h12n4o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier wnw8115tm9, chemically known as sulfanilamide, n(sup1)-2-quinoxalinyl- but generally known as sulfaquinoxaline, which bears us nih compound identifier 5338. european medicines agency schedules sulfaquinoxaline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10725mig. the term sulfaquinoxaline is an international non-proprietary name. sulfaquinoxaline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sulfaquinoxaline under hs 29350090 and sitc 51580. as of q4 2014, sulfaquinoxaline remains the us fda preferred term for this commodity. sulfaquinoxaline bears us nlm identifiers umls id c0038711 and nci concept code c76979. smiles: s(=o)(=o)(nc1nc2c(nc1)cccc2)c1ccc(n)cc1.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfathiazole. this classification denotes a sulfonamide anti-infective agent with the molecular formula c9h9n3o2s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier y7fks2xwqh, chemically known as 4-amino-n-1,3-thiazol-2-ylbenzenesulfonamide but generally known as sulfathiazole, which bears us nih compound identifier 5340. european medicines agency schedules sulfathiazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10731mig. the term sulfathiazole is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules sulfathiazole in its anatomical therapeutic chemical (atc) classification. sulfathiazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sulfathiazole under hs 29350090 and sitc 51580. as of q4 2014, sulfathiazole remains the us fda preferred term for this commodity. sulfathiazole bears us nlm identifiers umls id c0038722 and nci concept code c66571. smiles: s(=o)(=o)(nc1sccn1)c1ccc(n)cc1.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfatolamide. this classification denotes a sulfonamide anti-infective agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3olh2hak9f. european medicines agency schedules sulfatolamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10733mig. sulfatolamide generally arises in the molecular formula c7h10n2o2s.c7h9n3o2s2. the term sulfatolamide is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4.) sulfatolamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sulfatolamide under hs 29350090 and sitc 51580. as of q4 2014, sulfatolamide remains the us fda preferred term for this commodity. sulfatolamide bears us nlm identifiers umls id c0075541 and nci concept code c76983. smiles: s(=o)(=o)(nc(=s)n)c1ccc(n)cc1.s(=o)(=o)(n)c1ccc(cc1)cn.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfaisodimidine or sulfamethin or sulfisomidine or sulphasomidine. this classification denotes an anti-infective agent and sulfanilamide with the molecular formula c12h14n4o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w03l3odk6e, chemically known as 4,6-dimethylsulfadiazine but generally known as sulfisomidine, which bears us nih compound identifier 5327. european medicines agency schedules sulfisomidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10739mig. sulfisomidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: cc1=cc(=nc(=n1)ns(=o)(=o)c2=cc=c(c=c2)n)c.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfanilamide or sulphanilamide. this classification denotes a sulfonamide anti-infective agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 21240mf57m. european medicines agency schedules sulfanilamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10718mig. sulfanilamide generally arises in the molecular formula c6h8n2o2s. the term sulfanilamide is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3.) sulfanilamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. sulfanilamide or sulphanilamide bears us nlm identifiers umls id c0038702 and nci concept code c47738. smiles: s(=o)(=o)(n)c1ccc(n)cc1.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. aldesulfone sodium or sulfoxone. this classification denotes a sulfonamide anti-infective agent with the molecular formula c14h16n2o6s3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0g3c18oh4d, chemically known as methanesulfinic acid, (sulfonylbis(4,1-phenyleneimino))bis- but generally known as sulfoxone, which bears us nih compound identifier 5351. aldesulfone sodium or sulfoxone bears us nlm identifiers umls id c0075606 and nci concept code c72856. smiles: c1=cc(=cc=c1ncs(=o)o)s(=o)(=o)c2=cc=c(c=c2)ncs(=o)o.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfatrozole. this classification denotes a sulfonamide anti-infective agent with the molecular formula c10h12n4o3s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g91kdp4m35, chemically known as n1-(4-ethoxy-1,2,5-thiadiazol-3-yl)sulfanilamid but generally known as sulfatrozole, which bears us nih compound identifier 216260. european medicines agency schedules sulfatrozole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10735mig. the term sulfatrozole is an international non-proprietary name or inn (see who inn reference publication, volume 25 , no. 10 1971, list 11). sulfatrozole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sulfatrozole under hs 29350090 and sitc 51580. as of q4 2014, sulfatrozole remains the us fda preferred term for this commodity. sulfatrozole bears us nlm identifiers umls id c2699719 and nci concept code c76984. smiles: ccoc1=nsn=c1ns(=o)(=o)c2=cc=c(c=c2)n.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfadicramide. this classification denotes a sulfonamide antiinfective with the molecular formula c11h14n2o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7wz5eg263c, chemically known as n-(3,3-dimethylacroyl)sulfanilamide but generally known as sulfadicramide, which bears us nih compound identifier 8281. the term sulfadicramide is an international non-proprietary name or inn. european medicines agency schedules sulfadicramide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10697mig. most nations schedule sulfadicramide under hs 29350090 and sitc 51580. as of q4 2014, sulfadicramide remains the us fda preferred term for this commodity. smiles: cc(=cc(=o)ns(=o)(=o)c1=cc=c(c=c1)n)c.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfafenazol. this classification denotes a sulfonamide anti-infective agent with the molecular formula c15h14n4o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0j8l4v3f81, chemically known as sulfanilamide, n(sup 1)-(1-phenylpyrazol-5-yl)- (8ci) but generally known as sulfaphenazole, which bears us nih compound identifier 5335. european medicines agency schedules sulfaphenazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10721mig. the term sulfaphenazole is an international non-proprietary name. world health organization schedules sulfaphenazole in its anatomical therapeutic chemical (atc) classification. sulfaphenazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s(=o)(=o)(nc1n(ncc1)c1ccccc1)c1ccc(n)cc1.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. mafenide acetate. this classification denotes a topical anti-infective agent with the molecular formula c7h10n2o2s.c2h4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier rq6lp6z0wy, chemically known as p-toluenesulfonamide, alpha-amino-, monoacetate but more generally known as mafenide acetate, which bears us nih compound identifier 25590. european medicines agency schedules mafenide acetate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02998mig. most nations, for tariff and trade purposes, schedule mafenide acetate under hs 29350090 and sitc 51580. as of q4 2014, mafenide acetate remains us fdas preferred term for this commodity. mafenide acetate bears us nlm identifiers umls id c0809894 and nci concept code c47591. smiles: cc(=o)o.c1cc(ccc1cn)s(=o)(=o)n.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. salazosulfathiazole. this classification denotes a sulfonamide anti-infective agent, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 56pe10f2ea. the european medicines agency schedules salazosulfathiazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10421mig. salazosulfathiazole generally arises in the molecular formula c16h12n4o5s2. the term salazosulfathiazole is an international non-proprietary name or inn. salazosulfathiazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s(=o)(=o)(nc1sccn1)c1ccc(n/n=c2/c=c(c(=o)c=c2)c(=o)o)cc1.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. mafenide hydrochloride. this classification denotes a carbonic anhydrase inhibitor, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3j751v0284. european medicines agency schedules mafenide hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02999mig. mafenide hydrochloride generally arises in the molecular formula c7h10n2o2s.clh. the term mafenide hydrochloride is an international nomenclature of cosmetic ingredients designation. most nations, for tariff and trade purposes, schedule mafenide hydrochloride under hs 29350090 and sitc 51580. as of q4 2014, mafenide hydrochloride remains us fdas preferred term for this commodity. mafenide hydrochloride bears us nlm identifiers umls id c2698002 and nci concept code c76107. smiles: c1cc(ccc1cn)s(=o)(=o)n.cl.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfachlorpyridazine or sulfaclozine. this classification denotes a sulfonamide anti-infective agent, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier p78d9p90c0. the european medicines agency schedules sulfachlorpyridazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10688mig. sulfachlorpyridazine generally arises in the molecular formula c10h9cln4o2s. the term sulfachlorpyridazine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 16, no. 3 1962, list 4.) sulfachlorpyridazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: c1=cc(=cc=c1n)s(=o)(=o)nc2=cc(=nn=c2)cl.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfacetamide sodium. this classification denotes a sulfonamide anti-infective agent with the molecular formula c8h9n2o3s.na.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4nrt660kjq, chemically known as sulfanilamide, n(sup 1)-acetyl- but more generally known as sulfacetamide sodium, which bears us nih compound identifier 5320. european medicines agency schedules sulfacetamide sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04620mig. most nations, for tariff and trade purposes, schedule sulfacetamide sodium under hs 29350090 and sitc 51580. as of q4 2014, sulfacetamide sodium remains us fdas preferred term for this commodity. sulfacetamide sodium bears us nlm identifiers umls id c0282356 and nci concept code c29467. smiles: cc(=o)[n-]s(=o)(=o)c1ccc(cc1)n.o.[na+].. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfachrysoidine. this classification denotes a sulfonamide anti-infective agent with the molecular formula c13h13n5o4s, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 39o1389k38, chemically known as 4,6-diamino-4-sulfamoylazobenzol-2-carbonsaeure but more generally known as sulfachrysoidine, which bears u.s. national institutes of health compound identifier 68090. the european medicines agency schedules sulfachrysoidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10689mig. the term sulfachrysoidine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 16, no. 3 1962, list 4). sulfachrysoidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s(=o)(=o)(n)c1ccc(/n=n/c2c(cc(n)cc2n)c(=o)o)cc1.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfacetamide sodium anhydrous. this classification denotes a sulfonamide anti-infective agent with the molecular formula c8h9n2o3s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 30760ze777, chemically known as acetamide, n-((4-aminophenyl)sulfonyl)-, monosodium salt, but more generally known as sulfacetamide sodium anhydrous, which bears us nih compound identifier 5320. european medicines agency schedules sulfacetamide sodium anhydrous or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10687mig. most nations, for tariff purposes, schedule sulfacetamide sodium anhydrous under hs 29350090. smiles: cc(=o)[n-]s(=o)(=o)c1ccc(cc1)n.[na+].. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfaclomide. this classification denotes a sulfonamide anti-infective agent with the molecular formula c12h13cln4o2s, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier axa8k5u95m, chemically known as 4-amino-n-(5-chloro-2,6-dimethyl-4-pyrimidinyl)benzenesulfonamide but more generally known as sulfaclomide, which bears u.s. national institutes of health compound identifier 71168. the european medicines agency schedules sulfaclomide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10691mig. the term sulfaclomide is an international non-proprietary name. sulfaclomide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: cc1=c(c(=nc(=n1)c)ns(=o)(=o)c2=cc=c(c=c2)n)cl.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfadiazine silver. this classification denotes a topical anti-infective agent and sulfonamide anti-infective agent with the molecular formula c10h9n4o2s.ag, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w46jy43ejr, chemically known as sulfanilamide, n(sup 1)-2-pyrimidinyl-, monosilver(1+) salt but more generally known as silver sulfadiazine, which bears us nih compound identifier 31011. european medicines agency schedules silver sulfadiazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04622mig. world health organization schedules silver sulfadiazine in its anatomical therapeutic chemical (atc) classification. most nations, for tariff and trade purposes, schedule sulfadiazine silver under hs 29350090 and sitc 51580. smiles: c1cnc(nc1)[n-]s(=o)(=o)c2ccc(cc2)n.[ag+].. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfamonomethoxine. this classification denotes a sulfonamide anti-infective agent with the molecular formula c11h12n4o3s, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier u700p169w2, chemically known as sulfanilamide, n(sup 1)-(6-methoxy-4-pyrimidinyl)- but more generally known as sulfamonomethoxine, which bears u.s. national institutes of health compound identifier 5332. the european medicines agency schedules sulfamonomethoxine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10716mig. the term sulfamonomethoxine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). sulfamonomethoxine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: coc1=nc=nc(=c1)ns(=o)(=o)c2=cc=c(c=c2)n.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfadiazine sodium. this classification denotes a sulfonamide anti-infective agent with the molecular formula c10h9n4o2s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 84cs1p306f, chemically known as trisulfapyrimidine, oral suspension but more generally known as sulfadiazine sodium, which bears us nih compound identifier 5215. european medicines agency schedules sulfadiazine sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10696mig. the term sulfadiazine sodium is an international non-proprietary name or inn (see world health organization inn reference publication, volume 13, no. 12, 1959, list 3). most nations, for tariff and trade purposes, schedule sulfadiazine sodium under hs 29350090 and sitc 51580. as of q4 2014, sulfadiazine sodium remains us fdas preferred term for this commodity. sulfadiazine sodium bears us nlm identifiers umls id c0723509 and nci concept code c66566. smiles: c1cnc(nc1)[n-]s(=o)(=o)c2ccc(cc2)n.[na+].. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfanitran. this classification denotes a sulfonamide anti-infective agent with the molecular formula c14h13n3o5s, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier qt35t5t35q, chemically known as acetanilide, 4-((p-nitrophenyl)sulfamoyl)- (8ci) but more generally known as sulfanitran, which bears u.s. national institutes of health compound identifier 5334. the european medicines agency schedules sulfanitran in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10719mig. the term sulfanitran is an international non-proprietary name. sulfanitran is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s(=o)(=o)(nc1ccc([n](=o)o)cc1)c1ccc(nc(=o)c)cc1.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfamerazine sodium. this classification denotes a sulfonamide anti-infective agent with the molecular formula c11h11n4o2s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier jov4ujy07o, chemically known as sulfanilamide, n(sup 1)-(4-methyl-2-pyrimidinyl)- but more generally known as sulfamerazine sodium, which bears us nih compound identifier 5325. european medicines agency schedules sulfamerazine sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10709mig. the term sulfamerazine sodium is an international non-proprietary name or inn (see world health organization inn reference publication, volume 13, no. 12, 1959, list 3). most nations, for tariff and trade purposes, schedule sulfamerazine sodium under hs 29350090 and sitc 51580. as of q4 2014, sulfamerazine sodium remains us fdas preferred term for this commodity. sulfamerazine sodium bears us nlm identifiers umls id c2728211 and nci concept code c80794. smiles: cc1ccnc(n1)[n-]s(=o)(=o)c2ccc(cc2)n.[na+].. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfaproxyline. this classification denotes a sulfonamide anti-infective agent with the molecular formula c16h18n2o4s, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier yr841r53vw, chemically known as benzamide, p-isopropoxy-n-sulfanilyl- (8ci) but more generally known as sulfaproxyline, which bears u.s. national institutes of health compound identifier 67002. the european medicines agency schedules sulfaproxyline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10722mig. the term sulfaproxyline is an international non-proprietary name or inn (see world health organization inn reference publication, volume 13, no. 12, 1959, list 3). sulfaproxyline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s(=o)(=o)(nc(=o)c1ccc(oc(c)c)cc1)c1ccc(n)cc1.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfamethoxazole sodium. this classification denotes a sulfonamide anti-infective agent c10h10n3o3s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier pj0x8h59ai, chemically known as benzenesulfonamide, 4-amino-n-(5-methyl-3-isoxazolyl)-, sodium salt (1:1), but more generally known as sulfamethoxazole sodium, which bears us nih compound identifier 5329. european medicines agency schedules sulfamethoxazole sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub35068. most nations, for tariff and trade purposes, schedule sulfamethoxazole sodium under hs 29350090 and sitc 51580. as of q4 2014, sulfamethoxazole sodium remains us fdas preferred term for this commodity. smiles: cc1cc(no1)[n-]s(=o)(=o)c2ccc(cc2)n.[na+].. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfarsphenamine. this classification denotes a topical anti-infective agent with the molecular formula c14h14as2n2o8s2.2na, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier b1ggh4zuzl, chemically known as 3,3-diamino-4,4-dihydroxyarsenobenzol-n,n-methanesulfonsaeure dinatrium salz but more generally known as sulfarsphenamine, which bears u.s. national institutes of health compound identifier 71510. the european medicines agency schedules sulfarsphenamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10726mig. the term sulfarsphenamine is an international non-proprietary name. sulfarsphenamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: [ash](=[ash]\\c1cc(ncs(=o)(=o)o)c(o)cc1)/c1cc(ncs(=o)(=o)o)c(o)cc1.[na].[na].. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfaquinoxaline sodium. this classification denotes a sulfonamide anti-infective agent with the molecular formula c14h11n4o2s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 21223epj40, chemically known as n1-(quinoxalin-2-yl)sulphanilamide sodium salt, but more generally known as sulfaquinoxaline sodium, which bears us nih compound identifier 71594. european medicines agency schedules sulfaquinoxaline sodium or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10725mig. most nations, for tariff purposes, schedule sulfaquinoxaline sodium under hs 29350090. sulfaquinoxaline sodium bears us nlm identifiers umls id c2728210 and nci concept code c90992. smiles: c1ccc2c(c1)ncc(n2)[n-]s(=o)(=o)c3ccc(cc3)n.[na+].. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. vanyldisulfamide. this classification denotes a sulfonamide anti-infective agent with the molecular formula c20h22n4o6s2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 541zdl2e7u, chemically known as n4,n4-vanillyldenebis(sulfanilamide) but more generally known as vanyldisulfamide, which bears u.s. national institutes of health compound identifier 216267. the european medicines agency schedules vanyldisulfamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00024mig. the term vanyldisulfamide is an international non-proprietary name. vanyldisulfamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s(=o)(=o)(n)c1ccc(nc(nc2ccc(s(=o)(=o)n)cc2)c2cc(oc)c(o)cc2)cc1.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfathiazole sodium. this classification denotes a sulfonamide anti-infective agent with the molecular formula c9h8n3o2s2.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier pv16n742vm, chemically known as sulfanilamide, n(sup 1)-2-thiazolyl-, n(sup 1)-sodium deriv. but more generally known as sulfathiazole sodium, which bears us nih compound identifier 67415. most nations, for tariff and trade purposes, schedule sulfathiazole sodium under hs 29350090 and sitc 51580. as of q4 2014, sulfathiazole sodium remains us fdas preferred term for this commodity. smiles: c1cc(ccc1n)s(=o)(=o)[n-]c2nccs2.[na+].. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfathiazole sodium monohydrate. this classification denotes a sulfonamide anti-infective agent with the molecular formula c9h8n3o2s2.na.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w6ndw4k12p, chemically known as benzenesulfonamide, 4-amino-n-2-thiazolyl-, sodium salt, hydrate (1:1:1), but more generally known as sulfathiazole sodium monohydrate, which bears us nih compound identifier 24975. european medicines agency schedules sulfathiazole sodium monohydrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10731mig. most nations, for tariff purposes, schedule sulfathiazole sodium monohydrate under hs 29350090. smiles: c1cc(ccc1n)s(=o)(=o)[n-]c2nccs2.o.[na+].. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfathiazole zinc. this classification denotes a sulfonamide anti-infective agent with the molecular formula 2c9h8n3o2s2.zn, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4kci0quf9q, chemically known as benzenesulfonamide, 4-amino-n-2-thiazolyl-, zinc salt, but more generally known as sulfathiazole zinc, which bears us nih compound identifier 21571. european medicines agency schedules sulfathiazole zinc or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10731mig. most nations, for tariff purposes, schedule sulfathiazole zinc under hs 29350090. smiles: c1cc(ccc1n)s(=o)(=o)[n-]c2nccs2.c1cc(ccc1n)s(=o)(=o)[n-]c2nccs2.[zn+2].. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. sulfisomidine sodium. this classification denotes an anti-infective agent and sulfanilamide c12h13n4o2s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 296707f7du, chemically known as sulfisomidine, sodium, but more generally known as sulfisomidine sodium, which bears us nih compound identifier 5343. most nations, for tariff and trade purposes, schedule sulfisomidine sodium under hs 29350090 and sitc 51580. as of q4 2014, sulfisomidine sodium remains us fdas preferred term for this commodity. smiles: cc1cc(nc(n1)c)[n-]s(=o)(=o)c2ccc(cc2)n.[na+].. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. benzylsulfamide. this classification denotes a topical anti-infective agent with the molecular formula c13h14n2o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ai9wdt80fq, chemically known as sulfanilamide, n(sup 4)-benzyl- but more generally known as benzylsulfamide, which bears us nih compound identifier 66909. european medicines agency schedules benzylsulfamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05773mig. the term benzylsulfamide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 16, no. 3 1962, list 4). benzylsulfamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s(=o)(=o)(ncc1ccccc1)c1ccc(n)cc1.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. ditolamide. this classification denotes a sulfonamide anti-infective agent with the molecular formula c13h21no2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier al8499km94, chemically known as 4-methyl-n,n-dipropyl-benzenesulfonamide but more generally known as ditolamide, which bears us nih compound identifier 208847. european medicines agency schedules ditolamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06335mig. the term ditolamide is an international non-proprietary name. ditolamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s(=o)(=o)(n(ccc)ccc)c1ccc(cc1)c.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. glucosulfamide. this classification denotes a sulfonamide anti-infective agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x40l29981f. european medicines agency schedules glucosulfamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07938mig. glucosulfamide generally arises in the molecular formula c13h21n2o11s2.na. the term glucosulfamide is an international non-proprietary name or inn. glucosulfamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s(=o)(=o)(o)c(nc1ccc(s(=o)(=o)nco)cc1)c(o)c(o)c(o)c(o)co.[na].. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. mesulfamide. this classification denotes an antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier y19vnl22l0. european medicines agency schedules mesulfamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08794mig. mesulfamide generally arises in the molecular formula c7h10n2o5s2. the term mesulfamide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 33, no. 10 1979, list 19.) mesulfamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s(=o)(=o)(n)c1ccc(ncs(=o)(=o)o)cc1.. "
"sulfonamide antibacterials. this classification denotes a group of compounds that contain the structure so2nh2. members of this group, also known as sulfa drugs, are derivatives of sulfanilamide (an amide composed of a sulfonyl group connected to an amine, hence the names sulfon-amide, sulfonamide, sulfonamides, or as here, sulfonamide antibacterials), which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. they have been largely supplanted by more effective and less toxic antibacterials.. phthalylsulfamethizole. this classification denotes a sulfonamide anti-infective agent with the molecular formula c17h14n4o5s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier tay5zbm0mo, chemically known as 4-((5-methyl-1,3,4-thiadiazol-2-yl)sulfamoyl)phthalanilic acid but more generally known as phthalylsulfamethizole, which bears us nih compound identifier 3047837. european medicines agency schedules phthalylsulfamethizole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09798mig. the term phthalylsulfamethizole is an international non-proprietary name. phthalylsulfamethizole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s(=o)(=o)(nc1sc(nn1)c)c1ccc(nc(=o)c2c(cccc2)c(=o)o)cc1.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. . "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. apicycline. this classification denotes a tetracycline antibiotic with the molecular formula c30h38n4o11, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t1y573bs7h, chemically known as alpha-(4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamido)-4-(2-hydroxyethyl)-1-piperazineacetic acid but generally known as apicycline, which bears us nih compound identifier 5490216. european medicines agency schedules apicycline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05537mig. the term apicycline is an international non-proprietary name. apicycline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule apicycline under hs 29413000 and sitc 54133. as of q4 2014, apicycline remains the us fda preferred term for this commodity. apicycline bears us nlm identifiers umls id c2698165 and nci concept code c76235. smiles: oc12c(cc3c(o)(c4c(c(=c3c1=o)o)c(o)ccc4)c)c(n(c)c)c(=o)c(=c(\\o)nc(n1ccn(cc1)cco)c(=o)o)\\c2=o.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. chlortetracycline. this classification denotes a tetracycline antibiotic with the molecular formula c22h23cln2o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier wck1kiq23q, chemically known as 2-(amino-hydroxy-methylidene)-7-chloro-4-dimethylamino-6,10,11,12a-tetrahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione but generally known as chlortetracycline, which bears us nih compound identifier 5280963. european medicines agency schedules chlortetracycline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06213mig. the term chlortetracycline is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules chlortetracycline in its anatomical therapeutic chemical (atc) classification. chlortetracycline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule chlortetracycline under hs 29413000 and sitc 54133. as of q4 2014, chlortetracycline remains the us fda preferred term for this commodity. chlortetracycline bears us nlm identifiers umls id c0008293 and nci concept code c61673. smiles: clc1c2c(o)(c3cc4c(o)(c(=o)c3=c(o)c2c(o)cc1)c(=o)/c(=c(\\o)n)c(=o)c4n(c)c)c.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. clomocycline. this classification denotes a tetracycline antibiotic with the molecular formula c23h25cln2o9, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier yp0241bu76, chemically known as 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-n-(hydroxymethyl)-6-methyl-1,11-dioxo-2-naphthacenecarboxamide but generally known as clomocycline, which bears us nih compound identifier 5464321. european medicines agency schedules clomocycline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06726mig. the term clomocycline is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7). world health organization schedules clomocycline in its anatomical therapeutic chemical (atc) classification. clomocycline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule clomocycline under hs 29413000 and sitc 54133. as of q4 2014, clomocycline remains the us fda preferred term for this commodity. clomocycline bears us nlm identifiers umls id c0055923 and nci concept code c76236. smiles: clc1c2c(o)(c3cc4c(o)(c(=o)c3=c(o)c2c(o)cc1)c(=o)/c(=c(\\o)nco)c(=o)c4n(c)c)c.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. demeclocycline. this classification denotes a tetracycline antibiotic with the molecular formula c21h21cln2o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5r5w9ici6o, chemically known as 7-chloro-4-dimethylamino-3,6,10,12,12a-pentahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide but generally known as demeclocycline, which bears us nih compound identifier 5281009. european medicines agency schedules demeclocycline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06963mig. the term demeclocycline is an international non-proprietary name or inn (see who inn reference publication, volume 25 , no. 10 1971, list 11). world health organization schedules demeclocycline in its anatomical therapeutic chemical (atc) classification. demeclocycline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule demeclocycline under hs 29413000 and sitc 54133. as of q4 2014, demeclocycline remains the us fda preferred term for this commodity. demeclocycline bears us nlm identifiers umls id c0011276 and nci concept code c47980. smiles: clc1c2c(o)c3cc4c(o)(c(=o)c3=c(o)c2c(o)cc1)c(=o)/c(=c(\\o)n)c(=o)c4n(c)c.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. demecycline. this classification denotes a tetracycline antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier tv240ch11p. european medicines agency schedules demecycline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06965mig. demecycline generally arises in the molecular formula c21h22n2o8. the term demecycline is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7.) demecycline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule demecycline under hs 29413000 and sitc 54133. as of q4 2014, demecycline remains the us fda preferred term for this commodity. demecycline bears us nlm identifiers umls id c2699585 and nci concept code c76237. smiles: oc12c(cc3c(=c(o)c4c(c3o)cccc4o)c1=o)c(n(c)c)c(=o)c(=c(\\o)n)/c2=o.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. doxycycline. this classification denotes a tetracycline antibiotic with the molecular formula c22h24n2o8.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, n12000u13o chemically known as 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4s-(4.alpha.,4a.alpha.,5.alpha.,5a.alpha.6.alpha.,12a.alpha.))-, monohydrate but generally known as doxycycline, which bears us nih compound identifier 5281011. european medicines agency schedules doxycycline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06393mig. the term doxycycline is an international non-proprietary name or inn (see who inn reference publication, volume 22, no. 10, 1968, list 8. ). most nations schedule doxycycline under hs 29413000 and sitc 54133. as of q4 2014, doxycycline remains the us fda preferred term for this commodity. doxycycline bears us nlm identifiers umls id c0013090 and nci concept code c457. smiles: oc1c2c(o)(c(=o)c3=c(o)c4c(c(c13)c)cccc4o)c(=o)/c(=c(\\o)n)c(=o)c2n(c)c.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. etamocycline. this classification denotes a tetracycline antibiotic with the molecular formula c50h60n6o16, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 96d1l38s9q chemically known as n,n,-(ethylenebis((methylimino)methylene))bis-(4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide) but generally known as etamocycline, which bears us nih compound identifier 5464330. european medicines agency schedules etamocycline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07260mig. the term etamocycline is an international non-proprietary name or inn (see who inn reference publication, volume 22, no. 10, 1968, list 8. ). most nations schedule etamocycline under hs 29413000 and sitc 54133. as of q4 2014, etamocycline remains the us fda preferred term for this commodity. etamocycline bears us nlm identifiers umls id c0601392 and nci concept code c65552. smiles: cc1(c2cc3c(c(=o)c(=c(ncn(c)ccn(c)cnc(=c4c(=o)c(c5cc6c(=c(c7=c(c6(c)o)c=cc=c7o)o)c(=o)c5(c4=o)o)n(c)c)o)o)c(=o)c3(c(=o)c2=c(c8=c1c=cc=c8o)o)o)n(c)c)o.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. guamecycline. this classification denotes a tetracycline antibiotic with the molecular formula c29h38n8o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 4nqr4r6g3s chemically known as n-((4-(amidinoamidino)-1-piperazinyl)methyl)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide but generally known as guamecycline, which bears us nih compound identifier 5464311. european medicines agency schedules guamecycline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07977mig. the term guamecycline is an international non-proprietary name or inn (see who inn reference publication, volume 24, no. 11 1970, list 10. ). most nations schedule guamecycline under hs 29413000 and sitc 54133. as of q4 2014, guamecycline remains the us fda preferred term for this commodity. guamecycline bears us nlm identifiers umls id c0061935 and nci concept code c90947. smiles: cc1(c2cc3c(c(=o)/c(=c(\\ncn4ccn(cc4)c(=n)n=c(n)n)/o)/c(=o)c3(c(=o)c2=c(c5=c1c=cc=c5o)o)o)n(c)c)o.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. lymecycline. this classification denotes a tetracycline antibiotic with the molecular formula c29h38n4o10, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7d6em3s13p, chemically known as 2-(amino-hydroxy-methylidene)-7-chloro-4-dimethylamino-6,10,11,12a-tetrahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione but generally known as lymecycline, which bears us nih compound identifier 5280963. european medicines agency schedules lymecycline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08625mig. the term lymecycline is an international non-proprietary name. world health organization schedules lymecycline in its anatomical therapeutic chemical (atc) classification. lymecycline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule lymecycline under hs 29413000 and sitc 54133. as of q4 2014, lymecycline remains the us fda preferred term for this commodity. lymecycline bears us nlm identifiers umls id c0024200 and nci concept code c76991. smiles: clc1c2c(o)(c3cc4c(o)(c(=o)c3=c(o)c2c(o)cc1)c(=o)/c(=c(\\o)n)c(=o)c4n(c)c)c.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. meclocycline. this classification denotes a tetracycline antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 23q8m2he6s. european medicines agency schedules meclocycline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08677mig. meclocycline generally arises in the molecular formula c22h21cln2o8. the term meclocycline is an international non-proprietary name or inn. meclocycline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule meclocycline under hs 29413000 and sitc 54133. as of q4 2014, meclocycline remains the us fda preferred term for this commodity. meclocycline bears us nlm identifiers umls id c0065841 and nci concept code c61825. smiles: clc1c2c(=c)c3c(o)c4c(o)(c(=o)c3=c(o)c2c(o)cc1)c(=o)/c(=c(\\o)n)c(=o)c4n(c)c.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. metacycline or methacycline. this classification denotes a macrolide antibiotic with the molecular formula c22h22n2o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ir235i7c5p, chemically known as 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-2-naphthacenecarboxamide but generally known as metacycline, which bears us nih compound identifier 5281054. european medicines agency schedules metacycline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08801mig. the term metacycline is an international non-proprietary name. world health organization schedules metacycline in its anatomical therapeutic chemical (atc) classification. metacycline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. metacycline or methacycline bears us nlm identifiers umls id c0025603 and nci concept code c61839. smiles: oc12c(c(o)c3c(=c(o)c4c(c3=c)cccc4o)c1=o)c(n(c)c)c(=o)c(=c(\\o)n)\\c2=o.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. minocycline. this classification denotes a tetracycline antibiotic with the molecular formula c23h27n3o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fyy3r43wgo, chemically known as 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide but generally known as minocycline, which bears us nih compound identifier 5281021. european medicines agency schedules minocycline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08980mig. the term minocycline is an international non-proprietary name. world health organization schedules minocycline in its anatomical therapeutic chemical (atc) classification. minocycline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule minocycline under hs 29413000 and sitc 54133. as of q4 2014, minocycline remains the us fda preferred term for this commodity. minocycline bears us nlm identifiers umls id c0026187 and nci concept code c61849. smiles: oc12c(cc3c(=c(o)c4c(c3)c(n(c)c)ccc4o)c1=o)c(n(c)c)c(=o)c(=c(\\o)n)\\c2=o.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. nitrocycline. this classification denotes a tetracycline antibiotic with the molecular formula c21h21n3o9, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2jh9lr1y6s, chemically known as 4-(dimethylamino)-1,3,3a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-7-nitro-1,11-dioxo-2-naphthacene-carboxamide but generally known as nitrocycline, which bears us nih compound identifier 5489904. european medicines agency schedules nitrocycline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09323mig. the term nitrocycline is an international non-proprietary name. nitrocycline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nitrocycline under hs 29413000 and sitc 54133. as of q4 2014, nitrocycline remains the us fda preferred term for this commodity. nitrocycline bears us nlm identifiers umls id c2698476 and nci concept code c76992. smiles: oc12c(cc3c(=c(o)c4c(c3)c([n](=o)o)ccc4o)c1=o)c(n(c)c)c(=o)c(=c(\\o)n)\\c2=o.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. oxytetracycline. this classification denotes a tetracycline antibiotic with the molecular formula c22h24n2o9.2h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x20i9en955, chemically known as 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo- but generally known as oxytetracycline, which bears us nih compound identifier 5280972. european medicines agency schedules oxytetracycline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09579mig. world health organization schedules oxytetracycline in its anatomical therapeutic chemical (atc) classification. oxytetracycline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule oxytetracycline under hs 29413000 and sitc 54133. as of q4 2014, oxytetracycline remains the us fda preferred term for this commodity. oxytetracycline bears us nlm identifiers umls id c0030092 and nci concept code c61872. smiles: oc1c2c(o)(c(=o)c3=c(o)c4c(c(o)(c13)c)cccc4o)c(=o)/c(=c(\\o)n)c(=o)c2n(c)c.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. pipacycline. this classification denotes a tetracycline antibiotic with the molecular formula c29h38n4o9, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, pq3p6082i5 chemically known as 4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-penta-hydroxy-n-((4-(2-hydroxyethyl)-1-piperazinyl)methyl)-6-methyl-1,11-dioxo-2-naphthacenecarboxamide but generally known as pipacycline, which bears us nih compound identifier 5357020. european medicines agency schedules pipacycline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09858mig. the term pipacycline is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5. ). most nations schedule pipacycline under hs 29413000 and sitc 54133. as of q4 2014, pipacycline remains the us fda preferred term for this commodity. pipacycline bears us nlm identifiers umls id c1882382 and nci concept code c66391. smiles: oc12c(cc3c(o)(c4c(c(=c3c1=o)o)c(o)ccc4)c)c(n(c)c)c(=o)c(=c(\\o)ncn1ccn(cc1)cco)\\c2=o.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. rolitetracycline. this classification denotes a tetracycline antibiotic with the molecular formula c27h33n3o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier gh9iw85221, chemically known as tetracycline, n-(pyrrolidinylmethyl)- but generally known as rolitetracycline, which bears us nih compound identifier 5282179. european medicines agency schedules rolitetracycline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10368mig. the term rolitetracycline is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules rolitetracycline in its anatomical therapeutic chemical (atc) classification. rolitetracycline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule rolitetracycline under hs 29413000 and sitc 54133. as of q4 2014, rolitetracycline remains the us fda preferred term for this commodity. rolitetracycline bears us nlm identifiers umls id c0035823 and nci concept code c80801. smiles: oc12c(cc3c(o)(c4c(c(=c3c1=o)o)c(o)ccc4)c)c(n(c)c)c(=o)c(=c(\\o)ncn1cccc1)\\c2=o.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. tetracycline. this classification denotes a tetracycline antibiotic with the molecular formula c22h24n2o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f8vb5m810t, chemically known as 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4s,4as,5as,6s,12as)- but generally known as tetracycline, which bears us nih compound identifier 5280962. european medicines agency schedules tetracycline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10942mig. the term tetracycline is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules tetracycline in its anatomical therapeutic chemical (atc) classification. tetracycline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tetracycline under hs 29413000 and sitc 54133. as of q4 2014, tetracycline remains the us fda preferred term for this commodity. tetracycline bears us nlm identifiers umls id c0039644 and nci concept code c865. smiles: oc12c(cc3c(o)(c4c(c(=c3c1=o)o)c(o)ccc4)c)c(n(c)c)c(=o)c(=c(\\o)n)\\c2=o.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. chlortetracycline bisulfate. this classification denotes a tetracycline antibiotic with the molecular formula c22h23cln2o8.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1d06kz672i, chemically known as 2-(amino-hydroxy-methylidene)-7-chloro-4-dimethylamino-6,10,11,12a-tetrahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione but more generally known as chlortetracycline bisulfate, which bears us nih compound identifier 5280963. most nations, for tariff and trade purposes, schedule chlortetracycline bisulfate under hs 29413000 and sitc 54133. as of q4 2014, chlortetracycline bisulfate remains us fdas preferred term for this commodity. chlortetracycline bisulfate bears us nlm identifiers umls id c0282101 and nci concept code c76989. smiles: c[c@]1(c2c(ccc(c2c(=o)c3=c([c@]4([c@@h](c[c@@h]31)[c@@h](c(=c(c4=o)c(=o)n)o)n(c)c)o)o)o)cl)o.os(=o)(=o)o.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. chlortetracycline calcium. this classification denotes a tetracycline antibiotic c22h23cln2o8.ca, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier nr4b2sx17s, chemically known as 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide calcium salt, but more generally known as chlortetracycline calcium, which bears us nih compound identifier 71458158. most nations, for tariff and trade purposes, schedule chlortetracycline calcium under hs 29413000 and sitc 54133. as of q4 2014, chlortetracycline calcium remains us fdas preferred term for this commodity. chlortetracycline calcium bears us nlm identifiers umls id c2723846 and nci concept code c80800. smiles: c[c@]1(c2c(ccc(c2c(=o)c3=c([c@]4([c@@h](c[c@@h]31)[c@@h](c(=c(c4=o)c(=o)n)o)n(c)c)o)o)o)cl)o.[ca+2].. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. chlortetracycline hydrochloride. this classification denotes a tetracycline antibiotic with the molecular formula c22h23cln2o8.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier o1gx33on8r, chemically known as 2-(amino-hydroxy-methylidene)-7-chloro-4-dimethylamino-6,10,11,12a-tetrahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione but more generally known as chlortetracycline hydrochloride, which bears us nih compound identifier 5280963. european medicines agency schedules chlortetracycline hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01258mig. most nations, for tariff and trade purposes, schedule chlortetracycline hydrochloride under hs 29413000 and sitc 54133. as of q4 2014, chlortetracycline hydrochloride remains us fdas preferred term for this commodity. chlortetracycline hydrochloride bears us nlm identifiers umls id c0728748 and nci concept code c47448. smiles: c[c@]1(c2c(ccc(c2c(=o)c3=c([c@]4([c@@h](c[c@@h]31)[c@@h](c(=c(c4=o)c(=o)n)o)n(c)c)o)o)o)cl)o.cl.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. clomocycline sodium. this classification denotes a tetracycline antibiotic c23h24cln2o9.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier v4jnk46u1u, chemically known as 2-naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-n-(hydroxymethyl)-6-methyl-1,11-dioxo-, monosodium salt, (4s-(4.alpha.,4a.alpha.,5a.alpha.,6.beta.,12a.alpha.))-, but more generally known as clomocycline sodium, which bears us nih compound identifier 72710627. most nations, for tariff and trade purposes, schedule clomocycline sodium under hs 29413000 and sitc 54133. as of q4 2014, clomocycline sodium remains us fdas preferred term for this commodity. smiles: c[c@]1(c2c(ccc(c2c(=o)c3=c([c@]4([c@@h](c[c@@h]31)[c@@h](c(=c(c4=o)c(=o)nco)[o-])n(c)c)o)o)o)cl)o.[na+].. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. demeclocycline calcium. this classification denotes a tetracycline antibiotic 2c21h20cln2o8.ca, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier sd6s4yy5hp, chemically known as 2-naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-, calcium salt (2:1), (4s-(4.alpha.,4a.alpha.,5a.alpha.,6.beta.,12a.alpha.))-, but more generally known as demeclocycline calcium, which bears us nih compound identifier 72941516. most nations, for tariff and trade purposes, schedule demeclocycline calcium under hs 29413000 and sitc 54133. as of q4 2014, demeclocycline calcium remains us fdas preferred term for this commodity. smiles: cn(c)[c@h]1[c@@h]2c[c@@h]3[c@@h](c4c(ccc(c4c(=o)c3=c([c@@]2(c(=o)c(=c1o)c(=o)n)o)o)[o-])cl)o.cn(c)[c@h]1[c@@h]2c[c@@h]3[c@@h](c4c(ccc(c4c(=o)c3=c([c@@]2(c(=o)c(=c1o)c(=o)n)o)o)[o-])cl)o.[ca+2].. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. demeclocycline hydrochloride. this classification denotes a tetracycline antibiotic with the molecular formula c21h21cln2o8.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 29o079ntyt, chemically known as 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride but more generally known as demeclocycline hydrochloride, which bears us nih compound identifier 5281008. european medicines agency schedules demeclocycline hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01578mig. most nations, for tariff and trade purposes, schedule demeclocycline hydrochloride under hs 29413000 and sitc 54133. as of q4 2014, demeclocycline hydrochloride remains us fdas preferred term for this commodity. demeclocycline hydrochloride bears us nlm identifiers umls id c0701198 and nci concept code c28975. smiles: cn(c)[c@h]1[c@@h]2c[c@@h]3[c@@h](c4c(ccc(c4c(=o)c3=c([c@@]2(c(=o)c(=c1o)c(=o)n)o)o)o)cl)o.cl.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. doxycycline anhydrous. this classification denotes a tetracycline antibiotic with the molecular formula c22h24n2o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 334895s862, chemically known as 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4s-(4.alpha.,4a.alpha.,5.alpha.,5a.alpha.,6.alpha.,12a.alpha.))-, but more generally known as doxycycline anhydrous, which bears us nih compound identifier 5281011. european medicines agency schedules doxycycline anhydrous or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06393mig. most nations, for tariff purposes, schedule doxycycline anhydrous under hs 29413000. doxycycline anhydrous bears us nlm identifiers umls id c2699808 and nci concept code c76990. smiles: c[c@h]1c2cccc(c2c(=o)c3=c([c@]4([c@@h]([c@h]([c@h]13)o)[c@@h](c(=c(c4=o)c(=o)n)o)n(c)c)o)o)o.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. doxycycline calcium. this classification denotes a tetracycline antibiotic c22h24n2o8.2ca, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8zl07i20sb, chemically known as 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4s-(4a,4aa,5a,5aa,6a,12aa))-, calcium salt (2:1), but more generally known as doxycycline calcium, which bears us nih compound identifier 62305. european medicines agency schedules doxycycline calcium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01828mig. most nations, for tariff and trade purposes, schedule doxycycline calcium under hs 29413000 and sitc 54133. as of q4 2014, doxycycline calcium remains us fdas preferred term for this commodity. doxycycline calcium bears us nlm identifiers umls id c0282155 and nci concept code c29008. smiles: c[c@h]1c2cccc(c2c(=o)c3=c([c@]4([c@@h]([c@h]([c@h]13)o)[c@@h](c(=c(c4=o)c(=o)n)o)n(c)c)o)o)o.[ca+2].[ca+2].. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. doxycycline fosfatex. this classification denotes a tetracycline antibiotic with the molecular formula 3c22h24n2o8.na.o3p.3ho3p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2iq26u2dzq, chemically known as (4s,4ar,5s,5ar,6r,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide, compound with sodium trihydrogen metaphosphate (h(sub 3)nap(sub 4)o(sub 12)) (3:1), but more generally known as doxycycline fosfatex, which bears us nih compound identifier 6441613. european medicines agency schedules doxycycline fosfatex or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06393mig. most nations, for tariff purposes, schedule doxycycline fosfatex under hs 29413000. smiles:. doxycycline fosfatex bears us nlm identifiers umls id c3468030 and nci concept code c98040.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. doxycycline hyclate. this classification denotes a tetracycline antibiotic with the molecular formula 2c22h24n2o8.c2h6o.2clh.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 19xts3t51u, chemically known as 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy- 6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrate but more generally known as doxycycline hyclate, which bears us nih compound identifier 5281011. european medicines agency schedules doxycycline hyclate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01830mig. most nations, for tariff and trade purposes, schedule doxycycline hyclate under hs 29413000 and sitc 54133. as of q4 2014, doxycycline hyclate remains us fdas preferred term for this commodity. doxycycline hyclate bears us nlm identifiers umls id c0058731 and nci concept code c29007. smiles: cco.c[c@h]1c2cccc(c2c(=o)c3=c([c@]4([c@@h]([c@h]([c@h]13)o)[c@@h](c(=c(c4=o)c(=o)n)o)n(c)c)o)o)o.c[c@h]1c2cccc(c2c(=o)c3=c([c@]4([c@@h]([c@h]([c@h]13)o)[c@@h](c(=c(c4=o)c(=o)n)o)n(c)c)o)o)o.o.cl.cl.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. doxycycline hydrochloride. this classification denotes a tetracycline antibiotic with the molecular formula c22h24n2o8.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4182z6t2et. european medicines agency schedules doxycycline hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01831mig. most nations, for tariff and trade purposes, schedule doxycycline hydrochloride under hs 29413000 and sitc 54133. as of q4 2014, doxycycline hydrochloride remains us fdas preferred term for this commodity. doxycycline hydrochloride bears us nlm identifiers umls id c0771947 and nci concept code c29010. smiles: c[c@h]1c2cccc(c2c(=o)c3=c([c@]4([c@@h]([c@h]([c@h]13)o)[c@@h](c(=c(c4=o)c(=o)n)o)n(c)c)o)o)o.cl.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. doxycycline hydrochloride hemiethanolate hemihydrate. this classification denotes a tetracycline antibiotic with the molecular formula 2c22h24n2o8.c2h6o.2clh.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 19xts3t51u, chemically known as 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride, compound with ethyl alcohol (2:1), monohydrate, but more generally known as doxycycline hydrochloride hemiethanolate hemihydrate, which bears us nih compound identifier 5282244. european medicines agency schedules doxycycline hydrochloride hemiethanolate hemihydrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06393mig. most nations, for tariff purposes, schedule doxycycline hydrochloride hemiethanolate hemihydrate under hs 29413000. smiles: cco.c[c@h]1c2cccc(c2c(=o)c3=c([c@]4([c@@h]([c@h]([c@h]13)o)[c@@h](c(=c(c4=o)c(=o)n)o)n(c)c)o)o)o.c[c@h]1c2cccc(c2c(=o)c3=c([c@]4([c@@h]([c@h]([c@h]13)o)[c@@h](c(=c(c4=o)c(=o)n)o)n(c)c)o)o)o.o.cl.cl.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. doxycycline monohydrate. this classification denotes a tetracycline antibiotic with the molecular structure c22h24n2o8.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, n12000u13o chemically known as 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4s-(4.alpha.,4a.alpha.,5.alpha.,5a.alpha.6.alpha.,12a.alpha.))-, monohydrate, but more commonly known as doxycycline, which bears us nih compound identifier 5281011. european medicines agency schedules doxycycline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06393mig. the term doxycycline is an international non-proprietary name or inn (see world health organization inn reference publication, volume 22, no. 10, 1968, list 8. ). most nations, for tariff and trade purposes, schedule doxycycline monohydrate under hs 29413000 and sitc 54133. smiles: c[c@h]1c2cccc(c2c(=o)c3=c([c@]4([c@@h]([c@h]([c@h]13)o)[c@@h](c(=c(c4=o)c(=o)n)o)n(c)c)o)o)o.o.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. doxycycline phosphate. this classification denotes a tetracycline antibiotic with the molecular formula c22h24n2o8.h3o4p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier qg2v1m96hm. european medicines agency schedules doxycycline phosphate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01833mig. most nations, for tariff and trade purposes, schedule doxycycline phosphate under hs 29413000 and sitc 54133. as of q4 2014, doxycycline phosphate remains us fdas preferred term for this commodity. doxycycline phosphate bears us nlm identifiers umls id cl436807 and nci concept code c102526. smiles: c[c@h]1c2cccc(c2c(=o)c3=c([c@]4([c@@h]([c@h]([c@h]13)o)[c@@h](c(=c(c4=o)c(=o)n)o)n(c)c)o)o)o.op(=o)(o)o.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. guamecycline dihydrochloride. this classification denotes a tetracycline antibiotic with the molecular formula c29h38n8o8.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier dl609mm5i8, chemically known as 2-naphthacenecarboxamide, n-((4-(((aminoiminomethyl)amino)iminomethyl)-1-piperazinyl)methyl)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, hydrochloride (1:2), (4s,4as,5as,6s,12as)-, but more generally known as guamecycline dihydrochloride, which bears us nih compound identifier 5464418. european medicines agency schedules guamecycline dihydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07977mig. most nations, for tariff purposes, schedule guamecycline dihydrochloride under hs 29413000. smiles: c[c@]1(c2cccc(c2c(=o)c3=c([c@]4([c@@h](c[c@@h]31)[c@@h](c(=c(c4=o)c(=o)ncn5ccn(cc5)c(=n)nc(=n)n)o)n(c)c)o)o)o)o.cl.cl.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. meclocycline sulfosalicylate. this classification denotes a tetracycline antibiotic with the molecular structure c22h21cln2o8.c7h6o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 46vza7rx2b chemically known as 2-naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-, (4s-(4.alpha.,4a.alpha.,5.alpha.,5a.alpha.,12a.alpha.))-, mono(2-hydroxy-5-sulfobenzoate) (salt), but more commonly known as meclocycline sulfosalicylate, which bears us nih compound identifier 5282520. european medicines agency schedules meclocycline sulfosalicylate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03105mig. most nations, for tariff and trade purposes, schedule meclocycline sulfosalicylate under hs 29413000 and sitc 54133. as of q4 2014, meclocycline sulfosalicylate remains us fdas preferred term for this commodity. meclocycline sulfosalicylate bears us nlm identifiers umls id c0700494 and nci concept code c47596. smiles: cn(c)[c@h]1[c@@h]2[c@h]([c@@h]3c(=c)c4c(ccc(c4c(=o)c3=c([c@@]2(c(=o)c(=c1o)c(=o)n)o)o)o)cl)o.c1cc(c(cc1s(=o)(=o)o)c(=o)o)o.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. methacycline hydrochloride. this classification denotes a tetracycline antibiotic with the molecular formula c22h22n2o8.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9gj0n7zap0, chemically known as 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride but more generally known as methacycline hydrochloride, which bears us nih compound identifier 5281092. most nations, for tariff and trade purposes, schedule methacycline hydrochloride under hs 29413000. as of q4 2014, methacycline hydrochloride remains us fdas preferred term for this commodity. methacycline hydrochloride bears us nlm identifiers umls id c0770655 and nci concept code c47608. smiles: cn(c)[c@h]1[c@@h]2[c@h]([c@@h]3c(=c)c4cccc(c4c(=o)c3=c([c@@]2(c(=o)c(=c1o)c(=o)n)o)o)o)o.cl.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. minocycline hydrochloride. this classification denotes a tetracycline antibiotic with the molecular formula c23h27n3o7.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0020414e5u, chemically known as 7-dimethylamino-6-demethyl-6-deoxytetracycline, hcl but more generally known as minocycline hydrochloride, which bears us nih compound identifier 5281093. european medicines agency schedules minocycline hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03304mig. most nations, for tariff and trade purposes, schedule minocycline hydrochloride under hs 29413000 and sitc 54133. as of q4 2014, minocycline hydrochloride remains us fdas preferred term for this commodity. minocycline hydrochloride bears us nlm identifiers umls id c0026186 and nci concept code c47622. smiles: cn(c)c1ccc(c2c1c[c@h]3c[c@h]4[c@@h](c(=c(c(=o)[c@]4(c(=c3c2=o)o)o)c(=o)n)o)n(c)c)o.cl.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. oxytetracycline anhydrous. this classification denotes a tetracycline antibiotic with the molecular formula c22h24n2o9, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier slf0d9077s, chemically known as oxytetracycline (anhydrous) [hsdb], but more generally known as oxytetracycline anhydrous, which bears us nih compound identifier 5280972. european medicines agency schedules oxytetracycline anhydrous or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09579mig. most nations, for tariff purposes, schedule oxytetracycline anhydrous under hs 29413000. oxytetracycline anhydrous bears us nlm identifiers umls id c2698682 and nci concept code c74596. smiles: c[c@]1(c2cccc(c2c(=o)c3=c([c@]4([c@@h]([c@h]([c@@h]31)o)[c@@h](c(=c(c4=o)c(=o)n)o)n(c)c)o)o)o)o.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. oxytetracycline calcium. this classification denotes a tetracycline antibiotic with the molecular formula 2c22h23n2o9.ca, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier c8mrz07fdv. european medicines agency schedules oxytetracycline calcium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03600mig. the term oxytetracycline calcium is a u.s. pharmacopeial convention designation. most nations, for tariff and trade purposes, schedule oxytetracycline calcium under hs 29413000 and sitc 54133. as of q4 2014, oxytetracycline calcium remains us fdas preferred term for this commodity. oxytetracycline calcium bears us nlm identifiers umls id c0282277 and nci concept code c66287. smiles: c[c@]1(c2cccc(c2c(=o)c3=c([c@]4([c@@h]([c@h]([c@@h]31)o)[c@@h](c(=c(c4=o)c(=o)n)[o-])n(c)c)o)o)o)o.c[c@]1(c2cccc(c2c(=o)c3=c([c@]4([c@@h]([c@h]([c@@h]31)o)[c@@h](c(=c(c4=o)c(=o)n)[o-])n(c)c)o)o)o)o.[ca+2].. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. oxytetracycline dihydrate. this classification denotes a tetracycline antibiotic with the molecular formula c22h24n2o9.2h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x20i9en955, chemically known as 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo- but more generally known as oxytetracycline, which bears us nih compound identifier 5280972. european medicines agency schedules oxytetracycline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09579mig. world health organization schedules oxytetracycline in its anatomical therapeutic chemical (atc) classification. oxytetracycline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule oxytetracycline dihydrate under hs 29413000 and sitc 54133. smiles: c[c@]1(c2cccc(c2c(=o)c3=c([c@]4([c@@h]([c@h]([c@@h]31)o)[c@@h](c(=c(c4=o)c(=o)n)o)n(c)c)o)o)o)o.o.o.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. oxytetracycline hydrochloride. this classification denotes a tetracycline antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4u7k4n52zm. european medicines agency schedules oxytetracycline hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14740mig. oxytetracycline hydrochloride generally arises in the molecular formula c22h24n2o9.clh. the term oxytetracycline hydrochloride is a u.s. pharmacopeial convention designation. most nations, for tariff and trade purposes, schedule oxytetracycline hydrochloride under hs 29413000 and sitc 54133. as of q4 2014, oxytetracycline hydrochloride remains us fdas preferred term for this commodity. oxytetracycline hydrochloride bears us nlm identifiers umls id c0017449 and nci concept code c47649. smiles: c[c@]1(c2cccc(c2c(=o)c3=c([c@]4([c@@h]([c@h]([c@@h]31)o)[c@@h](c(=c(c4=o)c(=o)n)o)n(c)c)o)o)o)o.cl.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. rolitetracycline nitrate. this classification denotes a tetracycline antibiotic with the molecular structure 2c27h33n3o8.2hno3.3h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, tg72bs085y chemically known as 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-n-(1-pyrrolidinylmethyl)-, (4s-(4.alpha.,4a.alpha.,5a.alpha.,6.beta.,12a.alpha.))-, mononitrate (salt), sesquihydrate, but more commonly known as rolitetracycline nitrate, which bears us nih compound identifier 5282178. european medicines agency schedules rolitetracycline nitrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04262mig. most nations, for tariff and trade purposes, schedule rolitetracycline nitrate under hs 29413000 and sitc 54133. as of q4 2014, rolitetracycline nitrate remains us fdas preferred term for this commodity. smiles: c[c@]1(c2cccc(c2c(=o)c3=c([c@]4([c@@h](c[c@@h]31)[c@@h](c(=c(c4=o)c(=o)ncn5cccc5)o)n(c)c)o)o)o)o.c[c@]1(c2cccc(c2c(=o)c3=c([c@]4([c@@h](c[c@@h]31)[c@@h](c(=c(c4=o)c(=o)ncn5cccc5)o)n(c)c)o)o)o)o.[n+](=o)(o)[o-].[n+](=o)(o)[o-].o.o.o.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. rolitetracycline nitrate anhydrous. this classification denotes a tetracycline antibiotic with the molecular formula c27h33n3o8.hno3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 496esb4hte, chemically known as 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-n-(1-pyrrolidinylmethyl)-, (4s-(4.alpha.,4a.alpha.,5a.alpha.,6.beta.,12a.alpha.))-, mononitrate (salt),, but more generally known as rolitetracycline nitrate anhydrous, which bears us nih compound identifier 5360293. european medicines agency schedules rolitetracycline nitrate anhydrous or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10368mig. most nations, for tariff purposes, schedule rolitetracycline nitrate anhydrous under hs 29413000. smiles: c[c@]1(c2cccc(c2c(=o)c3=c([c@]4([c@@h](c[c@@h]31)[c@@h](c(=c(c4=o)c(=o)ncn5cccc5)o)n(c)c)o)o)o)o.[n+](=o)(o)[o-].. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. tetracycline guaiacolsulfonate. this classification denotes a tetracycline antibiotic c22h24n2o8.c7h8o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 05t77p89we, chemically known as 4-hydroxy-3-methoxybenzenesulfonic acid, (2z,4s,4as,5as,6r,12as)-2-(amino(hydroxy)methylidene)-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-6-methyl-4a,5a,6,12a-tetrahydrotetracene-1,3,12(2h,4h,5h)-trione (1:1), but more generally known as tetracycline guaiacolsulfonate, which bears us nih compound identifier 71300435. european medicines agency schedules tetracycline guaiacolsulfonate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04759mig. most nations, for tariff and trade purposes, schedule tetracycline guaiacolsulfonate under hs 29413000 and sitc 54133. as of q4 2014, tetracycline guaiacolsulfonate remains us fdas preferred term for this commodity. smiles: c[c@]1(c2cccc(c2c(=o)c3=c([c@]4([c@@h](c[c@@h]31)[c@@h](c(=c(c4=o)c(=o)n)o)n(c)c)o)o)o)o.coc1cc(ccc1o)s(=o)(=o)o.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. tetracycline hydrochloride. this classification denotes a tetracycline antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier p6r62377kv. european medicines agency schedules tetracycline hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04760mig. tetracycline hydrochloride generally arises in the molecular formula c22h24n2o8.clh. the term tetracycline hydrochloride is a u.s. pharmacopeial convention designation. most nations, for tariff and trade purposes, schedule tetracycline hydrochloride under hs 29413000 and sitc 54133. as of q4 2014, tetracycline hydrochloride remains us fdas preferred term for this commodity. tetracycline hydrochloride bears us nlm identifiers umls id c0546879 and nci concept code c48020. smiles: c[c@]1(c2cccc(c2c(=o)c3=c([c@]4([c@@h](c[c@@h]31)[c@@h](c(=c(c4=o)c(=o)n)o)n(c)c)o)o)o)o.cl.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. tetracycline metaphosphate. this classification denotes a tetracycline antibiotic with the molecular structure c22h24n2o8.(na)mod.(o3p)mod, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 6b7bk5h33b chemically known as 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo, (4s-(4.alpha.,4a.alpha.,5a.alpha.,6.beta.,12a.alpha.))-, phosphate complex, but more commonly known as tetracycline phosphate complex, which bears us nih compound identifier 16131193. european medicines agency schedules tetracycline phosphate complex in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04761mig. most nations, for tariff and trade purposes, schedule tetracycline metaphosphate under hs 29413000. smiles:.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. tetracycline phosphate. this classification denotes a tetracycline antibiotic with the molecular formula c22h24n2o8.h3o4p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier nz662xy5pp. the term tetracycline phosphate is a u.s. fda green book designation. most nations, for tariff and trade purposes, schedule tetracycline phosphate under hs 29413000. as of q4 2014, tetracycline phosphate remains us fdas preferred term for this commodity. smiles: c[c@@]1(c2cccc(c2c(=o)c3=c([c@]4([c@@h](c[c@@h]31)[c@@h](c(=c(c4=o)c(=o)n)o)n(c)c)o)o)o)o.op(=o)(o)o.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. tetracycline phosphate complex. this classification denotes a tetracycline antibiotic with the molecular structure c22h24n2o8.(na)mod.(o3p)mod, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 6b7bk5h33b chemically known as 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo, (4s-(4.alpha.,4a.alpha.,5a.alpha.,6.beta.,12a.alpha.))-, phosphate complex, but more commonly known as tetracycline phosphate complex, which bears us nih compound identifier 16131193. european medicines agency schedules tetracycline phosphate complex in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04761mig. most nations, for tariff and trade purposes, schedule tetracycline phosphate complex under hs 29413000 and sitc 54133. tetracycline phosphate complex bears us nlm identifiers umls id c0521901 and nci concept code c87225. smiles: as of q4 2014, tetracycline phosphate complex remains us fdas preferred term for this commodity.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. tetracycline trihydrate. this classification denotes a tetracycline antibiotic c22h24n2o8.3h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 93v6nc52sb, chemically known as 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, hydrate (1:3), (4s,4as,5as,6s,12as)-, but more generally known as tetracycline trihydrate, which bears us nih compound identifier 67858637. most nations, for tariff and trade purposes, schedule tetracycline trihydrate under hs 29413000 and sitc 54133. as of q4 2014, tetracycline trihydrate remains us fdas preferred term for this commodity. smiles: c[c@]1(c2cccc(c2c(=o)c3=c([c@]4([c@@h](c[c@@h]31)[c@@h](c(=c(c4=o)c(=o)n)o)n(c)c)o)o)o)o.o.o.o.. "
"tetracyclines. this classification denotes closely congeneric derivatives of the polycyclic naphthacenecarboxamide, and naphthacene antibiotics that inhibits amino acyl trna binding during protein synthesis, a four-ringed cyclic compound, tetra-cycline, tetrac-yclines, and tetracycline antibiotics.. bismuth subcitrate + furazolidone + tetracycline. treatment for helicobacter pilori. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. . "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefcapene. this classification denotes a cephalosporin antibiotic with the molecular formula c17h19n5o6s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4d5d3422mw, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-(2-amino-4-thiazolyl)-1-oxo-2-pentenyl)amino)-8-oxo-, (6r-(6alpha,7beta(z)))- but generally known as cefcapene, which bears us nih compound identifier 6436055. european medicines agency schedules cefcapene in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07383mig. the term cefcapene is an international non-proprietary name or inn (see who inn reference publication, volume 8 no. 3 1994, list 34). world health organization schedules cefcapene in its anatomical therapeutic chemical (atc) classification. cefcapene is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefcapene under hs 29419000 and sitc 54139. as of q4 2014, cefcapene remains the us fda preferred term for this commodity. cefcapene bears us nlm identifiers umls id c2699134 and nci concept code c76160. smiles: s1c2n(c(=o)c2nc(=o)/c(=c\\cc)c2nc(sc2)n)c(=c(c1)coc(=o)n)c(=o)o.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefdaloxime. this classification denotes a cephalosporin antibiotic with the molecular formula c14h15n5o6s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6856hdt30f, chemically known as (+)-(6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(z)-oxime but generally known as cefdaloxime, which bears us nih compound identifier 9571072. european medicines agency schedules cefdaloxime in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07385mig. the term cefdaloxime is an international non-proprietary name. cefdaloxime is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefdaloxime under hs 29419000 and sitc 54139. as of q4 2014, cefdaloxime remains the us fda preferred term for this commodity. cefdaloxime bears us nlm identifiers umls id c2699135 and nci concept code c76161. smiles: s1c2n(c(=o)c2nc(=o)/c(=n\\o)c2nc(sc2)n)c(=c(c1)coc)c(=o)o.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefdinir. this classification denotes a cephalosporin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ci0fao63wc. european medicines agency schedules cefdinir in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07386mig. cefdinir generally arises in the molecular formula c14h13n5o5s2. the term cefdinir is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30.) cefdinir is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefdinir under hs 29419000 and sitc 54139. as of q4 2014, cefdinir remains the us fda preferred term for this commodity. cefdinir bears us nlm identifiers umls id c0060405 and nci concept code c28914. smiles: s1c2n(c(=o)c2nc(=o)/c(=n/o)c2nc(sc2)n)c(=c(c1)c=c)c(=o)o.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefditoren. this classification denotes a cephalosporin antibiotic with the molecular formula c19h18n6o5s3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 81qs09v3yw, chemically known as cefditoren pivoxil, me-1207, meiact but generally known as cefditoren, which bears us nih compound identifier 444006. european medicines agency schedules cefditoren in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07387mig. the term cefditoren is an international non-proprietary name or inn (see who inn reference publication, volume 6, no, 3 1992, list 32). world health organization schedules cefditoren in its anatomical therapeutic chemical (atc) classification. cefditoren is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefditoren under hs 29419000 and sitc 54139. as of q4 2014, cefditoren remains the us fda preferred term for this commodity. cefditoren bears us nlm identifiers umls id c0287573 and nci concept code c72625. smiles: s1c2n(c(=o)c2nc(=o)/c(=n/oc)c2nc(sc2)n)c(=c(c1)/c=c/c1scnc1c)c(=o)ococ(=o)c(c)(c)c.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefetamet. this classification denotes a cephalosporin antibiotic with the molecular formula c14h15n5o5s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4r5tv783x3, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-methyl-8-oxo-, (6r-(6alpha,7beta(z)))- but generally known as cefetamet, which bears us nih compound identifier 5487888. european medicines agency schedules cefetamet in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07391mig. the term cefetamet is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). world health organization schedules cefetamet in its anatomical therapeutic chemical (atc) classification. cefetamet is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefetamet under hs 29419000 and sitc 54139. as of q4 2014, cefetamet remains the us fda preferred term for this commodity. cefetamet bears us nlm identifiers umls id c0055004 and nci concept code c76164. smiles: s1c2n(c(=o)c2nc(=o)/c(=n\\oc)c2nc(sc2)n)c(=c(c1)c)c(=o)o.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefixime. this classification denotes a cephalosporin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 97i1c92e55. european medicines agency schedules cefixime in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07395mig. cefixime generally arises in the molecular formula c16h15n5o7s2. the term cefixime is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25.) cefixime is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefixime under hs 29419000 and sitc 54139. as of q4 2014, cefixime remains the us fda preferred term for this commodity. cefixime bears us nlm identifiers umls id c0060400 and nci concept code c1100. smiles: s1c2n(c(=o)c2nc(=o)/c(=n/occ(=o)o)c2nc(sc2)n)c(=c(c1)c=c)c(=o)o.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefmenoxime. this classification denotes a cephalosporin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier kbz4844cxn. european medicines agency schedules cefmenoxime in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07397mig. cefmenoxime generally arises in the molecular formula c16h17n9o5s3. the term cefmenoxime is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21.) cefmenoxime is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefmenoxime under hs 29419000 and sitc 54139. as of q4 2014, cefmenoxime remains the us fda preferred term for this commodity. cefmenoxime bears us nlm identifiers umls id c0007549 and nci concept code c65295. smiles: s1c2n(c(=o)c2nc(=o)/c(=n/oc)c2nc(sc2)n)c(=c(c1)csc1n(nnn1)c)c(=o)o.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. ceftazidime. this classification denotes a cephalosporin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9m416z9qnr. european medicines agency schedules ceftazidime pentahydrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01134mig. ceftazidime generally arises in the molecular formula c22h22n6o7s2. the term ceftazidime is a european pharmacopoeia designation. ceftazidime is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ceftazidime under hs 29419000 and sitc 54139. as of q4 2014, ceftazidime remains the us fda preferred term for this commodity. ceftazidime bears us nlm identifiers umls id c0007559 and nci concept code c66868. smiles: s1c2n(c(=o)c2nc(=o)/c(=n/oc(c)(c)c(=o)o)c2nc(sc2)n)c(=c(c1)c[n]1ccccc1)c(=o)o.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefotaxime. this classification denotes a cephalosporin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier n2gi8b1gk7. european medicines agency schedules cefotaxime in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07405mig. cefotaxime generally arises in the molecular formula c16h17n5o7s2. the term cefotaxime is an international non-proprietary name or inn (see who inn reference publication, volume 33, no. 10 1979, list 19.) cefotaxime is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefotaxime under hs 29419000 and sitc 54139. as of q4 2014, cefotaxime remains the us fda preferred term for this commodity. cefotaxime bears us nlm identifiers umls id c0007554 and nci concept code c354. smiles: s1c2n(c(=o)c2nc(=o)/c(=n/oc)c2nc(sc2)n)c(=c(c1)coc(=o)c)c(=o)o.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefpimizole. this classification denotes a cephalosporin antibiotic with the molecular formula c28h26n6o10s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 24s58uhu7n, chemically known as 1-(((6r,7r)-2-carboxy-7-((r)-2-(5-carboxyimidazole-4-carboxamido)-2-phenylacetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-4-(2-sulfoethyl)pyridinium hydroxide, inner salt but generally known as cefpimizole, which bears us nih compound identifier 68597. european medicines agency schedules cefpimizole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07411mig. the term cefpimizole is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24). cefpimizole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefpimizole under hs 29419000 and sitc 54139. as of q4 2014, cefpimizole remains the us fda preferred term for this commodity. cefpimizole bears us nlm identifiers umls id c0055009 and nci concept code c76173. smiles: s1c2n(c(=o)c2nc(=o)c(nc(=o)c2nc[nh]c2c(=o)o)c2ccccc2)c(=c(c1)c[n]1ccc(cc1)ccs(=o)(=o)o)c(=o)o.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefpiramide. this classification denotes a cephalosporin antibiotic with the molecular formula c25h24n8o7s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier p936ya152n, chemically known as wy 44,635 but generally known as cefpiramide, which bears us nih compound identifier 53130. european medicines agency schedules cefpiramide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07412mig. the term cefpiramide is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). world health organization schedules cefpiramide in its anatomical therapeutic chemical (atc) classification. cefpiramide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefpiramide under hs 29419000 and sitc 54139. as of q4 2014, cefpiramide remains the us fda preferred term for this commodity. cefpiramide bears us nlm identifiers umls id c0055010 and nci concept code c65303. smiles: s1c2n(c(=o)c2nc(=o)c(nc(=o)c2c(=o)cc([nh]c2)c)c2ccc(o)cc2)c(=c(c1)csc1n(nnn1)c)c(=o)o.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefpodoxime. this classification denotes a cephalosporin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7r4f94tvgy. european medicines agency schedules cefpodoxime in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07414mig. cefpodoxime generally arises in the molecular formula c15h17n5o6s2. the term cefpodoxime is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27.) cefpodoxime is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefpodoxime under hs 29419000 and sitc 54139. as of q4 2014, cefpodoxime remains the us fda preferred term for this commodity. cefpodoxime bears us nlm identifiers umls id c0055011 and nci concept code c65305. smiles: s1c2n(c(=o)c2nc(=o)/c(=n\\oc)c2nc(sc2)n)c(=c(c1)coc)c(=o)o.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefsulodin. this classification denotes an anti-bacterial agent with the molecular formula c22h20n4o8s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ov42lhe42b, chemically known as 4-carbamoyl-1-(((6r,7r)-2-carboxy-8-oxo-7-((2r)-2-phenyl-2-sulfoacetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)pyridinium hydroxide, inner salt, monosodium salt but generally known as cefsulodin, which bears us nih compound identifier 40246. european medicines agency schedules cefsulodin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07420mig. world health organization schedules cefsulodin in its anatomical therapeutic chemical (atc) classification. cefsulodin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefsulodin under hs 29419000 and sitc 54139. as of q4 2014, cefsulodin remains the us fda preferred term for this commodity. cefsulodin bears us nlm identifiers umls id c0007558 and nci concept code c98227. smiles: s1c2n(c(=o)c2nc(=o)c(s(=o)(=o)o)c2ccccc2)c(=c(c1)c[n]1ccc(cc1)c(=o)n)c(=o)o.[na].. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefteram. this classification denotes a cephalosporin antibiotic with the molecular formula c16h17n9o5s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 74cq4q3n63, chemically known as (+)-(6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-((5-methyl-2h-tetrazol-2-yl)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(z)-(o-methyloxime) but generally known as cefteram, which bears us nih compound identifier 6537431. european medicines agency schedules cefteram in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07423mig. the term cefteram is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). cefteram is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefteram under hs 29419000 and sitc 54139. as of q4 2014, cefteram remains the us fda preferred term for this commodity. cefteram bears us nlm identifiers umls id c0108946 and nci concept code c81035. smiles: s1c2n(c(=o)c2nc(=o)/c(=n\\oc)c2nc(sc2)n)c(=c(c1)cn1nc(nn1)c)c(=o)o.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. ceftibuten. this classification denotes a cephalosporin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier iw71n46b4y. european medicines agency schedules ceftibuten in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07425mig. ceftibuten generally arises in the molecular formula c15h14n4o6s2. the term ceftibuten is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29.) ceftibuten is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ceftibuten under hs 29419000 and sitc 54139. as of q4 2014, ceftibuten remains the us fda preferred term for this commodity. ceftibuten bears us nlm identifiers umls id c0055014 and nci concept code c61666. smiles: s1c2n(c(=o)c2nc(=o)/c(=c\\cc(=o)o)c2nc(sc2)n)c(=cc1)c(=o)o.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. ceftiofur. this classification denotes a cephalosporin antibiotic with the molecular formula c19h17n5o7s3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 83jl932i1c, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(((2-furanylcarbonyl)thio)methyl)-8-oxo, monohydrochloride, (6r,7r) but generally known as ceftiofur, which bears us nih compound identifier 6328657. european medicines agency schedules ceftiofur in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07426mig. the term ceftiofur is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). ceftiofur is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ceftiofur under hs 29419000 and sitc 54139. as of q4 2014, ceftiofur remains the us fda preferred term for this commodity. ceftiofur bears us nlm identifiers umls id c0081959 and nci concept code c81036. smiles: s1c2n(c(=o)c2nc(=o)/c(=n\\oc)c2nc(sc2)n)c(=c(c1)csc(=o)c1occc1)c(=o)o.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. ceftiolene. this classification denotes a cephalosporin antibiotic with the molecular formula c20h18n8o8s3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 28tv2p33kf, chemically known as (6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-((e)-2-((4-(formylmethyl)-1,4,5,6-tetrahydro-5,6-dioxo-as-triazin-3-yl)thio)vinyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid 7(sup 2)-(z)-(o-methyloxime) but generally known as ceftiolene, which bears us nih compound identifier 6537430. european medicines agency schedules ceftiolene in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07427mig. the term ceftiolene is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). ceftiolene is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ceftiolene under hs 29419000 and sitc 54139. as of q4 2014, ceftiolene remains the us fda preferred term for this commodity. ceftiolene bears us nlm identifiers umls id c2699149 and nci concept code c76175. smiles: s1c2n(c(=o)c2nc(=o)/c(=n\\oc)c2nc(sc2)n)c(=c(c1)/c=c/sc1n(cc=o)c(=o)c(=o)[nh]n1)c(=o)o.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. ceftioxide. this classification denotes a cephalosporin antibiotic with the molecular formula c16h17n5o8s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6z9dv0v6tg, chemically known as (5s,6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-2-ene-carboxylic acid 7,2-(z)-(o-methyloxime), acetate (ester), 5-oxide but generally known as ceftioxide, which bears us nih compound identifier 9589416. european medicines agency schedules ceftioxide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07428mig. the term ceftioxide is an international non-proprietary name or inn (see who inn reference publication, volume 34, no. 10 1980, list 20). ceftioxide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ceftioxide under hs 29419000 and sitc 54139. as of q4 2014, ceftioxide remains the us fda preferred term for this commodity. ceftioxide bears us nlm identifiers umls id c2699150 and nci concept code c76176. smiles: s1(=o)c2n(c(=o)c2nc(=o)/c(=n\\oc)c2nc(sc2)n)c(=c(c1)coc(=o)c)c(=o)o.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. ceftriaxone. this classification denotes a cephalosporin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 75j73v1629. european medicines agency schedules ceftriaxone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07431mig. ceftriaxone generally arises in the molecular formula c18h18n8o7s3. the term ceftriaxone is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21.) ceftriaxone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ceftriaxone under hs 29419000 and sitc 54139. as of q4 2014, ceftriaxone remains the us fda preferred term for this commodity. ceftriaxone bears us nlm identifiers umls id c0007561 and nci concept code c62020. smiles: s1c2n(c(=o)c2nc(=o)/c(=n/oc)c2nc(sc2)n)c(=c(c1)csc1n([nh]c(=o)c(=o)n1)c)c(=o)o.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. ceftizoxime. this classification denotes an anti-bacterial agent with the molecular formula c13h13n5o5s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier c43c467dpe, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-, (6r-(6alpha,7beta(z)))- but generally known as ceftizoxime, which bears us nih compound identifier 6533629. european medicines agency schedules ceftizoxime in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07429mig. the term ceftizoxime is an international non-proprietary name or inn (see who inn reference publication, volume 34, no. 10 1980, list 20). world health organization schedules ceftizoxime in its anatomical therapeutic chemical (atc) classification. ceftizoxime is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ceftizoxime under hs 29419000 and sitc 54139. as of q4 2014, ceftizoxime remains the us fda preferred term for this commodity. ceftizoxime bears us nlm identifiers umls id c0007560 and nci concept code c61668. smiles: s1c2n(c(=o)c2nc(=o)/c(=n\\oc)c2nc(sc2)n)c(=cc1)c(=o)o.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefoperazone. this classification denotes a cephalosporin antibiotic with the molecular formula c25h27n9o8s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7u75i1278d, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((((4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)(4-hydroxyphenyl)acetyl)amino)-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r-(6-alpha,7-beta(r*)))- but generally known as cefoperazone, which bears us nih compound identifier 44185. european medicines agency schedules cefoperazone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07402mig. the term cefoperazone is an international non-proprietary name or inn (see who inn reference publication, volume 34, no. 10 1980, list 20). world health organization schedules cefoperazone in its anatomical therapeutic chemical (atc) classification. cefoperazone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefoperazone under hs 29419000 and sitc 54139. as of q4 2014, cefoperazone remains the us fda preferred term for this commodity. cefoperazone bears us nlm identifiers umls id c0007552 and nci concept code c61663. smiles: s1c2n(c(=o)c2nc(=o)c(nc(=o)n2ccn(c(=o)c2=o)cc)c2ccc(o)cc2)c(=c(c1)csc1n(nnn1)c)c(=o)o.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefodizime. this classification denotes a beta-lactam antibacterial with the molecular formula c20h20n6o7s4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hc1t51593a, chemically known as (6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(((5-(carboxymethyl)-4-methyl-2-thiazolyl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid 7(sup 2)-(z)-(o-methyloxime) but generally known as cefodizime, which bears us nih compound identifier 5361871. most nations schedule cefodizime under hs 29419000 and sitc 54139. as of q4 2014, cefodizime remains the us fda preferred term for this commodity. cefodizime bears us nlm identifiers umls id c0055007 and nci concept code c98224. smiles: cc1=c(sc(=n1)scc2=c(n3c(c(c3=o)nc(=o)c(=noc)c4=csc(=n4)n)sc2)c(=o)o)cc(=o)o.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefcapene pivoxil. this classification denotes a cephalosporin antibiotic c23h29n5o8s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8i8mj56xfq, chemically known as 2,2-dimethylpropanoyloxymethyl (6r,7r)-7-(((z)-2-(2-amino-1,3-thiazol-4-yl)pent-2-enoyl)amino)-3-(carbamoyloxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, but more generally known as cefcapene pivoxil, which bears us nih compound identifier 5282438. european medicines agency schedules cefcapene pivoxil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01110mig. most nations, for tariff and trade purposes, schedule cefcapene pivoxil under hs 29419000 and sitc 54139. as of q4 2014, cefcapene pivoxil remains us fdas preferred term for this commodity. cefcapene pivoxil bears us nlm identifiers umls id c0171230 and nci concept code c98218. smiles: cc/c=c(/c1csc(n1)n)\\c(=o)n[c@h]2[c@@h]3n(c2=o)c(=c(cs3)coc(=o)n)c(=o)ococ(=o)c(c)(c)c.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefcapene pivoxil hydrochloride. this classification denotes a cephalosporin antibiotic c23h29n5o8s2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5j77167p9e, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-(2-amino-4-thiazolyl)-1-oxo-2- pentenyl)amino)-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester,(6r- (6-.alpha.,7-.beta.(z)))-, monohydrochloride, but more generally known as cefcapene pivoxil hydrochloride, which bears us nih compound identifier 6918126. european medicines agency schedules cefcapene pivoxil hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01111mig. most nations, for tariff and trade purposes, schedule cefcapene pivoxil hydrochloride under hs 29419000 and sitc 54139. as of q4 2014, cefcapene pivoxil hydrochloride remains us fdas preferred term for this commodity. smiles: cc/c=c(/c1csc(n1)n)\\c(=o)n[c@h]2[c@@h]3n(c2=o)c(=c(cs3)coc(=o)n)c(=o)ococ(=o)c(c)(c)c.cl.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefditoren pivaloyloxymethyl ester. this classification denotes a cephalosporin antibiotic with the molecular formula c25h28n6o7s3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 78tha212dh, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(((2z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-((1z)-2-(4-methyl-5-thiazolyl)ethenyl)-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (6r,7r)-, but more generally known as cefditoren pivaloyloxymethyl ester, which bears us nih compound identifier 444006. european medicines agency schedules cefditoren pivaloyloxymethyl ester or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07387mig. most nations, for tariff purposes, schedule cefditoren pivaloyloxymethyl ester under hs 29419000. smiles: cc1c(scn1)/c=c\\c2=c(n3[c@@h]([c@@h](c3=o)nc(=o)/c(=n\\oc)/c4csc(n4)n)sc2)c(=o)ococ(=o)c(c)(c)c.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefditoren pivoxil. this classification denotes a cephalosporin antibiotic with the molecular formula c25h28n6o7s3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 78tha212dh, chemically known as cefditoren pivoxil, me-1207, meiact but more generally known as cefditoren pivoxil, which bears us nih compound identifier 444006. european medicines agency schedules cefditoren pivoxil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01112mig. most nations, for tariff and trade purposes, schedule cefditoren pivoxil under hs 29419000 and sitc 54139. as of q4 2014, cefditoren pivoxil remains us fdas preferred term for this commodity. cefditoren pivoxil bears us nlm identifiers umls id c0245519 and nci concept code c47434. smiles: cc1c(scn1)/c=c\\c2=c(n3[c@@h]([c@@h](c3=o)nc(=o)/c(=n\\oc)/c4csc(n4)n)sc2)c(=o)ococ(=o)c(c)(c)c.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefetamet pivaloyloxymethyl ester. this classification denotes a cephalosporin antibiotic with the molecular formula c20h25n5o7s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f6xa85n260, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-methyl-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (6r-(6.alpha.,7.beta.(z)))-, but more generally known as cefetamet pivaloyloxymethyl ester, which bears us nih compound identifier 5485222. european medicines agency schedules cefetamet pivaloyloxymethyl ester or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07391mig. most nations, for tariff purposes, schedule cefetamet pivaloyloxymethyl ester under hs 29419000. smiles: cc1=c(n2[c@@h]([c@@h](c2=o)nc(=o)/c(=n\\oc)/c3csc(n3)n)sc1)c(=o)ococ(=o)c(c)(c)c.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefetamet pivoxil. this classification denotes a cephalosporin antibiotic c20h25n5o7s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f6xa85n260, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-methyl-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (6r-(6.alpha.,7.beta.(z)))-, but more generally known as cefetamet pivoxil, which bears us nih compound identifier 5486182. european medicines agency schedules cefetamet pivoxil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01114mig. most nations, for tariff and trade purposes, schedule cefetamet pivoxil under hs 29419000 and sitc 54139. as of q4 2014, cefetamet pivoxil remains us fdas preferred term for this commodity. cefetamet pivoxil bears us nlm identifiers umls id c0055005 and nci concept code c98221. smiles: cc1=c(n2[c@@h]([c@@h](c2=o)nc(=o)/c(=n\\oc)/c3csc(n3)n)sc1)c(=o)ococ(=o)c(c)(c)c.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefetamet pivoxil hydrochloride. this classification denotes a cephalosporin antibiotic c20h25n5o7s2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2ye9732gfu, chemically known as (6r,7r)-7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid (2,2-dimethyl-1-oxopropoxy)methyl ester hydrochloride, but more generally known as cefetamet pivoxil hydrochloride, which bears us nih compound identifier 5485221. european medicines agency schedules cefetamet pivoxil hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13274mig. most nations, for tariff and trade purposes, schedule cefetamet pivoxil hydrochloride under hs 29419000 and sitc 54139. as of q4 2014, cefetamet pivoxil hydrochloride remains us fdas preferred term for this commodity. cefetamet pivoxil hydrochloride bears us nlm identifiers umls id c0140755 and nci concept code c98222. smiles: cc1=c(n2[c@@h]([c@@h](c2=o)nc(=o)/c(=n\\oc)/c3csc(n3)n)sc1)c(=o)ococ(=o)c(c)(c)c.cl.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefixime anhydrous. this classification denotes a cephalosporin antibiotic with the molecular formula c16h15n5o7s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier xz7bg04gjx, chemically known as (6r,7r)-7-((2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl)amino)-3-ethenyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, but more generally known as cefixime anhydrous, which bears us nih compound identifier 54362. european medicines agency schedules cefixime anhydrous or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07395mig. most nations, for tariff purposes, schedule cefixime anhydrous under hs 29419000. smiles: c=cc1=c(n2[c@@h]([c@@h](c2=o)nc(=o)/c(=n\\occ(=o)o)/c3csc(n3)n)sc1)c(=o)o.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefixime trihydrate. this classification denotes a cephalosporin antibiotic with the molecular formula c16h15n5o7s2.3h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 97i1c92e55, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)((carboxymethoxy)imino)acetyl)amino)-3-ethenyl-8-oxo-, trihydrate, (6r-(6.alpha.,7.beta.(z)))-, but more generally known as cefixime trihydrate, which bears us nih compound identifier 6321411. european medicines agency schedules cefixime trihydrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07395mig. most nations, for tariff purposes, schedule cefixime trihydrate under hs 29419000. smiles: c=cc1=c(n2[c@@h]([c@@h](c2=o)nc(=o)/c(=n\\occ(=o)o)/c3csc(n3)n)sc1)c(=o)o.o.o.o.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefmenoxime hydrochloride. this classification denotes a cephalosporin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier non736d32w. european medicines agency schedules cefmenoxime hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01117mig. cefmenoxime hydrochloride generally arises in the molecular formula 2c16h17n9o5s3.clh. the term cefmenoxime hydrochloride is a united states adopted name designation. most nations, for tariff and trade purposes, schedule cefmenoxime hydrochloride under hs 29419000 and sitc 54139. as of q4 2014, cefmenoxime hydrochloride remains us fdas preferred term for this commodity. cefmenoxime hydrochloride bears us nlm identifiers umls id c0282390 and nci concept code c65296. smiles: cn1nnnc1scc2=c(n3c(=o)[c@h]([c@h]3sc2)nc(=o)/c(=n\\oc)/c4nc(sc4)n)c(=o)o.cn1nnnc1scc2=c(n3c(=o)[c@h]([c@h]3sc2)nc(=o)/c(=n\\oc)/c4nc(sc4)n)c(=o)o.cl.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefodizime disodium. this classification denotes a beta-lactam antibacterial with the molecular formula c20h18n6o7s4.2na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hc1t51593a, chemically known as (z)-7-(2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido)-3-(5-carboxymethyl-4-methylthiazol-2-ylthiomethyl)-3-cephem-4-carboxylic acid, disodium salt, but more generally known as cefodizime disodium, which bears us nih compound identifier 6321412. european medicines agency schedules cefodizime disodium or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07401mig. most nations, for tariff purposes, schedule cefodizime disodium under hs 29419000. smiles: cc1c(sc(n1)scc2=c(n3[c@@h]([c@@h](c3=o)nc(=o)/c(=n\\oc)/c4csc(n4)n)sc2)c(=o)[o-])cc(=o)[o-].[na+].[na+].. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefodizime sodium. this classification denotes a beta-lactam antibacterial with the molecular formula c20h18n6o7s4.2na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hc1t51593a, chemically known as (z)-7-(2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido)-3-(5-carboxymethyl-4-methylthiazol-2-ylthiomethyl)-3-cephem-4-carboxylic acid, disodium salt, but more generally known as cefodizime sodium, which bears us nih compound identifier 9576734. european medicines agency schedules cefodizime sodium or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07401mig. most nations, for tariff purposes, schedule cefodizime sodium under hs 29419000. cefodizime sodium bears us nlm identifiers umls id c0122398 and nci concept code c98225. smiles: cc1c(sc(n1)scc2=c(n3[c@@h]([c@@h](c3=o)nc(=o)/c(=n\\oc)/c4csc(n4)n)sc2)c(=o)[o-])cc(=o)[o-].[na+].[na+].. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefoperazone sodium. this classification denotes a cephalosporin antibiotic with the molecular formula c25h26n9o8s2.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5fqg9774wd, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((((4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)(4-hydroxyphenyl)acetyl)amino)-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, monosodium salt, (6r-(6alpha,7beta(r*)))- but more generally known as cefoperazone sodium, which bears us nih compound identifier 44186. european medicines agency schedules cefoperazone sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01122mig. most nations, for tariff and trade purposes, schedule cefoperazone sodium under hs 29419000 and sitc 54139. as of q4 2014, cefoperazone sodium remains us fdas preferred term for this commodity. cefoperazone sodium bears us nlm identifiers umls id c0733367 and nci concept code c47435. smiles: ccn1ccn(c(=o)c1=o)c(=o)n[c@h](c2ccc(cc2)o)c(=o)n[c@h]3[c@@h]4n(c3=o)c(=c(cs4)csc5nnnn5c)c(=o)[o-].[na+].. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefotaxime sodium. this classification denotes a cephalosporin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 258j72s7tz. european medicines agency schedules cefotaxime sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13276mig. cefotaxime sodium generally arises in the molecular formula c16h16n5nao7s2. the term cefotaxime sodium is a united states adopted name designation. most nations, for tariff and trade purposes, schedule cefotaxime sodium under hs 29419000 and sitc 54139. as of q4 2014, cefotaxime sodium remains us fdas preferred term for this commodity. cefotaxime sodium bears us nlm identifiers umls id c0700445 and nci concept code c2328. smiles: cc(=o)occ1=c(n2[c@@h]([c@@h](c2=o)nc(=o)/c(=n\\oc)/c3csc(n3)n)sc1)c(=o)[o-].[na+].. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefpimizole sodium. this classification denotes a cephalosporin antibiotic with the molecular formula c28h24n6o10s2.h+.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x4628imc52, chemically known as 1-(((6r,7r)-2-carboxy-7-((r)-2-(5-carboxyimidazole-4-carboxamido)-2-phenylacetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-4-(2-sulfoethyl)pyridinium hydroxide, inner salt, monosodium salt but more generally known as cefpimizole sodium, which bears us nih compound identifier 55324. european medicines agency schedules cefpimizole sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01129mig. most nations, for tariff and trade purposes, schedule cefpimizole sodium under hs 29419000 and sitc 54139. cefpimizole sodium bears us nlm identifiers umls id c0050383 and nci concept code c81031. smiles: as of q4 2014, cefpimizole sodium remains us fdas preferred term for this commodity.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefpiramide sodium. this classification denotes a cephalosporin antibiotic with the molecular formula c25h23n8o7s2.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 137kb7gykb, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((((4-hydroxy-6-methyl-3-pyridinyl)carbonyl)amino)(4-hydroxyphenyl)acetyl)amino)-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, monosodium salt, (6r-(6alpha,7beta(r*)))- but more generally known as cefpiramide sodium, which bears us nih compound identifier 53129. european medicines agency schedules cefpiramide sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01130mig. most nations, for tariff and trade purposes, schedule cefpiramide sodium under hs 29419000 and sitc 54139. as of q4 2014, cefpiramide sodium remains us fdas preferred term for this commodity. cefpiramide sodium bears us nlm identifiers umls id c0955901 and nci concept code c65304. smiles: cc1cc(c(cn1)c(=o)n[c@h](c2ccc(cc2)o)c(=o)n[c@h]3[c@@h]4n(c3=o)c(=c(cs4)csc5nnnn5c)c(=o)[o-])o.[na+].. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefpodoxime proxetil. this classification denotes a cephalosporin antibiotic c21h27n5o9s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2tb00a1z7n, chemically known as (+/-)-1-hydroxyethyl (+)-(6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7 (sup 2)-(z)-(o-methyloxime), isopropyl carbonate (ester), but more generally known as cefpodoxime proxetil, which bears us nih compound identifier 6526396. european medicines agency schedules cefpodoxime proxetil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01132mig. most nations, for tariff and trade purposes, schedule cefpodoxime proxetil under hs 29419000 and sitc 54139. as of q4 2014, cefpodoxime proxetil remains us fdas preferred term for this commodity. cefpodoxime proxetil bears us nlm identifiers umls id c0108938 and nci concept code c28916. smiles: cc(c)oc(=o)oc(c)oc(=o)c1=c(cs[c@h]2n1c(=o)[c@h]2nc(=o)/c(=n\\oc)/c3csc(n3)n)coc.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefsulodin sodium. this classification denotes the sodium form of an anti-bacterial agent with the molecular formula c22h20n4o8s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ov42lhe42b, chemically known as 4-carbamoyl-1-(((6r,7r)-2-carboxy-8-oxo-7-((2r)-2-phenyl-2-sulfoacetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)pyridinium hydroxide, inner salt, monosodium salt but more generally known as cefsulodin, which bears us nih compound identifier 40246. european medicines agency schedules cefsulodin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07420mig. world health organization schedules cefsulodin in its anatomical therapeutic chemical (atc) classification. cefsulodin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule cefsulodin sodium under hs 29419000 and sitc 54139. as of q4 2014, cefsulodin sodium remains us fdas preferred term for this commodity. cefsulodin sodium bears us nlm identifiers umls id c0887647 and nci concept code c98228. smiles: c1ccc(cc1)[c@h](c(=o)n[c@h]2[c@@h]3n(c2=o)c(=c(cs3)c[n+]4ccc(cc4)c(=o)n)c(=o)[o-])s(=o)(=o)[o-].[na+].. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. ceftazidime pentahydrate. this classification denotes a cephalosporin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9m416z9qnr. european medicines agency schedules ceftazidime pentahydrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01134mig. ceftazidime generally arises in the molecular formula c22h22n6o7s2. the term ceftazidime is a european pharmacopoeia designation. ceftazidime is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule ceftazidime pentahydrate under hs 29419000 and sitc 54139. smiles: [h+].cc(c)(c(=o)[o-])o/n=c(/c1csc(n1)n)\\c(=o)n[c@h]2[c@@h]3n(c2=o)c(=c(cs3)c[n+]4ccccc4)c(=o)[o-].o.o.o.o.o.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. ceftazidime sodium. this classification denotes a cephalosporin antibiotic with the molecular formula c22h21n6o7s2.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier cmc30v039k. the term ceftazidime sodium is a u.s. fda designation. most nations, for tariff and trade purposes, schedule ceftazidime sodium under hs 29419000 and sitc 54139. as of q4 2014, ceftazidime sodium remains us fdas preferred term for this commodity. ceftazidime sodium bears us nlm identifiers umls id c0700860 and nci concept code c355. smiles: cc(c)(c(=o)[o-])o/n=c(/c1csc(n1)n)\\c(=o)n[c@h]2[c@@h]3n(c2=o)c(=c(cs3)c[n+]4ccccc4)c(=o)[o-].[na+].. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefteram pivaloyloxymethyl ester. this classification denotes a cephalosporin antibiotic with the molecular formula c22h27n9o7s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0od86rt58c, chemically known as pivaloyloxymethyl (z)-7-(2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido)-3-(5-methyl-2h-tetrazol-2-ylmethyl)-3-cephem-4-carboxylate, but more generally known as cefteram pivaloyloxymethyl ester, which bears us nih compound identifier 6917871. european medicines agency schedules cefteram pivaloyloxymethyl ester or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07423mig. most nations, for tariff purposes, schedule cefteram pivaloyloxymethyl ester under hs 29419000. smiles: cc1nnn(n1)cc2=c(n3[c@@h]([c@@h](c3=o)nc(=o)/c(=n\\oc)/c4csc(n4)n)sc2)c(=o)ococ(=o)c(c)(c)c.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. cefteram pivoxil. this classification denotes a cephalosporin antibiotic c22h27n9o7s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0od86rt58c, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl)amino)-3-((5-methyl-2h-tetrazol-2-yl)methyl)-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (6r,7r)-, but more generally known as cefteram pivoxil, which bears us nih compound identifier 54885. european medicines agency schedules cefteram pivoxil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01135mig. most nations, for tariff and trade purposes, schedule cefteram pivoxil under hs 29419000 and sitc 54139. as of q4 2014, cefteram pivoxil remains us fdas preferred term for this commodity. cefteram pivoxil bears us nlm identifiers umls id c0108947 and nci concept code c98230. smiles: cc1nnn(n1)cc2=c(n3[c@@h]([c@@h](c3=o)nc(=o)/c(=n\\oc)/c4csc(n4)n)sc2)c(=o)ococ(=o)c(c)(c)c.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. ceftibuten dihydrate. this classification denotes a cephalosporin antibiotic c15h14n4o6s2.2h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 62f4443rwp, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((2-(2-amino-4-thiazolyl)-4-carboxy-1-oxo-2-butenyl)amino)-8-oxo-, dihydrate, (6r-(6.alpha.,7.beta.(z)))-, but more generally known as ceftibuten dihydrate, which bears us nih compound identifier 5282241. european medicines agency schedules ceftibuten dihydrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub35311. most nations, for tariff and trade purposes, schedule ceftibuten dihydrate under hs 29419000 and sitc 54139. as of q4 2014, ceftibuten dihydrate remains us fdas preferred term for this commodity. ceftibuten dihydrate bears us nlm identifiers umls id c0591239 and nci concept code c61667. smiles: c1c(nc(s1)n)/c(=c/cc(=o)o)/c(=o)n[c@h]2[c@@h]3n(c2=o)c(=ccs3)c(=o)o.o.o.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. ceftiofur hydrochloride. this classification denotes a cephalosporin antibiotic with the molecular formula c19h17n5o7s3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6822a07436, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(((2-furanylcarbonyl)thio)methyl)-8-oxo, monohydrochloride, (6r,7r) but more generally known as ceftiofur hydrochloride, which bears us nih compound identifier 6328657. most nations, for tariff and trade purposes, schedule ceftiofur hydrochloride under hs 29419000 and sitc 54139. as of q4 2014, ceftiofur hydrochloride remains us fdas preferred term for this commodity. ceftiofur hydrochloride bears us nlm identifiers umls id c0521899 and nci concept code c76174. smiles: co/n=c(/c1csc(n1)n)\\c(=o)n[c@h]2[c@@h]3n(c2=o)c(=c(cs3)csc(=o)c4ccco4)c(=o)o.cl.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. ceftiofur sodium. this classification denotes a cephalosporin antibiotic with the molecular formula c19h16n5o7s3.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier nhi34is56e, chemically known as sodium (6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(mercaptomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 72-(z)-(o-methyloxime), 2-furoate (ester), but more generally known as ceftiofur sodium, which bears us nih compound identifier 9571073. european medicines agency schedules ceftiofur sodium or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07426mig. most nations, for tariff purposes, schedule ceftiofur sodium under hs 29419000. ceftiofur sodium bears us nlm identifiers umls id c0108950 and nci concept code c77190. smiles: co/n=c(/c1csc(n1)n)\\c(=o)n[c@h]2[c@@h]3n(c2=o)c(=c(cs3)csc(=o)c4ccco4)c(=o)[o-].[na+].. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. ceftizoxime alapivoxil. this classification denotes a cephalosporin antibiotic with the molecular formula c22h28n6o8s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3mm3320ljn, chemically known as ( )-(pivaloyloxy)methyl (6r,7r)-7-(2-(2-(l-alanylamino)thiazol-4-yl)glyoxylamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate 7,2-(z)-(o)-methyloxime). but more generally known as ceftizoxime alapivoxil, which bears us nih compound identifier 9578661. european medicines agency schedules ceftizoxime alapivoxil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07430mig. the term ceftizoxime alapivoxil is an international non-proprietary name or inn (see world health organization inn reference publication, volume 12 no. 1 1998, list 39). most nations, for tariff and trade purposes, schedule ceftizoxime alapivoxil under hs 29419000 and sitc 54139. as of q4 2014, ceftizoxime alapivoxil remains us fdas preferred term for this commodity. ceftizoxime alapivoxil bears us nlm identifiers umls id c0908922 and nci concept code c90828. smiles: c[c@@h](c(=o)nc1nc(cs1)/c(=n/oc)/c(=o)n[c@h]2[c@@h]3n(c2=o)c(=ccs3)c(=o)ococ(=o)c(c)(c)c)n.. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. ceftizoxime sodium. this classification denotes a cephalosporin antibiotic with the molecular formula c13h12n5o5s2.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 26337d5x88, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)-(methoxyimino)acetyl)amino)-8-oxo-, monosodium salt, (6r-(6-alpha,7-beta(z)))- but more generally known as ceftizoxime sodium, which bears us nih compound identifier 9570777. european medicines agency schedules ceftizoxime sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01137mig. most nations, for tariff and trade purposes, schedule ceftizoxime sodium under hs 29419000 and sitc 54139. as of q4 2014, ceftizoxime sodium remains us fdas preferred term for this commodity. ceftizoxime sodium bears us nlm identifiers umls id c0282391 and nci concept code c47438. smiles: co/n=c(/c1csc(n1)n)\\c(=o)n[c@h]2[c@@h]3n(c2=o)c(=ccs3)c(=o)[o-].[na+].. "
"third generation cephalosporins. this classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin.. ceftriaxone sodium. this classification denotes a cephalosporin antibiotic with the molecular formula 2c18h16n8o7s3.4na.7h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 023z5br09k, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio)methyl)-, disodium salt, (6r-(6alpha,7beta(z)))- but more generally known as ceftriaxone sodium, which bears us nih compound identifier 9570832. european medicines agency schedules ceftriaxone sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01138mig. most nations, for tariff and trade purposes, schedule ceftriaxone sodium under hs 29419000 and sitc 54139. as of q4 2014, ceftriaxone sodium remains us fdas preferred term for this commodity. ceftriaxone sodium bears us nlm identifiers umls id c0035750 and nci concept code c817. smiles: cn1[n-]c(=o)c(=o)nc1scc2=c(n3c(=o)[c@h]([c@h]3sc2)nc(=o)/c(=n\\oc)/c4nc(sc4)n)c(=o)[o-].cn1[n-]c(=o)c(=o)nc1scc2=c(n3c(=o)[c@h]([c@h]3sc2)nc(=o)/c(=n\\oc)/c4nc(sc4)n)c(=o)[o-].o.o.o.o.o.o.o.[na+].[na+].[na+].[na+].. "
"amphenicols. this classification denotes phenylalanine-based, phenylpropanoids and antibacterials thar inhibit bacterial protein synthesis, and which are therefore called amphenicols.. . "
"amphenicols. this classification denotes phenylalanine-based, phenylpropanoids and antibacterials thar inhibit bacterial protein synthesis, and which are therefore called amphenicols.. azidamfenicol. this classification denotes an antibiotic with the molecular formula c11h13n5o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 40257685lm, chemically known as acetamide, 2-azido-n-(beta-hydroxy-alpha-(hydroxymethyl)-p-nitrophenethyl)-, d-threo-(-)- but generally known as azidamfenicol, which bears us nih compound identifier 62858. european medicines agency schedules azidamfenicol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05654mig. the term azidamfenicol is an international non-proprietary name. world health organization schedules azidamfenicol in its anatomical therapeutic chemical (atc) classification. azidamfenicol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule azidamfenicol under hs 29414000 and sitc 54139. as of q4 2014, azidamfenicol remains the us fda preferred term for this commodity. azidamfenicol bears us nlm identifiers umls id c0771992 and nci concept code c72712. smiles: c1=cc(=cc=c1c(c(co)nc(=o)cn=[n+]=[n-])o)[n+](=o)[o-].. "
"amphenicols. this classification denotes phenylalanine-based, phenylpropanoids and antibacterials thar inhibit bacterial protein synthesis, and which are therefore called amphenicols.. florfenicol. this classification denotes a protein synthesis inhibitor and antibiotic with the molecular formula c12h14cl2fno4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9j97307y1h, chemically known as 2,2-dichloro-n-(1-(fluoromethyl)-2-hydroxy-2-(4-(methylsulfonyl)phenyl)ethyl)acetamide but generally known as florfenicol, which bears us nih compound identifier 114811. european medicines agency schedules florfenicol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07651mig. the term florfenicol is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). florfenicol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule florfenicol under hs 29414000 and sitc 54139. as of q4 2014, florfenicol remains the us fda preferred term for this commodity. florfenicol bears us nlm identifiers umls id c0060466 and nci concept code c75146. smiles: cs(=o)(=o)c1=cc=c(c=c1)c(c(cf)nc(=o)c(cl)cl)o.. "
"amphenicols. this classification denotes phenylalanine-based, phenylpropanoids and antibacterials thar inhibit bacterial protein synthesis, and which are therefore called amphenicols.. thiamphenicol. this classification denotes a protein synthesis inhibitor and antibiotic with the molecular formula c12h15cl2no5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier flq7571npm, chemically known as (+-)-threo-2,2-dichloro-n-(beta-hydroxy-alpha-(hydroxymethyl)-p-(methylsulfonyl)phenethyl)acetamide but generally known as thiamphenicol, which bears us nih compound identifier 5433. european medicines agency schedules thiamphenicol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10970mig. the term thiamphenicol is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules thiamphenicol in its anatomical therapeutic chemical (atc) classification. thiamphenicol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule thiamphenicol under hs 29414000 and sitc 54139. as of q4 2014, thiamphenicol remains the us fda preferred term for this commodity. thiamphenicol bears us nlm identifiers umls id c0039854 and nci concept code c61969. smiles: cs(=o)(=o)c1=cc=c(c=c1)c(c(co)nc(=o)c(cl)cl)o.. "
"amphenicols. this classification denotes phenylalanine-based, phenylpropanoids and antibacterials thar inhibit bacterial protein synthesis, and which are therefore called amphenicols.. racefenicol or racephenicol. this classification denotes an antibiotic with the molecular formula c12h15cl2no5s, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 283383no13, chemically known as (+-)-threo-2,2-dichloro-n-(beta-hydroxy-alpha-(hydroxymethyl)-p-(methylsulfonyl)phenethyl)acetamide but more generally known as racefenicol, which bears u.s. national institutes of health compound identifier 5433. the european medicines agency schedules racefenicol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10231mig. the term racefenicol is an international non-proprietary name or inn (see world health organization inn reference publication, volume 23, no. 10 1969, list 9). racefenicol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: clc(cl)c(=o)nc(c(o)c1ccc(s(=o)(=o)c)cc1)co.. "
"amphenicols. this classification denotes phenylalanine-based, phenylpropanoids and antibacterials thar inhibit bacterial protein synthesis, and which are therefore called amphenicols.. thiamphenicol aminoacetate hydrochloride. this classification denotes a protein synthesis inhibitor and antibiotic c14h18cl2n2o6s.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 88vgc22bwe, chemically known as glycine, (2r,3r)-2-((2,2-dichloroacetyl)amino)-3-hydroxy-3-(4-(methylsulfonyl)phenyl)propyl ester, hydrochloride (1:1), but more generally known as thiamphenicol aminoacetate hydrochloride, which bears us nih compound identifier 3039735. european medicines agency schedules thiamphenicol aminoacetate hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04802mig. most nations, for tariff and trade purposes, schedule thiamphenicol aminoacetate hydrochloride under hs 29414000 and sitc 54139. as of q4 2014, thiamphenicol aminoacetate hydrochloride remains us fdas preferred term for this commodity. smiles: cs(=o)(=o)c1ccc(cc1)[c@h]([c@@h](coc(=o)cn)nc(=o)c(cl)cl)o.cl.. "
"amphenicols. this classification denotes phenylalanine-based, phenylpropanoids and antibacterials thar inhibit bacterial protein synthesis, and which are therefore called amphenicols.. thiamphenicol glycinate. this classification denotes a protein synthesis inhibitor and antibiotic with the molecular formula c14h18cl2n2o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w5h94cy6v6, chemically known as glycine, (2r,3r)-2-((2,2-dichloroacetyl)amino)-3-hydroxy-3-(4-(methylsulfonyl)phenyl)propyl ester, but more generally known as thiamphenicol glycinate, which bears us nih compound identifier 115817. european medicines agency schedules thiamphenicol glycinate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10970mig. most nations, for tariff purposes, schedule thiamphenicol glycinate under hs 29414000. smiles: cs(=o)(=o)c1ccc(cc1)[c@h]([c@@h](coc(=o)cn)nc(=o)c(cl)cl)o.. "
"amphenicols. this classification denotes phenylalanine-based, phenylpropanoids and antibacterials thar inhibit bacterial protein synthesis, and which are therefore called amphenicols.. thiamphenicol glycinate hydrochloride. this classification denotes a protein synthesis inhibitor and antibiotic with the molecular formula c14h18cl2n2o6s.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 88vgc22bwe, chemically known as glycine, (2r,3r)-2-((2,2-dichloroacetyl)amino)-3-hydroxy-3-(4-(methylsulfonyl)phenyl)propyl ester, hydrochloride (1:1), but more generally known as thiamphenicol glycinate hydrochloride, which bears us nih compound identifier 197006. european medicines agency schedules thiamphenicol glycinate hydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10970mig. most nations, for tariff purposes, schedule thiamphenicol glycinate hydrochloride under hs 29414000. smiles: cs(=o)(=o)c1ccc(cc1)[c@h]([c@@h](coc(=o)cn)nc(=o)c(cl)cl)o.cl.. "
"fifth generation cephalosporins. this classification denotes the original variety of broad-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin. these differ from other cephalosporins both in their chronological development and that these are effective against methicillin-resistant staphylococcus aureus, a strain of staphylococcus aureus that is non-susceptible to the action of methicillin. the mechanism of resistance usually involves modification of normal or the presence of acquired penicillin binding proteins.. . "
"fifth generation cephalosporins. this classification denotes the original variety of broad-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin. these differ from other cephalosporins both in their chronological development and that these are effective against methicillin-resistant staphylococcus aureus, a strain of staphylococcus aureus that is non-susceptible to the action of methicillin. the mechanism of resistance usually involves modification of normal or the presence of acquired penicillin binding proteins.. ceftaroline fosamil. this classification denotes a cephalosporin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7p6fqa5d21. european medicines agency schedules ceftaroline fosamil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub31648. ceftaroline fosamil generally arises in the molecular formula c22h21n8o8ps4. the term ceftaroline fosamil is an international non-proprietary name or inn (see who inn reference publication, volume 22, no. 1, 2008, list 59.) as of q4 2014, ceftaroline fosamil remains the us fda preferred term for this commodity. ceftaroline fosamil bears us nlm identifiers umls id c1873118 and nci concept code c81034. smiles: cco/n=c(/c1=nsc(=n1)np(=o)(o)o)\\c(=o)n[c@h]2[c@@h]3n(c2=o)c(=c(cs3)sc4=nc(=cs4)c5=cc=[n+](c=c5)c)c(=o)o.cc(=o)[o-].o.. "
"fifth generation cephalosporins. this classification denotes the original variety of broad-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin. these differ from other cephalosporins both in their chronological development and that these are effective against methicillin-resistant staphylococcus aureus, a strain of staphylococcus aureus that is non-susceptible to the action of methicillin. the mechanism of resistance usually involves modification of normal or the presence of acquired penicillin binding proteins.. ceftobiprole. this classification denotes a cephalosporin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5t97333yzk. european medicines agency schedules ceftobiprole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25723. ceftobiprole generally arises in the molecular formula c20h22n8o6s2. the term ceftobiprole is an international non-proprietary name or inn (see who inn reference publication, volume 19, no. 3, 2005, list 54.) most nations schedule ceftobiprole under hs 29419000 and sitc 54139. as of q4 2014, ceftobiprole remains the us fda preferred term for this commodity. ceftobiprole bears us nlm identifiers umls id c1100584 and nci concept code c65306. smiles: s1c2n(c(=o)c2nc(=o)c(=c2\\[nh]sc(n2)n)\\n=o)c(=c(c1)/c=c1\\ccn(c2ccnc2)c1=o)c(=o)o.. "
"fifth generation cephalosporins. this classification denotes the original variety of broad-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term cephalosporin. these differ from other cephalosporins both in their chronological development and that these are effective against methicillin-resistant staphylococcus aureus, a strain of staphylococcus aureus that is non-susceptible to the action of methicillin. the mechanism of resistance usually involves modification of normal or the presence of acquired penicillin binding proteins.. ceftobiprole medocaril. this classification denotes a cephalosporin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier n99027v28j. european medicines agency schedules ceftobiprole medocaril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25721. ceftobiprole medocaril generally arises in the molecular formula c26h25n8o11s2.na. the term ceftobiprole medocaril is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19, no. 3, 2005, list 54.) most nations, for tariff and trade purposes, schedule ceftobiprole medocaril under hs 29419000 and sitc 54139. as of q4 2014, ceftobiprole medocaril remains us fdas preferred term for this commodity. ceftobiprole medocaril bears us nlm identifiers umls id c1622308 and nci concept code c70597. smiles: cc1c(oc(=o)o1)coc(=o)n2cc[c@h](c2)n3cc/c(=c\\c4=c(n5[c@@h]([c@@h](c5=o)nc(=o)/c(=n\\o)/c6nc(sn6)n)sc4)c(=o)[o-])/c3=o.[na+].. "
"lincomycins and monobactam antibacterials and polymyxin antibacterials and polysaccharide antibacterials. this classification denotes antibacterial drugs made from or based in part on lincomycins, monobactam antibacterials, polymyxin antibacterials, or polysaccharide antibacterials. . "
"lincomycins and monobactam antibacterials and polymyxin antibacterials and polysaccharide antibacterials. this classification denotes antibacterial drugs made from or based in part on lincomycins, monobactam antibacterials, polymyxin antibacterials, or polysaccharide antibacterials. lincomycin. this classification denotes a lincosamide antibiotic with the molecular formula c18h34n2o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier bod072yw0f, chemically known as lincolnensin, hydrochloride, hemihydrate but generally known as lincomycin, which bears us nih compound identifier 3928. european medicines agency schedules lincomycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08517mig. the term lincomycin is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules lincomycin in its anatomical therapeutic chemical (atc) classification. lincomycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule lincomycin under hs 29419000 and sitc 54139. as of q4 2014, lincomycin remains the us fda preferred term for this commodity. lincomycin bears us nlm identifiers umls id c0023726 and nci concept code c61811. smiles: s(c1oc(c(nc(=o)c2n(cc(c2)ccc)c)c(o)c)c(o)c(o)c1o)c.. "
"lincomycins and monobactam antibacterials and polymyxin antibacterials and polysaccharide antibacterials. this classification denotes antibacterial drugs made from or based in part on lincomycins, monobactam antibacterials, polymyxin antibacterials, or polysaccharide antibacterials. aztreonam. this classification denotes a beta-lactam antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g2b4ve5gh8. european medicines agency schedules aztreonam in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05664mig. aztreonam generally arises in the molecular formula c13h17n5o8s2. the term aztreonam is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23.) aztreonam is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule aztreonam under hs 29419000 and sitc 54139. as of q4 2014, aztreonam remains the us fda preferred term for this commodity. aztreonam bears us nlm identifiers umls id c0699281 and nci concept code c28845. smiles: s(=o)(=o)(o)n1c(c(nc(=o)/c(=n\\oc(c)(c)c(=o)o)c2nc(sc2)[nh3])c1=o)c.. "
"lincomycins and monobactam antibacterials and polymyxin antibacterials and polysaccharide antibacterials. this classification denotes antibacterial drugs made from or based in part on lincomycins, monobactam antibacterials, polymyxin antibacterials, or polysaccharide antibacterials. colistin. this classification denotes a polymyxin antibiotic with the molecular formula c52h98n16o13, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier z67x93hjg1, more generally known as colistin. european medicines agency schedules colistin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01429mig. the term colistin is an international non-proprietary name or inn. colistin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule colistin under hs 29419000 and sitc 54139. as of q4 2014, colistin remains the us fda preferred term for this commodity. colistin bears us nlm identifiers umls id c0009316 and nci concept code c65350. smiles: ccc(c)cccc(=o)nc(ccn)c(=o)nc(c(c)o)c(=o)nc(ccn)c(=o)nc1ccnc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc1=o)ccn)cc(c)c)cc(c)c)ccn)ccn)c(c)o.. "
"lincomycins and monobactam antibacterials and polymyxin antibacterials and polysaccharide antibacterials. this classification denotes antibacterial drugs made from or based in part on lincomycins, monobactam antibacterials, polymyxin antibacterials, or polysaccharide antibacterials. bambermycin. this classification denotes a polysaccharide antibiotic with the molecular formula c70h109n4o35p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier pp922a42v2, chemically known as (2s,3s,4r,5r,6r)-5-[(2s,3r,4r,5s,6r)-3-acetamido-5-[(2s,3r,4r,5s,6r)-3-acetamido-4-hydroxy-6-methyl-5-[(2r,3r,4s,5r,6s)-3,4,5-trihydroxy-6-[(2-hydroxy-5-oxocyclopenten-1-yl)carbamoyl]oxan-2-yl]oxyoxan-2-yl]oxy-4-hydroxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-4-carbamoyloxy-3-hydroxy-6-[hydroxy-[(2r)-2-hydroxy-3-oxo-3-[(3e,7e,14e)-4,9,9,15,19-pentamethyl-12-methylideneicosa-3,7,14,18-tetraenoxy]propoxy]phosphoryl]oxy-3-methyloxane-2-carboxylic acid but generally known as bambermycin, which bears us nih compound identifier 6433554. bambermycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bambermycin under hs 29419000 and sitc 54139. smiles: cc1c(c(c(c(o1)oc2c(oc(c(c2o)nc(=o)c)oc3c(c(c(oc3op(=o)(o)occ(c(=o)occc=c(c)ccc=cc(c)(c)ccc(=c)cc=c(c)ccc=c(c)c)o)c(=o)o)(c)o)oc(=o)n)coc4c(c(c(c(o4)co)o)o)o)nc(=o)c)o)oc5c(c(c(c(o5)c(=o)nc6=c(ccc6=o)o)o)o)o.. "
"lincomycins and monobactam antibacterials and polymyxin antibacterials and polysaccharide antibacterials. this classification denotes antibacterial drugs made from or based in part on lincomycins, monobactam antibacterials, polymyxin antibacterials, or polysaccharide antibacterials. aztreonam lysine. this classification denotes a beta-lactam antibiotic with the molecular formula c13h17n5o8s2.c6h14n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier xnm7lt65np. european medicines agency schedules aztreonam lysine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub30777. the term aztreonam lysine is a united states adopted name designation. most nations, for tariff and trade purposes, schedule aztreonam lysine under hs 29419000 and sitc 54139. as of q4 2014, aztreonam lysine remains us fdas preferred term for this commodity. aztreonam lysine bears us nlm identifiers umls id c2698293 and nci concept code c76021. smiles: c[c@h]1[c@@h](c(=o)n1s(=o)(=o)o)nc(=o)/c(=n\\oc(c)(c)c(=o)o)/c2csc(n2)n.c(ccn)c[c@@h](c(=o)o)n.. "
"lincomycins and monobactam antibacterials and polymyxin antibacterials and polysaccharide antibacterials. this classification denotes antibacterial drugs made from or based in part on lincomycins, monobactam antibacterials, polymyxin antibacterials, or polysaccharide antibacterials. colistin sulfate. this classification denotes a polymyxin antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier wp15dxu577. european medicines agency schedules colistin sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01431mig. colistin sulfate generally arises in the molecular formula c52h102n16o21s2. the term colistin sulfate is a u.s. pharmacopeial convention designation. most nations, for tariff and trade purposes, schedule colistin sulfate under hs 29419000 and sitc 54139. colistin sulfate bears us nlm identifiers umls id c0009317 and nci concept code c386. smiles: as of q4 2014, colistin sulfate remains us fdas preferred term for this commodity.. "
"lincomycins and monobactam antibacterials and polymyxin antibacterials and polysaccharide antibacterials. this classification denotes antibacterial drugs made from or based in part on lincomycins, monobactam antibacterials, polymyxin antibacterials, or polysaccharide antibacterials. lincomycin hydrochloride. this classification denotes a lincosamide antibiotic with the molecular formula c18h34n2o6s.clh.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m6t05z2b68, chemically known as lincolnensin, hydrochloride, hemihydrate but more generally known as lincomycin hydrochloride, which bears us nih compound identifier 3928. european medicines agency schedules lincomycin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02924mig. most nations, for tariff and trade purposes, schedule lincomycin hydrochloride under hs 29419000 and sitc 54139. as of q4 2014, lincomycin hydrochloride remains us fdas preferred term for this commodity. lincomycin hydrochloride bears us nlm identifiers umls id c0282219 and nci concept code c66013. smiles: ccc[c@@h]1c[c@h](n(c1)c)c(=o)n[c@@h]([c@@h]2[c@@h]([c@@h]([c@h]([c@h](o2)sc)o)o)o)[c@@h](c)o.o.cl.. "
"lincomycins and monobactam antibacterials and polymyxin antibacterials and polysaccharide antibacterials. this classification denotes antibacterial drugs made from or based in part on lincomycins, monobactam antibacterials, polymyxin antibacterials, or polysaccharide antibacterials. lincomycin hydrochloride anhydrous. this classification denotes a lincosamide antibiotic with the molecular formula c18h34n2o6s.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier gcw8y9936l, chemically known as d-erythro-.alpha.-d-galacto-octopyranoside, methyl 6,8-dideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, monohydrochloride, (2s-trans)-, but more generally known as lincomycin hydrochloride anhydrous, which bears us nih compound identifier 64710. european medicines agency schedules lincomycin hydrochloride anhydrous or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08517mig. most nations, for tariff purposes, schedule lincomycin hydrochloride anhydrous under hs 29419000. lincomycin hydrochloride anhydrous bears us nlm identifiers umls id c2983919 and nci concept code c90876. smiles: ccc[c@@h]1c[c@h](n(c1)c)c(=o)n[c@@h]([c@@h]2[c@@h]([c@@h]([c@h]([c@h](o2)sc)o)o)o)[c@@h](c)o.cl.. "
"lincomycins and monobactam antibacterials and polymyxin antibacterials and polysaccharide antibacterials. this classification denotes antibacterial drugs made from or based in part on lincomycins, monobactam antibacterials, polymyxin antibacterials, or polysaccharide antibacterials. lincomycin hydrochloride monohydrate. this classification denotes a lincosamide antibiotic with the molecular formula c18h34n2o6s.clh.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m6t05z2b68, chemically known as lincolnensin, hydrochloride, hemihydrate but more generally known as lincomycin hydrochloride, which bears us nih compound identifier 3928. european medicines agency schedules lincomycin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02924mig. most nations, for tariff and trade purposes, schedule lincomycin hydrochloride monohydrate under hs 29419000 and sitc 54139. smiles: ccc[c@@h]1c[c@h](n(c1)c)c(=o)n[c@@h]([c@@h]2[c@@h]([c@@h]([c@h]([c@h](o2)sc)o)o)o)[c@@h](c)o.o.cl.. "
"carbapenems. this classification denotes broad-sspectrum antibiotics in which the sulfur atom in the thiazolidine ring of the penicillin molecule is replaced by a carbon atom, which are therefore called carbapenems.. . "
"carbapenems. this classification denotes broad-sspectrum antibiotics in which the sulfur atom in the thiazolidine ring of the penicillin molecule is replaced by a carbon atom, which are therefore called carbapenems.. biapenem. this classification denotes a beta-lactam antibiotic with the molecular formula c15h18n4o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier yr5u3l9zh1, chemically known as 6-(((4r,5s,6s)-2-carboxy-6-((1r)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-en-3-yl)thio)-6,7-dihydro-5h-pyrazolo(1,2-a)-s-triazol-4-ium hydroxide, inner salt but generally known as biapenem, which bears us nih compound identifier 71339. european medicines agency schedules biapenem in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05813mig. the term biapenem is an international non-proprietary name. world health organization schedules biapenem in its anatomical therapeutic chemical (atc) classification. most nations schedule biapenem under hs 29419000 and sitc 54139. as of q4 2014, biapenem remains the us fda preferred term for this commodity. biapenem bears us nlm identifiers umls id c0209475 and nci concept code c72620. smiles: s(c1=c(n2c(c(c2=o)c(o)c)c1c)c(=o)o)c1c[n]2n(c1)cnc2.. "
"carbapenems. this classification denotes broad-sspectrum antibiotics in which the sulfur atom in the thiazolidine ring of the penicillin molecule is replaced by a carbon atom, which are therefore called carbapenems.. doripenem. this classification denotes a beta-lactam antibiotic with the molecular formula c15h24n4o6s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier bhv525jobh, chemically known as 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-((5-(((aminosulfonyl)amino)methyl)-3-pyrrolidinyl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-, (4r-(3(3s*,5s*),4alpha,5beta,6beta(r*)))- but generally known as doripenem, which bears us nih compound identifier 73303. european medicines agency schedules doripenem in its extended eudravigilance medicinal product dictionary or xevmpd under index sub22196. the term doripenem is an international non-proprietary name or inn (see who inn reference publication, volume 15 no. 1, 2001, list 45). world health organization schedules doripenem in its anatomical therapeutic chemical (atc) classification. most nations schedule doripenem under hs 29419000 and sitc 54139. as of q4 2014, doripenem remains the us fda preferred term for this commodity. doripenem bears us nlm identifiers umls id c0389169 and nci concept code c65470. smiles: s(c1=c(n2c(c(c2=o)c(o)c)c1c)c(=o)o)c1cc(nc1)cns(=o)(=o)n.. "
"carbapenems. this classification denotes broad-sspectrum antibiotics in which the sulfur atom in the thiazolidine ring of the penicillin molecule is replaced by a carbon atom, which are therefore called carbapenems.. ertapenem. this classification denotes a beta-lactam antibiotic with the molecular formula c22h25n3o7s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g32f6eid2h, chemically known as 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-((5-(((3-carboxyphenyl)amino)carbonyl)-3-pyrrolidinyl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-, (4r-(3(3s*,5s*),4alpha,5beta,6beta(r*)))- but generally known as ertapenem, which bears us nih compound identifier 150610. european medicines agency schedules ertapenem in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25388. the term ertapenem is an international non-proprietary name or inn (see who inn reference publication, volume 15 no. 3-4, 2001, list 46). world health organization schedules ertapenem in its anatomical therapeutic chemical (atc) classification. most nations schedule ertapenem under hs 29419000 and sitc 54139. as of q4 2014, ertapenem remains the us fda preferred term for this commodity. ertapenem bears us nlm identifiers umls id c1120106 and nci concept code c61752. smiles: s(c1=c(n2c(c(c2=o)c(o)c)c1c)c(=o)o)c1cc(nc1)c(=o)nc1cc(ccc1)c(=o)o.. "
"carbapenems. this classification denotes broad-sspectrum antibiotics in which the sulfur atom in the thiazolidine ring of the penicillin molecule is replaced by a carbon atom, which are therefore called carbapenems.. imipenem. this classification denotes a beta-lactam antibiotic with the molecular formula c12h17n3o4s.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 71otz9ze0a, chemically known as 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-(1-hydroxyethyl)-3-((2-((iminomethyl)amino)ethyl)thio)-7-oxo-, (5r-(5-alpha,6-alpha(r*)))- but generally known as imipenem, which bears us nih compound identifier 47317. european medicines agency schedules imipenem in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08151mig. imipenem is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule imipenem under hs 29419000 and sitc 54139. as of q4 2014, imipenem remains the us fda preferred term for this commodity. imipenem bears us nlm identifiers umls id c0020933 and nci concept code c570. smiles: cc(c1c2cc(=c(n2c1=o)c(=o)o)sccn=cn)o.. "
"carbapenems. this classification denotes broad-sspectrum antibiotics in which the sulfur atom in the thiazolidine ring of the penicillin molecule is replaced by a carbon atom, which are therefore called carbapenems.. meropenem. this classification denotes a beta-lactam antibiotic with the molecular formula c17h25n3o5s.3h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fv9j3ju8b1, chemically known as 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-((5-((dimethylamino)carbonyl)-3-pyrrolidinyl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-, trihydrate, (4r-(3(3s*,5s*),4alpha,5beta,6beta(r*)))- but generally known as meropenem, which bears us nih compound identifier 60706. european medicines agency schedules meropenem in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08778mig. world health organization schedules meropenem in its anatomical therapeutic chemical (atc) classification. meropenem is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule meropenem under hs 29419000 and sitc 54139. as of q4 2014, meropenem remains the us fda preferred term for this commodity. meropenem bears us nlm identifiers umls id c0066005 and nci concept code c1160. smiles: s(c1=c(n2c(c(c2=o)c(o)c)c1c)c(=o)o)c1cc(nc1)c(=o)n(c)c.o.o.o.. "
"carbapenems. this classification denotes broad-sspectrum antibiotics in which the sulfur atom in the thiazolidine ring of the penicillin molecule is replaced by a carbon atom, which are therefore called carbapenems.. panipenem. this classification denotes a beta-lactam antibiotic with the molecular formula c15h21n3o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w9769w09jf, chemically known as 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-(1-hydroxyethyl)-3-((1-(1-iminoethyl)-3-pyrrolidinyl)thio)-7-oxo-, (5r-(3(s*),5-alpha,6-alpha(r*)))- but generally known as panipenem, which bears us nih compound identifier 72015. european medicines agency schedules panipenem in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09605mig. the term panipenem is an international non-proprietary name. panipenem is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule panipenem under hs 29419000 and sitc 54139. as of q4 2014, panipenem remains the us fda preferred term for this commodity. panipenem bears us nlm identifiers umls id c0207932 and nci concept code c66303. smiles: s(c1=c(n2c(c(c2=o)c(o)c)c1)c(=o)o)c1ccn(c1)c(=n)c.. "
"carbapenems. this classification denotes broad-sspectrum antibiotics in which the sulfur atom in the thiazolidine ring of the penicillin molecule is replaced by a carbon atom, which are therefore called carbapenems.. doripenem hydrate. this classification denotes a beta-lactam antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4b035t6nkt. european medicines agency schedules doripenem hydrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub26847. doripenem hydrate generally arises in the molecular formula c15h24n4o6s2.h2o. the term doripenem hydrate is a japanese accepted name designation. most nations, for tariff and trade purposes, schedule doripenem hydrate under hs 29419000. smiles: c[c@@h]1[c@@h]2[c@h](c(=o)n2c(=c1s[c@h]3c[c@h](nc3)cns(=o)(=o)n)c(=o)o)[c@@h](c)o.o.. "
"carbapenems. this classification denotes broad-sspectrum antibiotics in which the sulfur atom in the thiazolidine ring of the penicillin molecule is replaced by a carbon atom, which are therefore called carbapenems.. doripenem monohydrate. this classification denotes a beta-lactam antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4b035t6nkt. european medicines agency schedules doripenem hydrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub26847. doripenem monohydrate generally arises in the molecular formula c15h24n4o6s2.h2o. the term doripenem monohydrate is a japanese accepted name designation. most nations, for tariff and trade purposes, schedule doripenem monohydrate under hs 29419000 and sitc 54139. as of q4 2014, doripenem monohydrate remains us fdas preferred term for this commodity. smiles: c[c@@h]1[c@@h]2[c@h](c(=o)n2c(=c1s[c@h]3c[c@h](nc3)cns(=o)(=o)n)c(=o)o)[c@@h](c)o.o.. "
"carbapenems. this classification denotes broad-sspectrum antibiotics in which the sulfur atom in the thiazolidine ring of the penicillin molecule is replaced by a carbon atom, which are therefore called carbapenems.. ertapenem disodium. this classification denotes a beta-lactam antibiotic c22h23n3o7s.2na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier p5hea33d9r, chemically known as 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-(((3s,5s)-5-(((3-carboxyphenyl)amino)carbonyl)-3-pyrrolidinyl)thio)-6-((1r)-1-hydroxyethyl)-4-methyl-7-oxo-, sodium salt (1:2), (4r,5s,6s)-, but more generally known as ertapenem disodium, which bears us nih compound identifier 150611. most nations, for tariff and trade purposes, schedule ertapenem disodium under hs 29419000 and sitc 54139. as of q4 2014, ertapenem disodium remains us fdas preferred term for this commodity. smiles: c[c@@h]1[c@@h]2[c@h](c(=o)n2c(=c1s[c@h]3c[c@h](nc3)c(=o)nc4cccc(c4)c(=o)[o-])c(=o)[o-])[c@@h](c)o.[na+].[na+].. "
"carbapenems. this classification denotes broad-sspectrum antibiotics in which the sulfur atom in the thiazolidine ring of the penicillin molecule is replaced by a carbon atom, which are therefore called carbapenems.. ertapenem sodium. this classification denotes a beta-lactam antibiotic with the molecular formula c22h23n3o7s.h+.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2t90ke67l0, chemically known as 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-((5-(((3-carboxyphenyl)amino)carbonyl)-3-pyrrolidinyl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-, disodium salt, (4r-(3(3s*,5s*),4alpha,5beta,6beta(r*)))- but more generally known as ertapenem sodium, which bears us nih compound identifier 150611. european medicines agency schedules ertapenem sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub16424mig. most nations, for tariff and trade purposes, schedule ertapenem sodium under hs 29419000 and sitc 54139. ertapenem sodium bears us nlm identifiers umls id c1170745 and nci concept code c61753. smiles: as of q4 2014, ertapenem sodium remains us fdas preferred term for this commodity.. "
"carbapenems. this classification denotes broad-sspectrum antibiotics in which the sulfur atom in the thiazolidine ring of the penicillin molecule is replaced by a carbon atom, which are therefore called carbapenems.. imipenem anhydrous. this classification denotes a beta-lactam antibiotic with the molecular formula c12h17n3o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q20im7he75, chemically known as 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-(1-hydroxyethyl)-3-((2-((iminomethyl)amino)ethyl)thio)-7-oxo-, (5r-(5.alpha.,6.alpha.(r*)))-, but more generally known as imipenem anhydrous, which bears us nih compound identifier 47317. european medicines agency schedules imipenem anhydrous or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08151mig. most nations, for tariff purposes, schedule imipenem anhydrous under hs 29419000. smiles: c[c@h]([c@@h]1[c@h]2cc(=c(n2c1=o)c(=o)o)sccnc=n)o.. "
"carbapenems. this classification denotes broad-sspectrum antibiotics in which the sulfur atom in the thiazolidine ring of the penicillin molecule is replaced by a carbon atom, which are therefore called carbapenems.. meropenem anhydrous. this classification denotes a beta-lactam antibiotic with the molecular formula c17h25n3o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier yop6px0bao, chemically known as (4r,5s,6s)-3-(((3s,5s)-5-(dimethylcarbamoyl)-3-pyrrolidinyl)thio)-6-((1r)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, but more generally known as meropenem anhydrous, which bears us nih compound identifier 64778. european medicines agency schedules meropenem anhydrous or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08778mig. most nations, for tariff purposes, schedule meropenem anhydrous under hs 29419000. meropenem anhydrous bears us nlm identifiers umls id c1881787 and nci concept code c61833. smiles: c[c@@h]1[c@@h]2[c@h](c(=o)n2c(=c1s[c@h]3c[c@h](nc3)c(=o)n(c)c)c(=o)o)[c@@h](c)o.. "
"carbapenems. this classification denotes broad-sspectrum antibiotics in which the sulfur atom in the thiazolidine ring of the penicillin molecule is replaced by a carbon atom, which are therefore called carbapenems.. meropenem trihydrate. this classification denotes a beta-lactam antibiotic with the molecular formula c17h25n3o5s.3h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fv9j3ju8b1, chemically known as 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-((5-((dimethylamino)carbonyl)-3-pyrrolidinyl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-, trihydrate, (4r-(3(3s*,5s*),4alpha,5beta,6beta(r*)))- but more generally known as meropenem, which bears us nih compound identifier 60706. european medicines agency schedules meropenem in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08778mig. world health organization schedules meropenem in its anatomical therapeutic chemical (atc) classification. meropenem is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule meropenem trihydrate under hs 29419000 and sitc 54139. smiles: c[c@@h]1[c@@h]2[c@h](c(=o)n2c(=c1s[c@h]3c[c@h](nc3)c(=o)n(c)c)c(=o)o)[c@@h](c)o.o.o.o.. "
"pleuromutilin antibacterials. this classification denotes a group of diterpene-based antibacterials which typically bear a glycolate structure and which inhibit protein proliferation.. . "
"pleuromutilin antibacterials. this classification denotes a group of diterpene-based antibacterials which typically bear a glycolate structure and which inhibit protein proliferation.. xibornol. this classification denotes a bornane and alcohol with the molecular formula c18h26o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier rq12gmy0fz, chemically known as 3,4-xylenol, 6-isobornyl- (8ci) but generally known as xibornol, which bears us nih compound identifier 72144. european medicines agency schedules xibornol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00111mig. world health organization schedules xibornol in its anatomical therapeutic chemical (atc) classification. xibornol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule xibornol under hs 29071990 and sitc 51243. as of q4 2014, xibornol remains the us fda preferred term for this commodity. smiles: oc1c(c2c3(c(c(c2)cc3)(c)c)c)cc(c(c1)c)c.. "
"pleuromutilin antibacterials. this classification denotes a group of diterpene-based antibacterials which typically bear a glycolate structure and which inhibit protein proliferation.. cloxiqine or cloxyquin. this classification denotes an anti-infective agent with the molecular formula c9h6clno, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier bpf36h1g6s, chemically known as 8-quinolinol, 5-chloro- but generally known as cloxiquine, which bears us nih compound identifier 2817. european medicines agency schedules cloxiquine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06784mig. the term cloxiquine is an international non-proprietary name or inn (see who inn reference publication, volume 28, no. 10 1974, list 14). cloxiquine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. cloxiqine or cloxyquin bears us nlm identifiers umls id c0772059 and nci concept code c61689. smiles: c1=cc2=c(c=cc(=c2n=c1)o)cl.. "
"pleuromutilin antibacterials. this classification denotes a group of diterpene-based antibacterials which typically bear a glycolate structure and which inhibit protein proliferation.. midecamycin. this classification denotes a leucomycin and macrolides with the molecular formula c41h67no15, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier n34z0y5uh7, chemically known as leucomycin v, 3,4b-dipropanoate but generally known as midecamycin, which bears us nih compound identifier 5382853. european medicines agency schedules midecamycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08951mig. the term midecamycin is an international non-proprietary name or inn. most nations schedule midecamycin under hs 29419000 and sitc 54139. as of q4 2014, midecamycin remains the us fda preferred term for this commodity. smiles: ccc(=o)oc1cc(=o)oc(cc=cc=cc(c(cc(c(c1oc)oc2c(c(c(c(o2)c)oc3cc(c(c(o3)c)oc(=o)cc)(c)o)n(c)c)o)cc=o)c)o)c.. "
"pleuromutilin antibacterials. this classification denotes a group of diterpene-based antibacterials which typically bear a glycolate structure and which inhibit protein proliferation.. penoctonium. this classification denotes a topical anti-infective agent with the molecular formula c26h50no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5vt390wd2g, chemically known as 2-(2,2-dicyclopentylacetyl)oxyethyl-diethyl-octylazanium but generally known as penoctonium, which bears us nih compound identifier 71690. european medicines agency schedules penoctonium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09672mig. the term penoctonium is an international non-proprietary name. as of q4 2014, penoctonium remains the us fda preferred term for this commodity. penoctonium bears us nlm identifiers umls id c0604630 and nci concept code c87269. smiles: cccccccc[n+](cc)(cc)ccoc(=o)c(c1cccc1)c2cccc2.. "
"pleuromutilin antibacterials. this classification denotes a group of diterpene-based antibacterials which typically bear a glycolate structure and which inhibit protein proliferation.. retapamulin. this classification denotes an antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4mg6o8991r. european medicines agency schedules retapamulin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25391. retapamulin generally arises in the molecular formula c30h47no4s. the term retapamulin is an international non-proprietary name or inn (see who inn reference publication, volume 19, no. 1, 2005, list 53.) most nations schedule retapamulin under hs 29419000 and sitc 54139. as of q4 2014, retapamulin remains the us fda preferred term for this commodity. retapamulin bears us nlm identifiers umls id c1703334 and nci concept code c61924. smiles: s(c1cc2n(c(c1)cc2)c)cc(=o)oc1c2(c3c(c(c(o)c(c1)(c)c=c)c)(ccc2c)ccc3=o)c.. "
"pleuromutilin antibacterials. this classification denotes a group of diterpene-based antibacterials which typically bear a glycolate structure and which inhibit protein proliferation.. distamycin a or stallimycin. this classification denotes a distamycin antibiotic and dna minor groove binding agent with the molecular formula c22h27n9o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 80o63p88is, chemically known as distamycin a, hydrochloride but generally known as distamycin a, which bears us nih compound identifier 3115. european medicines agency schedules stallimycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10640mig. the term distamycin a is an international non-proprietary name. distamycin a or stallimycin bears us nlm identifiers umls id c0244119 and nci concept code c1517. smiles: o=c(nc1cc(n(c1)c)c(=o)nccc(=n)n)c1n(cc(nc(=o)c2n(cc(nc=o)c2)c)c1)c.. "
"pleuromutilin antibacterials. this classification denotes a group of diterpene-based antibacterials which typically bear a glycolate structure and which inhibit protein proliferation.. tiamulin. this classification denotes an antibiotic with the molecular formula c28h47no4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, e38wz4u54r chemically known as ((2-(diethylamino)ethyl)thio)-, 6-ethenyldecahydro-5-hydroxy-4,6,9,10-tetramethyl-1-oxo-3a,9-propano-3ah-cyclopentacycloocten-8-yl ester (3as-(3a.alpha.,4.beta.,5.alpha.,6.alpha.,8.beta.,9.alpha.,9a.beta.,10s*))- but generally known as tiamulin, which bears us nih compound identifier 65343. european medicines agency schedules tiamulin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11005mig. the term tiamulin is an international non-proprietary name or inn (see who inn reference publication, volume 30, no. 10 1976, list 16). most nations schedule tiamulin under hs 29419000 and sitc 54139. as of q4 2014, tiamulin remains the us fda preferred term for this commodity. tiamulin bears us nlm identifiers umls id c0076651 and nci concept code c84207. smiles: ccn(cc)ccscc(=o)oc1cc(c(c(c23ccc(c1(c2c(=o)cc3)c)c)c)o)(c)c=c.. "
"pleuromutilin antibacterials. this classification denotes a group of diterpene-based antibacterials which typically bear a glycolate structure and which inhibit protein proliferation.. valnemulin. this classification denotes an antibiotic with the molecular formula c31h52n2o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2ahc415bqg, chemically known as ((2-((r)-2-amino-3-methylbutyramido)-1,1-dimethylethyl)thio)acetic acid, 8-ester with (3as,4r,5s,6s,8r,9r,9ar,10r)-octahydro-5,8-dihydroxy-4,6,9,10-tetramethyl-6-vinyl-3a,9-propano-3ah-cyclopentacycloocten-1(4h)-one but generally known as valnemulin, which bears us nih compound identifier 127791. european medicines agency schedules valnemulin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00009mig. the term valnemulin is an international non-proprietary name or inn (see who inn reference publication, volume 10, no. 3, 1996, list 36). valnemulin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule valnemulin under hs 29419000 and sitc 54139. as of q4 2014, valnemulin remains the us fda preferred term for this commodity. valnemulin bears us nlm identifiers umls id c0764565 and nci concept code c75151. smiles: s(cc(=o)oc1c2(c3c(c(c(o)c(c1)(c)c=c)c)(ccc2c)ccc3=o)c)c(cnc(=o)c(n)c(c)c)(c)c.. "
"pleuromutilin antibacterials. this classification denotes a group of diterpene-based antibacterials which typically bear a glycolate structure and which inhibit protein proliferation.. midecamycin acetate. this classification denotes a leucomycin and macrolides with the molecular formula c45h71no17, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3t48cps7u2, chemically known as leucomycin v, 3b,9-diacetate 3,4b-dipropanoate, but more generally known as midecamycin acetate, which bears us nih compound identifier 5282188. european medicines agency schedules midecamycin acetate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08951mig. most nations, for tariff purposes, schedule midecamycin acetate under hs 29419000. smiles: ccc(=o)o[c@@h]1cc(=o)o[c@@h](c/c=c/c=c/[c@@h]([c@@h](c[c@@h]([c@@h]([c@h]1oc)o[c@h]2[c@@h]([c@h]([c@@h]([c@h](o2)c)o[c@h]3c[c@@]([c@h]([c@@h](o3)c)oc(=o)cc)(c)oc(=o)c)n(c)c)o)cc=o)c)oc(=o)c)c.. "
"pleuromutilin antibacterials. this classification denotes a group of diterpene-based antibacterials which typically bear a glycolate structure and which inhibit protein proliferation.. penoctonium bromide. this classification denotes a topical anti-infective agent with the molecular formula c26h50no2.br, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hf11ntt6mz, chemically known as 1-octanaminium, n-(2-((dicyclopentylacetyl)oxy)ethyl)-n,n-diethyl-, bromide (9ci) but more generally known as penoctonium bromide, which bears us nih compound identifier 71690. european medicines agency schedules penoctonium bromide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09672mig. the term penoctonium bromide is an international non-proprietary name. most nations, for tariff and trade purposes, schedule penoctonium bromide under hs 29239000 and sitc 51481. as of q4 2014, penoctonium bromide remains us fdas preferred term for this commodity. penoctonium bromide bears us nlm identifiers umls id c2825365 and nci concept code c80863. smiles: cccccccc[n+](cc)(cc)ccoc(=o)c(c1cccc1)c2cccc2.[br-].. "
"pleuromutilin antibacterials. this classification denotes a group of diterpene-based antibacterials which typically bear a glycolate structure and which inhibit protein proliferation.. stallimycin hydrochloride. this classification denotes a distamycin antibiotic and dna minor groove binding agent with the molecular formula c22h27n9o4.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f6010n240f, chemically known as distamycin a, hydrochloride but more generally known as stallimycin hydrochloride, which bears us nih compound identifier 3115. most nations, for tariff and trade purposes, schedule stallimycin hydrochloride under hs 29419000. as of q4 2014, stallimycin hydrochloride remains us fdas preferred term for this commodity. smiles: cn1cc(cc1c(=o)nc2cc(n(c2)c)c(=o)nc3cc(n(c3)c)c(=o)nccc(=n)n)nc=o.cl.. "
"pleuromutilin antibacterials. this classification denotes a group of diterpene-based antibacterials which typically bear a glycolate structure and which inhibit protein proliferation.. sulfadiasulfone sodium. this classification denotes a sulfone anti-infective agent with the molecular formula c14h14n3o5s2.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fq3m2y4bu3, chemically known as 4, 4-diaminodiphenylsulfone-2-n-acetylsulfonamide, sodium but more generally known as acetosulfone sodium, which bears us nih compound identifier 31400. european medicines agency schedules sulfadiasulfone sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10694mig. the term sulfadiasulfone sodium is an international non-proprietary name or inn (see world health organization inn reference publication, volume 16, no. 3 1962, list 4). most nations, for tariff and trade purposes, schedule sulfadiasulfone sodium under hs 29350090. smiles: cc(=o)[n-]s(=o)(=o)c1cc(ccc1s(=o)(=o)c2ccc(cc2)n)n.[na+].. "
"pleuromutilin antibacterials. this classification denotes a group of diterpene-based antibacterials which typically bear a glycolate structure and which inhibit protein proliferation.. tiamulin fumarate. this classification denotes an antibiotic with the molecular formula c28h47no4s.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ion1q02zcx, chemically known as acetic acid, ((2-(diethylamino)ethyl)thio)-, 6-ethenyldecahydro-5-hydroxy-4,6,9,10-tetramethyl-1-oxo-3-alpha,9-propano-3-alpha-h-cyclopentacycloocten-8-yl ester, (e)-2-butenedioate (1:1) (salt) but more generally known as tiamulin fumarate, which bears us nih compound identifier 6434500. most nations, for tariff and trade purposes, schedule tiamulin fumarate under hs 29419000 and sitc 54139. as of q4 2014, tiamulin fumarate remains us fdas preferred term for this commodity. tiamulin fumarate bears us nlm identifiers umls id c0521890 and nci concept code c84208. smiles: ccn(cc)ccscc(=o)o[c@@h]1c[c@@]([c@h]([c@@h]([c@@]23cc[c@h]([c@@]1([c@@h]2c(=o)cc3)c)c)c)o)(c)c=c.c(=c/c(=o)o)\\c(=o)o.. "
"pleuromutilin antibacterials. this classification denotes a group of diterpene-based antibacterials which typically bear a glycolate structure and which inhibit protein proliferation.. tiamulin hydrogen fumarate. this classification denotes an antibiotic with the molecular formula c28h47no4s.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ion1q02zcx, chemically known as acetic acid, ((2-(diethylamino)ethyl)thio)-, 6-ethenyldecahydro-5-hydroxy-4,6,9,10-tetramethyl-1-oxo-3-alpha,9-propano-3-alpha-h-cyclopentacycloocten-8-yl ester, (e)-2-butenedioate (1:1) (salt) but more generally known as tiamulin fumarate, which bears us nih compound identifier 6434500. most nations, for tariff and trade purposes, schedule tiamulin hydrogen fumarate under hs 29419000. smiles: ccn(cc)ccscc(=o)o[c@@h]1c[c@@]([c@h]([c@@h]([c@@]23cc[c@h]([c@@]1([c@@h]2c(=o)cc3)c)c)c)o)(c)c=c.c(=c/c(=o)o)\\c(=o)o.. "
"pleuromutilin antibacterials. this classification denotes a group of diterpene-based antibacterials which typically bear a glycolate structure and which inhibit protein proliferation.. azamulin. this classification denotes an antimicrobial with the molecular formula c24h38n4o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 875aq866x1, chemically known as ((5-amino-s-triazol-3-yl)thio)acetic acid, 8-ester with (3as,4r,5s,6r,8r,9ar,10r)-6-ethyloctahydro-5,8-dihydroxy-4,6,9,10-tetramethyl-3a,9-propano-3ah-cyclopentacycloocten-1(4h)-one but more generally known as azamulin, which bears us nih compound identifier 3086060. european medicines agency schedules azamulin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05633mig. the term azamulin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 39, no. 5, 1985, list 25). azamulin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s(cc(=o)oc1c2(c3c(c(c(o)c(c1)(cc)c)c)(ccc2c)ccc3=o)c)c1nc([nh]n1)n.. "
"combination antibacterials. this classification denotes combination drugs that reduce the growth or reproduction of bacteria. typical combination antibacterial constituents are benzalkonium, benzethonium chloride, camphor, chlorhexidine gluconate, ichthammol, and iodine.. . "
"combination antibacterials. this classification denotes combination drugs that reduce the growth or reproduction of bacteria. typical combination antibacterial constituents are benzalkonium, benzethonium chloride, camphor, chlorhexidine gluconate, ichthammol, and iodine.. benzalkonium/lidocaine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de101. this va drug class (de101) classifies this compound as belonging to the group antibacterial, topical.. "
"combination antibacterials. this classification denotes combination drugs that reduce the growth or reproduction of bacteria. typical combination antibacterial constituents are benzalkonium, benzethonium chloride, camphor, chlorhexidine gluconate, ichthammol, and iodine.. benzethonium chloride/corn starch/kaolin/zinc oxide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de101. this va drug class (de101) classifies this compound as belonging to the group antibacterial, topical.. "
"combination antibacterials. this classification denotes combination drugs that reduce the growth or reproduction of bacteria. typical combination antibacterial constituents are benzalkonium, benzethonium chloride, camphor, chlorhexidine gluconate, ichthammol, and iodine.. camphor/corn starch/eucalyptus/kaolin/triclosan/zinc oxide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de101. this va drug class (de101) classifies this compound as belonging to the group antibacterial, topical.. "
"combination antibacterials. this classification denotes combination drugs that reduce the growth or reproduction of bacteria. typical combination antibacterial constituents are benzalkonium, benzethonium chloride, camphor, chlorhexidine gluconate, ichthammol, and iodine.. chlorhexidine gluconate/ispropyl alcohol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de101. this va drug class (de101) classifies this compound as belonging to the group antibacterial, topical.. "
"combination antibacterials. this classification denotes combination drugs that reduce the growth or reproduction of bacteria. typical combination antibacterial constituents are benzalkonium, benzethonium chloride, camphor, chlorhexidine gluconate, ichthammol, and iodine.. ichthammol/lanolin/petrolatum. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de101. this va drug class (de101) classifies this compound as belonging to the group antibacterial, topical.. "
"combination antibacterials. this classification denotes combination drugs that reduce the growth or reproduction of bacteria. typical combination antibacterial constituents are benzalkonium, benzethonium chloride, camphor, chlorhexidine gluconate, ichthammol, and iodine.. iodine/potassium iodide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de101. this va drug class (de101) classifies this compound as belonging to the group antibacterial, topical.. "
"combination antibacterials. this classification denotes combination drugs that reduce the growth or reproduction of bacteria. typical combination antibacterial constituents are benzalkonium, benzethonium chloride, camphor, chlorhexidine gluconate, ichthammol, and iodine.. iodine/sodium iodide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class de101. this va drug class (de101) classifies this compound as belonging to the group antibacterial, topical.. "
"combination antimicrobials. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or which kill infectious agents and thereby prevent spread of infection. typical combination antimicrobial constituents aztreonam, cilastatin, methenamine, methinamine, phenazopyridine, sulfadiazine, sulfamethizole, and sulfamethoxazole.. . "
"combination antimicrobials. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or which kill infectious agents and thereby prevent spread of infection. typical combination antimicrobial constituents aztreonam, cilastatin, methenamine, methinamine, phenazopyridine, sulfadiazine, sulfamethizole, and sulfamethoxazole.. sulfamethizole/trimethoprim. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class am650. this va drug class (am650) classifies this compound as belonging to the group sulfonamide/related antimicrobials.. "
"combination antimicrobials. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or which kill infectious agents and thereby prevent spread of infection. typical combination antimicrobial constituents aztreonam, cilastatin, methenamine, methinamine, phenazopyridine, sulfadiazine, sulfamethizole, and sulfamethoxazole.. aztreonam/dextrose. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class am119. this va drug class (am119) classifies this compound as belonging to the group beta-lactams antimicrobials, other.. "
"combination antimicrobials. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or which kill infectious agents and thereby prevent spread of infection. typical combination antimicrobial constituents aztreonam, cilastatin, methenamine, methinamine, phenazopyridine, sulfadiazine, sulfamethizole, and sulfamethoxazole.. cilastatin/imipenem. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class am119. this va drug class (am119) classifies this compound as belonging to the group beta-lactams antimicrobials, other.. "
"combination antimicrobials. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or which kill infectious agents and thereby prevent spread of infection. typical combination antimicrobial constituents aztreonam, cilastatin, methenamine, methinamine, phenazopyridine, sulfadiazine, sulfamethizole, and sulfamethoxazole.. methenamine/potassium phosphate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class am550. this va drug class (am550) classifies this compound as belonging to the group methenamine salts antimicrobials.. "
"combination antimicrobials. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or which kill infectious agents and thereby prevent spread of infection. typical combination antimicrobial constituents aztreonam, cilastatin, methenamine, methinamine, phenazopyridine, sulfadiazine, sulfamethizole, and sulfamethoxazole.. methenamine/sodium biphosphate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class am550. this va drug class (am550) classifies this compound as belonging to the group methenamine salts antimicrobials.. "
"combination antimicrobials. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or which kill infectious agents and thereby prevent spread of infection. typical combination antimicrobial constituents aztreonam, cilastatin, methenamine, methinamine, phenazopyridine, sulfadiazine, sulfamethizole, and sulfamethoxazole.. methinamine/sodium salicylate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class am550. this va drug class (am550) classifies this compound as belonging to the group methenamine salts antimicrobials.. "
"combination antimicrobials. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or which kill infectious agents and thereby prevent spread of infection. typical combination antimicrobial constituents aztreonam, cilastatin, methenamine, methinamine, phenazopyridine, sulfadiazine, sulfamethizole, and sulfamethoxazole.. phenazopyridine/sulfamethizole. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class am650. this va drug class (am650) classifies this compound as belonging to the group sulfonamide/related antimicrobials.. "
"combination antimicrobials. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or which kill infectious agents and thereby prevent spread of infection. typical combination antimicrobial constituents aztreonam, cilastatin, methenamine, methinamine, phenazopyridine, sulfadiazine, sulfamethizole, and sulfamethoxazole.. phenazopyridine/sulfamethoxazole. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class am650. this va drug class (am650) classifies this compound as belonging to the group sulfonamide/related antimicrobials.. "
"combination antimicrobials. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or which kill infectious agents and thereby prevent spread of infection. typical combination antimicrobial constituents aztreonam, cilastatin, methenamine, methinamine, phenazopyridine, sulfadiazine, sulfamethizole, and sulfamethoxazole.. phenazopyridine/sulfisoxazole. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class am650. this va drug class (am650) classifies this compound as belonging to the group sulfonamide/related antimicrobials.. "
"combination antimicrobials. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or which kill infectious agents and thereby prevent spread of infection. typical combination antimicrobial constituents aztreonam, cilastatin, methenamine, methinamine, phenazopyridine, sulfadiazine, sulfamethizole, and sulfamethoxazole.. sulfadiazine/sulfamerazine/sulfamethazine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class am650. this va drug class (am650) classifies this compound as belonging to the group sulfonamide/related antimicrobials.. "
"combination antimicrobials. this classification denotes combination drugs that prevent infectious agents or organisms from spreading or which kill infectious agents and thereby prevent spread of infection. typical combination antimicrobial constituents aztreonam, cilastatin, methenamine, methinamine, phenazopyridine, sulfadiazine, sulfamethizole, and sulfamethoxazole.. sulfamethoxazole/trimethoprim. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class am650. this va drug class (am650) classifies this compound as belonging to the group sulfonamide/related antimicrobials.. "
"combination extended spectrum penicillins. this classification denotes combination drugs and preparations that constitute penicillin-derived antibiotics (taken from a group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group) and which possesss wide antibacterial spectrum, hence the designation extended-spectrum penicillins. typical combination extended spectrum penicillin constituents are tazobactam and ticarcillin.. . "
"combination extended spectrum penicillins. this classification denotes combination drugs and preparations that constitute penicillin-derived antibiotics (taken from a group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group) and which possesss wide antibacterial spectrum, hence the designation extended-spectrum penicillins. typical combination extended spectrum penicillin constituents are tazobactam and ticarcillin.. clavulanate/ticarcillin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class am113. this va drug class (am113) classifies this compound as belonging to the group extended spectrum penicillins.. "
"combination extended spectrum penicillins. this classification denotes combination drugs and preparations that constitute penicillin-derived antibiotics (taken from a group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group) and which possesss wide antibacterial spectrum, hence the designation extended-spectrum penicillins. typical combination extended spectrum penicillin constituents are tazobactam and ticarcillin.. dextrose/ticarcillin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class am113. this va drug class (am113) classifies this compound as belonging to the group extended spectrum penicillins.. "
"combination extended spectrum penicillins. this classification denotes combination drugs and preparations that constitute penicillin-derived antibiotics (taken from a group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group) and which possesss wide antibacterial spectrum, hence the designation extended-spectrum penicillins. typical combination extended spectrum penicillin constituents are tazobactam and ticarcillin.. piperacillin/tazobactam. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class am113. this va drug class (am113) classifies this compound as belonging to the group extended spectrum penicillins.. "
"combination h. pylori agents. this classification denotes combination drugs and preparations that combat a spiral, gram-negative, urease-positive bacterium active as a human gastric pathogen of genous helicobacter, and which therefore bears the name helicobacter pylori or h. pylori, and which therefore constitute h. pylori agents. typical combination h. pylori agent constituents are clarithromycin and metronidazole.. . "
"combination h. pylori agents. this classification denotes combination drugs and preparations that combat a spiral, gram-negative, urease-positive bacterium active as a human gastric pathogen of genous helicobacter, and which therefore bears the name helicobacter pylori or h. pylori, and which therefore constitute h. pylori agents. typical combination h. pylori agent constituents are clarithromycin and metronidazole.. amoxicillin/clarithromycin/lansoprazole. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga303. this va drug class (ga303) classifies this compound as belonging to the group h. pylori agents.. "
"combination h. pylori agents. this classification denotes combination drugs and preparations that combat a spiral, gram-negative, urease-positive bacterium active as a human gastric pathogen of genous helicobacter, and which therefore bears the name helicobacter pylori or h. pylori, and which therefore constitute h. pylori agents. typical combination h. pylori agent constituents are clarithromycin and metronidazole.. bismuth subsalicylate/metronidazole/tetracycline. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga303. this va drug class (ga303) classifies this compound as belonging to the group h. pylori agents.. "
"combination h. pylori agents. this classification denotes combination drugs and preparations that combat a spiral, gram-negative, urease-positive bacterium active as a human gastric pathogen of genous helicobacter, and which therefore bears the name helicobacter pylori or h. pylori, and which therefore constitute h. pylori agents. typical combination h. pylori agent constituents are clarithromycin and metronidazole.. bismuth/metronidazole/tetracycline. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga303. this va drug class (ga303) classifies this compound as belonging to the group h. pylori agents.. "
"dihydrofolate reductase inhibitor antibacterials. this classification denotes substances that inhibit dihydrofolate reductase, an enzyme which holds sway over cell division; these instant substances can, under certain circumstances, prevent cells from dividing and thus prevent spread of infection or even malignant cancer, substances that are therefore called dihydrofolate reductase inhibitors, this the term dihydrofolate reductase inhibitor antibacterials. this classification aims at the power of such substances to stay the proliferation of bacteria, which rely in part on dihydrofolate reductase to multiply.\u00a0. . "
"dihydrofolate reductase inhibitor antibacterials. this classification denotes substances that inhibit dihydrofolate reductase, an enzyme which holds sway over cell division; these instant substances can, under certain circumstances, prevent cells from dividing and thus prevent spread of infection or even malignant cancer, substances that are therefore called dihydrofolate reductase inhibitors, this the term dihydrofolate reductase inhibitor antibacterials. this classification aims at the power of such substances to stay the proliferation of bacteria, which rely in part on dihydrofolate reductase to multiply.\u00a0. baquiloprim. this classification denotes an antiprotozoal agent with the molecular formula c17h20n6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3de766vig6, chemically known as 5-((2,4-diamino-5-pyrimidinyl)methyl)-8-(dimethylamino)-7-methylquinoline but more generally known as baquiloprim, which bears us nih compound identifier 72121. european medicines agency schedules baquiloprim in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06100mig. the term baquiloprim is an international non-proprietary name. baquiloprim is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix.. "
"dihydrofolate reductase inhibitor antibacterials. this classification denotes substances that inhibit dihydrofolate reductase, an enzyme which holds sway over cell division; these instant substances can, under certain circumstances, prevent cells from dividing and thus prevent spread of infection or even malignant cancer, substances that are therefore called dihydrofolate reductase inhibitors, this the term dihydrofolate reductase inhibitor antibacterials. this classification aims at the power of such substances to stay the proliferation of bacteria, which rely in part on dihydrofolate reductase to multiply.\u00a0. epiroprim. this classification denotes a folate antagonist and antiprotozoal agent with the molecular structure c19h23n5o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 9g69d95443 chemically known as 2,4-diamino-5-(3,5-diethoxy-4-pyrrol-1-ylbenzyl)pyrimidine, but more commonly known as epiroprim, which bears us nih compound identifier 68916. european medicines agency schedules epiroprim in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06570mig. the term epiroprim is an international non-proprietary name or inn (see world health organization inn reference publication, volume 35, no. 5 1981, list 21).. "
"dihydrofolate reductase inhibitor antibacterials. this classification denotes substances that inhibit dihydrofolate reductase, an enzyme which holds sway over cell division; these instant substances can, under certain circumstances, prevent cells from dividing and thus prevent spread of infection or even malignant cancer, substances that are therefore called dihydrofolate reductase inhibitors, this the term dihydrofolate reductase inhibitor antibacterials. this classification aims at the power of such substances to stay the proliferation of bacteria, which rely in part on dihydrofolate reductase to multiply.\u00a0. trimethoprim. this classification denotes a urinary anti-infective agent with the molecular formula c14h18n4o3, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier an164j8y0x, chemically known as 2,4-pyrimidinediamine, 5-((3,4,5-trimethoxyphenyl)methyl)- but more generally known as trimethoprim, which bears u.s. national institutes of health compound identifier 5578. the european medicines agency schedules trimethoprim in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11310mig. the term trimethoprim is an international non-proprietary name. the world health organization schedules trimethoprim in its anatomical therapeutic chemical (atc) classification. trimethoprim is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: o(c1cc(cc2c(nc(nc2)n)n)cc(oc)c1oc)c.. "
"dihydrofolate reductase inhibitor antibacterials. this classification denotes substances that inhibit dihydrofolate reductase, an enzyme which holds sway over cell division; these instant substances can, under certain circumstances, prevent cells from dividing and thus prevent spread of infection or even malignant cancer, substances that are therefore called dihydrofolate reductase inhibitors, this the term dihydrofolate reductase inhibitor antibacterials. this classification aims at the power of such substances to stay the proliferation of bacteria, which rely in part on dihydrofolate reductase to multiply.\u00a0. trimethoprim hydrochloride. this classification denotes a dihydrofolate reductase inhibitor with the molecular formula c14h18n4o3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9xe000ou9b. the term trimethoprim hydrochloride is a u.s. fda designation. most nations, for tariff and trade purposes, schedule trimethoprim hydrochloride under hs 29335995 and sitc 51576. smiles: coc1=cc(=cc(=c1oc)oc)cc2=cn=c(n=c2n)n.cl.. "
"dihydrofolate reductase inhibitor antibacterials. this classification denotes substances that inhibit dihydrofolate reductase, an enzyme which holds sway over cell division; these instant substances can, under certain circumstances, prevent cells from dividing and thus prevent spread of infection or even malignant cancer, substances that are therefore called dihydrofolate reductase inhibitors, this the term dihydrofolate reductase inhibitor antibacterials. this classification aims at the power of such substances to stay the proliferation of bacteria, which rely in part on dihydrofolate reductase to multiply.\u00a0. trimethoprim pamoate. this classification denotes the pamoate form of a urinary anti-infective agent with the molecular formula c14h18n4o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier an164j8y0x, chemically known as 2,4-pyrimidinediamine, 5-((3,4,5-trimethoxyphenyl)methyl)- but more generally known as trimethoprim, which bears us nih compound identifier 5578. european medicines agency schedules trimethoprim in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11310mig. the term trimethoprim is an international non-proprietary name world health organization schedules trimethoprim in its anatomical therapeutic chemical (atc) classification. trimethoprim is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule trimethoprim pamoate under hs 29335995 and sitc 51576. smiles: coc1=cc(=cc(=c1oc)oc)cc2=cn=c(n=c2n)n.c1=cc=c2c(=c1)c=c(c(=c2cc3=c(c(=cc4=cc=cc=c43)c(=o)o)o)o)c(=o)o.. "
"dihydrofolate reductase inhibitor antibacterials. this classification denotes substances that inhibit dihydrofolate reductase, an enzyme which holds sway over cell division; these instant substances can, under certain circumstances, prevent cells from dividing and thus prevent spread of infection or even malignant cancer, substances that are therefore called dihydrofolate reductase inhibitors, this the term dihydrofolate reductase inhibitor antibacterials. this classification aims at the power of such substances to stay the proliferation of bacteria, which rely in part on dihydrofolate reductase to multiply.\u00a0. trimethoprim sulfate. this classification denotes a urinary anti-infective agent with the molecular formula 2c14h18n4o3.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier e377mf8eq8, chemically known as 2,4-pyrimidinediamine, 5-((3,4-trimethoxyphenyl)methyl)-, sulfate (2:1) but more generally known as trimethoprim sulfate, which bears us nih compound identifier 64936. european medicines agency schedules trimethoprim sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15618mig. most nations, for tariff and trade purposes, schedule trimethoprim sulfate under hs 29335995 and sitc 51576. smiles: coc1=cc(=cc(=c1oc)oc)cc2=cn=c(n=c2n)n.os(=o)(=o)o.. "
"antibacterial nitrofurans. this classification denotes a class of agents that kill or inhibit growth of microorganisms and which structrally bear a furan ring and a nitro group, compounds called nitrofurans, thus the term nitrofuran antibacterials.. . "
"antibacterial nitrofurans. this classification denotes a class of agents that kill or inhibit growth of microorganisms and which structrally bear a furan ring and a nitro group, compounds called nitrofurans, thus the term nitrofuran antibacterials.. ranbezolid. this classification denotes a nitrofuran-based antibacterial and anti-infective agent with the molecular formula c21h24fn5o6, chemically known as acetamide, n-[[(5s)-3-[3-fluoro-4-[4-[(5-nitro-2-furanyl)methyl]-1-piperazinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl]-n-[[(5s)-3-[3-fluoro-4-[4-[(5-nitrofuran-2-yl)methyl]piperazin-1-yl]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide but more generally known as ranbezolid, which bears u.s. national institutes of health compound identifier 496993. smiles: cc(=o)ncc1cn(c(=o)o1)c2=cc(=c(c=c2)n3ccn(cc3)cc4=cc=c(o4)[n+](=o)[o-])f.. "
"antibacterial nitrofurans. this classification denotes a class of agents that kill or inhibit growth of microorganisms and which structrally bear a furan ring and a nitro group, compounds called nitrofurans, thus the term nitrofuran antibacterials.. furazolidone. this classification denotes an anti-infective agent with the molecular formula c8h7n3o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 5j9cpu3re0, chemically known as 2-furanmethanimine, 5-nitro-n-(2-oxo-3-oxazolidinyl)- but more generally known as furazolidone, which bears us nih compound identifier 3435. european medicines agency schedules furazolidone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07834mig. the term furazolidone is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). world health organization schedules furazolidone in its anatomical therapeutic chemical (atc) classification. furazolidone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule furazolidone under hs 29349920 and sitc 51579. as of q4 2014, furazolidone remains us fdas preferred term for this commodity. furazolidone bears us nlm identifiers umls id c0016855 and nci concept code c65783. smiles: o1ccn(/n=c/c2oc([n](=o)o)cc2)c1=o.. "
"antibacterial nitrofurans. this classification denotes a class of agents that kill or inhibit growth of microorganisms and which structrally bear a furan ring and a nitro group, compounds called nitrofurans, thus the term nitrofuran antibacterials.. nifurquinazol. this classification denotes an antimicrobial with the molecular formula c16h16n4o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 44e5rrl600, chemically known as 2,2-((2-(5-nitro-2-furyl)-4-quinazolinyl)imino)diethanol but more generally known as nifurquinazol, which bears us nih compound identifier 21139. european medicines agency schedules nifurquinazol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09276mig. the term nifurquinazol is an international non-proprietary name or inn (see world health organization inn reference publication, volume 22, no. 10, 1968, list 8). nifurquinazol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule nifurquinazol under hs 29349990 and sitc 51579. as of q4 2014, nifurquinazol remains us fdas preferred term for this commodity. nifurquinazol bears us nlm identifiers umls id c2983987 and nci concept code c91015. smiles: occn(c1nc(nc2c1cccc2)c1oc([n](=o)o)cc1)cco.. "
"antibacterial nitrofurans. this classification denotes a class of agents that kill or inhibit growth of microorganisms and which structrally bear a furan ring and a nitro group, compounds called nitrofurans, thus the term nitrofuran antibacterials.. nifurtoinol. this classification denotes a urinary anti-infective agent with the molecular formula c9h8n4o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 980688h13o, chemically known as 2,4-imidazolidinedione, 3-(hydroxymethyl)-1-(((5-nitro-2-furanyl)methylene)amino)- but more generally known as nifurtoinol, which bears us nih compound identifier 9571062. european medicines agency schedules nifurtoinol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09281mig. the term nifurtoinol is an international non-proprietary name or inn (see world health organization inn reference publication, volume 31, no10, 1977, list 17). world health organization schedules nifurtoinol in its anatomical therapeutic chemical (atc) classification. nifurtoinol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule nifurtoinol under hs 29349990 and sitc 51579. as of q4 2014, nifurtoinol remains us fdas preferred term for this commodity. nifurtoinol bears us nlm identifiers umls id c0077875 and nci concept code c90997. smiles: o=c1n(c(=o)n(/n=c/c2oc([n](=o)o)cc2)c1)co.. "
"antibacterial nitrofurans. this classification denotes a class of agents that kill or inhibit growth of microorganisms and which structrally bear a furan ring and a nitro group, compounds called nitrofurans, thus the term nitrofuran antibacterials.. nifurzide. this classification denotes an anti-infective agent with the molecular formula c12h8n4o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) z35r6k4c26, chemically known as 2-thiophenecarboxylic acid, 5-nitro-, (3-(5-nitro-2-furanyl)-2-propenylidene)hydrazide but more generally known as nifurzide, which bears us nih compound identifier 9571044. european medicines agency schedules nifurzide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09283mig. the term nifurzide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 31, no10, 1977, list 17). world health organization schedules nifurzide in its anatomical therapeutic chemical (atc) classification. nifurzide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule nifurzide under hs 29349990 and sitc 51579. as of q4 2014, nifurzide remains us fdas preferred term for this commodity. nifurzide bears us nlm identifiers umls id c0068746 and nci concept code c90985. smiles: s1c(ccc1[n](=o)o)c(=o)n/n=c/c=c/c1oc([n](=o)o)cc1.. "
"antibacterial nitrofurans. this classification denotes a class of agents that kill or inhibit growth of microorganisms and which structrally bear a furan ring and a nitro group, compounds called nitrofurans, thus the term nitrofuran antibacterials.. furalazine. this classification denotes an anti-infective agent with the molecular formula c9h7n5o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2133jvq6ve, chemically known as 1,2,4-triazin-3-amine, 6-(2-(5-nitro-2-furanyl)ethenyl)- (9ci) but more generally known as furalazine, which bears us nih compound identifier 6436102. european medicines agency schedules furalazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07830mig. the term furalazine is an international non-proprietary name. furalazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule furalazine under hs 29349990 and sitc 51579. as of q4 2014, furalazine remains the us fda preferred term for this commodity. furalazine bears us nlm identifiers umls id c0603287 and nci concept code c65780. smiles: o1c(ccc1[n](=o)o)/c=c/c1nnc(nc1)n.. "
"antibacterial nitrofurans. this classification denotes a class of agents that kill or inhibit growth of microorganisms and which structrally bear a furan ring and a nitro group, compounds called nitrofurans, thus the term nitrofuran antibacterials.. nitrofurantoin. this classification denotes a urinary anti-infective agent with the molecular formula c8h6n4o5, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 927ah8112l, chemically known as hydantoin, 1-(5-nitro-furfurylideneamino)- but more generally known as nitrofurantoin, which bears u.s. national institutes of health compound identifier 4509. the european medicines agency schedules nitrofurantoin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09326mig. the term nitrofurantoin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). the world health organization schedules nitrofurantoin in its anatomical therapeutic chemical (atc) classification. nitrofurantoin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: o1c(/c=n/n2cc(=o)nc2=o)ccc1[n](=o)o.. "
"antibacterial nitrofurans. this classification denotes a class of agents that kill or inhibit growth of microorganisms and which structrally bear a furan ring and a nitro group, compounds called nitrofurans, thus the term nitrofuran antibacterials.. furaltadone. this classification denotes an anti-infective agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5x4v82zn30. european medicines agency schedules furaltadone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07831mig. furaltadone generally arises in the molecular formula c13h16n4o6. the term furaltadone is an international non-proprietary name or inn (see world health organization inn reference publication, volume 21 no. 12 1967, list 7.) furaltadone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule furaltadone under hs 29349990 and sitc 51579. as of q4 2014, furaltadone remains the us fda preferred term for this commodity. furaltadone bears us nlm identifiers umls id c0060849 and nci concept code c75249. smiles: o1c(cn2ccocc2)cn(/n=c/c2oc([n](=o)o)cc2)c1=o.. "
"antibacterial nitrofurans. this classification denotes a class of agents that kill or inhibit growth of microorganisms and which structrally bear a furan ring and a nitro group, compounds called nitrofurans, thus the term nitrofuran antibacterials.. furaltadone hydrochloride. this classification denotes an anti-infective agent with the molecular formula c13h16n4o6.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 37q02h7jt2, chemically known as 2-oxazolidinone, 5-(morpholinomethyl)-3-((5-nitrofurfurylidene)amino)-, monohydrochloride but more generally known as furaltadone hydrochloride, which bears us nih compound identifier 92968. european medicines agency schedules furaltadone hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02285mig. most nations schedule furaltadone hydrochloride under hs 29349990. as of q4 2014, furaltadone hydrochloride remains the us fda preferred term for this commodity. smiles: c1cc(oc1/c=n/n2cc(oc2=o)cn3ccocc3)[n+](=o)[o-].cl.. "
"antibacterial nitrofurans. this classification denotes a class of agents that kill or inhibit growth of microorganisms and which structrally bear a furan ring and a nitro group, compounds called nitrofurans, thus the term nitrofuran antibacterials.. nifuradene. this classification denotes a topical anti-infective agent with the molecular formula c8h8n4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2vx65207dr, chemically known as 2-imidazolidinone, 1-(5-nitrofurfurylideneamino)- but more generally known as nifuradene, which bears us nih compound identifier 11154. european medicines agency schedules nifuradene in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09258mig. the term nifuradene is an international non-proprietary name or inn (see world health organization inn reference publication, volume 21 no. 12 1967, list 7). nifuradene is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. nifuradene remains the us fda preferred term for this commodity. nifuradene bears nci cuid c84015 and umls uid c2827289. most nations, for tariff and trade purposes, schedule nifuradene under 29349990 and sitc 51579. smiles: o1c(/c=n/n2ccnc2=o)ccc1[n](=o)o.. "
"antibacterial nitrofurans. this classification denotes a class of agents that kill or inhibit growth of microorganisms and which structrally bear a furan ring and a nitro group, compounds called nitrofurans, thus the term nitrofuran antibacterials.. nifuralide. this classification denotes an anti-infective agent and antifungal agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 98sro07q7s. european medicines agency schedules nifuralide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09260mig. nifuralide generally arises in the molecular formula c14h13n5o4s. the term nifuralide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 30, no. 10 1976, list 16.) nifuralide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nifuralide under hs 29341000 and sitc 51579. as of q4 2014, nifuralide remains the us fda preferred term for this commodity. nifuralide bears us nlm identifiers umls id c2983803 and nci concept code c90618. smiles: s1c(ncc=c)nc(c1)c(=o)n/n=c/c=c/c1oc([n](=o)o)cc1.. "
"antibacterial nitrofurans. this classification denotes a class of agents that kill or inhibit growth of microorganisms and which structrally bear a furan ring and a nitro group, compounds called nitrofurans, thus the term nitrofuran antibacterials.. nifurethazone. this classification denotes a topical anti-infective agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 699m5q0ykn. european medicines agency schedules nifurethazone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09264mig. nifurethazone generally arises in the molecular formula c10h15n5o4. the term nifurethazone is an international non-proprietary name or inn (see world health organization inn reference publication, volume 16, no. 3 1962, list 4.) nifurethazone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nifurethazone under hs 29321900 and sitc 51569. as of q4 2014, nifurethazone remains the us fda preferred term for this commodity. nifurethazone bears us nlm identifiers umls id c2983964 and nci concept code c90978. smiles: cn(c)ccn(c(=o)n)/n=c/c1=cc=c(o1)[n+](=o)[o-].. "
"antibacterial nitrofurans. this classification denotes a class of agents that kill or inhibit growth of microorganisms and which structrally bear a furan ring and a nitro group, compounds called nitrofurans, thus the term nitrofuran antibacterials.. nifurimide. this classification denotes a topical anti-infective agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) nii0a33sql. european medicines agency schedules nifurimide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09266mig. nifurimide generally arises in the molecular formula c9h10n4o4. the term nifurimide is an international non-proprietary name or inn. nifurimide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule nifurimide under hs 29349990 and sitc 51579. as of q4 2014, nifurimide remains us fdas preferred term for this commodity. nifurimide bears us nlm identifiers umls id c2983966 and nci concept code c90980. smiles: o=c1n(/n=c/c2oc([n](=o)o)cc2)c(cn1)c.. "
"antibacterial nitrofurans. this classification denotes a class of agents that kill or inhibit growth of microorganisms and which structrally bear a furan ring and a nitro group, compounds called nitrofurans, thus the term nitrofuran antibacterials.. nifurizone. this classification denotes an anti-infective agent with the molecular formula c12h13n5o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 26lo5z6ihq, chemically known as 1-imidazolidinecarboxamide, n-methyl-3-((3-(5-nitro-2-furyl)allylidene)amino)-2-oxo- but more generally known as nifurizone, which bears us nih compound identifier 9577579. european medicines agency schedules nifurizone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09267mig. the term nifurizone is an international non-proprietary name. nifurizone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule nifurizone under hs 29349990 and sitc 51579. as of q4 2014, nifurizone remains us fdas preferred term for this commodity. nifurizone bears us nlm identifiers umls id c2983967 and nci concept code c90981. smiles: cnc(=o)n1ccn(c1=o)/n=c/c=c/c2=cc=c(o2)[n+](=o)[o-].. "
"antibacterial nitrofurans. this classification denotes a class of agents that kill or inhibit growth of microorganisms and which structrally bear a furan ring and a nitro group, compounds called nitrofurans, thus the term nitrofuran antibacterials.. nifurmazole. this classification denotes an anti-infective agent with the molecular formula c11h10n4o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) lof2a7032c, chemically known as 3-(hydroxymethyl)-1-(3-(5-nitro-2-furyl)allylidenamino)-2,4-imidazolidindion but more generally known as nifurmazole, which bears us nih compound identifier 72086. european medicines agency schedules nifurmazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09268mig. the term nifurmazole is an international non-proprietary name or inn (see world health organization inn reference publication, volume 24, no. 11 1970, list 10). nifurmazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule nifurmazole under hs 29349990 and sitc 51579. as of q4 2014, nifurmazole remains us fdas preferred term for this commodity. nifurmazole bears us nlm identifiers umls id c0068740 and nci concept code c84016. smiles: c1c(=o)n(c(=o)n1/n=c/c=cc2=cc=c(o2)[n+](=o)[o-])co.. "
"antibacterial nitrofurans. this classification denotes a class of agents that kill or inhibit growth of microorganisms and which structrally bear a furan ring and a nitro group, compounds called nitrofurans, thus the term nitrofuran antibacterials.. nifuroxime. this classification denotes an anti-infective agent with the molecular formula c5h4n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 465n7p5u85, chemically known as 2-furancarboxaldehyde, 5-nitro-, oxime, (z)- but more generally known as nifuroxime, which bears us nih compound identifier 22601. european medicines agency schedules nifuroxime in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09272mig. the term nifuroxime is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). nifuroxime is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nifuroxime under hs 29321900 and sitc 51569. as of q4 2014, nifuroxime remains the us fda preferred term for this commodity. nifuroxime bears us nlm identifiers umls id c0028072 and nci concept code c77053. smiles: o1c(ccc1[n](=o)o)/c=n/o.. "
"antibacterial nitrofurans. this classification denotes a class of agents that kill or inhibit growth of microorganisms and which structrally bear a furan ring and a nitro group, compounds called nitrofurans, thus the term nitrofuran antibacterials.. nifurpirinol. this classification denotes a topical anti-infective agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7o5a98xy8u. european medicines agency schedules nifurpirinol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09274mig. nifurpirinol generally arises in the molecular formula c12h10n2o4. the term nifurpirinol is an international non-proprietary name or inn (see world health organization inn reference publication, volume 24, no. 11 1970, list 10.) nifurpirinol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nifurpirinol under hs 29349990 and sitc 51579. as of q4 2014, nifurpirinol remains the us fda preferred term for this commodity. nifurpirinol bears us nlm identifiers umls id c0068743 and nci concept code c90983. smiles: c1=cc(=nc(=c1)co)/c=c/c2=cc=c(o2)[n+](=o)[o-].. "
"antibacterial nitrofurans. this classification denotes a class of agents that kill or inhibit growth of microorganisms and which structrally bear a furan ring and a nitro group, compounds called nitrofurans, thus the term nitrofuran antibacterials.. nifurvidine. this classification denotes an anti-infective agent with the molecular formula c11h9n3o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier y0g95d5k2w, chemically known as 4-pyrimidinol, 2-methyl-6-(2-(5-nitro-2-furyl)vinyl)- but more generally known as nifurvidine, which bears us nih compound identifier 6441378. european medicines agency schedules nifurvidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09282mig. the term nifurvidine is an international non-proprietary name. nifurvidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nifurvidine under hs 29349990 and sitc 51579. as of q4 2014, nifurvidine remains the us fda preferred term for this commodity. nifurvidine bears us nlm identifiers umls id c2827290 and nci concept code c84017. smiles: cc1=nc(=o)c=c(n1)/c=c/c2=cc=c(o2)[n+](=o)[o-].. "
"antibacterial nitrofurans. this classification denotes a class of agents that kill or inhibit growth of microorganisms and which structrally bear a furan ring and a nitro group, compounds called nitrofurans, thus the term nitrofuran antibacterials.. nifuratel. this classification denotes an antifungal agents and antitrichomonal agents and antiprotozoal, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier u60u6p08sp. european medicines agency schedules nifuratel in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09261mig. nifuratel generally arises in the molecular formula c10h11n3o5s. the term nifuratel is an international non-proprietary name or inn (see world health organization inn reference publication, volume 21 no. 12 1967, list 7.) nifuratel is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix.. "
"a-generational cephalosporins. this classification denotes a variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, but which medical researchers have not yet designated as first-, second-, third-, fourth-, or fifth-generation, hence the term a-generational cephalosporins.. . "
"a-generational cephalosporins. this classification denotes a variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, but which medical researchers have not yet designated as first-, second-, third-, fourth-, or fifth-generation, hence the term a-generational cephalosporins.. cefaloram. this classification denotes a cephalosporin antibiotic with the molecular formula c18h18n2o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) k3086gqj9z, chemically known as (6r,7r)-3-(acetoxymethyl)-8-oxo-7-(2-phenylacetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure but more generally known as cefaloram, which bears us nih compound identifier 68940. european medicines agency schedules cefaloram in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06168mig. the term cefaloram is an international non-proprietary name. cefaloram is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule cefaloram under hs 29419000 and sitc 54139. as of q4 2014, cefaloram remains us fdas preferred term for this commodity. cefaloram bears us nlm identifiers umls id c0637533 and nci concept code c76156. smiles: s1c2n(c(=o)c2nc(=o)cc2ccccc2)c(=c(c1)coc(=o)c)c(=o)o.. "
"a-generational cephalosporins. this classification denotes a variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, but which medical researchers have not yet designated as first-, second-, third-, fourth-, or fifth-generation, hence the term a-generational cephalosporins.. cefedrolor. this classification denotes a cephalosporin antibiotic with the molecular formula c16h16cln3o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) o3ty87kjii, chemically known as (6r,7r)-7-((r)-2-amino-2-(3-chloro-4-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid. but more generally known as cefedrolor, which bears us nih compound identifier 193953. european medicines agency schedules cefedrolor in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07388mig. the term cefedrolor is an international non-proprietary name. cefedrolor is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule cefedrolor under hs 29419000 and sitc 54139. as of q4 2014, cefedrolor remains us fdas preferred term for this commodity. cefedrolor bears us nlm identifiers umls id c2699136 and nci concept code c76162. smiles: clc1cc(c(n)c(=o)nc2c3scc(=c(n3c2=o)c(=o)o)c)ccc1o.. "
"a-generational cephalosporins. this classification denotes a variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, but which medical researchers have not yet designated as first-, second-, third-, fourth-, or fifth-generation, hence the term a-generational cephalosporins.. cefivitril. this classification denotes a cephalosporin antibiotic with the molecular formula c15h15n7o4s3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 776e09gmhq, chemically known as (6r,7r)-7-(2-(((z)-2-cyanovinyl)thio)acetamido)-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid. but more generally known as cefivitril, which bears us nih compound identifier 6443795. european medicines agency schedules cefivitril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07394mig. the term cefivitril is an international non-proprietary name or inn (see world health organization inn reference publication, volume 39, no. 5, 1985, list 25). cefivitril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule cefivitril under hs 29419000 and sitc 54139. as of q4 2014, cefivitril remains us fdas preferred term for this commodity. cefivitril bears us nlm identifiers umls id c2699140 and nci concept code c76167. smiles: s1c2n(c(=o)c2nc(=o)cs/c=c\\c#n)c(=c(c1)csc1n(nnn1)c)c(=o)o.. "
"a-generational cephalosporins. this classification denotes a variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, but which medical researchers have not yet designated as first-, second-, third-, fourth-, or fifth-generation, hence the term a-generational cephalosporins.. cefoxazole. this classification denotes a cephalosporin antibiotic with the molecular formula c21h18cln3o7s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) bn10x2tl6i, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetoxy)methyl)-7-(((3-(2-chlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-8-oxo-, (6r-trans)- but more generally known as cefoxazole, which bears us nih compound identifier 65798. european medicines agency schedules cefoxazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07408mig. the term cefoxazole is an international non-proprietary name or inn (see world health organization inn reference publication, volume 30, no. 10 1976, list 16). cefoxazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule cefoxazole under hs 29419000 and sitc 54139. as of q4 2014, cefoxazole remains us fdas preferred term for this commodity. cefoxazole bears us nlm identifiers umls id c0055084 and nci concept code c76171. smiles: clc1c(c2noc(c2c(=o)nc2c3scc(=c(n3c2=o)c(=o)o)coc(=o)c)c)cccc1.. "
"a-generational cephalosporins. this classification denotes a variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, but which medical researchers have not yet designated as first-, second-, third-, fourth-, or fifth-generation, hence the term a-generational cephalosporins.. cefrotil. this classification denotes a cephalosporin antibiotic with the molecular formula c20h22n4o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 44p98h0a27, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-methyl-8-oxo-7-(((4-(1,4,5,6-tetrahydro-2-pyrimidinyl)phenyl)acetyl)amino)-, (6r,7r)- but more generally known as cefrotil, which bears us nih compound identifier 68692. european medicines agency schedules cefrotil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07418mig. the term cefrotil is an international non-proprietary name or inn (see world health organization inn reference publication, volume 30, no. 10 1976, list 16). cefrotil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule cefrotil under hs 29419000 and sitc 54139. as of q4 2014, cefrotil remains us fdas preferred term for this commodity. cefrotil bears us nlm identifiers umls id c2699148 and nci concept code c76591. smiles: s1c2n(c(=o)c2nc(=o)cc2ccc(c3=ncccn3)cc2)c(=c(c1)c)c(=o)o.. "
"a-generational cephalosporins. this classification denotes a variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, but which medical researchers have not yet designated as first-, second-, third-, fourth-, or fifth-generation, hence the term a-generational cephalosporins.. cefuracetime. this classification denotes a cephalosporin antibiotic with the molecular formula c17h17n3o8s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) f69ea18270, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-7-((2-furanyl(methylimino)acetyl)amino)-8-oxo-, (6r-(6alpha,7beta(z)))- but more generally known as cefuracetime, which bears us nih compound identifier 9571078. european medicines agency schedules cefuracetime in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07432mig. the term cefuracetime is an international non-proprietary name or inn (see world health organization inn reference publication, volume 35, no. 5 1981, list 21). cefuracetime is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule cefuracetime under hs 29419000 and sitc 54139. as of q4 2014, cefuracetime remains us fdas preferred term for this commodity. cefuracetime bears us nlm identifiers umls id c2699151 and nci concept code c76177. smiles: s1c2n(c(=o)c2nc(=o)/c(=n\\oc)c2occc2)c(=c(c1)coc(=o)c)c(=o)o.. "
"a-generational cephalosporins. this classification denotes a variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, but which medical researchers have not yet designated as first-, second-, third-, fourth-, or fifth-generation, hence the term a-generational cephalosporins.. cefcanel. this classification denotes a cephalosporin antibiotic with the molecular formula c19h18n4o5s3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2f5v2r6vx8, chemically known as (6r,7r)-7-((r)-mandelamido)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid but generally known as cefcanel, which bears us nih compound identifier 68666. european medicines agency schedules cefcanel in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07381mig. the term cefcanel is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). cefcanel is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefcanel under hs 29419000 and sitc 54139. as of q4 2014, cefcanel remains the us fda preferred term for this commodity. cefcanel bears us nlm identifiers umls id c0055001 and nci concept code c76158. smiles: s1c2n(c(=o)c2nc(=o)c(o)c2ccccc2)c(=c(c1)csc1sc(nn1)c)c(=o)o.. "
"a-generational cephalosporins. this classification denotes a variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, but which medical researchers have not yet designated as first-, second-, third-, fourth-, or fifth-generation, hence the term a-generational cephalosporins.. cefmatilen. this classification denotes a cephalosporin antibiotic with the molecular formula c15h17cln8o6s4, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier pa4o9ckp1m, chemically known as (6r,7r)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyiminoacetyl]amino]-8-oxo-3-(2h-triazol-4-ylsulfanylmethylsulfanyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid but more generally known as cefmatilen, which bears u.s. national institutes of health compound identifier 9690121. the term cefmatilen is an international non-proprietary name or inn. cefmatilen is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s(cc1=c(n2c(oc1)c(oc)(nc(=o)csc(f)f)c2=o)c(=o)o)c1n(nnn1)cco.. "
"a-generational cephalosporins. this classification denotes a variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, but which medical researchers have not yet designated as first-, second-, third-, fourth-, or fifth-generation, hence the term a-generational cephalosporins.. cefsumide. this classification denotes a cephalosporin antibiotic with the molecular formula c17h20n4o6s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 3642w81j7a, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(3-((methylsulfonyl)amino)phenyl)acetyl)amino)-3-methyl-8-oxo-, (6r-(6alpha,7beta(r*)))- but more generally known as cefsumide, which bears us nih compound identifier 68718. european medicines agency schedules cefsumide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07421mig. the term cefsumide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 32, no 10 1978, list 18). cefsumide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule cefsumide under hs 29419000 and sitc 54139. as of q4 2014, cefsumide remains us fdas preferred term for this commodity. cefsumide bears us nlm identifiers umls id c0605109 and nci concept code c76037. smiles: s1c2n(c(=o)c2nc(=o)c(n)c2cc(ns(=o)(=o)c)ccc2)c(=c(c1)c)c(=o)o.. "
"antibacterials, synthesized. this classification denotes antibacterials composed of multiple constituents, with no dominant constituent.. . "
"antibacterials, synthesized. this classification denotes antibacterials composed of multiple constituents, with no dominant constituent.. clazuril. this classification denotes an antiparasitic agent with the molecular formula c17h10cl2n4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier o8w0r05772, chemically known as benzeneacetonitrile, 2-chloro-alpha-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3h)-yl)- but generally known as clazuril, which bears us nih compound identifier 58901. european medicines agency schedules clazuril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06645mig. the term clazuril is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). clazuril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule clazuril under hs 29336980 and sitc 51576. as of q4 2014, clazuril remains the us fda preferred term for this commodity. clazuril bears us nlm identifiers umls id c0055867 and nci concept code c82246. smiles: clc1c(c(c2ccc(cl)cc2)c#n)ccc(n2ncc(=o)[nh]c2=o)c1.. "
"antibacterials, synthesized. this classification denotes antibacterials composed of multiple constituents, with no dominant constituent.. clofoctol. this classification denotes an anti-infective agent with the molecular formula c21h26cl2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 704083ni0r, chemically known as 2-((2,4-dichlorophenyl)methyl)-4-(1,1,3,3-tetramethylbutyl)phenol but generally known as clofoctol, which bears us nih compound identifier 2799. european medicines agency schedules clofoctol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06711mig. the term clofoctol is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17). world health organization schedules clofoctol in its anatomical therapeutic chemical (atc) classification. clofoctol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule clofoctol under hs 29081900 and sitc 51244. as of q4 2014, clofoctol remains the us fda preferred term for this commodity. clofoctol bears us nlm identifiers umls id c0055915 and nci concept code c78048. smiles: clc1c(cc2cc(c(cc(c)(c)c)(c)c)ccc2o)ccc(cl)c1.. "
"antibacterials, synthesized. this classification denotes antibacterials composed of multiple constituents, with no dominant constituent.. ditophal. this classification denotes an antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 40sr2754gl. european medicines agency schedules ditophal in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06336mig. ditophal generally arises in the molecular formula c12h14o2s2. the term ditophal is an international non-proprietary name or inn. ditophal is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ditophal under hs 29309085 and sitc 51549. as of q4 2014, ditophal remains the us fda preferred term for this commodity. ditophal bears us nlm identifiers umls id c1880369 and nci concept code c65445. smiles: ccsc(=o)c1=cc(=cc=c1)c(=o)scc.. "
"antibacterials, synthesized. this classification denotes antibacterials composed of multiple constituents, with no dominant constituent.. fusidate or fusidic acid. this classification denotes a protein synthesis inhibitor and antimicrobial solution with the molecular formula c31h48o6, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 59xe10c19c, chemically known as 29-nordammara-17 (20),24-dien-21-oic acid, 16-(acetyloxy)-3,11-dihydroxy-, (3.alpha.,4.alpha.,8.alpha., 9.beta.,11.alpha.,13.alpha.,14.beta.,16.beta.,17z)- but more generally known as fusidic acid, which bears u.s. national institutes of health compound identifier 3000226. the european medicines agency schedules fusidic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02292mig. the term fusidic acid is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). the world health organization schedules fusidic acid in its anatomical therapeutic chemical (atc) classification. smiles: cc1c2ccc3(c(c2(ccc1o)c)c(cc4c3(cc(c4=c(ccc=c(c)c)c(=o)o)oc(=o)c)c)o)c.. "
"antibacterials, synthesized. this classification denotes antibacterials composed of multiple constituents, with no dominant constituent.. oxibetaine. this classification denotes an anti-lipidemic agent with the molecular formula c6h13no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier y0wvv18vui, chemically known as n-(2-hydroxyethyl) n,n-dimethylammonioacetat but generally known as oxibetaine, which bears us nih compound identifier 168886. european medicines agency schedules oxibetaine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09522mig. the term oxibetaine is an international non-proprietary name. oxibetaine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule oxibetaine under hs 29239000 and sitc 51481. as of q4 2014, oxibetaine remains the us fda preferred term for this commodity. oxibetaine bears us nlm identifiers umls id c1882237 and nci concept code c66263. smiles: occ[n](cc(=o)o)(c)c.. "
"antibacterials, synthesized. this classification denotes antibacterials composed of multiple constituents, with no dominant constituent.. cefempidone. this classification denotes a cephalosporin antibiotic with the molecular formula c22h21n7o6s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3yuz4494bq, chemically known as 1-(((6r,7r)-7-(2-(2-amino-5-thiazolyl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-azacicyclo(4.2.0)oct-2-en-3-yl)methyl)pyridinium hydroxide, inner salt, 7,2-(e)-(o-(2-oxo-3-pyrrolidinyl)oxime). but more generally known as cefempidone, which bears us nih compound identifier 9578269. european medicines agency schedules cefempidone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07389mig. the term cefempidone is an international non-proprietary name or inn (see world health organization inn reference publication, volume 1, no. 4, 1987, list 27). cefempidone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cefempidone under hs 29419000 and sitc 54139. as of q4 2014, cefempidone remains the us fda preferred term for this commodity. cefempidone bears us nlm identifiers umls id c2699137 and nci concept code c76163. smiles: s1c2n(c(=o)c2nc(=o)/c(=n/oc2ccnc2=o)c2sc(nc2)n)c(=c(c1)c[n]1ccccc1)c(=o)o.. "
"antibacterials, synthesized. this classification denotes antibacterials composed of multiple constituents, with no dominant constituent.. heliomycin. this classification denotes an antibiotic with the molecular formula c22h16o6, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 7n3a092a5x, chemically known as 2h-benzo(cd)pyrene-2,6(1h)-dione, 3,5,7,10-tetrahydroxy-1,1,9-trimethyl- but more generally known as heliomycin, which bears u.s. national institutes of health compound identifier 5282060. the european medicines agency schedules heliomycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08013mig. the term heliomycin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 25 , no. 10 1971, list 11). heliomycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: o=c1c(c2c3c4c1c(o)cc(o)c4c(=o)c1c3c(c(o)c2)c(cc1o)c)(c)c.. "
"antibacterial alcohols. this classification denotes antibacterials composed of alkyl compounds containing a hydroxyl group, substances called alcohols. . "
"antibacterial alcohols. this classification denotes antibacterials composed of alkyl compounds containing a hydroxyl group, substances called alcohols. azacosterol. this classification denotes an anti-lipidemic agent with the molecular formula c25h44n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ept876j73a, chemically known as 20,25-diazacholesterol but more generally known as azacosterol, which bears us nih compound identifier 9402. azacosterol most often comes in base, dihydrochloride, and hydrochloride forms. european medicines agency schedules azacosterol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05627mig. the term azacosterol is an international non-proprietary name or inn (see world health organization inn reference publication, volume 21 no. 12 1967, list 7). azacosterol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: oc1cc2=ccc3c4c(c(n(cccn(c)c)c)cc4)(ccc3c2(cc1)c)c.. "
"antibacterial alcohols. this classification denotes antibacterials composed of alkyl compounds containing a hydroxyl group, substances called alcohols. azacosterol hydrochloride. this classification denotes an enzyme inhibitor and anti-lipidemic agent with the molecular formula c25h44n2o.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier b32804uauq, chemically known as 20,25-diazacholesterol dihydrochloride but more generally known as azacosterol hydrochloride, which bears us nih compound identifier 14729.. "
"antibacterial alcohols. this classification denotes antibacterials composed of alkyl compounds containing a hydroxyl group, substances called alcohols. delmopinol. this classification denotes a surface-active agent with the molecular formula c16h33no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) dt67wl708f, chemically known as 4-morpholineethanol, 3-(4-propylheptyl)-, ( -)- but more generally known as delmopinol, which bears u.s. national institutes of health compound identifier 57337. european medicines agency schedules delmopinol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06956mig. the term delmopinol is an international non-proprietary name or inn (see world health organization inn reference publication, volume 3, no. 3, 1989, list 29). delmopinol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule delmopinol under hs 29349990 and sitc 51579. as of q4 2014, delmopinol remains the us fda preferred term for this commodity. delmopinol bears us nlm identifiers umls id c0166532 and nci concept code c78112. smiles: o1cc(n(cc1)cco)cccc(ccc)ccc.. "
"antibacterial alcohols. this classification denotes antibacterials composed of alkyl compounds containing a hydroxyl group, substances called alcohols. delmopinol hydrochloride. this classfication denotes a surface-active agent with the molecular formula c16h33no2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier sre423v9z9, chemically known as 4-morpholineethanol, 3-(4-propylheptyl)-, hydrochloride (1:1), but more generally known as delmopinol hydrochloride, which bears u.s. national institutes of health compound identifier 57337. european medicines agency schedules delmopinol hydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06956mig. most nations, for tariff purposes, schedule delmopinol hydrochloride under hs 29349990. smiles: cccc(ccc)cccc1coccn1cco.cl.. "
"antibacterial alcohols. this classification denotes antibacterials composed of alkyl compounds containing a hydroxyl group, substances called alcohols. lasalocid. this classification denotes an antibiotic with the molecular formula c34h54o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w7v2zz2fwb, chemically known as 2,3-cresotic acid, 6-(7-(5-ethyl-5-(5-ethyltetrahydro-5-hydroxy-6-methyl-2h-pyra but more generally known as lasalocid, which bears us nih compound identifier 3888. european medicines agency schedules lasalocid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08406mig. the term lasalocid is an international non-proprietary name or inn (see world health organization inn reference publication, volume 28, no. 10 1974, list 14). lasalocid is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule lasalocid under hs 29419000 and sitc 54139. as of q4 2014, lasalocid remains the us fda preferred term for this commodity. lasalocid bears us nlm identifiers umls id c0023082 and nci concept code c79131. smiles: o1c(cc(c1c(cc)c(=o)c(c(o)c(ccc1c(c(o)c(cc1)c)c(=o)o)c)c)c)(c1oc(c(o)(cc1)cc)c)cc.. "
"antibacterial alcohols. this classification denotes antibacterials composed of alkyl compounds containing a hydroxyl group, substances called alcohols. lasalocid a. this classification denotes an antibiotic with the molecular formula c34h54o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w7v2zz2fwb, chemically known as 2,3-cresotic acid, 6-(7-(5-ethyl-5-(5-ethyltetrahydro-5-hydroxy-6-methyl-2h-pyra but more generally known as lasalocid, which bears us nih compound identifier 3888. european medicines agency schedules lasalocid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08406mig. the term lasalocid is an international non-proprietary name or inn (see world health organization inn reference publication, volume 28, no. 10 1974, list 14). lasalocid is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule lasalocid a under hs 29419000. smiles: cc[c@h]([c@@h]1[c@h](c[c@@](o1)(cc)[c@h]2cc[c@@]([c@@h](o2)c)(cc)o)c)c(=o)[c@@h](c)[c@h]([c@h](c)ccc3ccc(c(c3c(=o)o)o)c)o.. "
"antibacterial alcohols. this classification denotes antibacterials composed of alkyl compounds containing a hydroxyl group, substances called alcohols. lasalocid sodium. this classification denotes an antibiotic with the molecular formula c34h53o8.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w2s5c71y3g, chemically known as 2,3-cresotic acid, 6-(7-(5-ethyl-5-(5-ethyltetrahydro-5-hydroxy-6-methyl-2h-pyran-2-yl)tetrahydro-3-methyl-2-furyl)-4-hydroxy-3,5-dimethyl-6-oxononyl)-, monosodium salt. (-)- but more generally known as lasalocid sodium, which bears us nih compound identifier 33265. most nations schedule lasalocid sodium under hs 29419000. as of q4 2014, lasalocid sodium remains the us fda preferred term for this commodity. lasalocid sodium bears us nlm identifiers umls id c0878439 and nci concept code c79535. smiles: cc[c@h]([c@@h]1[c@h](c[c@@](o1)(cc)[c@h]2cc[c@@]([c@@h](o2)c)(cc)o)c)c(=o)[c@@h](c)[c@h]([c@h](c)ccc3ccc(c(c3c(=o)[o-])o)c)o.[na+].. "
"antibacterial amides. this classification denotes antibacterials composed of organic compounds containing the -co-nh2 radical (amides).. . "
"antibacterial amides. this classification denotes antibacterials composed of organic compounds containing the -co-nh2 radical (amides).. betamipron. this classification denotes an artificial sweetener with the molecular formula c10h11no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3w0m245736, chemically known as beta-alanine, n-benzoyl- but more generally known as betamipron, which bears us nih compound identifier 71651. european medicines agency schedules betamipron in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05800mig. the term betamipron is an international non-proprietary name. betamipron is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule betamipron under hs 29242995 and sitc 51479. as of q4 2014, betamipron remains the us fda preferred term for this commodity. betamipron bears us nlm identifiers umls id c0208283 and nci concept code c72565. smiles: c1=cc=c(c=c1)c(=o)nccc(=o)o.. "
"antibacterial amides. this classification denotes antibacterials composed of organic compounds containing the -co-nh2 radical (amides).. tolfamide. this classification denotes an enzyme inhibitor, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7tjt8x832u. european medicines agency schedules tolfamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11154mig. tolfamide generally arises in the molecular formula c8h12n3o2p. the term tolfamide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 35, no. 5 1981, list 21.) tolfamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix.. "
"antibacterial amidines. this classification denotes antibacterials composed of oxoacid derivatives.. . "
"antibacterial amidines. this classification denotes antibacterials composed of oxoacid derivatives.. aconiazide. this classification denotes an antitubercular agent with the molecular formula c15h13n3o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8okq9ns8mo, chemically known as 4-pyridinecarboxylic acid, ((2-(carboxymethoxy)phenyl)methylene)hydrazide but more generally known as aconiazide, which bears us nih compound identifier 5391612. european medicines agency schedules aconiazide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05246mig. the term aconiazide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). aconiazide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: o(c1c(cccc1)/c=n\\nc(=o)c1ccncc1)cc(=o)o.. "
"antibacterial amidines. this classification denotes antibacterials composed of oxoacid derivatives.. hexamidine. this classification denotes an antibiotic with the molecular formula c20h26n4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3483c2h13h, chemically known as 4,6(1h,5h)-pyrimidinedione, 5-ethyldihydro-5-phenyl- but more generally known as hexamidine, which bears us nih compound identifier 4909. european medicines agency schedules hexamidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08029mig. the term hexamidine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). the world health organization schedules hexamidine in its anatomical therapeutic chemical (atc) classification. hexamidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: o=c1ncnc(=o)c1(cc)c1ccccc1.. "
"antibacterial amidines. this classification denotes antibacterials composed of oxoacid derivatives.. hexamidine diisethionate. this classfication denotes an antibiotic with the molecular formula c20h26n4o2.2c2h6o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 023xa5z50l, chemically known as 4,4-(hexamethylenedioxy)dibenzamidine bis(2-hydroxyethanesulphonate), but more generally known as hexamidine diisethionate, which bears us nih compound identifier 3080571. european medicines agency schedules hexamidine diisethionate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08029mig. most nations, for tariff purposes, schedule hexamidine diisethionate under hs 29252900. smiles: c1cc(ccc1c(=n)n)occccccoc2ccc(cc2)c(=n)n.c(cs(=o)(=o)o)o.c(cs(=o)(=o)o)o.. "
"antibacterial amidines. this classification denotes antibacterials composed of oxoacid derivatives.. hexamine mandelate. this classification denotes a urinary anti-infective agent with the molecular formula c8h8o3.c6h12n4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 695n30cinr, chemically known as 1,3,5,7-tetraazatricyclo(3.3.1.1(3,7))decane, mono(alpha-hydroxybenzeneacetate) but more generally known as hexamine mandelate, which bears us nih compound identifier 11478. european medicines agency schedules methenamine mandelate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03216mig. most nations schedule hexamine mandelate under hs 29339990. smiles: c1ccc(cc1)c(c(=o)o)o.c1n2cn3cn1cn(c2)c3.. "
"antibacterial amidines. this classification denotes antibacterials composed of oxoacid derivatives.. hexamine or methenamine. this classification denotes a urinary anti-infective agent with the molecular formula c6h12n4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier j50oix95qv, chemically known as 1,3,5,7-tetraazatricyclo(3.3.1.1(sup 37))decane but more generally known as hexamine, which bears us nih compound identifier 4101. european medicines agency schedules methenamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08845mig. the term hexamine is an international non-proprietary name. the world health organization schedules hexamine in its anatomical therapeutic chemical (atc) classification. smiles: c1n2cn3cn1cn(c2)c3.. "
"antibacterial amidines. this classification denotes antibacterials composed of oxoacid derivatives.. opiniazide. this classification denotes an antitubercular agent with the molecular formula c16h15n3o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier kd4681n5w4, chemically known as 5,6-dimethoxyphthalaldehydic acid isonicotinoylhydrazone but more generally known as opiniazide, which bears us nih compound identifier 6871212. european medicines agency schedules opiniazide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09449mig. the term opiniazide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). opiniazide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: o(c1c(c(ccc1oc)/c=n/nc(=o)c1ccncc1)c(=o)o)c.. "
"antibacterial amines. this classification denotes antibacterials derived from ammonia by substituting organic radicals for the hydrogens, substances called amines.. . "
"antibacterial amines. this classification denotes antibacterials derived from ammonia by substituting organic radicals for the hydrogens, substances called amines.. benurestat. this classification denotes an enzyme inhibitor with the molecular formula c9h9cln2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9ra9a22z0w, chemically known as benzamide, 4-chloro-n-(2-(hydroxyamino)-2-oxoethyl)- but more generally known as benurestat, which bears us nih compound identifier 38000. european medicines agency schedules benurestat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05738mig. the term benurestat is an international non-proprietary name or inn (see world health organization inn reference publication, volume 28, no. 10 1974, list 14). benurestat is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: clc1ccc(c(=o)ncc(=o)no)cc1.. "
"antibacterial amines. this classification denotes antibacterials derived from ammonia by substituting organic radicals for the hydrogens, substances called amines.. cilastatin. this classification denotes a protease inhibitor, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 141a6amn38. european medicines agency schedules cilastatin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06264mig. cilastatin generally arises in the molecular formula c16h26n2o5s. the term cilastatin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 38, no. 6, 1984, list 24.) cilastatin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: o=c(n/c(=c\\ccc)c(=o)o)c1c(c1)(c)c.. "
"antibacterial amines. this classification denotes antibacterials derived from ammonia by substituting organic radicals for the hydrogens, substances called amines.. cilastatin sodium. this classification denotes a protease inhibitor with the molecular formula c16h24n2o5s.h+.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5428wxz74m, chemically known as 2-heptenoic acid, 7-((2-amino-2-carboxyethyl)thio)-2-(((2,2-dimethylcyclopropyl)carbonyl)amino)-, monosodium salt, (r-(r*,s*-(z)))- but more generally known as cilastatin sodium, which bears us nih compound identifier 5282480. european medicines agency schedules cilastatin sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01295mig. most nations schedule cilastatin sodium under hs 29309016. smiles:. as of q4 2014, cilastatin sodium remains the us fda preferred term for this commodity. . cilastatin sodium bears us nlm identifiers umls id c0282395 and nci concept code c65329.. "
"antibacterial amines. this classification denotes antibacterials derived from ammonia by substituting organic radicals for the hydrogens, substances called amines.. dectaflur. this classification denotes a protective agent with the molecular formula c18h37n.fh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q3b1y93c1s, chemically known as 9-octadecen-1-amine, hydrofluoride but more generally known as dectaflur, which bears us nih compound identifier 6436136. european medicines agency schedules dectaflur in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06939mig. the term dectaflur is an international non-proprietary name or inn (see world health organization inn reference publication, volume 27, no. 10 1973, list 13). dectaflur is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: ccccccccc=cccccccccn.f.. "
"antibacterial amines. this classification denotes antibacterials derived from ammonia by substituting organic radicals for the hydrogens, substances called amines.. etisomicin. this classification denotes an antibiotic with the molecular formula c20h39n5o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0bzk9fe5de, chemically known as o-3-deoxy-3-(ethylamino)-4-c-methyl-beta-l-arabinopyranosyl-(1->4)-o-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-d-glycero-hex-4-enopyranosyl-(1->6))-2-deoxy-l-streptamine. but more generally known as etisomicin, which bears us nih compound identifier 216268. european medicines agency schedules etisomicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07311mig. the term etisomicin is an international non-proprietary name. etisomicin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: o(c1c(o)c(oc2oc(=ccc2n)cn)c(n)cc1n)c1occ(o)(c(ncc)c1o)c.. "
"antibacterial amines. this classification denotes antibacterials derived from ammonia by substituting organic radicals for the hydrogens, substances called amines.. hexamethylenetetramine or methenamine hippurate. this classification denotes a urinary anti-infective agent with the molecular formula c9h9no3.c6h12n4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m329791l57, chemically known as n-benzoylglycine, compound with 1,3,5,7-tetraazatricyclo(3.3.1.13,7)decane (1:1) but more generally known as methenamine hippurate, which bears us nih compound identifier 21945. european medicines agency schedules methenamine hippurate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14537mig. smiles: o=c(ncc(=o)o)c1ccccc1.n12cn3cn(cn(c3)c2)c1.. "
"antibacterial amines. this classification denotes antibacterials derived from ammonia by substituting organic radicals for the hydrogens, substances called amines.. methenamine mandelate. this classification denotes a urinary anti-infective agent with the molecular formula c8h8o3.c6h12n4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 695n30cinr, chemically known as 1,3,5,7-tetraazatricyclo(3.3.1.1(3,7))decane, mono(alpha-hydroxybenzeneacetate) but more generally known as methenamine mandelate, which bears us nih compound identifier 11478. european medicines agency schedules methenamine mandelate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03216mig. smiles: oc(c1ccccc1)c(=o)o.n12cn3cn(cn(c3)c2)c1.. "
"antibacterial amines. this classification denotes antibacterials derived from ammonia by substituting organic radicals for the hydrogens, substances called amines.. pirtenidine. this classification denotes a topical anti-infective agent with the molecular formula c21h38n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier s6on6743tm, chemically known as 1,4-dihydro-1-octyl-4-(octylimino)pyridine but more generally known as pirtenidine, which bears us nih compound identifier 65879. european medicines agency schedules pirtenidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09944mig. the term pirtenidine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 1, no. 4, 1987, list 27). pirtenidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: n1(cccccccc)cc/c(=n/cccccccc)cc1.. "
"antibacterial arsenicals. this classification denotes antibacterial compounds that bear as an integral part of their molecule arsenic or arsenic acid.. . "
"antibacterial arsenicals. this classification denotes antibacterial compounds that bear as an integral part of their molecule arsenic or arsenic acid.. dichlorophenarsine. this classification denotes an anti-infective agent with the molecular formula c6h6ascl2no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3wd5400t9n, chemically known as phenol, 2-amino-4- (dichloroarsino)-, hydrochloride but more generally known as dichlorophenarsine, which bears us nih compound identifier 68302. european medicines agency schedules dichlorophenarsine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07086mig. the term dichlorophenarsine is an international non-proprietary name. dichlorophenarsine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: [as](cl)(cl)c1cc(n)c(o)cc1.. "
"antibacterial azoles. this classification denotes antibacterials composed of five-membered rings that contain a nitrogen atom, substances called azoles.. . "
"antibacterial azoles. this classification denotes antibacterials composed of five-membered rings that contain a nitrogen atom, substances called azoles.. enoxamast. this classification denotes an anti-asthmatic agent with the molecular formula c13h10n2o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 08703r750l, chemically known as (4-(1,4-benzodioxan-6-yl)-2-thiazolyl)oxamic acid. but more generally known as enoxamast, which bears us nih compound identifier 194595. european medicines agency schedules enoxamast in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06541mig. the term enoxamast is an international non-proprietary name or inn (see world health organization inn reference publication, volume 39, no. 5, 1985, list 25). enoxamast is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s1cc(nc1nc(=o)c(=o)o)c1cc2occoc2cc1.. "
"antibacterial azoles. this classification denotes antibacterials composed of five-membered rings that contain a nitrogen atom, substances called azoles.. hexedine. this classification denotes a topical anti-infective agent with the molecular formula c22h45n3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier lre2528y9e, chemically known as 2,6-bis(2-ethylhexyl)-hexahydro-7a-methyl-1h-imidazo(1,5-c)imidazole but more generally known as hexedine, which bears us nih compound identifier 22291. european medicines agency schedules hexedine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08035mig. the term hexedine is an international non-proprietary name. hexedine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: n12c(cn(c1)cc(cccc)cc)(cn(c2)cc(cccc)cc)c.. "
"antibacterial organophosphorus compounds. this classification denotes antibacterial compounds that bear as an integral part of their molecule phosphorous.. . "
"antibacterial organophosphorus compounds. this classification denotes antibacterial compounds that bear as an integral part of their molecule phosphorous.. fosfomycin. this classification denotes a urinary anti-infective agent with the molecular formula c3h7o4p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2n81my12te, chemically known as phosphonic acid, (3-methyloxiranyl)-, disodium salt, (2r-cis)- but more generally known as fosfomycin, which bears us nih compound identifier 3417. european medicines agency schedules fosfomycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07797mig. the term fosfomycin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 33, no. 10 1979, list 19). the world health organization schedules fosfomycin in its anatomical therapeutic chemical (atc) classification. fosfomycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: p(=o)(o)(o)c1oc1c.. "
"antibacterial organophosphorus compounds. this classification denotes antibacterial compounds that bear as an integral part of their molecule phosphorous.. fosfomycin calcium. this classification denotes a urinary anti-infective agent c3h5o4p.ca, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 76eik6888n, chemically known as monocalcium (-)-(1r,2s)-(1,2-epoxypropyl)phosphonate, but more generally known as fosfomycin calcium, which bears us nih compound identifier 93095. european medicines agency schedules sub02261migin its extended eudravigilance medicinal product dictionary or xevmpd under index sub02261mig. most nations schedule fosfomycin calcium under hs 29419000 and sitc 54139. as of q4 2014, fosfomycin calcium remains the us fda preferred term for this commodity. smiles: c[c@h]1[c@h](o1)p(=o)([o-])[o-].[ca+2].. "
"antibacterial organophosphorus compounds. this classification denotes antibacterial compounds that bear as an integral part of their molecule phosphorous.. fosfomycin calcium monohydrate. this classfication denotes a urinary anti-infective agent with the molecular formula c3h5o4p.ca.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t330qg2nys, chemically known as monocalcium (-)-(1r,2s)-(1,2-epoxypropyl)phosphonate monohydrate, but more generally known as fosfomycin calcium monohydrate, which bears us nih compound identifier 11954232. european medicines agency schedules fosfomycin calcium monohydrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07797mig. most nations, for tariff purposes, schedule fosfomycin calcium monohydrate under hs 29419000. smiles: c[c@h]1[c@h](o1)p(=o)([o-])[o-].o.[ca+2].. "
"antibacterial organophosphorus compounds. this classification denotes antibacterial compounds that bear as an integral part of their molecule phosphorous.. fosfomycin disodium. this classfication denotes a urinary anti-infective agent with the molecular formula c3h5o4p.2na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 97mmo19fno, chemically known as disodium (2r,3s)-3-methyloxiran-2-ylphosphonate, but more generally known as fosfomycin disodium, which bears us nih compound identifier 3417. european medicines agency schedules fosfomycin disodium or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07797mig. most nations, for tariff purposes, schedule fosfomycin disodium under hs 29419000. smiles: c[c@h]1[c@h](o1)p(=o)([o-])[o-].[na+].[na+].. "
"antibacterial organophosphorus compounds. this classification denotes antibacterial compounds that bear as an integral part of their molecule phosphorous.. fosfomycin sodium. this classification denotes a urinary anti-infective agent with the molecular formula c3h5o4p.2na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 97mmo19fno, chemically known as phosphonic acid, (3-methyloxiranyl)-, disodium salt, (2r-cis)- but more generally known as fosfomycin sodium, which bears us nih compound identifier 3417. european medicines agency schedules fosfomycin sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02262mig. most nations schedule fosfomycin sodium under hs 29419000. as of q4 2014, fosfomycin sodium remains the us fda preferred term for this commodity. smiles: c[c@h]1[c@h](o1)p(=o)([o-])[o-].[na+].[na+].. "
"antibacterial organophosphorus compounds. this classification denotes antibacterial compounds that bear as an integral part of their molecule phosphorous.. fosfomycin trometamol. this classification denotes a urinary anti-infective agent with the molecular formula c4h11no3.c3h7o4p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7fxw6u30gy, chemically known as phosphonic acid, (3-methyloxiranyl)-, (2r-cis)-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1) but more generally known as fosfomycin trometamol, which bears us nih compound identifier 54331. european medicines agency schedules fosfomycin trometamol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02263mig. most nations schedule fosfomycin trometamol under hs 29419000. smiles: c[c@h]1[c@h](o1)p(=o)(o)o.c(c(co)(co)n)o.. "
"antibacterial organophosphorus compounds. this classification denotes antibacterial compounds that bear as an integral part of their molecule phosphorous.. fosfomycin tromethamine. this classification denotes a urinary anti-infective agent with the molecular formula c4h11no3.c3h7o4p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7fxw6u30gy, chemically known as phosphonic acid, (3-methyloxiranyl)-, (2r-cis)-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1) but more generally known as fosfomycin trometamol, which bears us nih compound identifier 54331. european medicines agency schedules fosfomycin trometamol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02263mig. most nations schedule fosfomycin tromethamine under hs 29419000. as of q4 2014, fosfomycin tromethamine remains the us fda preferred term for this commodity. fosfomycin tromethamine bears us nlm identifiers umls id c0543454 and nci concept code c47541. smiles: c[c@h]1[c@h](o1)p(=o)(o)o.c(c(co)(co)n)o.. "
"antibacterial organophosphorus compounds. this classification denotes antibacterial compounds that bear as an integral part of their molecule phosphorous.. fosmidomycin. this classification denotes an antibiotic with the molecular formula c4h10no5p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5829e3d9i9, chemically known as (3-(formylhydroxyamino)propyl)phosphonic acid, monosodium salt but more generally known as fosmidomycin, which bears us nih compound identifier 572. european medicines agency schedules fosmidomycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07802mig. the term fosmidomycin is an international non-proprietary name. fosmidomycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: p(=o)(o)(o)cccn(o)c=o.. "
"antibacterial piperazines. this classification denotes antibacterials composed of six-membered rings with two nitrogen atoms positioned opposite to one another, substances called piperazines.. . "
"antibacterial piperazines. this classification denotes antibacterials composed of six-membered rings with two nitrogen atoms positioned opposite to one another, substances called piperazines.. picloxydine. this classification denotes a topical anti-infective agent with the molecular formula c20h24cl2n10, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4yc2py3aeu, chemically known as 1,1-(1,4-piperazinediylbis(imidocarbonyl))bis(3-(p-chlorophenyl)guanidine) but more generally known as picloxydine, which bears us nih compound identifier 5748610. european medicines agency schedules picloxydine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09813mig. the term picloxydine is an international non-proprietary name. the world health organization schedules picloxydine in its anatomical therapeutic chemical (atc) classification. picloxydine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: clc1ccc(/n=c(/n=c(\\n2ccn(cc2)/c(=n\\c(=n\\c2ccc(cl)cc2)n)n)n)n)cc1.. "
"antibacterial piperazines. this classification denotes antibacterials composed of six-membered rings with two nitrogen atoms positioned opposite to one another, substances called piperazines.. picloxydine dihydrochloride. this classfication denotes a topical anti-infective agent with the molecular formula c20h24cl2n10.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier wzk4co345v, chemically known as 1,1-(1,4-piperazinediylbis(imidocarbonyl))bis(3-(p-chlorophenyl)guanidine) dihydrochloride, but more generally known as picloxydine dihydrochloride, which bears us nih compound identifier 9578346. european medicines agency schedules picloxydine dihydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09813mig. most nations, for tariff purposes, schedule picloxydine dihydrochloride under hs 29335995. smiles: c1cc(ccc1nc(=n)nc(=n)n2ccn(cc2)c(=n)nc(=n)nc3ccc(cc3)cl)cl.cl.cl.. "
"antibacterial piperidines. this classification denotes antibacterials based on the (ch2)5nh structure.. . "
"antibacterial piperidines. this classification denotes antibacterials based on the (ch2)5nh structure.. octapinol. this classification denotes an antimicrobial with the molecular formula c15h31no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4758kdh62a, chemically known as 1-piperidineethanol, 4-(2-procylpentyl)- but more generally known as octapinol, which bears us nih compound identifier 68906. european medicines agency schedules octapinol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09406mig. the term octapinol is an international non-proprietary name or inn (see world health organization inn reference publication, volume 34, no. 10 1980, list 20). octapinol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: occn1ccc(cc(ccc)ccc)cc1.. "
"antibacterial piperidines. this classification denotes antibacterials based on the (ch2)5nh structure.. pecocycline. this classification denotes an antibiotic with the molecular formula c29h35n3o10, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0cg6o25zc4, chemically known as n-((4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacene carboxamido)-methyl)nipecotic acid but more generally known as pecocycline, which bears us nih compound identifier 5745800. european medicines agency schedules pecocycline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09644mig. the term pecocycline is an international non-proprietary name. pecocycline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: oc12c(cc3c(o)(c4c(c(=c3c1=o)o)c(o)ccc4)c)c(n(c)c)c(=o)c(=c(\\o)ncn1cc(ccc1)c(=o)o)\\c2=o.. "
"antibacterial pyrans. this classification denotes antibacterials that have five carbon atoms, one oxygen atom, and two double bonds, substances also sometimes called oxines.. . "
"antibacterial pyrans. this classification denotes antibacterials that have five carbon atoms, one oxygen atom, and two double bonds, substances also sometimes called oxines.. mupirocin. this classification denotes a topical anti-infective agent with the molecular formula c26h44o9, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier d0gx863oa5, chemically known as 8-carboxyoctyl (e)-4-(2s,3r,4r,5s)-5-((2s,3s,4s,5s)-2,3-epoxy-5-hydroxy-4-methylhexyl)-3,4-dihydroxytetrahydro-2h-pyran-2-yl)-3-methylcrotonat but more generally known as mupirocin, which bears us nih compound identifier 446596. european medicines agency schedules mupirocin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09093mig. the term mupirocin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 39, no. 5, 1985, list 25). the world health organization schedules mupirocin in its anatomical therapeutic chemical (atc) classification. mupirocin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: o1c(c1c(c(o)c)c)cc1c(o)c(o)c(oc1)c/c(=c/c(=o)occccccccc(=o)o)c.. "
"antibacterial pyrans. this classification denotes antibacterials that have five carbon atoms, one oxygen atom, and two double bonds, substances also sometimes called oxines.. mupirocin calcium. this classification denotes a topical anti-infective agent with the molecular structure 2c26h43o9.ca.2h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, rg38i2p540 chemically known as (.alpha.e,2s,3r,4r,5s)-5-((2s,3s,4s,5s)-2,3-epoxy-5-hydroxy-4-methylhexyl)tetrahydro-3,4-dihydroxy-.beta.-methyl-2h-pyran-2-crotonic acid, ester with 9-hydroxynonanoic acid, calcium salt (2:1), dihydrate, but more commonly known as mupirocin calcium, which bears us nih compound identifier 5282317. european medicines agency schedules mupirocin calcium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14612mig.. "
"antibacterial pyrans. this classification denotes antibacterials that have five carbon atoms, one oxygen atom, and two double bonds, substances also sometimes called oxines.. narasin. this classification denotes an antibiotic with the molecular formula c43h72o11, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier dzy9vu539p, chemically known as 2h-pyran-2-acetic acid, alpha-ethyl-6-(5-(2-(5-ethyltetrahydro-5-hydroxy-6-methyl-2h-pyran-2-yl)-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro(4.1.5.3)pentadec-13-en-9-yl)-2-hydroxy-1,3-dimethyl-4-oxoheptyl)tetrahydro-3,5-dimethyl- but more generally known as narasin, which bears us nih compound identifier 65452. european medicines agency schedules narasin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09163mig. the term narasin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 30, no. 10 1976, list 16). narasin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: o1c(ccc21oc1(oc(c(cc1c)c)c(c(=o)c(c(o)c(c1oc(c(cc1c)c)c(cc)c(=o)o)c)c)cc)c=cc2o)(c1oc(c(o)(cc1)cc)c)c.. "
"antibacterial pyrans. this classification denotes antibacterials that have five carbon atoms, one oxygen atom, and two double bonds, substances also sometimes called oxines.. novobiocin. this classification denotes an antibiotic with the molecular formula c31h36n2o11, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 17ec19951n, chemically known as novobiocin, sodium deriv. but more generally known as novobiocin, which bears us nih compound identifier 4546. european medicines agency schedules novobiocin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09385mig. the term novobiocin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 13, no. 12, 1959, list 3). novobiocin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: o1c(c(oc)c(oc(=o)n)c(o)c1oc1c(c2oc(o)c(nc(=o)c3cc(c/c=c(/c)c)c(o)cc3)c(=o)c2cc1)c)(c)c.. "
"antibacterial pyrans. this classification denotes antibacterials that have five carbon atoms, one oxygen atom, and two double bonds, substances also sometimes called oxines.. novobiocin calcium. this classification denotes an antibiotic 2c31h35n2o11.ca, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier rhw5bu180n, chemically known as benzamide, n-(7-((3-o-(aminocarbonyl)-6-deoxy-5-c-methyl-4-o-methyl-.alpha.-l-lyxo-hexopyranosyl)oxy)-4-hydroxy-8-methyl-2-oxo-2h-1-benzopyran-3-yl)-4-hydroxy-3-(3-methyl-2-butenyl)-, calcium salt (2:1), but more generally known as novobiocin calcium, which bears us nih compound identifier 20297. most nations schedule novobiocin calcium under hs 29419000 and sitc 54139. as of q4 2014, novobiocin calcium remains the us fda preferred term for this commodity. novobiocin calcium bears us nlm identifiers umls id c0282264 and nci concept code c81448. smiles: cc1c(ccc2c1oc(=o)c(c2[o-])nc(=o)c3ccc(c(c3)cc=c(c)c)o)o[c@h]4[c@@h]([c@@h]([c@h](c(o4)(c)c)oc)oc(=o)n)o.cc1c(ccc2c1oc(=o)c(c2[o-])nc(=o)c3ccc(c(c3)cc=c(c)c)o)o[c@h]4[c@@h]([c@@h]([c@h](c(o4)(c)c)oc)oc(=o)n)o.[ca+2].. "
"antibacterial pyridines. this classification denotes antibacterials that have a benzene-like structure (c5h5n).. . "
"antibacterial pyridines. this classification denotes antibacterials that have a benzene-like structure (c5h5n).. efrotomycin. this classification denotes an antibiotic with the molecular formula c59h88n2o20, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5bpj82q45x, chemically known as mocimycin, 31-o-(6-deoxy-4-o-(6-deoxy-2,4-di-o-methyl-alpha-l-mannopyranosyl)-3-o-methyl-beta-d-allopyranosyl)-1-methyl- but more generally known as efrotomycin, which bears us nih compound identifier 6436033. european medicines agency schedules efrotomycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06472mig. the term efrotomycin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 39, no. 5, 1985, list 25). efrotomycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: o1c(o)(c(o)c(oc2oc(c(oc3oc(c(oc)c(o)c3oc)c)c(oc)c2o)c)c(c1/c=c/c=c/c)(c)c)c(cc)c(=o)nc/c=c/c=c(/c(oc)c(c1oc(c(o)c1o)/c=c/c=c/c=c(\\c)c(=o)c1c(o)n(ccc1=o)c)c)c.. "
"antibacterial pyridines. this classification denotes antibacterials that have a benzene-like structure (c5h5n).. ftivazide. this classification denotes an antitubercular agent with the molecular formula c14h13n3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 40q4c3o4v0, chemically known as isonicotinic acid, vanillylidenehydrazide but more generally known as ftivazide, which bears us nih compound identifier 5355297. european medicines agency schedules ftivazide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07821mig. the term ftivazide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). ftivazide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: o(c1=c/c(=c/nnc(=o)c2ccncc2)c=cc1=o)c.. "
"antibacterial pyrimidines. this classification denotes antibacterials composed of six-membered rings with two nitrogen atoms at positions 1 and 3, respectively.. . "
"antibacterial pyrimidines. this classification denotes antibacterials composed of six-membered rings with two nitrogen atoms at positions 1 and 3, respectively.. aditoprim. this classification denotes a dihydrofolate reductase inhibitor and anti-infective agent with the molecular formula c15h21n5o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2z81wdx2zh, chemically known as 2,4-pyrimidinediamine, 5-((4-(dimethylamino)-3,5-dimethoxyphenyl)methyl)- but more generally known as aditoprim, which bears us nih compound identifier 68755. european medicines agency schedules aditoprim in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05275mig. the term aditoprim is an international non-proprietary name or inn (see world health organization inn reference publication, volume 37, no. 6, 1983, list 23). aditoprim is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: o(c1c(n(c)c)c(oc)cc(cc2c(nc(nc2)n)n)c1)c.. "
"antibacterial pyrimidines. this classification denotes antibacterials composed of six-membered rings with two nitrogen atoms at positions 1 and 3, respectively.. brodimoprim. this classification denotes a dihydrofolate reductase inhibitor with the molecular formula c13h15brn4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier v1yc7t6lli, chemically known as 2,4-pyrimidinediamine, 5-((4-bromo-3,5-dimethoxyphenyl)methyl)- but more generally known as brodimoprim, which bears us nih compound identifier 68760. european medicines agency schedules brodimoprim in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05898mig. the term brodimoprim is an international non-proprietary name or inn (see world health organization inn reference publication, volume 35, no. 5 1981, list 21). the world health organization schedules brodimoprim in its anatomical therapeutic chemical (atc) classification. brodimoprim is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: brc1c(oc)cc(cc2c(nc(nc2)n)n)cc1oc.. "
"antibacterial pyrimidines. this classification denotes antibacterials composed of six-membered rings with two nitrogen atoms at positions 1 and 3, respectively.. iclaprim. this classification denotes an antibiotic with the molecular formula c19h22n4o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 42445huu0o, chemically known as 5-((2rs)-2-cyclopropyl-7,8-dimethoxy-2h-chromen-5-ylmethyl)pyrimidine-2,4-diamine but more generally known as iclaprim, which bears us nih compound identifier 213043. european medicines agency schedules iclaprim in its extended eudravigilance medicinal product dictionary or xevmpd under index sub32201. the term iclaprim is an international non-proprietary name or inn (see world health organization inn reference publication, volume 17, no. 4, 2003, list 50). the world health organization schedules iclaprim in its anatomical therapeutic chemical (atc) classification. smiles: o1c(c2cc2)c=cc2c1c(oc)c(oc)cc2cc1c(nc(nc1)n)n.. "
"antibacterial pyrimidines. this classification denotes antibacterials composed of six-membered rings with two nitrogen atoms at positions 1 and 3, respectively.. metioprim. this classification denotes an antibiotic with the molecular formula c14h18n4o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k29kwu39j0, chemically known as 2,4-pyrimidinediamine, 5-((3,5-dimethoxy-4-(methylthio)phenyl)methyl)- but more generally known as metioprim, which bears us nih compound identifier 68590. european medicines agency schedules metioprim in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08889mig. the term metioprim is an international non-proprietary name or inn (see world health organization inn reference publication, volume 34, no. 10 1980, list 20). metioprim is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s(c1c(oc)cc(cc2c(nc(nc2)n)n)cc1oc)c.. "
"antibacterial pyrimidines. this classification denotes antibacterials composed of six-membered rings with two nitrogen atoms at positions 1 and 3, respectively.. ormetoprim. this classification denotes a dihydrofolate reductase inhibitor with the molecular formula c14h18n4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m3efs94984, chemically known as 2,4-pyrimidinediamine, 5-((4,5-dimethoxy-2-methylphenyl)methyl)- but more generally known as ormetoprim, which bears us nih compound identifier 23418. european medicines agency schedules ormetoprim in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09463mig. the term ormetoprim is an international non-proprietary name or inn (see world health organization inn reference publication, volume 23, no. 10 1969, list 9). ormetoprim is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: o(c1cc(cc2c(nc(nc2)n)n)c(cc1oc)c)c.. "
"antibacterial pyrimidines. this classification denotes antibacterials composed of six-membered rings with two nitrogen atoms at positions 1 and 3, respectively.. talmetoprim. this classification denotes a topical anti-infective agent with the molecular formula c22h20n4o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x8w4cw0qhk, chemically known as 2-(4-amino-5-((3,4,5-trimethoxyphenyl)methyl)-2-pyrimidinyl)-1h-isoindole-1,3(2h)-dione but more generally known as talmetoprim, which bears us nih compound identifier 163307. european medicines agency schedules talmetoprim in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10809mig. the term talmetoprim is an international non-proprietary name or inn (see world health organization inn reference publication, volume 33, no. 10 1979, list 19). talmetoprim is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix.. "
"antibacterial pyrimidines. this classification denotes antibacterials composed of six-membered rings with two nitrogen atoms at positions 1 and 3, respectively.. tetroxoprim. this classification denotes a dihydrofolate reductase inhibitor with the molecular formula c16h22n4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5r6712ay0k, chemically known as 2,4-pyrimidinediamine, 5-((3,5-dimethoxy-4-(2-methoxyethoxy)phenyl)methyl)- but more generally known as tetroxoprim, which bears us nih compound identifier 65450. european medicines agency schedules tetroxoprim in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10953mig. the term tetroxoprim is an international non-proprietary name or inn (see world health organization inn reference publication, volume 29, no. 10 1975, list 15). tetroxoprim is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix.. "
"antibacterial pyrimidines. this classification denotes antibacterials composed of six-membered rings with two nitrogen atoms at positions 1 and 3, respectively.. vaneprim. this classification denotes an antibiotic with the molecular formula c23h28n4o8s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m3ekf65mhg, chemically known as ( -)-alpha-(4-amino-5-(3,4,5-trimethoxybenzyl)-2-pyrimidinylamino)-3-ethoxy-4-hydroxy-alpha-toluenesulfonsaeure but more generally known as vaneprim, which bears us nih compound identifier 216266. european medicines agency schedules vaneprim in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00021mig. the term vaneprim is an international non-proprietary name or inn (see world health organization inn reference publication, volume 37, no. 6, 1983, list 23). vaneprim is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix.. "
"quinoline antibacterials. this classification denotes antibacterials based on the molecular structure c9h7n.. . "
"quinoline antibacterials. this classification denotes antibacterials based on the molecular structure c9h7n.. chlorquinaldol. this classification denotes a topical anti-infective agent with the molecular formula c10h7cl2no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier d6vhc87lls, chemically known as 5,7-dichloro-8-quinaldinol but more generally known as chlorquinaldol, which bears us nih compound identifier 6301. european medicines agency schedules chlorquinaldol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06211mig. the term chlorquinaldol is an international non-proprietary name. the world health organization schedules chlorquinaldol in its anatomical therapeutic chemical (atc) classification. chlorquinaldol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: cc1=nc2=c(c=c1)c(=cc(=c2o)cl)cl.. "
"quinoline antibacterials. this classification denotes antibacterials based on the molecular structure c9h7n.. iclaprim mesilate or mesylate. this classification denotes an antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7u972cj5at. european medicines agency schedules iclaprim mesylate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub28993. iclaprim mesilate generally arises in the molecular formula c19h22n4o3.ch4o3s. the term iclaprim mesilate is a united states adopted name designation.. "
"quinoline antibacterials. this classification denotes antibacterials based on the molecular structure c9h7n.. nitroxoline. this classification denotes a quinolone antibiotic with the molecular formula c9h6n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier a8m33244m6, chemically known as 8-quinolinol, 5-nitro- but more generally known as nitroxoline, which bears us nih compound identifier 19910. european medicines agency schedules nitroxoline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09331mig. the term nitroxoline is an international non-proprietary name. the world health organization schedules nitroxoline in its anatomical therapeutic chemical (atc) classification. nitroxoline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: oc1c2ncccc2c([n](=o)o)cc1.. "
"quinoline antibacterials. this classification denotes antibacterials based on the molecular structure c9h7n.. proquinolate. this classification denotes an antimicrobial with the molecular formula c17h21no5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5m91328o79, chemically known as 3-quinolinecarboxylic acid, 4-hydroxy-6,7-diisopropoxy-, methyl ester but more generally known as proquinolate, which bears us nih compound identifier 15547. european medicines agency schedules proquinolate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10128mig. the term proquinolate is an international non-proprietary name or inn (see world health organization inn reference publication, volume 21 no. 12 1967, list 7). proquinolate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: o(c1c(oc(c)c)cc2[nh]cc(c(=o)c2c1)c(=o)oc)c(c)c.. "
"antibacterial quinoxalines. this classification denotes antibacterials made of benzopyrazines (benzene + pyrazine).. . "
"antibacterial quinoxalines. this classification denotes antibacterials made of benzopyrazines (benzene + pyrazine).. carbadox. this classification denotes an anti-infective agent with the molecular formula c11h10n4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m2x04r2e2y, chemically known as 3-(2-quinoxalinylmethylene)carbazic acid methyl ester n,n\u2032-dioxide but more generally known as carbadox, which bears us nih compound identifier 5353472. european medicines agency schedules carbadox in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06088mig. the term carbadox is an international non-proprietary name. carbadox is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: coc(=o)n=n/c=c/1\\c=[n+](c2=cc=cc=c2n1o)[o-].. "
"antibacterial quinoxalines. this classification denotes antibacterials made of benzopyrazines (benzene + pyrazine).. cinoquidox. this classification denotes a topical anti-infective agent with the molecular formula c13h12n4o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5743f6u086, chemically known as n-(2-cyanoethyl)-3-methyl-2-quinoxalinecarboxamide 1,4-dioxide. but more generally known as cinoquidox, which bears us nih compound identifier 193984. european medicines agency schedules cinoquidox in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06308mig. the term cinoquidox is an international non-proprietary name or inn (see world health organization inn reference publication, volume 33, no. 10 1979, list 19). cinoquidox is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: o=[n]1c(c(n(o)c2c1cccc2)c)c(=o)nccc#n.. "
"antibacterial quinoxalines. this classification denotes antibacterials made of benzopyrazines (benzene + pyrazine).. drazidox. this classification denotes an antibiotic with the molecular formula c10h10n4o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w193003xw5, chemically known as 3-methyl-2-quinoxalinecarboxylic acid hydrazide 1,4-dioxide. but more generally known as drazidox, which bears us nih compound identifier 208897. european medicines agency schedules drazidox in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06398mig. the term drazidox is an international non-proprietary name. drazidox is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: cc1=c(n(c2=cc=cc=c2n1o)o)c(=o)n=n.. "
"antibacterial quinoxalines. this classification denotes antibacterials made of benzopyrazines (benzene + pyrazine).. levcycloserine. this classification denotes an enzyme inhibitor with the molecular formula c3h6n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ak7drb7fmo, chemically known as 3-isoxazolidinone, 4-amino-, (s)- but more generally known as levcycloserine, which bears us nih compound identifier 401. european medicines agency schedules levcycloserine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08456mig. the term levcycloserine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 6, no, 3 1992, list 32). levcycloserine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: o1nc(=o)c(n)c1.. "
"antibacterial quinoxalines. this classification denotes antibacterials made of benzopyrazines (benzene + pyrazine).. mequidox. this classification denotes a topical anti-infective agent with the molecular formula c10h10n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4uv6363i81, chemically known as 3-methyl-2-quinoxalinylmethanol n(sup1),n(sup4)-dioxide but more generally known as mequidox, which bears us nih compound identifier 28143. european medicines agency schedules mequidox in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08763mig. the term mequidox is an international non-proprietary name or inn (see world health organization inn reference publication, volume 22, no. 10, 1968, list 8). mequidox is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: cc1=c([n+](=o)c2=cc=cc=c2n1[o-])co.. "
"antibacterial quinoxalines. this classification denotes antibacterials made of benzopyrazines (benzene + pyrazine).. olaquindox. this classification denotes an antimalarial agent with the molecular formula c12h13n3o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g3law9u88t, chemically known as 1,4-dihydroxy-n-(2-hydroxyethyl)-3-methyl-1.lambda.~5~,4.lambda.~5~-quinoxaline-2-carboxamide but more generally known as olaquindox, which bears us nih compound identifier 71905. european medicines agency schedules olaquindox in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09427mig. the term olaquindox is an international non-proprietary name or inn (see world health organization inn reference publication, volume 28, no. 10 1974, list 14). olaquindox is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: cc1=c([n+](=o)c2=cc=cc=c2n1[o-])c(=o)ncco.. "
"antibacterial sulfones. this classification denotes antibacterials made of organosulfur compounds consisting of a sulfonyl functional group + two carbon atoms (r-s(=o)2-r, where r represents carbon groups, or simply, carbon groups + so2), many of which treat leprosy.. . "
"antibacterial sulfones. this classification denotes antibacterials made of organosulfur compounds consisting of a sulfonyl functional group + two carbon atoms (r-s(=o)2-r, where r represents carbon groups, or simply, carbon groups + so2), many of which treat leprosy.. acedapsone. this classification denotes a sulfone anti-infective agent with the molecular formula c16h16n2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0gz72u84tn, chemically known as 4,4-sulphonyldianiline but more generally known as acedapsone, which bears us nih compound identifier 2955. european medicines agency schedules acedapsone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05201mig. the term acedapsone is an international non-proprietary name or inn (see world health organization inn reference publication, volume 24, no. 11 1970, list 10). acedapsone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s(=o)(=o)(c1ccc(n)cc1)c1ccc(n)cc1.. "
"antibacterial sulfones. this classification denotes antibacterials made of organosulfur compounds consisting of a sulfonyl functional group + two carbon atoms (r-s(=o)2-r, where r represents carbon groups, or simply, carbon groups + so2), many of which treat leprosy.. acetosulfone or sulfadiasulfone. this classification denotes a sulfone anti-infective agent with the molecular formula c14h14n3o5s2.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fq3m2y4bu3, chemically known as 4, 4-diaminodiphenylsulfone-2-n-acetylsulfonamide, but more generally known as acetosulfone, which bears us nih compound identifier 31400. european medicines agency schedules sulfadiasulfone sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04621mig. the term sulfadiasulfone is an international non-proprietary name or inn (see world health organization inn reference publication, volume 16, no. 3 1962, list 4). smiles: s(=o)(=o)(c1c(s(=o)(=o)nc(=o)c)cc(n)cc1)c1ccc(n)cc1.. "
"antibacterial sulfones. this classification denotes antibacterials made of organosulfur compounds consisting of a sulfonyl functional group + two carbon atoms (r-s(=o)2-r, where r represents carbon groups, or simply, carbon groups + so2), many of which treat leprosy.. chaulmosulfone. this classification denotes a topical anti-infective agent with the molecular formula c48h76n2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1s50w1wu8t, chemically known as 4,4-sulfonylbis-(cyclopentanetridecananilide). but more generally known as chaulmosulfone, which bears us nih compound identifier 193966. european medicines agency schedules chaulmosulfone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07462mig. the term chaulmosulfone is an international non-proprietary name or inn (see world health organization inn reference publication, volume 16, no. 3 1962, list 4). chaulmosulfone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s(=o)(=o)(c1cc(cc1)ccccccccccccc(=o)nc1ccccc1)c1cc(cc1)ccccccccccccc(=o)nc1ccccc1.. "
"antibacterial sulfones. this classification denotes antibacterials made of organosulfur compounds consisting of a sulfonyl functional group + two carbon atoms (r-s(=o)2-r, where r represents carbon groups, or simply, carbon groups + so2), many of which treat leprosy.. dapsone. this classification denotes a sulfone anti-infective agent with the molecular formula c12h12n2o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8w5c518302, chemically known as 4,4-sulphonyldianiline but more generally known as dapsone, which bears us nih compound identifier 2955. european medicines agency schedules dapsone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06909mig. the term dapsone is an international non-proprietary name. the world health organization schedules dapsone in its anatomical therapeutic chemical (atc) classification. smiles: c1=cc(=cc=c1n)s(=o)(=o)c2=cc=c(c=c2)n.. "
"antibacterial sulfones. this classification denotes antibacterials made of organosulfur compounds consisting of a sulfonyl functional group + two carbon atoms (r-s(=o)2-r, where r represents carbon groups, or simply, carbon groups + so2), many of which treat leprosy.. diathymosulfone. this classification denotes a sulfone anti-infective agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier uk27rq38ix. european medicines agency schedules diathymosulfone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07067mig. diathymosulfone generally arises in the molecular formula c32h34n4o4s. the term diathymosulfone is an international non-proprietary name or inn (see world health organization inn reference publication, volume 16, no. 3 1962, list 4.) diathymosulfone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s(=o)(=o)(c1ccc(n/n=c2/c=c(c(c)c)c(=o)c=c2c)cc1)c1ccc(n/n=c2\\c=c(c(c)c)c(=o)c=c2c)cc1.. "
"antibacterial sulfones. this classification denotes antibacterials made of organosulfur compounds consisting of a sulfonyl functional group + two carbon atoms (r-s(=o)2-r, where r represents carbon groups, or simply, carbon groups + so2), many of which treat leprosy.. glucosulfone. this classification denotes a sulfone anti-infective agent with the molecular formula c24h34n2o18s3.2na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier i6rln7d44f, chemically known as sodium glucosulfone, injection but more generally known as glucosulfone, which bears us nih compound identifier 3481. european medicines agency schedules glucosulfone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07939mig. the term glucosulfone is an international non-proprietary name. glucosulfone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s(=o)(=o)(o)c(nc1ccc(s(=o)(=o)c2ccc(nc(s(=o)(=o)o)c(o)c(o)c(o)c(o)co)cc2)cc1)c(o)c(o)c(o)c(o)co.. "
"antibacterial sulfones. this classification denotes antibacterials made of organosulfur compounds consisting of a sulfonyl functional group + two carbon atoms (r-s(=o)2-r, where r represents carbon groups, or simply, carbon groups + so2), many of which treat leprosy.. glucosulfone sodium. this classification denotes a sulfone anti-infective agent with the molecular formula c24h34n2o18s3.2na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier i6rln7d44f, chemically known as sodium glucosulfone, injection but more generally known as glucosulfone, which bears us nih compound identifier 3481. european medicines agency schedules glucosulfone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07939mig. the term glucosulfone is an international non-proprietary name. glucosulfone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule glucosulfone sodium under hs 29309085. as of q4 2014, glucosulfone sodium remains the us fda preferred term for this commodity. glucosulfone sodium bears us nlm identifiers umls id c0301338 and nci concept code c87219. smiles: c1cc(ccc1nc([c@@h]([c@h]([c@@h]([c@@h](co)o)o)o)o)s(=o)(=o)[o-])s(=o)(=o)c2ccc(cc2)nc([c@@h]([c@h]([c@@h]([c@@h](co)o)o)o)o)s(=o)(=o)[o-].[na+].[na+].. "
"antibacterial sulfones. this classification denotes antibacterials made of organosulfur compounds consisting of a sulfonyl functional group + two carbon atoms (r-s(=o)2-r, where r represents carbon groups, or simply, carbon groups + so2), many of which treat leprosy.. solasulfone. this classification denotes a sulfonamide anti-infective agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h12je4313s. european medicines agency schedules solasulfone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10575mig. solasulfone generally arises in the molecular formula c30h28n2na4o14s5. the term solasulfone is an international non-proprietary name or inn. solasulfone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s(=o)(=o)(o)c(cc(s(=o)(=o)o)nc1ccc(s(=o)(=o)c2ccc(nc(s(=o)(=o)o)cc(s(=o)(=o)o)c3ccccc3)cc2)cc1)c1ccccc1.[na].[na].[na].[na].. "
"antibacterial sulfones. this classification denotes antibacterials made of organosulfur compounds consisting of a sulfonyl functional group + two carbon atoms (r-s(=o)2-r, where r represents carbon groups, or simply, carbon groups + so2), many of which treat leprosy.. antibacterial ureas. this classification denotes antibacterials made of carbamide, or co(nh2)2.. "
"antibacterial sulfones. this classification denotes antibacterials made of organosulfur compounds consisting of a sulfonyl functional group + two carbon atoms (r-s(=o)2-r, where r represents carbon groups, or simply, carbon groups + so2), many of which treat leprosy.. dicloralurea. this classification denotes an industrial aid with the molecular formula c5h6cl6n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9j3zb93fie, chemically known as 1,3-bis(2,2,2-trichloro-1-hydroxyethyl)urea but more generally known as dicloralurea, which bears us nih compound identifier 8313. european medicines agency schedules dicloralurea in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07098mig. the term dicloralurea is an international non-proprietary name or inn (see world health organization inn reference publication, volume 28, no. 10 1974, list 14). dicloralurea is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: clc(cl)(cl)c(o)nc(=o)nc(o)c(cl)(cl)cl.. "
"antibacterial sulfones. this classification denotes antibacterials made of organosulfur compounds consisting of a sulfonyl functional group + two carbon atoms (r-s(=o)2-r, where r represents carbon groups, or simply, carbon groups + so2), many of which treat leprosy.. etocarlide. this classification denotes an antitubercular agent with the molecular formula c17h20n2o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 46v3v5eqam, chemically known as 4,4-diethoxythiocarbanilide but more generally known as etocarlide, which bears us nih compound identifier 667483. european medicines agency schedules etocarlide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07314mig. the term etocarlide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 26, no. 10 1972, list 12). etocarlide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s=c(nc1ccc(occ)cc1)nc1ccc(occ)cc1.. "
